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Abstract 
Human Streptococcus suis infection is an emerging zoonotic disease in 
Southeast Asian countries. It can seriously threaten human heath causing both 
outbreaks with high morbidity and mortality and endemic disease. It can also have a 
major negative impact on the economically important pig industry across the region.  
The aims of this thesis were to understand the epidemiology of human S. suis 
infection in Viet Nam, focusing on the incidence rate, seasonality and risk factors for 
infection with S. suis. 
I conducted a prospective surveillance of central nervous system (CNS) 
infections in twelve provinces of Viet Nam including the Central, the Highlands and 
the south of the country.  I was able to demonstrate that S. suis was an endemic 
disease across southern Viet Nam, and responsible for 49% of adult purulent bacterial 
meningitis.  The incidence rate was 0.57 per 100,000 adult person-years (95% CI, 
0.47-0.70) and infection had a case fatality rate of 8%. S. suis meningitis tended to 
predominantly occur in the hottest months of the year in central Viet Nam, but this 
seasonal pattern was not documented in the south of the country. 
 A case control study demonstrated that occupational exposure to pigs or pork 
was a significant risk factor for S. suis infection.  I was also able to identify novel and 
important risk factors for S. suis disease among the Vietnamese population.  Eating 
fresh blood and undercooked pig products (OR1 = 2.22; 95%CI = [1.15-4.28] and OR2 
= 4.44; 95%CI = [2.15-9.15]) and exposures of people with skin injuries to pigs or 
pork (OR = 7.48; 95% CI = [1.97-28.44] and OR2 = 15.96; 95%CI = [2.97-85.72]), 
were significant risk factors. These risk factors can be addressed in health education 
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programs targeted at individuals and communities at risk, focusing on skin protection 
for those in direct contact with pigs or pork and avoiding eating fresh blood and 
undercooked pig products. In addition, we were unable to detect S. suis serotype 2 
DNA from the throat and rectal swab samples of 1523 healthy persons and non-S. suis 
infected patients, including those with  exposure to pigs and pork meat.  Hence I was 
not able to demonstrate human carriage of S. suis serotype 2 in the Vietnamese 
population. 
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Chapter 1 
Introduction 
Emerging infectious diseases, most of which are considered zoonotic in origin, 
continue to bring about a significant toll on society (Greger 2007). In a review of 
1,407 species of human pathogenic organisms, 816 (58%) were classified as zoonotic 
(Woolhouse et al. 2005). Since the beginning of the new millennium, Asian countries 
have experienced at least three outbreaks in humans related to emerging zoonotic 
pathogens. The first outbreak, which happened in 2002-2003 with over 800 deaths, 
was caused by a new virus, SARS-associated coronavirus, suspected to have 
originated in bats (Li et al. 2005). After that, human infection with influenzavirus A 
subtype H5N1, a highly pathogenic avian influenza virus, firstly appeared in the Hong 
Kong Special Administrative Region in May 1997. This virus has since spread to 
other countries in the world and has caused major outbreaks in poultry and humans 
(Ma et al. 2009). A neglected zoonotic pathogen, Streptococcus suis serotype 2, 
caused an explosive outbreak in humans in Sichuan province of China in 2005, with 
215 patients and 39 deaths. Prior to this S. suis had been reported to cause sporadic 
cases in humans in some European and Asian countries (Arends et al. 1988; Walsh et 
al. 1992; Kay et al. 1995; Yu et al. 2006). S. suis infections are recognized as a major 
problem in the swine industry worldwide, after it was first isolated from pigs in 1956 
(Arends et al. 1988; Gottschalk et al. 2007). It is not a new pathogen in humans but 
the Chinese outbreak significantly increased the awareness of this bacterium in the 
medical community because of its high morbidity and mortality. In Viet Nam, S. suis 
meningitis in humans was first reported in 1996 (Mai et al. 2008). The number of 
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human cases has increased annually and it is now the most common pathogen of acute 
adult bacterial meningitis in the south of Viet Nam (Mai et al. 2008). To date little is 
known of the epidemiology of human S. suis infection in Viet Nam, including risk 
factors, and my thesis will focus on this aspect of the infection. 
1.1 Epidemiology 
1.1.1 Streptococcus suis infection in pigs 
1.1.1.1 Prevalence of Streptococcus suis infection in pigs 
S. suis can be a pathogen or a commensal in the respiratory, alimentary and 
reproductive tracts of pigs. The prevalence of asymptomatic or symptomatic infection 
of S. suis varies among herds (Staats et al. 1997). Although the pig carrier rate can 
reach up to 100%, the incidence of disease varies over time and affects generally less 
than 5% of a herd (Clifton-Hadley et al. 1986). Pigs can carry multiple serotypes in 
their tonsils, but serotype 2 is most often related to serious disease. Outbreaks caused 
by S. suis serotype 2 occur predominantly in piglets between 4 to 12 weeks of age. 
The peak of disease happens during the weaning period (about 6 weeks of age) and 
after mixing of pigs. Pigs at any age can be affected but susceptibility generally 
decreases with age following weaning (Lamont et al. 1980; Clifton-Hadley et al. 
1984; Reams et al. 1993). There may be an association between infection with porcine 
reproductive and respiratory syndrome virus and increasing susceptibility of pigs to S. 
suis infection. However, more field research is needed to confirm this hypothesis 
(Thanawongnuwech et al. 2000; Feng et al. 2001; Xu et al. 2010). In addition to pigs, 
S. suis can be also isolated from other animals, such as ruminants, cats, dogs, deer, 
and horses and is believed to be commensal in the intestinal flora (Staats et al. 1997). 
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1.1.1.2 Transmission of Streptococcus suis among pigs 
S. suis usually colonizes the palatine tonsils, nasal cavity, alimentary and 
reproductive tract of subclinical carriers. Carriers of S. suis are nasally or orally 
infectious to other pigs. The transmission of bacteria between herds usually occurs by 
the movement of healthy carrier pigs (Marois et al. 2007). That means infection is 
more likely at weaning when they are moved, mixed and housed in crowded 
conditions. Sows are also another probable source of infection. Gilts and sows may 
harbour S. suis in their uterus or vagina and transmit the bacteria to infant piglets after 
early contact (Staats et al. 1997; Huang et al. 2005; Sriskandan et al. 2006; Marois et 
al. 2007). However, the carrier pigs are not the sole source of infection. The other 
sources may be the contamination of the environment, personnel or materials. S. suis 
serotype 2 is an important contaminant of faeces, dust and water. It can survive in 
water for 10 minutes at 60 0C and for 2 hours at 50 0C, whereas at 25 0C, the organism 
can survive for 24 hours in dust and for 8 days in faeces. Vectors of S. suis can also 
play a role in disease transmission in pigs and include houseflies and mice (Staats et 
al. 1997). 
1.1.1.3 Manifestations of disease in pigs 
In acute cases, pigs may die within hours of the onset of clinical signs but it is 
not uncommon for death to occur without apparent clinical signs. Meningitis is the 
most striking feature and often the basis of a presumptive diagnosis. Other 
manifestations of S. suis infection are arthritis, endocarditis, pneumonia, rhinitis, 
abortion and vaginitis (Windsor et al. 1975; Gottschalk et al. 2007). In the acute forms 
of the disease, the clinical signs may include fever, depression, anorexia, and 
lassitude, followed by one or more of the following: ataxia, incoordination, tremors, 
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opisthotonus, blindness, loss of hearing, paddling, paralysis, dyspnoea, convulsions, 
nystagmus, arthritis, lameness, erythema and abortion (Staats et al. 1997). 
1.1.2 Streptococcus suis infection in humans 
1.1.2.1 Streptococcus suis infection in human situation 
Streptococcus suis infection is known to occur sporadically in humans, in 
intensive pig rearing countries, without an obvious seasonal pattern (Gottschalk et al. 
2007). The first human case was reported in Denmark in 1968 (Perch et al. 1968). 
After that, this infection was also documented in other European countries, including 
30 cases in the Netherlands in a period between 1969 and 1984, 35 cases in England 
from 1975 to 1990, 7 cases in France, and 4 cases in Germany. Figure 1-1 presents the 
world map of human S. suis cases with background pig density data (Arends et al. 
1988; Walsh et al. 1992; Kay et al. 1995; Wertheim et al. 2009).  
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Figure 1-1 World map of human S. suis cases with background pig density data 
(Wertheim et al. 2009) 
 
 
In Asia, human S. suis infection had mainly been reported in Hong Kong, 
where 61 cases occurred in the period of 1981 – 1993, and in Thailand with 9 cases 
(Chau et al. 1983; Kay et al. 1995; Leelarasamee et al. 1997). However, the number of 
human cases in Asian countries reported in the medical literature sharply increased 
after the serious outbreak in Sichuan province of China in July 2005 (Hui et al. 2005; 
Wangkaew et al. 2006; Yu et al. 2006; Mai et al. 2008; Wangsomboonsiri et al. 2008; 
Wertheim et al. 2009). It is difficult to prove whether Asian human cases have truly 
increased since the year 2005. One hypothesis is that the 2005 outbreak significantly 
increased not only the interest of the scientific world in this poorly known pathogen, 
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but also the awareness of this infection in humans. As a consequence, S. suis 
diagnostics was probably improved in Asian countries (Gottschalk et al. 2010).  
While most human S. suis were reported as sporadic cases, three outbreaks in 
humans have been reported. These include the outbreak in China mentioned above, 
with 215 cases and 39 deaths, a smaller outbreak in Jiangsu provinces of China in 
1998 with 25 cases and 14 deaths, and a recent outbreak in Thailand with 49 cases 
and 3 deaths (Yu et al. 2006; Lun et al. 2007; Khadthasrima et al. 2009). 
1.1.2.2 Risk factors of Streptococcus suis infection in humans 
S. suis infection was usually described in middle-aged males, who had an 
occupational exposure to pigs or pork. The relatively high mean patient age (47-55 
years of age) as well as the high male-to-female patient ratio (which ranged from 3.5 
to 6.5) supports the notion that infection with S. suis is generally an occupational 
disease in which males predominate in the work force (Arends et al. 1988; Walsh et 
al. 1992; Kay et al. 1995; Wangkaew et al. 2006; Yu et al. 2006; Mai et al. 2008). In 
the Netherlands, the annual risk of developing S. suis meningitis among abattoir 
workers and pig breeders was estimated at 3.0 per 100,000 people; the risk was lower 
for butchers, at 1.2 per 100,000 people. This rate was 1,500 times higher than the rate 
among general population (not working in the swine industry), which was 0.002 per 
100,000 people (Arends et al. 1988). However, the risk of infection appears 
dramatically higher in Asian countries. The rates were 0.09 per 100,000 in general 
population and 32 per 100,000 in population having occupations related to pigs or 
pork in Hong Kong, China (Ma et al. 2008). Such an estimate has not been made for 
the Southeast Asia, where the pig density is high. 
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 It is hypothesized that patients may be infected through minor cuts or 
abrasions on their skin when exposed to pork or pigs (Arends et al. 1988; Walsh et al. 
1992). Handling diseased pigs certainly increases the risk of human infection. In a 
matched case-control study of risk factors for human S. suis infection during the 
outbreak in Sichuan province of China, slaughtering (OR, 11.9; 95%CI, 3.4-42.8) and 
cutting carcasses and processing sick or dead pigs (OR, 3.0; 95%CI, 1.0-8.8) were 
important independent risk factors for human infection (Yu et al. 2005). However, 
whilst occupational exposure to pigs or pork was documented in 88% of European 
patients, it was reported in less than 50% of Asian cases, suggesting the contribution 
of other behavioural or exposure related risk factors in the Asian population (Kay et 
al. 1995; Mai et al. 2008). Asian farmers often share their accommodation with pigs, 
and it is common practice for diseased animals to be slaughtered at home and 
consumed (Sriskandan et al. 2006). In addition, case series from Hong Kong and Viet 
Nam included not only a significant number of housewives, presumably infected as a 
result of contact with contaminated pork, but also other individuals who could not 
recall any exposure to pigs or pork prior to their illness (Kay et al. 1995; Mai et al. 
2008). Asian consumers prefer to buy fresh pork from wet markets, where animals are 
usually caged and killed for live preparation and its products are generally stored for 
short periods of time and are always expected to be fresh. S. suis was isolated from 
6.1% of raw pork meat from 3 of the 6 wet markets in Hong Kong (Ip et al. 2007). 
Consequently, it is hypothesized that processing or consuming uncooked or partial 
cooked pork products is also a risk factor for S. suis infection. Local delicacies, such 
as undercooked pig tonsils, intestines, uterus, and fresh pig blood, may also represent 
important sources of infection. More research is needed to elucidate this hypothesis. 
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 Skin lesions, the suspected portal of entry in human cases, were documented 
in 15-50% of S. suis infection patients (Figure 1-2) (Arends et al. 1988; Walsh et al. 
1992; Kay et al. 1995; Yu et al. 2006). Many patients had no history of skin injury at 
all, and the respiratory or oral route of infection remains a possibility. The latter 
scenario might explain why diarrhoea was one of the present symptoms documented 
in about 15% of patients (Kay et al. 1995).  
Although asymptomatic carriage of S. suis is common in healthy pigs, it is 
unknown whether human carriage is common. This status could potentially contribute 
to an increased risk of infection, and to the possibility of person-to-person 
transmission. Subclinical infection may also occur in humans. None of 16 veterinarian 
students, but 9/96 (9%) of dairy farmers, 11/107 (10%) of meat inspectors, and 15/70 
(21%) of pig farmers were seropositive to S. suis serotype 2 in a study in New 
Zealand (Robertson et al. 1989). Nasopharyngeal carriage of S. suis was studied in a 
group at high risk of infection (butchers, abattoir workers and meat processing 
employees) in Germany. Carriage rate was reported as 5.3% (7/132) of high risk 
group, compared to 0% (0/130) of a control group (Strangmann et al. 2002). These 
findings indicate that S. suis carriage does occur in individuals with prolonged and 
recurrent exposure to pigs and pork. However, the prevalence, duration and 
importance of S. suis carriage in humans are unknown. 
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Figure 1-2 Small cuts on the second digit of a butcher presenting with S. suis 
meningitis 
 
 
 
1.2 Clinical aspects of Streptococcus suis infection in humans 
In humans, the most common clinical manifestation of S. suis infection is 
purulent bacterial meningitis (Arends et al. 1988; Kay et al. 1995; Mai et al. 2008). 
The majority of patients presented with symptoms and signs of bacterial meningitis, 
including fever, headache, neck stiffness and CSF leukocytosis (Mai et al. 2008; 
Wertheim et al. 2009). A striking feature, which is indicative of S. suis infection in a 
Vietnamese middle-aged patient presenting with signs and symptoms of meningitis, is 
the presence of unilateral or bilateral hearing loss accompanied with tinnitus and 
vestibular dysfunction on or shortly after admission. Hearing loss is the most common 
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sequel of S. suis meningitis, which was reported in 50-80% of S. suis meningitis 
patients, compared to 20-30% of S. pneumoniae meningitis patients (Arends et al. 
1988; Walsh et al. 1992; Kay et al. 1995; Mai et al. 2008). Cochlear sepsis, resulting 
from passage of the organism from the subarachnoid space to the perilymph via the 
cochlear aqueduct, might be primary responsible for the hearing loss (Kay 1991). The 
mortality of S. suis meningitis ranges between 1% (1/102) in China and 7% (2/30) in 
the Netherlands (Arends et al. 1988; Kay et al. 1995; Yu et al. 2006; Mai et al. 2008)  
S. suis infection may also present with septic shock syndrome, similar to other 
encapsulated microorganisms which cause meningitis, such as Streptococcus 
pneumoniae and Neisseria meningitidis. Findings include widespread skin lesions, 
ranging from petechia or purpura to large hemorrhages with central necrosis and/or 
conjunctival hemorrhages (Figure 1-3). Necrotic fingers or toes may be present in 
very severe cases (Figure 1- 4). The mortality rate in patients presenting with septic 
shock case was over 60% while that of meningitis was less than 10% (Arends et al. 
1988; Leelarasamee et al. 1997; Yu et al. 2006; Mai et al. 2008).  The presence of 
septic shock complicating S. suis infection varies in the published literature from 
2/151 (1%) in southern Viet Nam, 6/50 (12%) in the north of Viet Nam and 61/215 
(28%) during the outbreak in the Sichuan province of China (Yu et al. 2006; Mai et al. 
2008; Wertheim et al. 2009). The reason of this difference is unknown but it may be 
explained by differences in virulence of pathogen, in bacterial load of infection, by 
different host genetic susceptibility, as well as by delay in presenting to hospital. In 
the outbreak report from China, septic shock cases met the case definition of 
streptococcal toxic shock syndrome caused by group A streptococci (GAS) 
established by the Centers for Disease Control and Prevention (CDC). However, 
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superantigens were not detected in these bacterial isolates. The exact mechanism by 
which S. suis serotype 2, a non-GAS, causes septic shock syndrome is yet to be 
determined (Stevens 1995; Tang et al. 2006).  
Other less common clinical manifestations of S. suis infection are endocarditis, 
arthritis, spondylodiscitis, cellulitis, pneumonia, peritonitis, and endophthalmitis 
(Walsh et al. 1992; Vilaichone et al. 2000; Wangkaew et al. 2006). In a series of 41 
cases from Chiang Mai University Hospital, infective endocarditis accounted for 39% 
(16/41) of patients. Onset of illness in 12 patients was longer than 1 week. Only 3 
patients had underlying heart diseases and no patient was an intravenous drug user 
(Wangkaew et al. 2006). A striking feature of the case series in UK was high 
incidence of arthritis, which was reported in 10 of 20 patients having available clinical 
details. Arthritis was usually suppurative and affected hips, knees, elbows and spine. 
Pus cells were found in joint fluids but there was only one report of successful 
isolation of S. suis from a human joint aspirate (Walsh et al. 1992).  
  
34
Figure 1-3 Hemorrhagic rashes in a septic shock syndrome patient with S.suis 
 
Figure 1-4 Necrotic toes in a septic shock syndrome patient with S.suis. 
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1.3 Microbiological aspects of Streptococcus suis 
1.3.1 Lancefield group and serotypes of Streptococcus suis 
Streptococcus suis is a Gram-positive facultative anaerobe, whose 
composition of the capsule defines 35 serotypes (Higgins et al. 1995). Initially, it was 
ascribed to Lancefield groups R, S, RS and T by de Moor (de Moor 1963). After that, 
researchers discovered that lipoteichoic acid extracted from cell wall of S. suis, 
reacted with group D antiserum (Elliott et al. 1977) and de Moor probably worked 
with antigens extracted from the capsular material rather than from the cell wall 
(Gottschalk et al. 2007). Lancefield groups S, R, RS and T were then reclassified as 
capsular types 1, 2, 1/2 and 15, respectively, according to immunological specificity 
of capsular polysaccharides (Elliott et al. 1978; Gottschalk et al. 1989). Some 
laboratories used the results of multi-test, such as API Strep system test (BioMérieux, 
France), to differentiate S. suis serotypes 1 and 2 based on biochemical properties, 
erroneously, since these tests only differentiate biotypes (e.g. I and II in API Strep). 
Serotyping is still an important part of the routine diagnostic procedure (Gottschalk 
2004). Though S. suis cell wall antigen shares epitopes with Lancefield group D, 
negative reactions are often observed with some strains and it is not closely related 
genetically to other members of this group, such as enterococci (Chau et al. 1983; 
Tarradas et al. 2001; Gottschalk et al. 2007). Recently, analysis of the sequences of 
16S rRNA and cpn60 genes of 35 serotypes of S. suis found that serotypes 32 and 34 
may present a distinct species, Streptococcus orisratti (Brousseau et al. 2001; Hill et 
al. 2005). Though other serotypes, such as serotype 1, 4, 14 and 16, were sporadically 
reported in human cases, serotype 2 is the most common serotype causing invasive 
diseases in human as well as in pigs. For example, 150/151 S. suis meningitis cases in 
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the Vietnamese case-series study and the largest human outbreak were caused by this 
serotype. According to a recent report from Thailand, 12/177 (6.8%) of human 
isolates of S. suis were belonged to serotype 14, which may be the second most 
common serotype in Southeast Asian countries (Kopic et al. 2002; Yu et al. 2006; Mai 
et al. 2008; Nghia et al. 2008; Kerdsin et al. 2009). 
1.3.2 Identification of Streptococcus suis 
Until March 2009, over 750 human cases of S. suis infection were reported in 
the medical literature mainly from Asian and European countries (Wertheim et al. 
2009). However, this number is likely to represent an underestimate because the 
bacteria are often only diagnosed as Gram positive cocci and not further typed or 
misidentified as Streptococcus pneumoniae, α-haemolytic or viridans streptococci, 
Enterococcus faecalis, group D enterococci and Streptococcus bovis (Arends et al. 
1988; Kay et al. 1995).  
S. suis colonies, which are small, greyish or transparent, and slightly mucoid, 
are α-haemolytic on sheep blood agar plates and are β-haemolytic on horse blood 
agar (Staats et al. 1997). Four tests are used for a presumptive identification of S. suis 
in a laboratory: no growth in 6.5% NaCl agar, a negative Voges-Proskauer (VP) test, 
and production of acid in trehalose and salicin broths. However, biochemical 
characteristics are so variable that identification is often difficult and may require a 
combination of biochemical reactions followed by confirmational serotyping. For 
instance, S. suis was originally considered negative for mannitol fermentation. 
However, over 70% of serotype 17, 19 and 21 tested positive (Higgins et al. 1990). 
Serotyping based on polysaccharides capsular antigens uses one or more of the 
following techniques: a slide agglutination test, a capsular reaction, a capillary 
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precipitation or a co-agglutination test (Staats et al. 1997). As a rule of thumb, 
microbiological laboratories should consider S. suis if optochin-resistant streptococci 
are cultured from a CSF sample obtained from a patient with meningitis (Wertheim et 
al. 2009). Many laboratories propose the use of multi-tests in identification of S. suis, 
such as API Strep System test (BioMérieux, France), the BBL Crystal Gram-positive 
ID kit (Becton-Dickinson, NJ, USA), the Vitek GPI Card (BioMérieux) and the 
Phoenix System PID (Becton-Dickinson) but some S. suis strains can be misidentified 
when using these commercial kits (Gottschalk et al. 2010). 
1.3.3 Antimicrobial susceptibility of Streptococcus suis 
Streptococcus suis strains isolated from pigs were still susceptible to 
penicillin, ampicillin, third generation cephalosporin drugs but highly resistant to 
tetracycline before the year 2000 (Table 1-1). The increased use antimicrobial drugs 
in the swine industry have led to a decrease in the antibiotic susceptibility of 
Streptococcus suis isolates. In a survey on clinically healthy sows at nine different 
regions in China, proportions of penicillin-, ampicillin- and ceftiofur-resistance S. suis 
isolates were 9.5 % (40/421), 4% (17/421) and 22.1% (93/421), respectively (Zhang 
et al. 2008). Similarly, in another study in northern Thailand, 27% (14/52) strains 
resistant to penicillin G, 23% (13/52) strains resistant to ampicillin and 0% (0/52) 
strain resistant to ceftiofur were reported (Lakkitjaroen et al. 2011). However, 
differences in antimicrobial susceptibility of S. suis isolates from country to country 
may reflect true regional difference but may also, to some extent, be the result of 
methodological variations (Han et al. 2001). For example, by disk diffusion method 
using Mueller-Hinton Agar II supplemented with sheep blood, 39% (53/135) of S. 
suis strains showed intermediate susceptibility of penicillin (inhibition zone diameter 
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<29 mm) while these strain were completely susceptible to penicillin G by 
microdilution method (Marie et al. 2002). In addition, the breakpoints used to define 
susceptible and resistance ranges may vary between studies. Hence, the results from 
northern Thailand should be cautiously interpreted because the authors used the disk 
diffusion method. 
 The decreased antimicrobial susceptibility of S. suis strains isolated from pigs 
raises a considerable concern about human infection with resistant strains, especially 
strains resistant to β-lactam class of antimicrobials. All of reported strains isolated 
from humans were completely susceptible to penicillin G, ceftriaxone and 
vancomycin, except one strain from a Thai patient with peritonitis, which had an MIC 
to penicillin G greater than 32 μg/ml. We also did not document any S. suis strain 
isolated from CSF samples of 175 Vietnamese meningitis patients which was resistant 
to these antibiotics (Vilaichone et al. 2002; Wangkaew et al. 2006; Mai et al. 2008; 
Wertheim et al. 2009; Hoa et al. 2011). However, monitoring of antimicrobial 
susceptibility should be done regularly for timely detection of resistance trends of S. 
suis in the context of increased antibiotic resistance of this pathogen in the pig 
population. 
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Table 1-1 Antimicrobial susceptibility of Streptococcus suis strains isolated from pigs 
Antimicrobial 
agents 
Minimal inhibitory concentration (MIC) values (μg/ml) 
USA1 
(n=50) 
European countries2 
1987 – 1997 
(n=384) 
Japan3 
1987 – 1996 
(n=689) 
China4 
2005 – 2007  
(n=421) 
Range MIC906 Range MIC906 (%R)5 Range MIC906 (%R)5 MIC506 MIC906 (%R)5 
Ceftiofur ≤0.03 – 1.0 0.13 0.03 – 0.13 0.03 (0.0) NA NA 0.24 8 (22.1) 
Penicillin NA NA 0.13 – 2.0 0.13 (0.0) 0.0125 – 25 0.2 (0.9) 0.12 2 (9.5) 
Ampicillin ≤0.03 – 8.0 0.06 NA NA 0.0125 – 25 0.1 (0.6) 0.12 2 (4.0) 
Tetracycline 0.5 – >32.0 >32.0 0.13 – >64.0 64.0 (75.0) 0.1 - >100.0 50 (86.9) >8 >8 (91.7) 
Enrofloxacin ≤ 0.03 – 0.5 0.5 0.06 – 1.0 0.5 (0.0) NA NA 1 4 (32.8) 
Chloramphenicol NA NA 0.5 – 4.0 2.0 (0.0) NA NA 4 64 (19.9) 
Spectinomycin 4.0 – >128.0 32.0 2.0 – >128.0 16.0 (3.6) NA NA NA NA 
Trimethoprim- 
Sulfamethoxazol 
≤0.015 – 0.25 0.13 0.06 – 16.0 2.0 (16.0) <0.025 – 3.12 1.57 (0) 16/304 >16/304 (59.1) 
1 (Salmon et al. 1995) 
2 (Wisselink et al. 2006) 
3 (Kataoka et al. 2000) 
4 (Zhang et al. 2008) 
5 Proportion of resistant strains 
6 MIC 50 or MIC90 means the growth of 50% or 90% strains, 
respectively, tested was inhibited at this drug concentration.
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1.3.4 Virulence of Streptococcus suis 
Apart from Canada where prevalence of S. suis serotype 2 strains isolated 
from diseased pigs was less than 25%, most of the pathogenic strains in European and 
Asian countries belonged to serotype 2 (Higgins et al. 2001). Human infection with S. 
suis has been rarely reported in North America, where diseased pigs are commonly 
documented. Up to 2010, there were only 3 cases in United States and 3 cases in 
Canada (Trottier et al. 1991; Willenburg et al. 2006; Lee et al. 2008; Fittipaldi et al. 
2009; Haleis et al. 2009). However, serological studies suggest that infection may be 
underreported in the USA (Smith et al. 2008). Taking together, serotype 2 strains may 
have high virulence and plays an important role in human infection with S. suis. It 
may be hypothesized that Euroasian and North American serotype 2 strains possess a 
different virulence potential (Gottschalk et al. 2000).  
Most studies on the virulence of S. suis have focused on serotype 2 strains. A 
series of potential virulence factors have been identified, including the capsular 
polysaccharide, extracellular protein factor, muramidase-released protein, suilysin, 
several adhesins, hyaluronate lyase, surface antigen one (Sao) (Vecht et al. 1991; 
Jacobs et al. 1994; Smith et al. 1999; Allen et al. 2004; Li et al. 2006; Gottschalk et al. 
2007; Esgleas et al. 2008; Zhang et al. 2009). With exception of the capsular 
polysaccharide, none of these were shown to be essential for virulence in animal 
models of infection. For example, phenotype MRP+ EF+ was presented in 77% 
(86/111) strains isolated from diseased pigs in a European country while phenotype 
MRP- EF- was reported in 77% (44/57) strains isolated from diseased pigs in Canada 
(Vecht et al. 1991; Gottschalk et al. 1998). In the case series from Viet Nam, 92/92 
(100%) of S. suis strains isolated from meningitis patients were sly positive. Other 
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virulence factors, such as epf, epf*, and MRP production, were present in 50% 
(46/92), 50% (46/92) and 70% (64/92) of strains, respectively. Infection with a strain 
carrying the epf gene was independently associated with severe deafness at discharge 
(p=0.045) (Mai et al. 2008) 
Two Chinese outbreak isolates were fully sequenced, and a proposed 
pathogenicity island, which may have been involved in the particular clinical 
manifestations observed during the outbreak in 2005, was identified (Chen et al. 
2007). Further bioinformatics analysis revealed a unique two-component signal 
transduction system that may be essential for full virulence of the highly invasive 
Chinese strains (Li et al. 2008). A Chinese outbreak strain was also sequenced along 
with a Vietnamese strain isolated from a human patient, not related to any outbreak, 
and a European reference strain isolated from a pig. Strains were shown to be highly 
similar and the Chinese and Vietnamese strain shared many of the genes on the 
pathogenicity island (Holden et al. 2009). More research is clearly needed to elucidate 
the bacterial factors that confer virulence in strains of S. suis. 
1.4 Treatment of Streptococcus suis infection 
1.4.1 Antimicrobial treatment 
Although most S. suis strains isolated from humans were sensitive to penicillin 
G, ampicillin, third-genenation cephalosporin (either ceftriaxone or cefotaxime) and 
vancomycin (Section 1.1.3), empirical antimicrobial therapy of community acquired 
meningitis should include third-generation cephalosporin with or without vancomycin 
to cover penicillin-resistant pneumococci. Reasons for this are the nonspecific 
manifestations of S. suis meningitis and the high antibiotic resistance of S. 
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pneumoniae in Asia. The prevalence of nonsusceptible S. pneumoniae strains in Asia, 
which were isolated from clinical specimens of patients with community-acquired 
pneumococcal diseases, such as blood, CSF, lower respiratory tract specimens, sinus 
and middle ear aspirates, exceeds 50% and MIC90 of penicillin of these strains was 
2.36 μg/ml (Song et al. 2004; Nudelman et al. 2009). Penicillin G or ampicillin can be 
used in the treatment of S. suis infection after results of culture and antimicrobial 
susceptibility have become available. Duration of antibiotic treatment varied from 2 to 
4 weeks according to clinical manifestations (Arends et al. 1988; Kay et al. 1995; 
Vilaichone et al. 2002; Wangkaew et al. 2006; Mai et al. 2008). 
1.4.2 Adjunctive dexamethasone in bacterial meningitis treatment 
In a randomized, double-blind, placebo-controlled clinical trial in Viet Nam, 
dexamethasone (0.4mg/kg twice daily for 4 days) resulted in a significant reduction in 
the risk of death at 1 month (relative risk, 0.43; 95%CI, 0.02-0.94) and in the risk of 
death and disability at 6 months (OR, 0.56; 95%CI, 0.32-0.98) in patients with 
confirmed bacterial meningitis. In the group of S. suis meningitis patients, 20/53 
(38%) of patients receiving placebo were deaf in at least 1 ear, compared to 7/57 
(12%) of patients given dexamethasone (RR, 0.33; 95%CI, 0.15-0.71) (Nguyen et al. 
2007). In a multivariate analysis, severe hearing loss was associated with older age 
(>50 years of age), infection with a strain carrying the epf gene and in those not 
receiving steroid treatment (Mai et al. 2008)  Dexamethasone is now given to all 
adults patients with acute bacterial meningitis in Viet Nam. 
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1.5 Prevention 
1.5.1 Vaccine 
A lot of trials of vaccines in pigs were conducted using inactivated bacteria, 
live avirulent strain or some virulence factors, such as purified capsular 
polysaccharides, suilysin, muramidase-released protein, extracellular factor and 
surface antigen one  (Elliott et al. 1980; Holt et al. 1990; Jacobs et al. 1996; Busque et 
al. 1997; Wisselink et al. 2001; Li et al. 2007). However, there are no effective 
vaccines available for swine because the adaptive (humoral) immune response against 
S. suis is low (data from mice and pigs). The reasons for this are unknown and require 
further research (Gottschalk et al. 2010). No vaccine is in development for humans. 
1.5.2 Other preventive measures 
Though S. suis can survive in the environment, it is rapidly inactivated by 
disinfectants and cleansers, commonly used in farms and laboratories (Clifton-Hadley 
et al. 1984). Several previous studies have shown that S. suis infection in human 
might be related to occupational exposure to pigs or pork (Arends et al. 1988; Walsh 
et al. 1992; Kay et al. 1995). Individuals in close occupational contact with pigs or 
pork should pay special attention to protective measures, such as wearing gloves and 
boots and to disinfect themselves, for example hand washing with disinfectants, 
before leaving. Individuals who have had a splenectomy should be excluded from the 
meat trade or pig farms because of the high morbidity and mortality rate reported in 
these patients following infection with capsulated bacteria including S. suis 
(Gallagher 2001). However, occupational exposure to pigs or pork was reported in 
less than 50% of Asian patients while eating habit related to raw or undercooked pork 
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and fresh blood is a local custom in these countries (Kay et al. 1995; Mai et al. 2008; 
Khadthasrima et al. 2009). Hence, the medical authorities of these countries 
recommend people avoid slaughtering and eating meat from diseased pigs. We need 
more epidemiological studies on the risk factors in Asian countries for effective 
prevention of S. suis infection in humans. 
1.6 Epidemiological studies on Streptococcus suis infection in Viet Nam 
The first case series of 151 Vietnamese S. suis meningitis cases admitted to a 
referral hospital for infectious diseases in the south of Viet Nam from 1996 to 2005, 
was published in 2008. A striking feature of this report was that S. suis was identified 
as the most common pathogen of acute adult bacterial meningitis, and accounted for 
approximately 34% (151/450) of meningitis cases (Figure 1-5) (Mai et al. 2008). 
Recently, another case-series from a referral hospital for infectious diseases in the 
north of Viet Nam revealed that 50/57 (88%) confirmed adult bacterial meningitis 
cases were caused by S. suis while S. pneumoniae was only isolated from 3 patients 
(Wertheim et al. 2009). It is difficult to conclude from these data that S. suis infection 
is really an endemic disease across Viet Nam because these tertiary hospitals received 
patients with severe central nervous sytem (CNS) infection referred from provincial 
hospitals. Therefore, additional studies on the aetiology of Central Nervous System 
(CNS) infection in other provinces of Viet Nam are needed to confirm the true extent 
of endemicity of human S. suis in the country.  
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Figure 1-5 Annual proportion of adult patients admitted to HTD (a referral 
hospital for infectious diseases)  with S. suis meningitis1 (Mai et al. 2008) 
 
1 S. suis meningitis (gray); other bacterial causes of acute adult meningitis (black); 
and unconfirmed bacterial meningitis (dashed) 
There are also no data on disease incidence in pigs or on the most common 
serotypes causing disease in pigs in Viet Nam. In a survey of S. suis carriage in 
healthy slaughterhouse pigs in six southern provinces of Viet Nam and the Ho Chi 
Minh City metropolitan area, 41% (222/542) of pigs carried S. suis of one or multiple 
serotypes. Approximately 8% (45/542) of healthy pigs carried S. suis serotype 2, 
which was the most common serotype reported (Hoa et al. 2011).  
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1.7 Summary 
After carefully reviewing medical literature on Streptococcus suis infection in 
humans, I had the following comments: 
1. S. suis can seriously threaten human health causing both outbreaks with high 
morbidity and mortality and endemic disease in humans in certain 
geographical regions. 
2. The number of human cases reported in medical literature has sharply 
increased in Asian countries, especially in the Southeast Asia. S. suis serotype 
2 was documented as one of the most common pathogens of purulent bacterial 
meningitis in Hong Kong and Viet Nam. However, this pathogen was only 
reported at two referral hospitals for infectious diseases in Ha Noi and Ho Chi 
Minh City. More research was needed in rural provinces to investigate 
whether S. suis infection are endemic across Viet Nam. 
3. Information related to the epidemiological characteristics of S. suis infection 
in Viet Nam is scarce. What is the population at risk in Viet Nam? What is the 
incidence rate of S. suis infection in Viet Nam? How does the incidence rate 
vary according to pig density or age groups?  
4. Recently, reports from China and Thailand showed that S. suis strains isolated 
from pigs had reduced susceptibility to penicillin G and third-generation 
cephalosporin (ceftiofur). Are these antimicrobial resistance patterns present 
in S. suis strains isolated from humans in Viet Nam? 
5. From case series in Viet Nam as well as in other Asian countries, occupational 
exposure to pigs or pork, the main risk factor in Western countries, was 
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reported in less than 50% of patients. Are culinary habits or close proximity of 
pigs within households important risk factors in the Vietnamese patients? 
6. Although asymptomatic carriage of S. suis is common in healthy pigs, it is 
unknown whether human carriage is common. This status could potentially 
contribute to an increased risk of infection, and to the possibility of person-to-
person transmission. 
1.8 Focus, Aims and Structures of the Thesis: 
This thesis examines human Streptococcus suis serotype 2 infection in Viet 
Nam, and aims to address the following questions: 
1. Is Streptococcus suis serotype 2 infection really a human endemic disease in 
Viet Nam? 
2. What are the epidemiological characteristics of human Streptococcus suis 
serotype 2 infection in Viet Nam? With a focus on seasonal patterns of 
infection, incidence rate of disease and antimicrobial susceptibility of bacterial 
strains isolated from humans. 
3. What are the important risk factors for human Streptococcus suis serotype 2 
infection in Viet Nam? 
4. Is there human carriage of Streptococcus suis serotype 2 in the respiratory and 
alimentary tracts? 
I designed two studies to address the research questions presented above. The 
first study was a prospective descriptive surveillance study of central nervous system 
infections in central and southern Vietnam (designated 01SS). The results of this 
study are described in Chapter 3 and Chapter 4.  The second study was a case-control 
study to identify risk factors of S. suis infection in patients presenting with S. suis 
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meningitis and to investigate whether there is human carriage of S. suis (designated 
EN study). This study is described in Chapter 5 and Chapter 6. The setting and 
methods used for these studies are described in Chapter 2. 
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Chapter 2 
Materials and Methods 
2.1 Introduction 
This chapter describes the research setting, including geographical regions, 
population structure, health service and study hospitals. The general clinical research 
and laboratory methods are also described. 
2.2 Setting 
2.2.1 Geography of Viet Nam 
Viet Nam is located on the Indochinese peninsula in Southeast Asia, between 
North latitudes 8027’ and 23023’ and between East longitudes 1020 and 1100. It is 
bordered by China to the north, Laos to the northwest, Cambodia to the southwest and 
the “Biển Đông” (East Sea) to the east. Its area is approximately 331,051.4 km2. Viet 
Nam, which lies in the tropical zone, has 2 major climate regions. Northern Viet Nam 
(north of Hai Van Mountain) has a climate with four distinguishable seasons, spring, 
summer, autumn and winter. Southern Viet Nam (southward from Hai Van Mountain) 
has a rather moderate tropical climate with a dry and a rainy season. Viet Nam is 
administratively divided into 58 provinces and 5 centrally-administered cities, 
including Ha Noi, Hai Phong, Da Nang, Ho Chi Minh and Can Tho, which belong to 
6 social-economic regions: Red river delta (Ha Noi, Vinh Phuc, Bac Ninh, Quang 
Ninh, Hai Duong, Hai Phong, Hung Yen, Thai Binh, Ha Nam, Nam Dinh and Ninh 
Binh); Northern Midlands and Mountain areas (Ha Giang, Cao Bang, Bac Kan, Tuyen 
Quang, Lao Cai, Yen Bai, Thai Nguyen, Lang Son, Bac Giang, Phu Tho, Dien Bien, 
  
50
Lai Chau, Son La and Hoa Binh); North Central and Central Coast areas (Thanh Hoa, 
Nghe An, Ha Tinh, Quang Binh, Quang Tri, Thua Thien – Hue, Da Nang, Quang 
Nam, Quang Ngai, Binh Dinh, Phu Yen, Khanh Hoa, Ninh Thuan and Binh Thuan); 
Central Highlands (Kon Tum, Gia Lai, Dak Lak, Dak Nong and Lam Dong); South 
East (Binh Phuoc, Tay Ninh, Binh Duong, Dong Nai, Ba Ria – Vung Tau and Ho Chi 
Minh City) and Mekong river delta (Long An, Tien Giang, Ben Tre, Tra Vinh, Vinh 
Long, Dong Thap, An Giang, Kien Giang, Can Tho, Hau Giang, Soc Trang, Bac Lieu 
and Ca Mau) (GSO 2010). Figure 2-1 shows the administrative map of Viet Nam 
(Source: Cartographic Publishing House, Vietnam). 
2.2.2 Population and ethnicity 
According to the result of the Viet Nam population and housing census, the 
Vietnamese population was 85,846,997 inhabitants in April 2009. Viet Nam is a 
multi-ethnic country with 54 ethnic groups, among which the Kinh ethnic group 
accounts for 86% of population. Most of the other ethnic groups live in the Northern 
Midlands and Mountain areas and the Central Highlands, in which they account for 
55% and 35% of population, respectively. The Khmer ethnic group mainly live in the 
Mekong river delta (CP&HCSC 2010).  
2.2.3 Health care system 
The health care system of Viet Nam has been established at four levels, 
including commune, district, provincial and national levels. There are well developed 
and reasonably efficient referral patterns from commune health centre to district 
hospital, then to provincial hospital and finally to central hospital (national referral 
hospital). The commune health centre is the first place providing health care services 
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in the community, such as primary health care, first aid, immunizations, family 
planning, and detection and reporting of outbreaks to the higher level. 
There were 1002 hospitals, 682 regional polyclinics and 10979 commune 
health centres with 27.1 beds and 6 physicians per 10,000 population, according to the 
Statistical Yearbook of Viet Nam 2009 and World Health Statistics 2010 (GSO 2010; 
WHO 2010). Total annual expenditure on health was 76 USD per capita and 
accounted for 7.3% of the Gross Domestic Product (GDP) in 2008. Life expectancy at 
birth was 73 years and neonatal, infant and under-five mortality rates were 9, 12 and 
14 per 1,000 live births (WHO 2010).  
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Figure 2-1 Administrative map of Viet Nam 
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2.2.4 Hospital for Tropical Diseases 
The Hospital for Tropical Diseases (HTD) in Ho Chi Minh City, previously 
called Cho Quan hospital, is a tertiary referral hospital for infectious diseases in the 
south of Viet Nam. It has 550 beds, 14 clinical wards and a laboratory centre for 
haematology, biochemistry, microbiology, virology, parasitology and mycology. This 
hospital has a catchment population of 40,000,000 people and receives approximately 
35,000 inpatients every year. The Viet-Anh ward, which has 17 beds with a dedicated 
5 beds intensive care unit, receives all patients with central nervous system (CNS) 
infections and severe malaria patients, except those with known HIV/AIDS.  
2.2.5 Oxford University Clinical Research Unit Viet Nam 
The Oxford University Clinical Research Unit Viet Nam (OUCRU-VN) was 
established at the Hospital for Tropical Diseases (HTD) in 1991 in a collaboration 
between Oxford University and this hospital and supported by the Wellcome Trust. Its 
clinical and scientific research programme focuses on the most significant infectious 
diseases in Viet Nam, such as dengue infection, malaria, tuberculosis, enteric, CNS 
infection and animal health and zoonoses. OUCRU-VN has developed strong links 
not only with HTD, but also with other hospitals in Ho Chi Minh City, Ha Noi and 
other regions in Viet Nam.  
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2.3 Methods 
2.3.1 A prospective descriptive surveillance study of CNS infections (01SS study) 
2.3.1.1 Study design and setting 
This study was designed as a prospective hospital-based descriptive 
surveillance study to describe the aetiology and epidemiology of CNS infections in 
southern and central Vietnam. The majority of patients with central nervous system 
infections are admitted to provincial hospitals, which functions as the tertiary referral 
hospital in each province, because it is a serious and life-threatening disease. A 
lumbar puncture procedure is rarely done at a district hospital. Hence, I decided to 
recruit patients at provincial hospitals (see Figure 2-2). I selected provinces at a 
distance of at least 150 km from Ho Chi Minh City (HCMC) to determine incidence 
rates for provinces, since patients from provinces close to HCMC may be admitted 
directly to the hospitals in this city, potentially resulting in underestimation of 
provincial incidence rates. In the Mekong river delta, I chose 7 provincial hospitals 
(Dong Thap, An Giang, Kien Giang, Soc Trang, Bac Lieu, Ca Mau, Tra Vinh), 1 
central hospital (Can Tho) and 1 district hospital (Sa Dec). Can Tho Central hospital, 
the biggest hospital in the Mekong river delta, is the tertiary referral hospital of Can 
Tho city. Sa Dec, the former administrative center of Dong Thap province before 
1994, is the second city of this province. A substantial number of patients who live in 
districts at the south bank of Tien river usually attend to Sa Dec district hospital. 
Therefore, Sa Dec district hospital was also included, in addition to Dong Thap 
provincial hospital. I also chose Binh Phuoc provincial hospital in the South East, Dak 
Lak provincial hospital in the Central Highlands, Khanh Hoa provincial hospital in 
  
55
the Central coastal areas and Hue Central hospital in the North Central of Viet Nam. I 
designated the Central coastal areas and North Central of Viet Nam as Central Viet 
Nam. 
The average population and age structure of the population of these 12 
provinces are presented in Table 2-1 and Table 2-2 (GSO 2009; CP&HCSC 2010; 
GSO 2010).  
Table 2-1 Average population of surveillance provinces in two years 2008-2009 
Province Average population (× 105 inhabitants) 
2008 2009 
Ca Mau 12.017 12.070 
Bac Lieu 8.475 8.584 
Soc Trang 12.851 12.932 
Can Tho 11.809 11.896 
Tra Vinh 10.008 10.044 
Dong Thap 16.625 16.677 
An Giang 21.426 21.492 
Kien Giang 16.723 16.879 
Binh Phuoc 8.580 8.775 
Dak Lak 17.151 17.331 
Khanh Hoa 11.493 11.597 
Thua Thien – Hue 10.849 10.887 
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Table 2-2 Population of surveillance provinces by age group in April 2009 
Province Population (× 105 inhabitants), n (%) Total 
 < 5  5-14 15-29 30-44 45-59 ≥ 60  
Ca Mau 0.96033 (7.96) 2.08880 (17.31) 3.77247 (31.26) 2.69800 (22.35) 1.73719 (14.39) 0.81259 (6.73) 12.06938 (100.00) 
Bac Lieu 0.61349 (7.16) 1.41374 (16.51) 2.78211 (32.48) 1.89115 (22.08) 1.25600 (14.66) 0.60869 (7.11) 8.56518 (100.00) 
Soc Trang 1.01367 (7.84) 2.15830 (16.69) 3.90859 (30.23) 2.94606 (22.79) 1.92498 (14.89) 0.97693 (7.56) 12.92853 (100.00) 
Can Tho 0.88719 (7.47) 1.69437 (14.26) 3.65884 (30.79) 2.92971 (24.65) 1.79244 (15.08) 0.92180 (7.76) 11.88435 (100.00) 
Tra Vinh 0.75551 (7.53) 1.56831 (15.64) 3.01903 (30.10) 2.29511 (22.88) 1.57996 (15.75) 0.81220 (8.10) 10.03012 (100.00) 
Dong Thap 1.30388 (7.82) 2.71592 (16.30) 4.73338 (28.40) 4.07945 (24.48) 2.45731 (14.75) 1.37473 (8.25) 16.66467 (100.00) 
An Giang 1.73988 (8.12) 3.46653 (16.18) 6.25032 (29.42) 5.27347 (24.82) 2.91764 (13.73) 1.77925 (8.37) 21.24709 (100.00) 
Kien Giang 1.36284 (8.07) 2.96728 (17.58) 5.28025 (31.28) 3.90191 (23.11) 2.23246 (13.22) 1.13774 (6.74) 16.88248 (100.00) 
Binh Phuoc 0.84521 (9.68) 1.70434 (19.51) 2.57899 (29.52) 1.98298 (22.70) 1.14401 (13.09) 0.48045 (5.50) 8.73598 (100.00) 
Dak Lak 1.59609 (9.21) 3.83971 (22.15) 5.01705 (28.94) 3.76013 (21.69) 2.12665 (12.27) 0.99661 (5.75) 17.33624 (100.00) 
Khanh Hoa 0.93743 (8.10) 2.05549 (17.76) 3.21538 (27.78) 2.83449 (24.48) 1.58783 (13.72) 0.94542 (8.17) 11.57604 (100.00) 
Thua Thien - Hue 0.85206 (7.83) 2.14076 (19.69) 2.99984 (27.59) 2.27876 (20.95) 1.48647 (13.67) 1.11631 (10.27) 10.87420 (100.00) 
Total 12.86758 (8.09) 27.81355 (17.50) 47.21625 (29.70) 36.87122 (23.19) 22.24294 (13.99) 11.96272 (7.52) 158.97426 (100.00) 
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Figure 2-2 Locations of study sites (red dots) 
 
(Source of map: http://www.learnnc.org/lp/multimedia/3311) 
East Sea 
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The study started at 10 provincial hospitals, 2 central hospitals and 1 district 
hospital in succession from August 2007 to April 2010.  The time frames for 
calculation of incidence rates of CNS infection for each of the provinces were chosen 
in one year period or in two years period according to period of recruitment (see 
Table 2-3).  
Table 2-3 Periods of recruitment and time frames for calculation of incidence 
rates of CNS infections 
Hospital Participants Period of recruitment Time frame for 
calculating incident rate 
Ca Mau Adults Aug 2007 – Mar 2009 Feb 2008 – Jan 2009 
Children Feb 2008 – Mar 2009 
Bac Lieu1 Adults Aug 2007 – Mar 2009 Feb 2008 – Jan 2009 
Children Feb 2008 – Aug 2008 
Soc Trang Adults Aug 2007 – Apr 2010 Feb 2008 – Jan 2010 
Children Feb 2008 – Apr 2010 
Can Tho Adults Sep 2009 – Aug 2010 Sep 2009 – Aug 2010 
Children - 
Tra Vinh Adults Feb 2008 – Mar 2009 Feb 2008 – Jan 2009 
Children Feb 2008 – Mar 2009 
Dong Thap Adults Dec 2007 – Mar 2010  
 
Feb 2008 – Jan 2009 
Children Dec 2007 – Mar 2010 
Sa Dec Adults Jan 2008 – Mar 2009 
Children Jan 2008 – Mar 2009 
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An Giang Adults Mar 2008 – Mar 2010 Mar 2008 – Feb 2010 
Children Mar 2008 – Mar 2010 
Kien Giang Adults Dec 2007 – Mar 2010 Mar 2008 – Feb 2010 
Children Feb 2008 – Mar 2010 
Binh Phuoc Adults Jan 2008 – Mar 2009 Mar 2008 – Feb 2009 
Children Jan 2008 – Mar 2009 
Dak Lak Adults Dec 2007 – Apr 2010 Jan 2008 – Dec 2009 
Children Dec 2007 – Apr 2010 
Khanh Hoa Adults Oct 2007 – Apr 2010 Jan 2008 – Dec 2009 
Children Oct 2007 – Apr 2010 
Hue Adults Mar 2008 – Apr 2010 Apr 2008 – Mar 2010 
Children Mar 2008 – Apr 2010 
1 Incidence rates were only calculated for adult patients because the period of 
recruitment in children group was less than 1 year.  
2.3.1.2 Inclusion and exclusion criteria 
2.3.1.2.1 Inclusion criteria 
Patients who satisfied the clinical criteria of suspected central nervous system 
infection were included if they: 
- were at least one month of age. 
- had fever ≥ 38 0C axillary. 
- had at least one of the following symptoms: headache, neck stiffness, 
altered consciousness, focal neurology signs. 
-  had a cerebrospinal fluid (CSF) sample taken. 
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2.3.1.2.2 Exclusion criteria 
Patients were excluded if they did not provide written informed consent. 
2.3.1.3 Recruitment 
During the period of surveillance, all patients who fulfilled the inclusion 
criteria were included in the study. Informed consent was obtained or proxy consent 
from a relative was obtained for a patient with GCS score <15 or a patient under 15 
year-old on admission. The attending physician examined the patient and filled in a 
standardized data form. Data forms included general demographics, base line data, 
past medical history of underlying diseases, pig exposures, clinical manifestations, 
laboratory findings, treatment and outcome. 
2.3.1.4 Sample collection 
Four millilitres of CSF were taken from each patient. Three millilitres CSF 
were sent to the hospital laboratory for cell count, biochemistry measurements and 
microbiology investigations according to standard care. One millilitre was stored in a 
freezer at – 200C on the ward or in the microbiology laboratory, and these CSF 
samples were transferred to HTD every two months on dry ice for further 
investigations, including 200μl for diagnostic PCR (bacteria and virus), 100μl for JE 
and Dengue serology, 200μl for “pathogen discovery” and 500μl stored in a freezer at 
– 800C. In addition, all the bacterial isolates from CSF and blood cultures were also 
sent to HTD to confirm bacterial identification and antimicrobial susceptibility. 
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2.3.1.5 Definitions 
2.3.1.5.1 Adults and children 
Patients were assigned as adults if they were older than or equal to 15 years of 
age on the day of admission. If they were less than 15 years of age, they were 
assigned as children. 
2.3.1.5.2 Case definitions of clinical syndromes 
Clinical syndromes were defined in accordance with WHO case definitions of 
bacterial meningitis and Japanese encephalitis, and using a consensus case definition 
of tuberculous meningitis (WHO 2003; Marais et al. 2010), as described below. 
2.3.1.5.2.1 Unsuspected (No) CNS infection 
A patient was considered not to have a CNS infection in the presence of 
- Normal CSF parameters AND 
- No pathogen confirmed AND 
- Discharge diagnosis of patient was stroke, epilepsy, mental disorders, 
drug/alcohol toxicity, hepatic encephalopathy, or sepsis, or benign 
febrile convulsion in children. 
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2.3.1.5.2.2 Bacterial meningitis 
2.3.1.5.2.2.1 Laboratory-confirmed bacterial meningitis 
Bacterial meningitis was considered laboratory-confirmed in the presence of at 
least one of the following criteria: 
- Laboratory confirmation of bacterial infection by culture, Gram stain 
or real-time PCR methods of CSF. 
- Positive bacterial blood culture and clinical syndrome consistent with 
bacterial meningitis (see below). 
2.3.1.5.2.2.2 Probable bacterial meningitis 
Probable bacterial meningitis was defined as the presence of the following 
criteria: 
- Sudden onset of fever (>380C) (less than 7 days) 
- AND at least one of the following signs: 
o Meningeal signs (neck stiffness, Kernig sign and Brudzinski sign) 
o Altered consciousness 
- AND CSF examination showing at least one of the following: 
o Leukocytosis (≥ 10 cells/μl) AND at least 2 of the following 
criteria(*): 
  an elevated protein (> 1g/l)  
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 decreased glucose (<2.2 mmol/l or less than 50% of blood 
glucose)  
  lactate ≥ 4 mmol/l 
o Turbid appearance (when WC is missing or WC < 10/μl) 
- AND no aetiologic agent was identified 
(*) If lactate concentration was not available, a patient was diagnosed as BM 
when having at least one of the remaining criteria. 
2.3.1.5.2.3 Viral encephalitis/meningitis 
2.3.1.5.2.3.1 Laboratory-confirmed viral encephalitis/meningitis 
Viral meningitis was considered laboratory confirmed in the presence of the 
following criteria: 
o Laboratory confirmation by real-time PCR (enterovirus and Herpes 
simplex) or MAC ELISA (Japanese Encephalitis virus) on CSF. 
o A case was classified as probable Japanese encephalitis (JE) if a 
patient had the following criteria: 
 Fulfilled the case definition of probable viral 
encephalitis/meningitis (see below) 
 JEV specific IgM titre in CSF was in the range from 8-12 U  
 No other pathogen detected. 
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o A case was classified as Dengue encephalitis/meningitis, if Dengue 
virus specific IgM titre in CSF was higher than 12 U. 
o A case was classified as possible Dengue encephalitis/meningitis if 
patient had the following criteria: 
 Fulfilled case definition of probable viral encephalitis/ 
meningitis (see below) 
 Dengue virus specific IgM titre in CSF was in the range from 
8-12 U  
 No other pathogen detected. 
2.3.1.5.2.3.2 Probable viral encephalitis/meningitis 
Probable viral encephalitis or meningitis was defined according to the 
following criteria: 
- Acute onset of fever (less than 7 days) 
- AND at least one of the following: 
o Meningeal signs (neck stiffness, Kernig sign, and Brudzinski sign) 
o Change in mental status (confusion, disorientation, coma or 
inability to talk) 
o New onset of seizures (excluding simple febrile seizures) 
- AND CSF examination showing at least one of the following: 
o Leukocytosis (≥10 cells/μl) AND at least 2 of these criteria 
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 protein ≤ 1g/l  
 normal glucose (≥ 2.2 mmol/l or ≥ 50% of blood glucose) 
 lactate < 4 mmol/l (*) 
o Clear appearance (when WC is missing or WC < 10/μl) 
- AND no aetiologic agent was identified 
(*) If lactate concentration was not available, a patient was diagnosed as viral 
encephalitis/meningitis when having the two remaining criteria. 
2.3.1.5.2.4 Tuberculous meningitis 
2.3.1.5.2.4.1 Laboratory-confirmed tuberculous meningitis 
Laboratory confirmation by positive smear (acid-fast bacilli, AFB) or real-
time PCR of CSF 
2.3.1.5.2.4.2 Probable and possible tuberculous meningitis: 
Probable and possible tuberculous meningitis were defined using the 
diagnostic criteria for classification of probable and possible tuberculous meningitis 
(Marais et al. 2010). The classification is depicted below (Table 2-4). 
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Table 2-4 Diagnostic score of probable and possible tuberculous meningitis 
 Diagnostic score 
Clinical criteria (Maximum 
category score=6) 
- Symptom duration of more than 5 days 4 
- Systemic symptoms suggestive of tuberculosis (one or more 
of the following): weight loss (or poor weight gain in 
children), night sweats, or persistent cough for more than 2 
weeks 
2 
- History of recent (within past year) close contact with an 
individual with pulmonary tuberculosis or a positive 
tuberculin skin test (TST) or interferon-gamma release assay 
(IGRA) (only in children <10 years of age) 
2 
- Focal neurological deficit (excluding cranial nerve palsies) 1 
- Cranial nerve palsy 1 
- Altered consciousness 1 
CSF criteria (Maximum 
category score=4) 
- Clear appearance 1 
- Cells: 10-500 per μl 1 
- Lymphocytic predominance (>50%) 1 
- Protein concentration greater than 1g/L 1 
- CSF to plasma glucose ratio of less than 50% or an absolute 
CSF glucose less than 2.2 mmol/L 
1 
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Cerebral imaging criteria (Maximum 
category score=6) 
- Hydrocephalus 1 
- Basal meningeal enhancement 2 
- Tuberculoma 2 
- Infarct 1 
- Pre-contrast basal hyperdensity 2 
Evidence of tuberculosis elsewhere (Maximum 
category score=4) 
- Chest radiograph suggestive of active tuberculosis: signs of 
tuberculosis= 2; miliary tuberculosis= 4 
2/4 
- CT/ MRI/ ultrasound evidence for tuberculosis outside the 
CNS 
2 
- AFB identified or Mycobacterium tuberculosis cultured from 
another source, such as sputum, lymph node, gastric 
washing, urine, blood culture 
4 
- Positive commercial M. tuberculosis nucleic acid 
amplification test (NAAT) from extra-neural specimen 
4 
 
Probable tuberculous meningitis: 
- Total diagnostic score of 10 or more points (when cerebral imaging is 
not available) or 12 or more points (when cerebral imaging is 
available) 
- At least 2 points should either come from CSF or cerebral imaging 
criteria. 
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Possible tuberculous meningitis: 
- Total diagnostic score of 6-9 points (when cerebral imaging is not 
available) or 6-11 points (when cerebral imaging is available) 
- Possible tuberculosis cannot be diagnosed or excluded without doing a 
lumbar puncture or cerebral imaging. 
2.3.1.5.2.5 Cryptococcal meningitis 
An India ink stain of CSF positive with yeasts, or Cryptococcus neoformans 
isolated from CSF. 
2.3.1.5.2.6 Eosinophilic meningitis 
2.3.1.5.2.6.1 Confirmed eosinophilic meningitis 
Eosinophilic meningitis was diagnosed in patients with meningitis and a 
percentage of eosinophils in CSF greater than 10% (Lo Re et al. 2003)  
2.3.1.5.2.6.2 Probable eosinophilic meningitis 
Probable eosinophilic meningitis was diagnosed if: 
the percentage of eosinophilic cells in blood > 10%,  
AND meningitis manifestations  
AND no pathogen confirmed in CSF by culture, PCR or ELISA method. 
2.3.1.5.3 Outcome of CNS infection 
Outcomes of CNS infection, such as alive, death, transfer, and unknown 
outcome, at the day of discharge, was based on discharge data recorded by the 
attending physician at the provincial hospital. 
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2.3.1.6 Classification of central nervous system infection cases 
We used the case definitions described to classify CNS infection cases in the 
following 4 steps. 
- Step 1: Apply criteria of laboratory-confirmed bacterial meningitis and viral 
encephalitis/meningitis. 
- Step 2: Exclude unsuspected CNS infection cases according to the criteria for 
unsuspected CNS infection. 
- Step 3: Apply the consensus case definition of tuberculous meningitis (TBM) 
on the cases with CNS infection with unconfirmed pathogen. 
• In the group of patients with TBM score <6 points, we applied the case 
definition of probable bacterial meningitis (BM) and viral 
encephalitis/meningitis to classify cases as BM or viral 
encephalitis/meningitis. 
• In the group of patients with TBM score ≥6 points (possible TBM 
according to the diagnostic algorithm), we assigned a case as TBM if 
the patient was treated with anti-tuberculous drugs, died, was 
transferred to another hospital, or had an unknown outcome. If these 
patients recovered without TB treatment, we applied the case definition 
of probable bacterial meningitis (BM) and viral encephalitis/meningitis 
to classify a case as BM or viral encephalitis/meningitis. 
- Step 4: Mycobacterium tuberculosis real-time PCR was done on all CSF 
samples of probable and possible TBM cases, i.e. all patients with TBM score 
≥6 points assigned as TBM, to confirm the diagnosis. 
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2.3.1.7 HIV status 
In Viet Nam, HIV test is not routinely done in all CNS infection patients. 
Patients are tested for HIV according to the decision of the attending physician 
relying on their risk of infection, such as intravenous drug abusers, sexual workers or 
unprotected sexual exposures.  Patients are also tested HIV when they have 
cryptococcal or tuberculous meningitis. 
2.3.1.8 Sample size 
All patients who met the inclusion criteria and who were admitted to the 
participating provincial hospitals during the period of surveillance were recruited into 
the study (Table 2-3).  
2.3.1.9 Statistical methods 
All variables of interest were summarized by group (adult or children). 
Categorical variables were summarized as number and percent (%). Continuous 
variables were summarized as median and interquartile range (IQR). Baseline 
variables were compared between adult and children groups and between groups with 
bacterial and viral CNS infection, using Chi-square test or Fisher’s exact test (when 
one or more of the expected count is less than 5) for categorical variables and 
Wilcoxon rank sum test for continuous variables. Logistic regression was used to 
assess univariate association of the pathogen of interest with age. In the analysis of 
aetiology of CNS infection, I excluded unsuspected CNS infection cases (see Section 
2.3.1.4.2.1). I also excluded dual infection cases when analyzing pathogens of 
bacterial meningitis or viral encephalitis/meningitis separately. Seasonality of 
admission numbers of children and adults with CNS infections as well as that of S. 
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suis meningitis cases was assessed using Poisson regression models, which modelled 
the monthly admission counts depending on a hospital effect, a global linear trend and 
a sinusoidal shape for the seasonality effect (modelled with a sine- and a cosine-term, 
i.e. a cosinor model) (Barnett et al. 2010). The log-number of days per month was 
used as an offset in the model to correct for unequal lengths of the month. For testing 
seasonality I tested whether the sine- and the cosine-term could jointly be omitted 
from the model using a likelihood ratio test. Incidence rates of CNS infection were 
calculated according to patient’s residence in one year of surveillance (Ca Mau, Bac 
Lieu, Can Tho, Tra Vinh, Dong Thap and Binh Phuoc) or in two years of surveillance 
(An Giang, Kien Giang, Soc Trang, Dak Lak, Khanh Hoa and Thua Thien – Hue). In 
Can Tho and Bac Lieu, I only calculated the incidence rate in adult population 
because we only recruited adult patients in Can Tho and the recruitment of paediatric 
patients in Bac Lieu only lasted 7 months. Average population of a year was 
calculated with assumption that the population changed regularly (GSO 2009; 
CP&HCSC 2010; GSO 2010). 
 
  : Average population 
S1: Population at the beginning of year 
S2: Population at the end of year.  
I used data related to age group population of the Vietnam population and house 
census in April 2009 to estimate the person-time of observation of adult and children 
population (Table 2-2). The 95% confidence intervals of incidence rates were 
calculated as exact Poisson confidence intervals. Incidence rate in a 
province/region/age group was compared with other province/region/age group by 
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Poisson regression. The association between the number of S. suis cases and the pig 
density was tested with Poisson regression with the number of person years of follow-
up in each province included as an offset. I used quasi-likelihood to adjust for over-
dispersion. All analyses were performed with Stata version 10.1 (StataCorp) and R 
version 2.11.1 software. 
2.3.1.10 Ethical approval 
This study was approved by the Scientific and Ethics Committee of each study 
site (provincial hospitals), the Hospital for Tropical Diseases and the University of 
Oxford Tropical Research Ethics Committee (OXTREC 01-08). 
2.3.2 A Case-control study to identify risk factors for Streptococcus suis infection 
in Vietnam (EN study) 
2.3.2.1 Study design and setting 
This study was designed as a case-control study, including one group of 
patients with invasive S. suis infection and two control groups: an unmatched hospital 
control group and a community control group, matched by residency and age. The 
ratio between cases and each control group was 1:3. The study was conducted at the 
Hospital for Tropical Diseases (HTD) between May 2006 and June 2009. The 
recruitment of cases and hospital control groups took place at the dedicated Central 
Nervous System (CNS) infectious disease ward (Viet-Anh ward) at HTD. Community 
controls were recruited according to the residency of the cases in the south of Viet 
Nam, mainly in Ho Chi Minh City and the provinces of the Mekong River Delta. 
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2.3.2.2 Inclusion and exclusion criteria 
2.3.2.2.1 Inclusion criteria 
Inclusion criteria are presented in Table 2-5. 
Table 2-5 Inclusion criteria of EN study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cases: 
- At least 15 year-old 
- Streptococcus suis meningitis or sepsis confirmed 
by blood culture or CSF culture or CSF real-time 
PCR positive 
- Admitted to CNS disease ward of HTD 
Hospital controls: 
- At least 15 year-old 
- Confirmed bacterial meningitis (not S. suis), 
eosinophilic meningitis, cryptococcal meningitis, 
viral encephalitis/meningitis or malaria (confirmed 
by blood smear) 
- Admitted to CNS disease ward of HTD 
Community controls: 
- Living in the same commune as case for at least 4 
weeks until inclusion of case 
- Age matched with case (10 years range) 
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2.3.2.2.2 Exclusion criteria 
Exclusion criteria are presented in Table 2-6. 
Table 2-6 Exclusion criteria of EN study 
 
 
 
 
 
 
 
 
 
 
 
2.3.2.3 Recruitment 
All consecutive patients admitted with signs and symptoms consistent with 
CNS infectious diseases, who met the inclusion criteria for case or hospital control, 
were recruited to the study (Table 2-5 and Table 2-6). If the patients fulfilled the 
inclusion criteria for a case or for a hospital control, informed consent was obtained. 
After inclusion of a patient as a case, the next three consecutive patients admitted to 
the ward who met the inclusion criteria were included as hospital controls. Three 
community controls, matched for age (within a 10 year age range), were randomly 
identified from a list of households available at the health centre in the community of 
- Did not provide informed consent. 
- Recent history of bacterial meningitis (< 1 year 
before admission). 
- Did not regain full consciousness (GCS 15) within 
14 days after admission. 
- Transferred to other hospitals shortly after 
admission (less than 7 days) 
- HIV positive. 
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residence of the case, by using random number tables. We contacted with health 
workers at these centres, where the cases lived, to enroll community controls. 
Household members were identified either at the HTD, when taking care of a case or 
hospital control, or during the household visits. A maximum of three adult household 
members of each case and control were recruited to study if they agreed to take part in 
it. 
2.3.2.4 CSF sample collection 
As part of the standard clinical assessment on admission, a cerebrospinal fluid 
(CSF) sample was directly taken from each patient suspected of CNS infection at the 
Viet-Anh ward of the Hospital for Tropical Diseases (HTD). Three millilitres CSF 
was sent to the hospital laboratory for cell count, biochemistry measurements and 
microbiology investigations. One millilitre was stored in a freezer at – 200C and was 
separately sent to the molecular diagnostic laboratory on the next day for diagnostic 
PCR for detection of S. suis serotype 2, S. pneumoniae, H. influenzae type b and N. 
meningitidis.  
2.3.2.5 Collecting throat and rectal swab samples/stool samples of cases, controls 
and their household members 
 All patients admitted to the Viet-Anh ward of the HTD had a throat and 
rectum swab taken on admission, to detect carriage of S. suis. Fourteen days after 
admission or at discharge, a second throat and rectum sample were taken from 
patients recruited in the study. In a previous study on human S. suis meningitis at 
HTD, over 60% of patients received antimicrobial treatment prior to admission (Mai 
et al. 2008). As detection of potential carriage in cases and hospital controls could be 
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affected by their antimicrobial treatment, household members were also studied for 
carriage of S. suis serotype 2 since if carriage and associated transmission were to 
occur, household members of carriers are the most likely to become positive. 
Individuals were fully informed about the nature of the study prior to being asked for 
written informed consent. The neighbourhood controls and a maximum of three adult 
household members of each case and control included were invited to submit a throat 
sample and rectal swab or stool sample (whichever the individual preferred) for 
detection of carriage of S. suis serotype 2, at patient’s admission or the first visit to the 
household and at 10 – 16 days after (Figure 2-3 and 2-4). We recorded sex, age, and 
occupation of household members 
2.3.2.6 Definitions of potential risk factors under investigation 
2.3.2.6.1 Occupational exposures: at least one of the following occupations 
- Butcher 
- Pig breeder 
- Slaughterer 
- Meat transporter 
- Meat processing 
- Veterinarian  
- Cook 
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2.3.2.6.2 Contact with pigs/pork: at least one of the following contacts or activities 
- Bathe pigs 
- Feed pigs 
- Clean up the piggery 
- Slaughter pigs 
- Prepare or handle blood, organs from pigs 
- Visit a pig farm in the last 2 weeks 
2.3.2.6.3 “High risk” dishes 
- Pig/duck fresh blood 
- Pig tonsils/tongue 
- Pig stomach/intestines 
- Pigs uterus 
- Under-cooked pig blood 
2.3.2.6.4 Skin injuries 
Patients were checked by nurses and doctors for skin injuries on forearms, 
hands and feet. Injuries were defined as lesions with signs of disruption of skin 
integrity. 
2.3.2.6.5 Underlying diseases 
The presence of at least one of these conditions: alcoholism, diabetes mellitus 
and splenectomy. 
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2.3.2.6.6 Alcoholism 
A person drinking beer >1500 ml/day or wine >250 ml/day in at least 5 
days/week (Wine=SPIRIT 30-400) 
2.3.2.6.7 Household exposure to pigs 
Living in a household with any number of pigs around the house which 
belonged to the household. 
2.3.2.6.8 Household members 
An adult household member was defined as any adult (at least 15 years old) 
who resided for at least 50% of the week in the same house as the case or control. 
2.3.2.7 Assessment of risk factors 
Risk factors were assessed from data collected using a standardized 
questionnaire. This questionnaire was developed in Vietnamese and validated at HTD 
and consisted of four parts: socio-demographic and cultural factors, medical history, 
potential exposure to pigs or pork and culinary habits and hygiene measures. The 
majority of the questions were “closed questions” but “open questions” which 
allowed participants to explain in their own words were also included. Patients and 
hospital controls were interviewed when they were fully conscious. The questionnaire 
was filled in by structured interview, which was carried out by one of two research 
nurses on the ward for cases and hospital controls, or at the residency of community 
controls. The interviewers were blinded towards the diagnosis of the patient in the 
case and hospital control groups. We focused on potential risk factors identified from 
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the literature, including underlying diseases (alcoholism, diabetes mellitus and 
splenectomy), occupational exposures, pigs or pork exposures, skin lesions, and 
household exposures to pigs. In addition, we hypothesized that consumption of “high 
risk” food dishes, potentially contaminated with S. suis, could function as a source of 
infection. 
2.3.2.8 Human carriage of Streptococcus suis 
Participants were assigned as confirmed carrier if they had 2 PCR positive 
throat or rectal swab samples taken on 2 separate occasions with a minimum of 14 
days in between. Possible carriage was defined as a single PCR positive throat or 
rectum swab sample/stool sample or a positive throat and rectum sample taken on the 
same day. 
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Figure 2-3 Recruitment of cases and hospital controls 
 
 
 
 
 
 
 
 
 
 
 
1 Study nurses were unaware of case or control status of patients 
 
Fulfilled inclusion criteria 
(Cases and hospital controls) 
Informed consent 
Interview by study nurse1 when 
fully conscious (GCS=15) 
Lumbar puncture First throat & rectal swabs 
Second throat & rectal swabs 
(after 10 – 14 days) 
Microbiological laboratories 
(culture & real-time PCR) 
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Figure 2-4  Recruitment of community controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Eligible households were defined as households in the same commune as a case 
 
 
 
 
 
Random selection from 
list of eligible households1 
Fulfilled inclusion criteria 
(Community controls) 
Informed consent 
Interview by study nurse 
First throat & rectal swabs 
Second throat & rectal swabs 
(After 10 – 16 days) 
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2.3.2.9 Detection of tonsillar carriage of S. suis serotype 2 in pigs in the 
households of cases and controls 
For all cases and controls who reported exposure to pigs at home, sampling of 
the pigs was performed in collaboration with the Sub-department of Animal Health of 
Ho Chi Minh City. Pigs were sampled for all cases and controls who reported 
exposure to pigs at home. Swab samples were taken from all pigs present (except 
pregnant sows to avoid stress-induced miscarriage) within 4 weeks of admission of 
the patient, or at the second visit to the community controls. Pigs were kept by a 
household member or by a special lasso. To avoid contamination of the swab sample 
with the bacteria in pig mouth, the veterinarian, who took the swab sample, used a 
rope to keep the mandible and tongue of pig out of the way when taking tonsil swab 
sample (Figure 2-5 and 2-6). 
Figure 2-5 Sterile cotton inoculating swab 
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Figure 2-6 Taking pig swab samples 
 
 
 
 
 
2.3.2.10 Sample size 
There was no data available from previous studies that allowed a definitive 
sample size calculation. However, when retrospectively looking at demographic data 
obtained during a randomized study on the efficacy of adjunct dexamethasone in the 
treatment of acute bacterial meningitis, 26% (59/226) of the non-S. suis patients (all 
other patients combined with different or unknown causes of meningitis) had potential 
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occupational exposure to pigs ( e.g. farmer, butcher) compared with 59% (46/78) of S. 
suis meningitis patients (Nguyen et al. 2007), corresponding to an odds ratio of 
approximately 4. We decided on a target sample size of 100 cases (and 300 matched 
controls), corresponding to a recruitment period of approximately 4 years and a target 
odds ratio for 80% power of 2.1 assuming a probability of exposure in controls of 
0.25 and a correlation coefficient for exposure between matched cases and controls of 
at most 0.2. With 100 cases, we also expected to fit reliable multivariate models with 
up to 10 covariates without over fitting the data (Harrell 2001). 
2.3.2.11 Statistical methods 
All variables of interest were summarized by group (case, hospital, community 
control and household member). Categorical variables were summarized as number 
and percent (%). Continuous variables were summarized as median and interquartile 
range (IQR). To assess univariate associations of S. suis with potential risk factors in 
hospital controls, we used both logistic regression without any adjustment for 
covariates and with adjustment for sex, age, and living in a rural or urban area. We 
used conditional logistic regression for the matched community controls and these 
analyses were performed with and without additional adjustment for sex (in addition 
to the matched variables age and place of living). In a multivariate analysis of 
potential risk factors of main interest, all potential risk factors plus the potential 
confounders (e.g. age, sex, place of living) were jointly included in a logistic (hospital 
controls) or conditional logistic (community controls) regression model. No model 
selection such as backwards elimination was performed. In the medical literature, S. 
suis infection through minor cuts or abrasions of the skin has been reported in 
individuals having contact with pigs or pork (Arends et al. 1988; Yu et al. 2006). 
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Therefore, we included separate effects of exposure to pigs or pork depending on 
whether the individual had skin injuries or not. S. suis infection occurred 
predominantly in males but controls were not matched by gender. As a sensitivity 
analysis, we therefore repeated the multivariate analysis including only male cases 
and controls. All analyses were performed with Stata version 10.1 (StataCorp) 
software. 
2.3.2.12 Ethical approval 
This study was approved by the Scientific and Ethics Committee of the 
Hospital for Tropical Diseases and the University of Oxford Tropical Research Ethics 
Committee (OXTREC 012-06). 
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2.4 Microbiological methods 
2.4.1 Gram stain of cerebrospinal fluid sample 
2.4.1.1 Prepare a slide smear 
- Aseptically collected specimen of CSF was sent to the bacteriology laboratory 
as soon as possible after collection. The CSF was then aseptically decanted 
into sterile centrifuge tubes and centrifuged at 4000 rpm for 4 minutes. 
- Transfer a drop of deposit to be examined on a slide with an inoculation loop 
and spread the sample with inoculation loop to an even thin film over a circle 
of 1.5 cm in diameter. On each slide, only one clinical specimen was applied. 
2.4.1.2 Gram staining 
Gram staining was carried out in 4 steps: 
- Step1: Staining with crystal violet solution for 60 seconds and rinsing. 
- Step 2: Staining with the iodine solution for 30 seconds and rinsing. 
- Step 3: Decolouring by ethanol/acetone for 5 seconds and rinsing.  
- Step 4: Counterstain with safranin solution for 20 seconds and rinsing. 
Finally, the slide is observed under a microscope (Figure 2-7) 
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Figure 2-7 Gram positive cocci on Gram stain of CSF sample 
 
 
2.4.2 Blood and cerebrospinal fluid (CSF) culture: 
2.4.2.1 Blood and CSF culture at the Hospital for Tropical Diseases (HTD) 
2.4.2.1.1 Blood culture 
Blood samples were taken on admission for all patients and blood cultures 
were performed in the microbiology laboratory of the HTD using the BD BACTEC® 
9050 blood culture system, using standard culture and identification methods. 
2.4.2.1.2 Cerebrospinal fluid (CSF) culture 
- Aseptically collected specimen of CSF is sent to the bacteriology laboratory as 
soon as possible after collection. 
- The CSF is then aseptically decanted into sterile tubes and centrifuged at 4000 
rpm for 4 minutes. 
- The deposit is cultured on blood agar, chocolate agar and in brain heart 
infusion broth using sterile bacteriological loops. 
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- These cultures are incubated overnight at 35 0C in 5% CO2 for 16 – 18 hours 
and then examined for growth. 
- Any colonies growing are identified by Gram stain and full identification 
carried out along with antibiograms. 
2.4.2.2 Blood and CSF culture at provincial hospitals 
Blood and CSF cultures were performed in the microbiology laboratory of 
provincial hospitals using standard culture methods. Blood culture was performed by 
the BD BACTEC® 9050 blood culture system (BD Microbiology, USA) in Dong 
Thap and Kien Giang hospitals, and by BacT/Alert blood culture system (bioMérieux, 
France) in Hue Central hospital. Manual blood culture using commercially available 
blood culture media made in Vietnam were used in the remaining hospitals. The CSF 
cultures were incubated overnight in candle jars, except in Hue Central hospital where 
a CO2 incubator was available. Laboratories used the locally available tools for 
identification of isolates from positive cultures. In addition, all bacterial isolates were 
sent to HTD for bacterial identification and antimicrobial susceptibility testing. 
2.4.3 Culture of throat and rectal swab samples of humans and pigs 
2.4.3.1 Culture of human swab samples 
Swab samples were inoculated in transport medium (TRANSWABS®, UK) at 
the site, and transferred to the laboratory at HTD or stored at 40C until transfer within 
48 hours (Figure 2-8). 
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Figure 2-8 Swab samples were inoculated in transport medium 
 
 
At the laboratory, swabs were inoculated into selective Todd-Hewitt broth 
(OXOID, UK), containing Streptococcal Selective Reagent (Oxoid) and crystal violet 
(Wisselink et al. 1999) and incubated overnight at 370C, followed by real-time PCR 
for detection of S. suis serotype 2 (Figure 2-9). Positive samples were cultured to 
retrieve S. suis isolates. 
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Figure 2-9 Selective Todd-Hewitt broth (OXOID, UK) [A] and after incubation 
overnight at 370C [B] 
 
2.4.3.2 Culture of pig tonsils swab samples 
Samples were cultured on blood agar (Figure 2-10) and were also inoculated 
into selective Todd-Hewitt broth (OXOID, UK). Both media contained Streptococcal 
Selective Reagent (Oxoid) and crystal violet (Wisselink et al. 1999). After that, they 
were incubated overnight at 370C, followed by real-time PCR for detection of S. suis 
serotype 2 of the Todd-Hewitt broth. Positive samples were cultured to retrieve S. suis 
isolates for further analysis. 
 
 
A B 
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Figure 2-10 Pig tonsil swab sample was cultured on blood agar 
 
 
2.4.4 Identification of bacterial strains 
All of the bacterial strains isolated from CSF and/or blood culture were 
identified according to the following figures (Figure 2-9 and 2-10). 
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Figure 2-11 Identification of Gram positive cocci from CSF and blood culture 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 on sheep blood agar plate
Gram positive cocci 
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Staphylococci 
Catalase negative 
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S. aureus S. epidermidis 
S. saprophyticus 
 
Group A 
Group B 
Group C 
Group G 
S. pneumoniae 
“Viridans” 
S. suis 
Other 
Streps 
Coagulase 
positive 
Coagulase 
negative 
Beta 
hemolytic1 
Alpha 
hemolytic1 
Non 
hemolytic1 
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Figure 2-12 Identification of Gram negative organisms from CSF culture 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Growth media 
Blood agar (BA) 
Chocolate blood agar (CA) 
(Incubate at 370C in 5%CO2) 
Gram negative on Gram stain 
Diplococci Coccobacilli 
Oxidase 
Positive Negative 
Suspected Neiserria spp 
Serum sugars: glucose, 
maltose and lactose  
Glucose (+), Maltose (+) 
and Lactose (–) 
Neisseria meningitidis 
Out with scope 
of study 
Growth on CA, but no 
growth on BA  
Test X, V& XV growth 
requirements on nutrient 
agar at 370C in 5% CO2
Haemophilus influenzae: 
growth around the XV disc 
only 
Haemophilus parinfluenzae: 
growth around the XV & V 
discs 
Haemophilus ducreyi: growth 
around the X disc only 
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2.4.5 Streptococcus suis identification and antimicrobial susceptibility 
2.4.5.1 Identification of Streptococcus suis strains 
S. suis was identified on the basis of colony morphology, negative catalase 
reaction, optochin resistance, and by APIStrep (Biomerieux, France) and subsequently 
serotyped by slide agglutination (Statens Serum Institute, Denmark) (Figure 2-13, 2-
14 and 2-15). 
Figure 2-13 Streptococcus suis colonies on blood agar 
 
Figure 2-14 Streptococcus suis was identified by APIStrep (Biomerieux, France) 
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Figure 2-15 Identifying serotype of Streptococcus suis 
 
 
2.4.5.2 Antimicrobial susceptibility of Streptococcus suis isolates 
Antimicrobial susceptibility of Streptococcus suis isolates was determined 
with E-test (AB Biodisk, Sweden), and results were interpreted according to Clinical 
and Laboratory Standards Institute criteria (Figure 2-16 and Table 2-7) (CLSI 2010) 
using breakpoints defined for Streptoccus species, viridans group. 
 
Figure 2-16 Antimicrobial susceptibility was determined by E-test (AB Biodisk, 
Sweden) 
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Table 2-7 Zone diameter interpretive standards and equivalent minimal 
inhibitory concentration (MIC) breakpoints for Streptococcus spp (viridans 
group) 
Antimicrobial agent Disk 
content 
Zone diameter (mm) Equivalent MIC 
breakpoints 
(μl/ml) 
R I S R S 
Penicillin  10 units N/A1 N/A1 N/A1 ≥ 4 ≤ 0.12 
Ceftriaxone 30 μg ≤ 24 25-26 ≥ 27 ≥ 4 ≤ 1 
Vancomycin 30 μg N/A1 N/A1 ≥ 17 N/A1 ≤ 1 
Levofloxacin 5 μg ≤ 13 14-16 ≥ 17 ≥ 8 ≤ 2 
Chloramphenicol 30 μg ≤ 17 18-20 ≥ 21 ≥ 16 ≤ 4 
Erythromycin 15 μg ≤ 15 16-20 ≥ 21 ≥ 1 ≤ 0.25 
Tetracycline 30 μg ≤ 18 19-22 ≥ 23 ≥ 8 ≤ 2 
1 not available. 
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2.5 Molecular methods 
In this work internally controlled real-time PCR was used for the detection of 
S. pneumoniae, H. influenzae type b, N. meningitidis, S. suis serotype 2, Herpes 
simplex 1/2, enteroviruses (generic) and Mycobacterium tuberculosis in CSF samples. 
The real-time PCR for detection of S. suis serotype 2 was also used on swab cultures.  
DNA and RNA were extracted from CSF or swab samples, which had already 
been pre-lysed with protein denaturants, using the EasyMag extraction system 
(BioMerieux, Ho Chi Minh City, Vietnam), according to manufacturer’s instructions. 
The DNA and RNA extractions were then subjected to consecutive duplex real-time 
PCRs, of which specific primers and probes are listed in Table 2-9, which amplified a 
single specific DNA sequence of a pathogen of interest and an internal control DNA 
sequence. Except for Mycobacterium tuberculosis PCR, the internal control DNA 
sequence was gB gene of Phocid Herpes virus and the internal control RNA sequence 
was NSP gene of Equine arteritis virus (van Doornum et al. 2003; Scheltinga et al. 
2005).  
An internally controlled real-time PCR for the detection of S. suis serotype 2 
in cerebrospinal fluid samples was developed which targeted the cps2J gene of S. suis 
serotype 2. Sensitivity and specificity of the assay in culture confirmed clinical 
samples were 100% (Nga et al. 2011). We applied RealAccurateTM Mycobacterium 
tuberculosis PCR kit (Patho Finder, The Netherlands), targeting the IS6110 sequence, 
to confirm tuberculous meningitis. This PCR kit had been validated by a set of CSF 
samples, including 24 TBM CSF samples confirmed by CSF smear (AFB) or 
mycobacterial growth indicator tube (MGIT) culture method, 9 pneumococcal 
meningitis CSF samples, 3 meningococcal meningitis CSF samples, 2 E. coli 
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meningitis CSF samples, 2 Listeria spp meningitis CSF samples, 1 Herpes simplex 
encephalitis meningitis and 1 unconfirmed viral encephalitis CSF samples. The 
sensitivity, specificity, positive predictive value and negative predictive value of it 
were 66.67%, 94.44%, 94.12% and 68.00%, respectively (Table 2-8). 
Table 2-8 Evaluation of RealAccurateTM PCR kit in TBM diagnosis 
 MTB1 Total 
Yes No  
Test result Positive 16 1 17 
Negative 8 17 25 
Total 24 18 32 
1 as confirmed by smear and/or culture 
Sensitivity: 66.67 % 
Specificity: 94.44 %  
Positive predictive value: 94.12 % 
Negative predictive value: 68.00 % 
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Table 2-9 Specific primers and probes used in this study 
Pathogen Gene 
target 
Oligo sequence (5’ – 3’) Reference 
Forward Reverse Probe 
Streptococcus 
pneumoniae 
Ply TGCAGAGCGTCCTTTG
GTCTAT                                
CTCTTACTCGTGGTTTCC
AACTTGA 
FAM-
TGGCGCCCATAAGCAACACT
CGAA-TAMRA 
(Corless et 
al. 2001) 
Haemophilus 
influenzae type b 
bexA GGCGAAATGGTGCTGG
TAA 
GGCCAAGAGATACTCAT
AGAACGTT 
FAM-
CACCACTCATCAAACGAATG
AGCGTGG-TAMRA 
(Corless et 
al. 2001) 
Neisseria 
meningitidis 
ctrA GCTGCGGTAGGTGGTT
CAA 
TTGTCGCGGATTTGCAA
CTA 
FAM-
CATTGCCACGTGTCAGCTGC
ACAT-TAMRA 
(Corless et 
al. 2001) 
Streptococcus suis 
serotype 2 
cps2J GGTTACTTGCTACTTTT
GATGGAAATT     
CGCACCTCTTTTATCTCT
TCCAA 
FAM-
TCAAGAATCTGAGCTGCAAA
AGTGTCAAATTGA 
-TAMRA 
(Nga et al. 
in press) 
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Herpes simplex 
1/2 
gB CCGTCAGCACCTTCATC
G A 
CGCTGGACCTCCGTGTA
GTC 
FAM-CCA CGA GAT CAA GGA 
CAG CGG CC-TAMRA 
(Jerome et 
al. 2002) 
Enteroviruses 5’UTR CCCTGAATGCGGCTAA
T 
ATTGTCACCATAAGCAG
CC 
FAM-CGG AAC CGA CTA CTT 
TGG GT-TAMRA 
(Beld et al. 
2004) 
Phocid Herpes 
virus (PhHV) (*) 
gB 
polymerase 
GGGCGAATCACAGATT
GAATC 
GCGGTTCCAAACGTACC
AA 
Cy5-
TTTTTATGTGTCCGCCACCAT
CTGGATC-BHQ3 
(van 
Doornum et 
al. 2003) 
Equine arteritis 
virus (EAV) (*) 
NSP CATCTCTTGCTTTGCTC
CTTAG 
AGCCGCACCTTCACATT
G 
Cy5-
CGCGCTCGCTGTCAGAACAA
CATTATTGCCCACAGCGCG-
BHQ3 
(Scheltinga 
et al. 2005) 
(*) PhHV was used as DNA internal control and EAV was used as RNA internal control. 
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2.6 Serological methods 
Viet Nam is a place where Japanese encephalitis virus (JEV) and Dengue virus 
(DENV) co-circulate. To confirm Japanese encephalitis or Dengue encephalitis, we 
used JEV/DENV IgM ELISA assay of Venture Technologies Sdn Bhd (Malaysia), 
which utilizes inactivated antigens from JEV and DENV1-DENV4 and can 
distinguish IgM elicited by JEV from that elicited by DENV (Cardosa et al. 2002). 
ELISA protocol was constructed according to manufacturer’s instructions. 
2.6.1 Components of ELISA kit 
Stored at room temperature 
ELISA plates – 5 plates/pack      3 packs 
ELISA plate covers – recyclable     1 piece 
Phosphate buffered saline (PBS) salts (×10)    3 packets 
Tween20        1 bottle 
Stopping solution       1 bottle 
Stored at 40C 
ELISA grade BSA – 1g/tube      3 tubes 
0.2M sodium carbonate      1 bottle 
0.2M sodium bicarbonate      1 bottle 
Anti-human μ-chain A425      1 vial 
Monoclonal antibody       1 bottle 
Conjugate P260       1 vial 
Substrate tablets – 5 mgOPD/tablet     15 tablets 
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Substrate buffer       1 bottle 
30% hydrogen peroxide      1 vial 
Stored at -200C 
Positive control sera       1 vial 
Negative control sera       1 vial 
Freeze-dried Dengue antigen      15 bottles 
Freeze-dried JEV       15 bottles 
Freeze-dried control antigen      15 bottles 
2.6.2 Preparation of reagents 
Preparation of coating buffer (0.05M carbonate-bicarbonate buffer, pH 9.6) 
Mix: 1.6 ml 0.2M sodium carbonate 
 3.4 ml 0.2M sodium bicarbonate 
 15 ml water 
Preparation of working phosphate buffered saline (PBS) 
 Dissolve one packet of PBS salts into 10 litres of water. 
 Store at room temperature 
Preparation of 10% BSA-PBS 
 Add 10 ml PBS to 1 g BSA 
 Store frozen at -200C 
Preparation of blocking buffer, 0.5% BSA-PBS 
 1 ml 10% BSA-PBS 
 19 ml PBS 
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 Store frozen at -200C 
Preparation of washing buffer, PBS-0.05% Tween20 
 1 ml Tween20 
 2 litres PBS 
 Store at room temperature 
Preparation of diluents, 0.1% BSA-PBS 
 1 ml 10% BSA-PBS 
 99 ml PBS 
 Store frozen at -200C 
2.6.3 ELISA protocol 
There are 13 steps (see below). 
1. Coating ELISA plate 
Dilute 5 μl anti-human μ-chain A425 in 10 ml coating buffer. 
Dispense 100 μl per well, cover plate and incubate overnight at 40C. 
2. Blocking coated ELISA plate 
Aspirate the coating solution. 
Dispense 200 μl blocking buffer per well, incubate 2 hours at room 
temperature. 
3. Wash plate 3 times with PBS-0.05% Tween20, soak for 1 minute in washing 
buffer between each wash. 
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4. Preparation of specimens, positive and negative control sera 
• CSF samples:  
100 μl CSF 
400 μl 0.1% BSA-PBS 
• Positive and negative controls: 
20 μl positive or negative control sera 
2 ml 0.1% BSA-PBS 
• Dispense 100 μl per well in triplicate for each specimen, three sets of 
triplicate for positive control and at least five sets of triplicate for negative 
control. 
• Incubate 2 hours at room temperature. 
5. Wash plate 5 times with PBS-0.05% Tween20, soak for 1 minute in washing 
buffer between each wash 
6. Freeze-dried antigen 
Reconstitute each vial of DENV antigen, JEV antigen and control antigen with 
5 ml PBS and vortex. 
Dispense 100 μl per well, cover plate and incubate overnight at 40C (each 
specimen has 1 well DENV antigen, 1 well JEV antigen and 1 well control 
antigen). 
7. Wash as for step 5 
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8. Monoclonal antibody mixture 
2.5 ml monoclonal antibody 
7.5 ml 0.1% BSA-PBS 
Mix well. 
Dispense 100 μl per well, incubate 1 hour at room temperature. 
9. Wash as for step 5. 
10. Conjugate 
Dilute 5 μl conjugate P260 in 10 ml 0.1% BSA-PBS, mix well. 
Dispense 100 μl per well, incubate 30 minute at room temperature in the dark. 
11. Wash as for step 5 
12. Preparation of substrate solution 
Dissolve 1 substrate tablet in 10 ml substrate buffer. 
Add 4 μl of 30% hydrogen peroxide just before use, mix well. 
Dispense 100 μl per well, incubate 30 minutes at room temperature in the 
dark. 
13. Stopping solution 
Add 50 μl of stopping solution per well to stop reaction. 
Read absorbance at 492 nm. 
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2.6.4 Interpretations of IgM capture ELISA readings 
1. Subtract the optical density (OD) value of the well containing control antigen 
(C) from the OD value of the well containing JEV antigen (AgJ) or DENV 
antigen (AgD) to get (AgJ-C) and (AgD-C) values. Calculate the mean of 
(AgD-C) and (AgJ-C) values for the negative controls. 
2. The positive cut-off values were 5 times of mean of (AgD-C) value for 
negative controls in the case of Dengue and 5 times of mean of (AgJ-C) value 
for negative controls in the case of JE. 
3. The OD values of the positive controls would be higher for DENV than for 
JEV because JEV positive antibodies are not as abundant as DENV positive 
antibodies. 
4. For each CSF specimen, calculate (AgJ-C) and (AgD-C) values of specimen. 
The unit (U) of ELISA test of CSF specimen was calculate as the below formula. 
 
The result of ELISA was interpreted as below: 
- Positive if titre of antibody was greater than 12 U. 
- Negative if titre of antibody was less than 8 U. 
- Indeterminate if titre of antibody was in the range of 8 to 12 U. 
For each CSF specimen, we compared the results of DENV and JEV ELISAs. The 
pathogen against which the higher titre was recorded was assigned as the cause of 
infection. 
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Chapter 3 
Aetiologies of central nervous system infection in Viet Nam 
3.1 Introduction 
Despite advances in antibiotic treatment and resuscitation, central nervous 
system (CNS) infection is still a serious and life-threatening disease, especially in the 
developing countries. It may manifest itself in a variety of clinical syndromes, 
including meningitis, encephalitis and focal central nervous system infections. 
According to the report of World Health Organization (WHO), the frequency of 
meningitis was 700,000 cases in 2004 and 70% of patients lived in Africa and South-
east Asia (WHO 2008). Japanese encephalitis virus, an important cause of 
encephalitis in Asia, causes 50,000 encephalitis cases and 15,000 deaths annually and 
leaves many survivors with severe neurological and neuropsychiatric sequelae 
(Solomon et al. 2000). Tuberculosis is an important health problem in developing 
countries with 9.4 million cases reported in 2009 (WHO 2010). Tuberculous 
meningitis, whose case fatality rate was 65.3% in HIV-infected patients and 24.8% in 
uninfected patients in Viet Nam, is the most serious manifestation of this disease 
(Thwaites et al. 2004). 
 To reduce morbidity and mortality of CNS infection, epidemiological studies 
are needed to establish a rational policy for prevention and treatment. The initial 
choice of empirical antibiotics for the treatment of acute bacterial meningitis is 
usually pathogen-oriented. However, the relative frequencies of implicated pathogens 
of bacterial meningitis have varied over time, geographic regions and with age, 
underlying medical and/or surgical conditions of patients, and the routes by which the 
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pathogens are acquired (Lu et al. 2002).  The most important pathogen of bacterial 
meningitis in children is Haemophilus influenzae type b, which caused 70% of 
bacterial meningitis among children under 5 year old in United States before the 
1990s (Wenger et al. 1990; Dawson et al. 1999).  The incidence of meningitis due to 
this organism in children aged 0 to 4 years before the conjugate vaccine era was 24 
per 100,000 per year in United Kingdom (UK) and 54 per 100,000 per year in United 
States (US), but following an extensive vaccination programme the incidence fell to 
0.6 per 100,000 per year and less than 1 per 100,000 per year, respectively (Peltola 
2000). Streptococcus pneumoniae has become the most common cause of acute 
bacterial meningitis in developed countries. In adults, most epidemiological data on 
bacterial meningitis comes from the developed countries, in which the four most 
common infecting organisms are Streptococcus pneumoniae (30-60%), Neisseria 
meningitidis (13-37%), Listeria monocytogenes, and Haemophilus influenzae (Durand 
et al. 1993; Aronin et al. 1998; Boisson et al. 1999; Tang et al. 1999; Flores-Cordero 
et al. 2003; van de Beek et al. 2004). Nevertheless, Neisseria meningitidis is the main 
pathogen of bacterial meningitis in countries of sub-Saharan Africa, known as the 
Africa meningitis belt. It can cause epidemics, in which the disease incidence may 
approach 1,000/100,000 inhabitants (Campagne et al. 1999; van Deuren et al. 2000; 
Stephens et al. 2007). The outbreak of Streptococcus suis infection in human in July, 
2005 in Sichuan, China with 215 cases and 38 deaths raised a question that whether 
this organism might be a neglected but important cause of CNS infection in Asia (Yu 
et al. 2006).  
Viral encephalitis is one of the most challenging infectious diseases in which 
to establish the cause and hence design treatment and preventative strategies. The 
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only effective treatment is acyclovir in the early stage of Herpes simplex and 
varicella-zoster virus encephalitis. These pathogens caused 63/1570 (4%) of suspected 
encephalitis cases in the California Encephalitis Project, 48/203 (24%) of suspected 
encephalitis cases in UK and 75/253 (30%) of suspected encephalitis cases in France. 
No aetiology was found for 996/1570 (63%), 75/203 (37%) and 122/253 (48%) of 
cases, respectively (Glaser et al. 2006; Mailles et al. 2009; Granerod et al. 2010). 
Furthermore, aetiologies of encephalitis may be geographically different, such as 
Japanese encephalitis virus in Asia, West Nile virus in the United States and Murray 
Valley encephalitis virus in Australia (Solomon 2004). 
The epidemiological data related to the aetiologies of central nervous system 
infections in Viet Nam is limited. The identification of the causes of CNS infections 
in Viet Nam is difficult for many reasons, including limited bacteriological culture 
facilities, lack of PCR and culture for viral identification and the use of antibiotics 
prior to presentation to hospital. In one report from the Hospital for Tropical diseases, 
Streptococcus suis caused 151/450 (33.6%) of adult bacterial meningitis, compared to 
81/450 (18.0%) of Streptococcus pneumoniae (Mai et al. 2008).  However from this 
data it is not possible to conclude that Streptococcus suis is an endemic disease 
because there was no epidemiological information from other provinces in Viet Nam, 
except Ha Noi (Wertheim et al. 2009). Until 2007, Haemophilus influenzae type b 
vaccine had not been introduced to the National Expanded Program on Immunization 
for children. The incidence of H. influenzae type b meningitis in children aged 0-5 
years in Ha Noi, Viet Nam was 12 cases per 100,000 per year (Anh DD et al. 2006). 
Japanese encephalitis vaccine was introduced to the National Expanded Program on 
Immunization for children 1-5 years of age in the northern region in 1997. The 
  
110
program was subsequently expanded to 437/676 districts of Viet Nam in 2007 (Yen 
NT et al. 2010). There is limited information on the incidence of Japanese 
encephalitis after introduction of vaccine, especially in the south of Viet Nam. 
Understanding the aetiologies of central nervous system infection may help 
improve policy and practice for the treatment and prevention of these diseases. We 
conducted a prospective provincial hospital-based surveillance study to identify the 
causes of CNS infections across southern Viet Nam.  
3.2 Aims 
1. To describe the epidemiological characteristics of central nervous system 
infection in Viet Nam. 
2. To identify the aetiologies of central nervous system infection in Viet Nam. 
3. To calculate the incidence rates of central nervous system infection for each 
province. 
 
3.3 Materials and Methods 
Materials and methods are described in Section 2.3.1, 2.4.2, 2.4.4, 2.4.5, 2.5, 
and 2.6. 
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3.4 Results 
Between August 2007 and April 2010, 1740 patients who fulfilled the 
inclusion criteria were admitted to 2 central, 10 provincial and 1 district hospitals.  
Clinical data were not available for 95 patients, including 52 adults and 43 
children. In these 95 patients, pathogens were confirmed in 12/52 adults (eight S. suis 
serotype 2 cases, one S. pneumoniae case, one Japanese encephalitis case, one 
enteroviruses encephalitis case and one co-infection case of S. suis and enteroviruses) 
and in 13/43 children (four enteroviruses encephalitis cases, two Japanese encephalitis 
cases, two dengue encephalitis cases, two H. influenza type b meningitis cases, one 
meningococcal meningitis and two co-infection cases of S. pneumoniae and Japanese 
encephalitis virus).  
After reviewing the clinical presentation and hospital tests of 1645 patients 
that had complete clinical data and CSF samples, I excluded 247 paediatric and 157 
adult patients in the final analysis of aetiology (Figure 3-1). All of these patients had 
normal CSF parameters, no pathogen in CSF and blood and discharged diagnosis 
unrelated to CNS infection, such as benign febrile convulsion (in 85 children), 
epilepsy (24 cases), stroke (29 cases), metabolic encephalopathy (29 cases), septic 
encephalopathy (55 cases) and viral illness (53 cases). Finally, 1241 patients, 
including 617 adults and 624 children, were included in the aetiological analysis of 
CNS infection. The surveillance study was conducted over one year at six hospitals 
(Ca Mau, Bac Lieu, Tra Vinh, Can Tho, Sa Dec and Binh Phuoc) and over two years 
at the other seven hospitals (Soc Trang, Dong Thap, An Giang, Kien Giang, Dak Lak, 
Khanh Hoa and Hue). The number of patients recruited and the number of suspected 
CNS infection cases at each hospital are presented in Table 3-1. Four adult patients 
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had TBM score >6 and died but two cases, that had cloudy CSF (in which WC > 
1000, high protein and low CSF glucose), were assigned as probable BM and two 
cases, that had clear CSF (in which normal CSF protein, CSF glucose and CSF 
lactate), were diagnosed as probable viral encephalitis. All other patients were 
classified according to Figure 3-2. 
In 617 adults and 624 children suspected CNS infection, WC in CSF was 
missing in 19 adults and 14 children and WC was less than 10/μl in 54 adults and 115 
children. Ten of these 73 adults and 2 of these 129 children had turbid CSF, in which 
7 adults and 2 children were confirmed bacterial pathogens in CSF samples. Lactate 
in CSF sample was not measured in 439/617 adult patients and 483/624 paediatric 
patients. 
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Figure 3-1 Study profile 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(*) Other diagnosis included sinusitis (5 cases), brain tumours (9 cases), cerebral malaria (8 cases), mental 
disorders (7 cases), headache (7 cases), typhoid fever (5 cases), fever unknown origin (3 cases), autoimmune 
diseases (12 cases), diarrhoea (6 cases), lumbar disc herniation (2 cases), congenital heart diseases (2 cases), 
hydrocephalus (1 case), tetanus (1 case), severe anaemia (1 case) and chronic colitis (1 case). 
Fulfilled inclusion criteria 
- 826 adult patients 
- 914 paediatric patients 
Unable to collect clinical data: 
- 52 adult patients 
- 43 paediatric patients 
Complete data form and CSF 
sample 
- 774 adult patients 
- 871 paediatric patients 
Unsuspected CNS infection  
(247 paediatric patients): 
- Benign febrile convulsion  
(85 cases) 
- Viral illness (38 cases) 
- Septic encephalopathy (23 cases) 
- Epilepsy (18 cases) 
- Pneumonia (14 cases) 
- Pharyngitis (14 cases) 
- Metabolic encephalopathy  
(9 cases) 
- Dysentery (7 cases) 
- Stroke (5 cases) 
- Other diagnosis* (34 cases) 
Unsuspected CNS infection  
(157 adult patients): 
- Septic encephalopathy  
(32 cases) 
- Stroke (24 cases) 
- Pneumonia (22 cases) 
- Metabolic encephalopathy  
(20 cases) 
- Viral illness (15 cases) 
- Epilepsy (8 cases) 
- Other diagnosis* (36 cases) 
Final analysis of aetiology 
- 617 adult patients 
- 624 pediatric patients 
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 Figure 3-2 Classification of central nervous system infection cases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 including 4 confirmed TBM cases co-infected with other pathogens 
2 Patients had typical manifestations of TBM, but short illness history. 
Final analysis of aetiology 
- 617 adult patients 
- 624 paediatric patients 
Confirmed pathogen cases1 
- 293 adult patients 
- 308 paediatric patients 
Unconfirmed pathogen cases 
- 324 adult patients 
- 316 paediatric patients 
TBM score < 6 
- 175 adult patients 
- 237 paediatric patients 
TBM score ≥ 6 
- 149 adult patients 
- 79 paediatric patients 
Probable 
BM 
 
78 adults 
46 children 
Probable 
Viral E/M 
 
94 adults 
191 children 
Probable/ 
possible 
TBM2 
3 adults 
Probable 
BM 
 
26 adults 
13 children 
Probable 
Viral E/M 
 
39 adults 
35 children 
Probable/ 
possible 
TBM 
84 adults 
31 children 
Confirmed 
TBM 
 
1 adult 
Confirmed 
TBM 
 
33 adults 
11 children 
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Table 3-1Time frame and patients recruited at each hospital 
Hospital Participants Time frame Duration 
(months) 
Patients 
recruited 
Suspected 
CNS infection 
Ca mau Adults Sep 2007 – Mar 2009 19 26 14 
Children Feb 2008 – Mar 2009 14 26 25 
Bac Lieu Adults Sep 2007 – Mar 2009 19 25 22 
Children Feb 2008 – Aug 2008 7 17 14 
Soc Trang Adults Sep 2007 – Apr 2010 32 100 83 
Children Feb 2008 – Apr 2010 27 84 65 
Can Tho Adults Sep 2009 – Aug 2010 12 52 48 
Children - - - - 
Tra Vinh Adults Feb 2008 – Mar 2009 14 3 3 
Children Feb 2008 – Mar 2009 14 24 22 
Dong Thap Adults Jan 2008 – Mar 2010 27 37 29 
Children Jan 2008 – Mar 2010 27 71 54 
Sa Dec Adults Jan 2008 – Mar 2009 15 2 2 
Children Jan 2008 – Mar 2009 15 56 32 
An Giang Adults Mar 2008 – Mar 2010 25 67 59 
Children Mar 2008 – Mar 2010 25 59 49 
Kien Giang Adults Feb 2008 – Mar 2010 26 125 97 
Children Mar 2008 – Mar 2010 25 66 47 
Binh Phuoc Adults Mar 2008 – Mar 2009 13 16 10 
Children Mar 2008 – Mar 2009 13 7 6 
Dak Lak Adults Jan 2008 – Apr 2010 28 44 38 
Children Jan 2008 – Apr 2010 28 137 104 
Khanh Hoa Adults Nov 2007 – Apr 2010 30 51 30 
Children Nov 2007 – Apr 2010 30 111 71 
Hue Adults Apr 2008 – Apr 2010 25 226 182 
Children Apr 2008 – Apr 2010 25 213 135 
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3.4.1 Characteristics of central nervous system infection patients 
3.4.1.1 Baseline characteristics of CNS infection patients 
Over 80% of CNS infection patients lived in rural areas and belonged to the 
Kinh ethnic group. The proportion of ethnic minorities in children group was higher 
than that in adult group (23.40% versus 14.42%, p<0.001). The overall ratio of male 
to female sex was 1.92/1.00. This ratio was highest in adult bacterial meningitis 
(3.03/1.00) and lowest in paediatric tuberculous meningitis (0.82/1.00).  The aetiology 
of CNS infection in the children population was different to that in adult population. 
Viral encephalitis and meningitis made up nearly 70% of paediatric CNS infection, 
compared to 34% of adult CNS infection.  Acute bacterial meningitis (BM) and 
tuberculous meningitis (TBM) presented with higher proportion in adult group (Table 
3-2). In the children, BM patients were younger than TBM and viral 
encephalitis/meningitis, of which the median ages were 1.63, 3.00 and 5.00 years, 
respectively (Table 3-4). However, adult BM patients were older than adult TBM and 
viral encephalitis/meningitis (Table 3-3). The overall case fatality rate (CFR) at 
provincial hospital was 11.83% in adults compared to 6.73% in children. One third of 
TBM patients died before receiving anti-tuberculosis drugs (Table 3-2, 3-3 and 3-4). 
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Table 3-2 Characteristics of CNS infection patients 
Characteristics Adults 
(n=617) 
Children 
(n=624) 
p value3 
    
Age (years), median (IQR) 38 (24; 52) 4 (1.29; 9) _ 
Male, n (%) 431 (69.85) 385 (61.70) 0.002 
Rural, n (%) 502 (81.36) 527 (84.86) 0.148 
Regions, n (%)   <0.0014
- Mekong river delta (n=622) 353 (53.32) 309 (46.68) - 
- Central Viet Nam (n=415) 211 (50.84) 204 (49.17) - 
- Central highlands (n=142) 38 (26.76) 104 (73.24) - 
- South East (n=16) 10 (62.50) 6 (37.50) - 
- Others1 (n=6) 5 (83.33) 1 (16.67) - 
Ethnicity, n (%)    
- Kinh 528 (85.58) 478 (76.60) <0.001 
- Khmer 64 (10.37) 68 (10.90) 0.764 
- E de 10 (1.62) 27 (4.33) 0.005 
- Raglai 3 (0.49) 14 (2.24) 0.008 
- Others2  12 (1.94) 37 (5.93) <0.001 
HIV status, n (%)    
- Positive 10 (1.62) 0 (0) - 
- Negative 488 (79.09) 50 (8.01) - 
- Unknown 119 (19.29) 574 (91.99) - 
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Diagnosis, n (%)    
- Bacterial meningitis 302 (48.95) 150 (24.04) <0.001 
- Viral encephalitis/ 
meningitis 
209 (33.87) 432 (69.23) <0.001 
- Tuberculous meningitis 87 (14.10) 31 (4.97) <0.001 
- Eosinophilic meningitis 4 (0.65) 1 (0.16) 0.215 
- Cryptococcal meningitis 2 (0.32) - 0.247 
- Cerebral toxoplasmosis 1 (0.16) - 0.497 
- Dual infection 12 (1.94) 10 (1.60) 0.648 
Outcomes, n (%)    
- Alive 429 (69.53) 493 (79.01) <0.001 
- Died 73 (11.83) 42 (6.73) 0.002 
- Transferred to other 
hospitals 
88 (14.26) 71 (11.38) 0.128 
- Unknown outcome 27 (4.38) 18 (2.88) 
 
0.160 
1 Cambodia, Laos 
2 Cham, Co Tu, Dao, H’Mong, Jarai, M’Nong, Mong, Nung, Pa Ko, STieng, Ta Oi, 
Tay, Thai, Xo Dang, Van Kieu, Chinese and Laotian. 
3 Chi-squared test or Fisher’s exact test (when one or more of the expected count is 
less than 5) 
4 Overall p-value for comparing age distribution (adults vs. children) between regions 
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Table 3-3 Characteristics of adult patients by diagnosis 
Characteristics Bacterial 
meningitis 
(n=302) 
Viral 
encephalitis/ 
meningitis 
(n=209) 
Tuberculous 
meningitis 
(n=87) 
    
Age (years), median (IQR)3  45.5 (31;58) 28 (19; 43) 38 (25; 52) 
Male, n (%)4 227 (75.17) 135 (64.59) 53 (60.92) 
Rural, n (%) 246 (81.46) 166 (79.43) 74 (85.06) 
Regions, n (%)    
- Mekong river delta (n=340) 158 (46.47) 118 (34.71) 64 (18.82) 
- Central Viet Nam (n=209) 124 (59.33) 66 (31.58) 19 (9.09) 
- Central highlands (n=35) 14 (40.00) 19 (54.29) 2 (5.71) 
- South East (n=10) 5 (50.00) 4 (40.00) 1 (10.00) 
- Others1 (n=4) 1 (25.00) 2 (50.00) 1 (25.00) 
Ethnicity, n (%)    
- Kinh 267 (88.41) 176 (84.21) 69 (79.31) 
- Khmer 27 (8.94) 20 (9.57) 15 (17.24) 
- E de 3 (0.99) 5 (2.39) 2 (2.30) 
- Raglai 1 (0.33) 1 (0.48) 1 (1.15) 
- Others2 4 (1.32) 7 (3.35) - 
Outcomes, n (%)    
- Alive 236 (78.15) 162 (77.51) 21 (24.14) 
- Died5 30 (9.93) 16 (7.66) 24 (27.59) 
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- Transferred to other 
hospitals 
24 (7.95) 21 (10.05) 37 (42.53) 
- Unknown outcome 12 (3.97) 10 (4.78) 5 (5.75) 
1 Cambodia 
2 Co Tu, Dao, Chinese, Nung, Ta Oi, Thai, Van Kieu and STieng. 
3  Bacterial meningitis patients were older than viral encephalitis and TBM patients 
with p<0.001 and p = 0.011, respectively. 
4 Male sex proportion of BM patients was higher than the one of viral encephalitis and 
TBM patients with p=0.010 and p=0.009, respectively. 
 5 Case fatality rate at provincial hospitals of TBM was higher than the one of BM and 
viral encephalitis/meningitis with OR=3.45; 95%CI [1.81; 6.58] and OR=4.60; 
95%CI [2.18; 9.74] 
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Table 3-4 Characteristics of paediatric patients by diagnosis 
Characteristics Bacterial 
meningitis 
(n=150) 
Viral encephalitis/ 
meningitis 
(n=432) 
Tuberculous 
meningitis 
(n=31) 
    
Age (years), median (IQR)3  1.63 (0.5; 6) 5 (2; 9) 3 (1.33; 9) 
Male, n (%) 89 (59.33) 273 (63.19) 14 (45.16) 
Rural, n (%) 124 (82.67) 366 (84.72) 27 (87.10) 
Regions, n (%)    
- Mekong river delta (n=305) 55 (18.03) 235 (77.05) 15 (4.92) 
- Central Viet Nam (n=200) 69 (34.50) 118 (59.00) 13 (6.50) 
- Central highlands (n=101) 26 (25.74) 73 (72.28) 2 (1.98) 
- South East (n=6) 0(0) 5 (83.33) 1 (16.67) 
- Others1 (n=1) 0(0) 1 (100.00) 0(0) 
Ethnicity, n (%)    
- Kinh 125 (83.33) 326 (75.46) 21 (67.74) 
- Khmer 8 (5.33) 55 (12.73) 4 (12.90) 
- E de 8 (5.33) 17 (3.94) - 
- Raglai 3 (2.00) 7 (1.62) 4 (12.90) 
- Others2 6 (4.00) 27 (6.25) 2 (6.45) 
Outcomes, n (%)    
- Alive 127 (84.67) 352 (81.84) 4 (12.90) 
- Died4   10 (6.67) 20 (4.63) 12 (38.71) 
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- Transferred to other 
hospitals 
11 (7.33) 47 (10.88) 12 (38.71) 
- Unknown outcome 2 (1.33) 13 (3.01) 3 (9.68) 
1 Cambodia 
2 Co Tu, Dao, H’Mong, Jarai, M’Nong, Mong, Nung, Pa Ko, STieng, Ta Oi, Tay and 
Thai. 
3 Bacterial meningitis patients were younger than viral encephalitis and TBM patients 
with p<0.001 and p = 0.046, respectively 
4 Case fatality rate at provincial hospitals of TBM was higher than the one of BM and 
viral encephalitis/meningitis with OR=8.84; 95%CI [3.05; 26.01] and OR=13.01; 
95%CI [5.12; 33.07]. 
 
3.4.1.2 Seasonality of CNS infection 
Admission of adult patients with CNS infection had a seasonal pattern 
(p<0.01), with a peak month in June and an amplitude of difference (peak month vs. 
average) was + 21% (95%CI [+8%; 36%]). Linear time trend of infection decreased 
13% per year (95%CI [-23%; -1%], p<0.05) but it was not significant if adjusted for 
over dispersion (p=0.06). However, the seasonal pattern was driven by Hue Central 
hospital alone. Test for seasonality was significant in Hue hospital (p<0.001) while it 
was not significant in all other hospitals (p=0.36) (Figure 3- 3). 
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Figure 3-3 Time distribution of adult CNS infection admission by hospitals1 
 
1 “Dong Thap” includes Dong Thap provincial hospital and Sa Dec hospital 
The seasonal change of CNS infection at Hue Central hospital seemed to be 
caused by infections caused by Streptococcus suis only (Figure 3-4). 
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Figure 3-4 Time distribution of adult CNS infection admission by all major 
pathogens at Hue Central hospital 
 
 
  
  
125
The seasonal pattern of paediatric CNS infection admissions was also noted 
(p<0.001). The admission to hospitals peaked in June and had an amplitude of 
difference (peak month vs. average) of +51% (95%CI [+34%; +69%]) and linear time 
trend of -24% per year (95% CI [-33%; -14%], p<0.001) (Figure 3-5). 
 
Figure 3-5 Time distribution of paediatric CNS infection admission by hospitals 
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3.4.1.3 Incidence rate of CNS infection 
The incidence rate of CNS infection ranged from 1.86 cases per 100,000 
person-years in Binh Phuoc province to 9.94 cases per 100,000 person-years in Thua 
Thien – Hue province. Age-specific incidence rates of CNS infection, of bacterial 
meningitis and of viral encephalitis/meningitis in Central Viet Nam were significantly 
higher than these rates in other regions, such as Mekong river delta, Central 
Highlands and South East. However, TBM’s incidence rate was significantly lower in 
Central Highlands than in the Mekong river delta (adults) and Central Viet Nam 
(children) (Table 3-5, 3-6, 3-7, 3-8 and 3-9). 
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Table 3-5 Incidence rates of CNS infection by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
CNS infection Confirmed (pathogen) cases Unconfirmed (pathogen) cases 
Number of 
patients 
Incidence rate, 
95%CI  (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95% CI (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Mekong river delta 156.726 482 3.08 (2.81; 3.36) 250 1.60 (1.40; 1.81) 232 1.48 (1.30; 1.68) 
- Ca Mau 12.017 31 2.58 (1.75; 3.66) 22 1.83 (1.15; 2.77) 9 0.75 (0.34; 1.42) 
- Bac Lieu1 6.470 9 1.39 (0.63; 2.64) 5 0.77 (0.25; 1.80) 4 0.62 (0.17; 1.58) 
- Soc Trang 25.783 112 4.34 (3.58; 5.27) 55 2.13 (1.61; 2.78) 57 2.21 (1.67; 2.86) 
- Can Tho1 9.303 21 2.26 (1.40; 3.45) 9 0.97 (0.44; 1.84) 12 1.29 (0.67; 2.25) 
- Tra Vinh 10.008 24 2.40 (1.54; 3.57) 16 1.60 (0.91; 2.60) 8 0.80 (0.35; 1.58) 
- Dong Thap 16.625 69 4.15 (3.23; 5.25) 34 2.05 (1.42; 2.86) 35 2.11 (1.47; 2.93) 
- An Giang 42.918 91 2.12 (1.71; 2.60) 37 0.86 (0.61; 1.19) 54 1.26 (0.95; 1.64) 
- Kien Giang 33.602 125 3.72 (3.10; 4.43) 72 2.14 (1.68; 2.70) 53 1.58 (1.18; 2.06) 
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Central Viet Nam 44.826 291 6.49 (5.77; 7.28) 180 4.02 (3.45; 4.65) 111 2.48 (2.04; 2.98) 
- Khanh Hoa 23.090 75 3.25 (2.55; 4.07) 29 1.26 (0.84; 1.80) 46 1.99 (1.46; 2.66) 
- Thua Thien-Hue 21.736 216 9.94 (8.66; 11.35) 151 6.95 (5.88; 8.15) 65 2.99 (2.31; 3.81) 
Central highlands        
- Dak Lak 34.482 111 3.22 (2.65; 3.88) 49 1.42 (1.05; 1.88) 62 1.80 (1.38; 2.31) 
South East        
- Binh Phuoc 8.580 16 1.86 (1.07; 3.03) 5 0.58 (0.19; 1.36) 11 1.28 (0.64; 2.29) 
Overall 244.614 900 3.68 (3.44; 3.93) 484 1.98 (1.81; 2.16) 416 1.70 (1.54; 1.87) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
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Table 3-6 Incidence rates of bacterial meningitis, viral encephalitis/meningitis and tuberculous meningitis by provinces2  
Province Total person-time 
of observation 
(× 105 person-years) 
Bacterial meningitis Viral encephalitis / meningitis Tuberculous meningitis 
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Mekong river delta 156.726 139 0.89 (0.75; 1.05) 268 1.71 (1.51; 1.93) 62 0.40 (0.30; 0.51) 
- Ca Mau 12.017 7 0.58 (0.23; 1.20) 22 1.83 (1.15; 2.77) 2 0.17 (0.02; 0.60) 
- Bac Lieu 1 6.470 2 0.31 (0.04; 1. 12) 1 0.15 (0.00; 0.86) 5 0.77 (0.25; 1.80) 
- Soc Trang 25.783 27 1.05 (0.69; 1.52) 67 2.60 (2.01; 3.30) 18 0.70 (0.41; 1.10) 
- Can Tho 1 9.303 6 0.64 (0.24; 1.40) 10 1.07 (0.52; 1.98) 3 0.32 (0.07; 0.94) 
- Tra Vinh 10.008 3 0.30 (0.06; 0.88) 17 1.70 (0.99; 2.72) 2 0.20 (0.02; 0.72) 
- Dong Thap 16.625 23 1.38 (0.88; 2.08) 40 2.41 (1.72; 3.28) 5 0.30 (0.10; 0.70) 
- An Giang 42.918 26 0.61 (0.40; 0.89) 53 1.23 (0.93; 1.62) 11 0.26 (0.13; 0.46) 
- Kien Giang 
 
33.602 45 1.34 (0.98; 1.79) 58 1.73 (1.31; 2.23) 16 0.48 (0.27; 0.77) 
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Central Viet Nam 44.826 137 3.05 (2.57; 3.61) 128 2.86 (2.38; 3.40) 20 0.45 (0.27; 0.69) 
- Khanh Hoa 23.090 25 1.08 (0.70; 1.60) 41 1.78 (1.27; 2.41) 8 0.35 (0.15; 0.68) 
- Thua Thien-Hue 21.736 112 5.15 (4.24; 6.20) 87 4.00 (3.21; 4.94) 12 0.55 (0.29; 0.96) 
Central highlands        
- Dak Lak 34.482 31 0.90 (0.61; 1.28) 71 2.06 (1.61; 2.50) 3 0.09 (0.02; 0.25) 
South East        
- Binh Phuoc 8.580 5 0.58 (0.19; 1.36) 9 1.05 (0.48; 1.99) 2 0.23 (0.03; 0.84) 
Overall 244.614 312 1.28 (1.14; 1.43) 476 1.95 (1.78; 2.13) 87 0.36 (0.28; 0.44) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
2 including both confirmed and probable cases and excluding co-infection cases. 
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Table 3-7 Incidence rates of CNS infection, bacterial meningitis, and viral encephalitis/meningitis in children by regions9 
Province Total person-time 
of observation 
(× 105 person-years) 
CNS infection Bacterial meningitis Viral encephalitis/meningitis 
Number 
of 
patients 
Incidence rate, 
95%CI  (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95% CI (/105 
person-years) 
Number 
of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Mekong river delta 161.324 × 0.24 238 6.15 (5.39; 6.98)1 41 1.06 (0.76; 1.44)4 180 4.65 (3.99; 5.38)6 
Central Viet Nam 44.826 × 0.27 138 11.40 (9.58; 13.47) 44 3.64 (2.64; 4.88) 81 6.69 (5.31; 8.32) 
Central highlands 34.482 × 0.31 82 7.67 (6.10; 9.52)2 21 1.96 (1.22; 3.00)5 57 5.33 (4.04; 6.91)7 
South East 8.580×0.29 6 2.41 (0.88; 5.25)3 - - 5 2.01 (0.65; 4.69)8 
Overall 249.212 × 0.26 464 7.16 (6.52; 7.84) 106 1.64 (1.34; 1.98) 323 4.98 (4.46; 5.56) 
 
1 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.54 (0.44; 0.66), p<0.001 
2 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.67 (0.51; 0.88), p=0.004 
3 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.24 (0.10; 0.53), p=0.001 
4 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.29 (0.19; 0.45), p<0.001 
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5 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.54 (0.32; 0.91), p=0.020 
6 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.69 (0.53; 0.90), p=0.006 
7 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.80 (0.57; 1.12), p=0.189 
8 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.33 (0.14; 0.83), p=0.018 
9 including both confirmed and probable cases and excluding co-infection cases. 
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Table 3-8 Incidence rates of CNS infection, bacterial meningitis, and viral encephalitis/meningitis in adults by regions10 
Province Total person-time 
of observation 
(× 105 person-years) 
CNS infection Bacterial meningitis Viral encephalitis/meningitis 
Number of 
patients 
Incidence rate, 
95%CI  (/105 
person-years) 
Number of 
patients 
Incidence rate, 
95% CI (/105 
person-years) 
Number 
of patients 
Incidence rate, 
95%CI (/105 
person-years) 
Mekong river delta 161.324 × 0.76 244 1.99 (1.75; 2.26)1 98 0.80 (0.65; 0.97)4 88 0.72 (0.58; 0.88)7 
Central Viet Nam 44.826 × 0.73 153 4.68 (3.96; 5.48) 93 2.84 (2.29; 3.48) 47 1.44 (1.06; 1.91) 
Central highlands 34.482 × 0.69 29 1.22 (0.82; 1.75)2 10 0.42 (0.20; 0.77)5 14 0.59 (0.32; 0.99)8 
South East 8.580 × 0.71 10 1.64 (0.79; 3.02)3 5 0.82 (0.27; 1.92)6 4 0.66 (0.18; 1.68)9 
Overall 249.212 × 0.74 436 2.36 (2.15; 2.60) 206 1.12 (0.97; 1.28) 153 0.83 (0.70; 0.97) 
 
1 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.43 (0.35; 0.52), p<0.001 
2 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.26 (0.18; 0.39), p<0.001 
3 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.35 (0.19; 0.67), p=0.001 
4 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.28 (0.21; 0.37), p<0.001 
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5 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.15 (0.08; 0.28), p<0.001 
6 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.29 (0.12; 0.71), p=0.007 
7 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.50 (0.35; 0.71), p<0.001 
8 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.41 (0.23; 0.74), p=0.003 
9 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.46 (0.16; 1.27), p=0.133 
10 including both confirmed and probable cases and excluding co-infection cases. 
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Table 3-9 Incidence rates of tuberculous meningitis by regions7  
Province Total person-time 
of observation 
(× 105 person-years) 
Tuberculous meningitis 
Adult patients Pediatric patients 
Proportion of 
adult group 
Number of 
patients 
Incidence rate, 
95%CI  (/105 
person-years) 
Proportion of 
children 
group 
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Mekong river delta 161.324 0.76 48 0.39 (0.29; 0.52)4 0.24 14 0.36 (0.20; 0.61)1 
Central Viet Nam 44.826 0.73 11 0.34 (0.17; 0.60)5 0.27 9 0.74 (0.34; 1.41)2 
Central highlands 34.482 0.69 2 0.08 (0.01; 0.30) 0.31 1 0.09 (0.00; 0.52) 
South East 8.580 0.71 1 0.16 (0.00; 0.91)6 0.29 1 0.40 (0.01; 2.24)3 
Overall 249.212 0.74 62 0.34 (0.26; 0.43) 0.26 25 0.39 (0.25; 0.57) 
 
1 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 3.87 (0.51; 29.39), p=0.191 
2 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 7.95 (1.01; 62.74), p=0.049 
3 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 4.79 (0.30; 76.61), p=0.268 
4 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 4.66 (1.13; 19.16), p=0.033 
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5 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 4.00 (0.89; 18.04), p=0.071 
6 In comparison with IR in Central Highlands Viet Nam, IRR (95%CI) = 1.95 (0.18; 21.54), p=0.585 
7 including both confirmed and probable or possible cases and excluding co-infection cases. 
 
 
  
137
3.4.2 Aetiology of central nervous system infection 
The aetiologies of CNS infection were identified in half of patients (Table 3-
10), in which the most common pathogen was Streptococcus suis serotype 2 in adult 
group (23.82%) and Japanese encephalitis virus in children group (22.76%). 
Mycobacterium tuberculosis was confirmed in 34/617 (5.51%) adult patients and 
11/624 (1.76%) paediatric patients. Dual infection was demonstrated in 22 cases, 
including 12 adults and 10 children. This condition was mainly related to dengue 
infection accompanying a bacterial pathogen (9/22 cases) or Japanese encephalitis and 
a bacterial pathogen (7/22 cases). 
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Table 3-10 Pathogens of central nervous system infection 
Pathogen, n (%) Adults 
(n=617) 
Children 
(n=624) 
Bacteria   
Streptococcus suis serotype 2 147 (23.82) - 
Streptococcus pneumoniae 35 (5.67) 37 (5.93) 
Haemophilus influenzae type b - 39 (6.25) 
Neisseria meningitidis 4 (0.65) 6 (0.96) 
Streptococcus spp 2 (0.32) - 
Staphylococcus spp 1 (0.16) 3 (0.48) 
Escherichia coli 2 (0.32) 2 (0.32) 
Acinetobacter spp 1 (0.16) 1 (0.16) 
Klebsiella pneumoniae 5 (0.81) 1 (0.16) 
Enterococcus spp 1 (0.16) - 
Salmonella spp - 2 (0.32) 
Virus   
Japanese Encephalitis (JE) virus 11 (1.78) 142 (22.76) 
Dengue virus 23 (3.73) 14 (2.24) 
Enteroviruses 20 (3.24) 36 (5.77) 
Herpes simplex 22 (3.57) 14 (2.24) 
Tuberculosis   
Mycobacterium tuberculosis 34 (5.51) 11 (1.76) 
Fungi   
Cryptococcus neoformans 2 (0.32) - 
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Dual infection   
Dengue virus + S. suis serotype 2 2 (0.32) - 
Dengue virus + S. pneumoniae 1 (0.16) - 
Dengue virus + N. meningitidis 1 (0.16) - 
Dengue virus + H. influenzae type b - 3 (0.48) 
Dengue virus + M. tuberculosis 2 (0.32) - 
Dengue virus + Eosinophilic meningitis1 2 (0.32)  
JE virus + S. pneumoniae 1 (0.16) - 
JE virus + N.meningitidis - 1 (0.16) 
JE virus + H. influenzae type b - 3 (0.48) 
JE virus + Salmonella spp - 1 (0.16) 
JE virus + Staphylococcus spp - 1 (0.16) 
Enteroviruses + H. influenzae type b - 1 (0.16) 
Enteroviruses + M. tuberculosis 1 (0.16) - 
K. pneumoniae + M. tuberculosis 1 (0.16) - 
K. pneumoniae + Herpes simplex 1 (0.16) - 
Unknown pathogen 295 (47.81) 306 (49.04) 
 
1 Number of eosinophils in CSF sample was 352/880 (40%) in one case and 330/1320 
(25%) in another case.  
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3.4.3 Aetiology of bacterial meningitis 
3.4.3.1 Pathogens of bacterial meningitis 
Bacterial pathogens were identified in over 60% of bacterial meningitis cases 
by culture or real-time PCR method. Streptococcus suis serotype 2 caused meningitis 
in 50% of the adult bacterial meningitis group, which was four times higher than 
meningitis cases caused by Streptococcus pneumoniae in this population. However, 
this pathogen was not reported in the paediatric patients. In children, Haemophilus 
influenzae type b and Streptococcus pneumoniae were the main pathogens causing 
bacterial meningitis, which were responsible for more than 50% of paediatric bacterial 
meningitis cases (Table 3-11).  
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Table 3-11 Pathogens of bacterial meningitis (excluding dual infection cases) 
Pathogen, n (%) Adults 
(n=302) 
Children 
(n=150) 
   
Streptococcus suis serotype 2 147 (48.68) - 
Streptococcus pneumoniae 35 (11.59) 37 (24.67) 
Haemophilus influenzae type b - 39 (26.00) 
Neisseria meningitidis 4 (1.32) 6 (4.00) 
Streptococcus spp 2 (0.66) - 
Staphylococcus spp 1 (0.33) 3 (2.00) 
Escherichia coli 2 (0.66) 2 (1.33) 
Acinetobacter spp 1 (0.33) 1 (0.67) 
Klebsiella pneumoniae 5 (1.66) 1 (0.67) 
Enterococcus spp 1 (0.33) - 
Salmonella spp - 2 (1.33) 
Unknown pathogen 104 (34.44) 59 (39.33) 
 
 
3.4.3.2 Age distribution of bacterial meningitis causes 
 Aetiology of bacterial meningitis varied clearly in age groups. H. influenzae 
type b was the most common pathogen in the children less than 1 year of age. It 
caused 40% of bacterial meningitis cases in this age group. Risk of infection 
decreased every one year of incremental age. Over 90% of H. influenzae type b cases 
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were reported in the first five years of life. In adult, S. suis serotype 2 only caused less 
than 10% of bacterial meningitis in young adult patients (<30 years of age). However, 
the risk of infection increased with age and was responsible for 60 % of bacterial 
meningitis cases after 30 years old. Twenty five percent of bacterial meningitis cases 
in children and young adults were caused by S. pneumoniae while it was reported in 
less than 10% of bacterial meningitis aetiologies after 30 years of age. Risk of 
pneumococcal infection decreased with age increased in both children and adults 
(Table 3-12, Table 3-13 and Figure 3-6). 
 
Figure 3-6 Age distribution of bacterial meningitis cases by cause 
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Table 3-12 Association between age and main pathogens of bacterial meningitis1 
Pathogens OR; 95% CI p value 
H. influenzae type b (in paediatric patients)   
- Age (by +1 year) 0.70; 95%CI [0.60; 0.83] <0.001 
Streptococcus suis serotype 2 (in adult patients) 
  
- Age ( by +5 years) 1.30; 95%CI [1.23; 1.38] <0.001 
Streptococcus pneumoniae   
- Children: age (by +5 years) 0.46; 95%CI [0.27; 0.76] 0.003 
- Adult: age (by +5 years) 0.89; 95%CI [0.80; 0.99] 0.028 
N. meningitidis   
- Children: age (by +5 years) 0.56; 95%CI [0.18; 1.76] 0.319 
- Adult: age (by +5 years) 1.10; 95%CI [0.86; 1.42] 0.452 
1 analyzed by logistic regression method. 
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Table 3-13 Pathogens of bacterial meningitis by age groups (excluding dual infection cases) 
 
 
Pathogen, n (%) 
Age group (years) 
≤ 1 
(n=66) 
1-4 
(n=38) 
5-14 
(n=46) 
15-29 
(n=70) 
30-44 
(n=76) 
45-59 
(n=93) 
≥ 60 
(n=63) 
        
Streptococcus suis serotype 2 - - - 6 (8.57) 38 (50.00) 62 (66.67) 41 (65.08) 
Streptococcus pneumoniae 18 (27.27) 12 (31.58) 7 (15.22) 19 (27.14) 7 (9.21) 7 (7.53) 2 (3.17) 
Haemophilus influenzae type b 27 (40.91) 9 (23.68) 3 (6.52) - - - - 
Neisseria meningitidis 3 (4.55) 2 (5.26) 1 (2.17) 1 (1.43) 1 (1.32) 1 (1.08) 1 (1.59) 
Streptococcus spp - - - - - 1 (1.08) 1 (1.59) 
Staphylococcus spp - 3 (7.89) - - - 1 (1.08) - 
Escherichia coli 2 (3.03) - - - - 2 (2.15) - 
Acinetobacter spp - - 1 (2.17) - 1 (1.32) - - 
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Klebsiella pneumoniae - 1 (2.63) - 3 (4.29) - 1 (1.08) 1 (1.59) 
Enterococcus spp - - - 1 (1.43) - - - 
Salmonella spp 2 (3.03) - - - - - - 
Unknown pathogen 14 (21.21) 11 (28.95) 34 (73.91) 40 (57.14) 29 (38.16) 18 (19.35) 17 (26.98) 
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3.4.3.3 Geographic distribution of bacterial meningitis causes 
There was not any marked difference when analyzing geographic distribution 
of bacterial meningitis pathogens among Central Viet Nam, Mekong river delta and 
Central Highlands (Table 3-14 and Table 3-15). 
Table 3-14 Aetiologies of adult bacterial meningitis by regions (excluding dual 
infection cases)1 
 
 
Pathogen, n (%) 
Adults 
Mekong 
river delta 
(n=158) 
Central  
Viet Nam 
(n=124) 
Central 
highlands 
(n=14) 
South East
 
(n=5) 
Streptococcus suis serotype 2 2 74 (46.84) 70 (56.45) 2 (14.29) - 
Streptococcus pneumoniae 3 16 (10.13) 15 (12.10) 4 (28.57) - 
Haemophilus influenzae type b - - - - 
Neisseria meningitidis 4 3 (1.90) 1 (0.81) - - 
Streptococcus spp 2 (1.27) - - - 
Staphylococcus spp 1 (0.63) - - - 
Escherichia coli 1 (0.63) - 1 (7.14) - 
Acinetobacter spp - 1 (0.81) - - 
Klebsiella pneumoniae 1 (0.63) 4 (3.23) - - 
Enterococcus spp 1 (0.63) - - - 
Salmonella spp - - - - 
Unknown pathogen 59 (37.34) 33 (26.61) 7 (50.00) 5 (100.00) 
1 Comparison of proportions of each 
main pathogen (S. suis, S. pneumoniae 
and N. meningitidis) among regions 
2 p= 0.001 
3 p= 0.213 
4 p= 1.000 
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Table 3-15 Aetiologies of paediatric bacterial meningitis by regions (excluding 
dual infection cases)1 
 
 
Pathogen, n (%) 
Children 
Mekong 
river delta 
(n=55) 
Central 
Viet Nam 
(n=69) 
Central 
highlands 
(n=26) 
South East
 
(n=0) 
     
Streptococcus suis serotype 2 - - - - 
Streptococcus pneumoniae 2 6 (10.91) 26 (37.68) 5 (19.23) - 
Haemophilus influenzae type b 3 16 (29.09) 15 (21.74) 8 (30.77) - 
Neisseria meningitidis 4 2 (3.64) 4 (5.80) -  
Streptococcus spp - - - - 
Staphylococcus spp 3 (5.45) - - - 
Escherichia coli 1 (1.82) - 1 (3.85) - 
Acinetobacter spp - 1 (1.45) - - 
Klebsiella pneumoniae - 1 (1.45) - - 
Enterococcus spp - - - - 
Salmonella spp - 2 (2.90) - - 
Unknown pathogen 27 (49.09) 20 (28.99) 12 (46.15) - 
1 Comparison of proportions of each main pathogen (S. suis, S. pneumoniae and N. 
meningitidis) among regions 
2 p= 0.002  
3 p= 0.540  
4 p= 0.650  
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3.4.3.4 Incidence rate of common pathogens of bacterial meningitis 
Incidence rate of Streptococcus suis serotype 2 in Thua Thien – Hue was 
significantly higher than other provinces. Rate ratio between Thua Thien – Hue and 
other provinces ranged from 3.6 to 25.5 times. The average incidence rates of this 
pathogen in adult population in Mekong river delta, Central Viet Nam and Central 
Highlands were 0.39, 1.68 and 0.13 per 100,000 person-years, respectively while 
these rates of Streptococcus pneumoniae meningitis were 0.10, 0.60 and 0.23 per 
100,000 person-years. In children aged less than 5 years, average incidence rates of H. 
influenzae type b meningitis in Mekong river delta was lower than in Central Viet 
Nam and Central Highlands (1.06 vs. 3.35 and 1.61 per 100,000 children <5 years of 
age) (Table 3-16, 3-17 and 3-18). 
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Table 3-16  Incidence rates of Streptococcus suis meningitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Streptococcus suis  
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Proportion of 
population made up 
of adult2 
Incidence rate  in adult 
population, 95%CI  
(/105 person-years) 
Mekong river delta 161.324 48 0.30 (0.22; 0.39) 0.76 0.39 (0.29; 0.52)3
- Ca Mau 12.017 3 0.25 (0.05; 0.73) 0.75 0.33 (0.07; 0.97) 
- Bac Lieu1 6.470 1 0.15 (0.00; 0.86) 1 0.15 (0.00; 0.86) 
- Soc Trang 25.783 10 0.39 (0.19; 0.71) 0.75 0.52 (0.25; 0.95) 
- Can Tho1 9.303 4 0.43 (0.12; 1.10) 1 0.43 (0.12; 1.10) 
- Tra Vinh 10.008 0 - 0.77 - 
- Dong Thap 16.625 2 0.12 (0.01; 0.43) 0.76 0.16 (0.02; 0.57) 
- An Giang 42.918 5 0.12 (0.04; 0.27) 0.76 0.15 (0.05; 0.36) 
- Kien Giang 33.602 23 0.68 (0.43; 1.03) 0.74 0.92 (0.59; 1.39) 
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Central Viet Nam 44.826 55 1.23 (0.92; 1.60) 0.73 1.68 (1.27; 2.19) 
- Khanh Hoa 23.090 3 0.13 (0.03; 0.38) 0.74 0.18 (0.04; 0.51) 
- Thua Thien - Hue 21.736 52 2.39 (1.79; 3.14) 0.72 3.32 (2.48; 4.36) 
Central highlands      
- Dak Lak 34.482 3 0.09 (0.02; 0.25) 0.69 0.13 (0.03; 0.37)4
South East      
- Binh Phuoc 8.580 0 - 0.71 - 
Overall 249.212 106 0.43 (0.35; 0.51) 0.74 0.57 (0.47; 0.70) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
2 Applying data of population by age group in the 2009 Vietnam population and house census (Table 2-2) (CP&HCSC 2010). 
3 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.24 (0.16; 0.35), p<0.001 
4 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.08 (0.02; 0.24), p<0.001 
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Table 3-17 Incidence rates of Streptococcus pneumoniae and Neisseria meningitidis meningitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Streptococcus pneumoniae Neisseria meningitidis 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Mekong river delta 156.726 15 0.10 (0.05; 0.16)2 5 0.03 (0.01; 0.07)4
- Ca Mau 12.017 1 0.08 (0.00; 0.46) 0 - 
- Bac Lieu1 6.470 0 - 0 - 
- Soc Trang 25.783 1 0.04 (0.00; 0.22) 1 0.04 (0.00; 0.22) 
- Can Tho1 9.303 1 0.11 (0.00; 0.60) 0 - 
- Tra Vinh 10.008 0 - 0 - 
- Dong Thap 16.625 5 0.30 (0.10; 0.70) 0 - 
- An Giang 42.918 3 0.07 (0.01; 0.20) 0 - 
- Kien Giang 
 
33.602 4 0.12 (0.03; 0.30) 4 0.12 (0.03; 0.30) 
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Central Viet Nam 44.826 27 0.60 (0.40; 0.88) 6 0.13 (0.05; 0.29) 
- Khanh Hoa 23.090 6 0.26 (0.10; 0.57) 2 0.09 (0.01; 0.31) 
- Thua Thien - Hue 21.736 21 0.97 (0.60; 1.48) 4 0.18 (0.05; 0.47) 
Central highlands      
- Dak Lak 34.482 8 0.23 (0.10; 0.46)3 0 - 
South East      
- Binh Phuoc 8.580 0 - 0 - 
Overall 244.614 50 0.20 (0.15; 0.27) 11 0.04 (0.02; 0.08) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
2 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.16 (0.08; 0.30), p<0.001 
3 In comparison with IR in Central Viet Nam (IRR (95%CI) = 0.39 (0.17; 0.85), p=0.018 
4 In comparison with IR in Central Viet Nam (IRR (95%CI) = 0.24 (0.07; 0.78), p=0.018 
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Table 3-18  Incidence rates of Haemophilus influenzae type b meningitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
 Haemophilus influenzae type b  
Number of patients Incidence rate, 95%CI 
(/105 person-years) 
Incidence rate1 
 in children <15 year 
old, 95%CI  
(/105 person-years) 
Incidence rate1 
 in children <5 year old, 
95%CI  
(/105 person-years) 
< 15 
year old 
<5  
year old 
Mekong river delta 140.953 12 12 0.09 (0.04; 0.15) 0.35 (0.18; 0.62) 1.06 (0.55; 1.86)2 
- Ca Mau 12.017 0 0 - - - 
- Soc Trang 25.783 2 2 0.08 (0.00; 0.28) 0.31 (0.04; 1.12) 0.97 (0.12; 3.50) 
- Tra Vinh 10.008 0 0 - - - 
- Dong Thap 16.625 5 5 0.30 (0.10; 0.70) 1.25 (0.41; 2.92) 3.76 (1.22; 8.77) 
- An Giang 42.918 2 2 0.05 (0.01; 0.17) 0.19 (0.02; 0.70) 0.58 (0.07; 2.10) 
- Kien Giang 
 
33.602 3 3 0.09 (0.02; 0.26) 0.34 (0.07; 1.00) 1.12 (0.23; 3.26) 
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Central Viet Nam 44.826 12 12 0.27 (0.14; 0.47) 0.99 (0.51; 1.73) 3.35 (1.73; 5.85) 
- Khanh Hoa 23.090 1 1 0.04 (0.00; 0.24) 0.17 (0.00; 0.93) 0.54 (0.01; 3.02) 
- Thua Thien - Hue 21.736 11 11 0.51 (0.25; 0.91) 1.81 (0.90; 3.23) 6.33 (3.16; 11.32) 
Central highlands       
- Dak Lak 34.482 9 5 0.26 (0.12; 0.50) 0.84 (0.38; 1.60) 1.61 (0.52; 3.76)3 
South East       
- Binh Phuoc 8.580 0 0 - - - 
Overall 228.841 33 29 0.14 (0.10; 0.20) 0.55 (0.38; 0.78) 1.58 (1.06; 2.27) 
1 Applying data of population by age group in the 2009 Vietnam population and house census (Table 2-2) (CP&HCSC 2010) 
2 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.32 (0.14; 0.71), p=0.005 
3 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.47 (0.17; 1.33), p=0.155 
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3.4.4 Aetiology of viral encephalitis/meningitis 
3.4.4.1 Pathogens of viral encephalitis/meningitis 
Japanese encephalitis virus was the most common pathogen identified in 
patients with encephalitis and was responsible for 33% of paediatric viral 
encephalitis/meningitis cases. Dengue virus, enteroviruses and Herpes simplex virus 
were the common pathogens of adult viral encephalitis/meningitis, of which each 
pathogen caused 10% of infection. However, aetiology was not identified in 60% of 
viral encephalitis/meningitis population (Table 3-19). 
Table 3-19 Pathogens of viral encephalitis/meningitis (excluding dual infection 
cases) 
Pathogen, n (%) Adults 
(n=209) 
Children 
(n=432) 
p value 
    
Japanese encephalitis virus 11 (5.26) 142 (32.87) <0.001 
Dengue virus  23 (11.00) 14 (3.24) <0.001 
Enteroviruses 20 (9.57) 36 (8.33) 0.603 
Herpes simplex 22 (10.53) 14 (3.24) <0.001 
Unknown pathogen 133 (63.64) 226 (52.31) 0.007 
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3.4.4.2 Age distribution of viral encephalitis/meningitis causes  
Japanese encephalitis virus (JEV) was responsible for nearly 40% of 
encephalitis/meningitis cases in the age group 1-14, but it was less common in 
patients that were younger than 1 year of age or older than 15 years of age. Risk of 
JEV and enteroviruses infection increased with age in children but decreased after 15 
years old. Though dengue encephalitis was more common in adults than children 
(11% versus 3.24%), trend of infection related to age was not statistically significant 
(Table 3-20, 3-21 and Figure 3-7). 
Figure 3-7 Age distribution of viral encephalitis/meningitis cases by cause 
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Table 3-20 Association between age and main pathogens of viral encephalitis/ 
meningitis1 
Pathogens OR; 95% CI p value 
Japanese encephalitis virus   
- Children: age (by + 5 years) 1.54; 95%CI [1.25; 1.89] <0.001 
- Adult: age (by +5 years) 0.63; 95%CI [0.45; 0.88] 0.007 
Enteroviruses   
- Children: age (by +5 years) 1.49; 95%CI [1.04; 2.14] 0.030 
- Adult: age (by +5 years) 0.65; 95%CI [0.52; 0.82] <0.001 
Herpes simplex   
- Children: age (by +5 years) 0.95; 95%CI [0.52; 1.75] 0.873 
- Adult: age (by +5 years) 1.00; 95%CI [0.89; 1.13] 0.955 
Dengue virus   
- Children: age (by +5 years) 0.95; 95%CI [0.52; 1.75] 0.869 
- Adult: age (by +5 years) 0.89; 95%CI [0.78; 1.02] 0.087 
1 analyzed by logistic regression method. 
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Table 3-21 Aetiologies of viral encephalitis/meningitis by age groups (excluding dual infection cases) 
 
 
Pathogen, n (%) 
Age group (years) 
≤ 1 
(n=63) 
1-5 
(n=146) 
6-14 
(n=223) 
15-29 
(n=111) 
30-44 
(n=52) 
45-59 
(n=31) 
≥ 60 
(n=15) 
        
Japanese encephalitis virus 2 (3.17) 54 (36.99) 86 (38.57) 9 (8.11) 2 (3.85) - - 
Dengue virus 3 (4.76) 3 (2.05) 8 (3.59) 12 (10.81) 7 (13.46) 3 (9.68) 1 (6.67) 
Enteroviruses 7 (11.11) 5 (3.42) 24 (10.76) 16 (14.41) 3 (5.77) - 1 (6.67) 
Herpes simplex 4 (6.35) 4 (2.74) 6 (2.69) 6 (5.41) 8 (15.38) 5 (16.13) 3 (20.00) 
Unknown pathogen 47 (74.60) 80 (54.79) 99 (44.39) 68 (61.26) 32 (61.54) 23 (74.19) 10 (66.67) 
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3.4.4.3 Geographic distribution of viral encephalitis/meningitis causes 
The aetiology of viral encephalitis/meningitis was rather homogenous among 
Mekong river delta, South East, Central Highlands and Central Viet Nam except 
enteroviruses caused 27% of viral aetiologies of adult encephalitis/meningitis in 
Central Viet Nam (Table 3-22 and Table 3-23). 
 
Table 3-22 Aetiologies of adult viral encephalitis/meningitis by regions 
(excluding dual infection cases) 
 
 
Pathogen, n (%) 
Adults 
Mekong 
river delta 
(n=118) 
Central  
Viet Nam 
(n=66) 
Central 
highlands 
(n=19) 
South East 
 
(n=4) 
     
Japanese encephalitis virus 4 (3.39) 4 (6.06) 3 (15.79) - 
Dengue virus 16 (13.56) 5 (7.58) 1 (5.26) 1 (25.00) 
Enterovirus 2 (1.69) 18 (27.27) - - 
Herpes simplex 18 (15.25) 4 (6.06) - - 
Unknown pathogen 78 (66.10) 35 (53.03) 15 (78.95) 3 (75.00) 
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Table 3-23 Aetiologies of paediatric viral encephalitis/meningitis were stratified 
for regions (excluding dual infection cases) 
 
 
Pathogen, n (%) 
Children  
Mekong 
river delta 
(n=235) 
Central  
Viet Nam 
(n=118) 
Central 
highlands 
(n=73) 
South East 
 
(n=5) 
     
Japanese Encephalitis virus 83 (35.32) 41 (34.75) 15 (20.55) 3 (60.00) 
Dengue virus 8 (3.40) 4 (3.39) 1 (1.37) 1 (20.00) 
Enterovirus 20 (8.51) 10 (8.47) 6 (8.22) - 
Herpes simplex 10 (4.26) 2 (1.69) 2 (2.74) - 
Unknown pathogen 114 (48.51) 61 (51.69) 49 (67.12) 
 
1 (20.00) 
 
3.4.4.4 Incidence rate of common pathogens of viral encephalitis/ meningitis 
Incidence rate of Japanese encephalitis in children less than 15 years of age 
was approximately 4 per 100,000 person-years in Ca Mau, Soc Trang, Tra Vinh and 
Thua Thien - Hue province. Average incidence rate of this pathogen, which was 2.07, 
2.56, 1.40 and 1.21 per 100,000 person-years in Mekong river delta, Central Viet 
Nam, Central Highlands and South East, was not significantly different among these 
surveillance regions. Incidence rates of other pathogens varied around 0.1 per 100,000 
person-years in Herpes simplex and around 0.2 per 100,000 person-years in Dengue 
virus and enteroviruses, except incidence rate of enteroviruses in Thua Thien – Hue 
reached 0.97 per 100,000 person-years (Table 3-24, 3-25 and 3-26). 
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Table 3-24 Incidence rates of Herpes simplex and enteroviruses meningitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Herpes simplex Enteroviruses 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Mekong river delta 156.726 21 0.13 (0.08; 0.20) 18 0.11 (0.07; 0.18) 
- Ca Mau 12.017 1 0.08 (0.00; 0.46) 0 - 
- Bac Lieu1 6.470 0 - 0 - 
- Soc Trang 25.783 1 0.04 (0.00; 0.22) 5 0.19 (0.06; 0.45) 
- Can Tho1 9.303 1 0.11 (0.00; 0.60) 0 - 
- Tra Vinh 10.008 2 0.20 (0.02; 0.72) 1 0.10 (0.00; 0.56) 
- Dong Thap 16.625 5 0.30 (0.10; 0.70) 4 0.24 (0.07; 0.62) 
- An Giang 42.918 3 0.07 (0.01; 0.20) 4 0.09 (0.03; 0.24) 
- Kien Giang 
 
33.602 8 0.24 (0.10; 0.47) 4 0.12 (0.03; 0.30) 
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Central Viet Nam 44.826 3 0.07 (0.01; 0.20) 22 0.49 (0.31; 0.74) 
- Khanh Hoa 23.090 0 - 1 0.04 (0.00; 0.24) 
- Thua Thien - Hue 21.736 3 0.14 (0.03; 0.40) 21 0.97 (0.60; 1.48) 
Central highlands      
- Dak Lak 34.482 2 0.06 (0.01; 0.21) 6 0.17 (0.06; 0.38) 
South East      
- Binh Phuoc 8.580 0 - 0 - 
Overall 244.614 26 0.11 (0.07; 0.16) 46 0.19 (0.14; 0.25) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
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 Table 3-25 Incidence rate of Japanese encephalitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Japanese encephalitis  
Number of 
patients 
Incidence rate, 
95%CI (/105 
person-years) 
Number of 
patients 
aged <15 
years 
Proportion of 
population made 
up of children aged 
<15 years2 
Incidence rate in children 
<15 year old, 95%CI  
(/105 person-years) 
Mekong river delta 156.726 74 0.47 (0.37; 0.59) 70 0.24 2.07 (1.61; 2.61)3 
- Ca Mau 12.017 13 1.08 (0.58; 1.85) 12 0.25 3.99 (2.06; 6.98) 
- Bac Lieu1 6.470 0 - - - - 
- Soc Trang 25.783 24 0.93 (0.60; 1.39) 24 0.25 3.72 (2.39; 5.54) 
- Can Tho1 9.303 1 0.11 (0.00; 0.60) - - - 
- Tra Vinh 10.008 10 1.00 (0.48; 1.84) 10 0.23 4.34 (2.08; 7.99) 
- Dong Thap 16.625 8 0.48 (0.21; 0.95) 8 0.24 2.00 (0.87; 3.95) 
- An Giang 42.918 8 0.19 (0.08; 0.37) 7 0.24 0.68 (0.27; 1.40) 
- Kien Giang 33.602 10 0.30 (0.14; 0.55) 9 0.26 1.03 (0.47; 1.96) 
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Central Viet Nam 44.826 34 0.76 (0.53; 1.06) 31 0.27 2.56 (1.74; 3.64) 
- Khanh Hoa 23.090 9 0.39 (0.18; 0.74) 9 0.26 1.50 (0.69; 2.85) 
- Thua Thien - Hue 21.736 25 1.15 (0.74; 1.70) 22 0.28 3.61 (2.27; 5.47) 
Central highlands       
- Dak Lak 34.482 18 0.52 (0.31; 0.83) 15 0.31 1.40 (0.79; 2.31)4 
South East       
- Binh Phuoc 8.580 3 0.35 (0.07; 1.02) 3 0.29 1.21 (0.25; 3.52)5 
Overall 244.614 129 0.53 (0.44; 0.63) 119 0.26 2.00 (1.66; 2.39) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
2 Data of population by age group in the 2009 Vietnam population and house census (Table 3-3) (CP&HCSC 2010) 
3 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.81 (0.53; 1.23), p=0.323 
4 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.55 (0.30; 1.01), p=0.056 
5 In comparison with IR in Central Viet Nam, IRR (95%CI) = 0.47 (0.14; 1.54), p=0.213 
 
 
  
165
Table 3-26  Incidence rate of Dengue encephalitis by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Dengue encephalitis 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Mekong river delta 156.726 26 0.17 (0.11; 0.24) 
- Ca Mau 12.017 4 0.33 (0.09; 0.85) 
- Bac Lieu1 6.470 1 0.15 (0.00; 0.86) 
- Soc Trang 25.783 2 0.08 (0.01; 0.28) 
- Can Tho1 9.303 1 0.11 (0.00; 0.60) 
- Tra Vinh 10.008 0 - 
- Dong Thap 16.625 2 0.12 (0.01; 0.43) 
- An Giang 42.918 7 0.16 (0.07; 0.34) 
- Kien Giang 33.602 9 0.27 (0.12; 0.51) 
Central Viet Nam 44.826 9 0.20 (0.09; 0.38) 
- Khanh Hoa 23.090 5 0.22 (0.07; 0.51) 
- Thua Thien - Hue 21.736 4 0.18 (0.05; 0.47) 
Central highlands    
- Dak Lak 34.482 4 0.12 (0.03; 0.30) 
South East    
- Binh Phuoc 8.580 2 0.23 (0.03; 0.84) 
Overall 244.614 41 0.17 (0.12; 0.23) 
1 Only recruiting adult patients and calculating incidence rate per 100,000 person-
years ≥ 15 years of age. 
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3.4.5 Tuberculous meningitis 
3.4.5.1 Classification of tuberculous meningitis  
Tuberculous meningitis (TBM) was responsible for 10% (122/1241) of CNS 
infection cases (Table 3-2). Forty nine cases (40%) were confirmed by real-time PCR 
method. According to case definition of TBM, we classified 12/122 (10%) patients as 
probable TBM cases and 61/122 (50%) patients as possible TBM cases. 
3.4.5.2 Age distribution of tuberculous meningitis cases 
Proportion of TBM in paediatric CNS infection was 31/624 (4.97%) compared 
to 87/617 (14.10%) in adult patients (p<0.001) and these proportions were 
homogenous among age groups of children or adult population (Figure 3-8). 
 
 
 
 
 
 
 
 
 
 
  
167
Figure 3-8 Relative frequency of tuberculous meningitis cases by age group 
 
 
3.4.5.3 Geographic distribution of tuberculous meningitis cases 
Two third (82/122) of TBM cases lived in Mekong river delta and adult TBM 
was more common in Mekong river delta than other regions (p=0.010) (Table 3-27). 
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Table 3-27 Epidemiological characteristics of TBM patients1 
Region Adults Children 
TBM Non-TBM Total TBM Non-TBM Total 
Mekong delta river 67 
(18.98) 
286 
(81.02) 
353 
(100.00) 
15 
(4.85) 
294 
(95.15) 
309 
(100.00) 
Central Viet Nam 19 
(9.00) 
192 
(91.00) 
211 
(100.00) 
13 
(6.37) 
191 
(93.63) 
204 
(100.00) 
Central Highlands 3 
(7.89) 
35  
(92.11) 
38 
(100.00) 
2 
(1.92) 
102 
(98.08) 
104 
(100.00) 
South East 1 
(10.00) 
9  
(90.00) 
10 
(100.00) 
1 
(16.67) 
5  
(83.33) 
6 
(100.00) 
Others2 1 
(20.00) 
4  
(80.00) 
5 
(100.00) 
0 
(0.00) 
1  
(100.00) 
1 
(100.00) 
1 Proportions of TBM in CNS infection were significantly different among regions of 
Viet Nam in adult population (p=0.010, Fisher’s exact test), but were not significantly 
different in children population (p=0.178, Fisher’s exact test). 
2 Laos and Cambodia 
 
3.4.5.4 Incidence rate of tuberculous meningitis 
Incidence rate of tuberculous meningitis in surveillance provinces ranged from 
0.12 to 0.70 per 100,000 person-years but the average incidence rates of confirmed or 
unconfirmed TBM were not statistically different among Mekong river delta, Central 
Viet Nam, Central Highlands and South East (Table 3-6 and 3-28). 
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Table 3-28 Incidence rates of confirmed and probable/possible tuberculous meningitis (TBM) by provinces 
Province Total person-time 
of observation 
(× 105 person-years) 
Confirmed TBM Probable/possible TBM 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Number of 
patients 
Incidence rate, 95%CI 
(/105 person-years) 
Mekong river delta 156.726 31 0.20 (0.13; 0.28) 35 0.22 (0.16; 0.31) 
- Ca Mau 12.017 0 - 3 0.25 (0.05; 0.73) 
- Bac Lieu1 6.470 4 0.62 (0.17; 1.58) 2 0.31 (0.04; 1.12) 
- Soc Trang 25.783 8 0.31 (0.13; 0.61) 10 0.39 (0.19; 0.71) 
- Can Tho1 9.303 1 0.11 (0.00; 0.60) 2 0.21 (0.03; 0.78) 
- Tra Vinh 10.008 1 0.10 (0.00; 0.56) 1 0.10 (0.00; 0.56) 
- Dong Thap 16.625 1 0.06 (0.00; 0.34) 4 0.24 (0.07; 0.62) 
- An Giang 42.918 6 0.14 (0.05; 0.30) 5 0.12 (0.04; 0.27) 
- Kien Giang 
 
33.602 10 0.30 (0.14; 0.55) 8  0.24 (0.10; 0.47)  
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Central Viet Nam 44.826 9 0.20 (0.09; 0.38) 11 0.25 (0.12; 0.44) 
- Khanh Hoa 23.090 3 0.13 (0.03; 0.38) 5 0.22 (0.07; 0.51) 
- Thua Thien – Hue 21.736 6 0.28 (0.10; 0.60) 6 0.28 (0.10; 0.60) 
Central highlands      
- Dak Lak 34.482 1 0.03 (0.00; 0.16) 3 0.09 (0.02; 0.25) 
South East      
- Binh Phuoc 8.580 0 - 2 0.23 (0.03; 0.84) 
Overall 244.614 41 0.17 (0.12; 0.23) 51 0.21 (0.16; 0.27) 
 1 Only recruiting adult patients and calculating incidence rate per 100,000 person-years ≥ 15 years of age. 
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3.5 Discussion 
This chapter describes the prospective provincial hospital-based surveillance 
study on central nervous system infection in the Central and the South Viet Nam, of 
which the average incidence was 3.71 per 100,000 person-years. Streptococcus suis 
serotype 2, which caused nearly half of adult bacterial meningitis, was the most 
common pathogen in adults while Japanese encephalitis virus was the most important 
cause of CNS infection in children. However, a viral pathogen although suspected 
was not confirmed in 60% of the viral encephalitis/meningitis patients. 
3.5.1 Epidemiological characteristics of central nervous system infection 
CNS infection was more common in the rural than in the urban areas because 
83% of patients, in comparison with 75% of surveillance population, lived in the rural 
areas. Some pathogens, such as Japanese encephalitis virus, may need suitable 
environmental factors present in the rural areas for their transmission (Solomon 2004; 
CP&HCSC 2010). Infection susceptibility was higher in males than in females but the 
level of susceptibility varied in different types of CNS infection and age groups, in 
which male to female ratio ranged from 0.82 to 3.03 (Table 3-3 and 3-4). This ratio 
was similarly from 0.94 to 2.69 in other studies (Khwannimit et al. 2004; Thwaites et 
al. 2004; Glaser et al. 2006; Weisfelt et al. 2006; Nguyen et al. 2007; Afifi et al. 2009; 
Al-Tawfiq et al. 2009; Gurley et al. 2009; Mailles et al. 2009; Cho et al. 2010; 
Granerod et al. 2010). Reason of high proportion of male patients in CNS infection is 
unknown. 
 Viral encephalitis/meningitis was more common in children than in adults 
(69% vs. 34%). Children who had viral encephalitis/meningitis were also older than 
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children having bacterial meningitis. This phenomenon could be explained by 
different causes of CNS infection in different age groups (Peltola 2000; Solomon 
2004; Yen NT et al. 2010). In the age group < 1 year, JE was documented in 2/142 
patients, compared to 27/142 patients infected with H. influeanzae type b. However, 
the proportions were 86/287 and 3/287 in age group 5-15 years, respectively. 
 Seasonality of CNS infection was seen in both adult and paediatric group, in 
which June was the peak month. However, in the adult patients, it was only found at 
Hue Central hospital, where Streptococcus suis serotype 2 was responsible for nearly 
40% of adult CNS infection. Japanese encephalitis was responsible for approximately 
25% of paediatric CNS infection. These two pathogens, which tend to occur in the 
summer or the rainy season in the South-east Asia, could be the drivers of  the 
seasonality of CNS infection (Kay et al. 1995; Solomon et al. 2000; Wangkaew et al. 
2006; Wertheim et al. 2009).  In China and Thailand, more S. suis patients were also 
admitted during rainy season, from June to September, than during the rest of the 
year. A parallel investigation by animal health authorities into illness and deaths of 
pigs occurring in the same region of China revealed evidence of S. suis infection (Kay 
et al. 1995; Huang et al. 2005; Wangkaew et al. 2006). There may be a high bacterial 
load in food items that are kept at high ambient temperatures or an increase in pig 
illnesses at the high ambient temperatures and humidity. Hence, S. suis increasingly 
transmits to humans in the hottest months when they directly contact with pigs or raw 
pork. In the case of JE, epidemiological studies have shown that after the monsoon 
rains Culex mosquitoes, the main vector of JE, breed prolifically and the transmission 
of virus is increase. In addition, temperature may be an important factor because the 
prolonged mosquito larval development time and longer extrinsic incubation period of 
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JEV at cooler temperature, which thus reduce the rate of virus transmission, could be 
another explanation (Solomon et al. 2000).  
 CNS infection is a serious group of diseases because of the high morbidity and 
mortality. Case fatality rate (CFR) in this study was 12% in adult group and 7% in 
children, but it widely varied among the pathogens causing the CNS infection. CFR 
ranged from 5-10% in bacterial meningitis and viral encephalitis/meningitis while it 
was 30-40% in tuberculous meningitis. This CFR was related to deaths before 
prescribing anti-tuberculous drugs because most Vietnamese tuberculous meningitis 
patients are admitted to an infectious diseases unit or a neurology unit in a general 
hospital before being transferred to a specialist tuberculosis unit or hospital. In 
addition, another 65% of HIV infected and 25% of HIV uninfected TBM patients died 
after receiving treatment (Thwaites et al. 2004). Therefore, TBM could be the most 
serious CNS infection in Viet Nam because of delayed diagnosis or misdiagnosis. 
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3.5.2 Aetiology of central nervous system infection 
3.5.2.1 Bacterial meningitis 
Streptococcus suis serotype 2 was responsible for causing 24% of all CNS 
infections and 49% of bacterial meningitis cases in adults. It has been the most 
important cause of adult acute bacterial meningitis in Viet Nam for the past fifteen 
years (Mai et al. 2008; Wertheim et al. 2009). The overall incidence rate of 
Streptococcus suis meningitis in the adult population (≥ 15 years of age) was 0.57 per 
100,000 person-years but incidence rate of each surveillance province ranged from 0 
to 3.32 per 100,000 person-years. The highest incidence rate was documented in Thua 
Thien – Hue province and S. suis meningitis was not reported in 2 provincial and 1 
district hospitals, such as Tra Vinh, Binh Phuoc and Sa Dec (Table 3-16). However, 
lumbar puncture procedure was rarely performed in adult patients at Tra Vinh and Sa 
Dec hospital because the patient’s relative often refused this procedure and requested 
that their relative be transferred to Hospital for Tropical diseases (HTD) in Ho Chi 
Minh city. In the same period of surveillance study (from August 2007 to April 2010), 
HTD received 5 S. suis meningitis cases from these hospitals (2 of Tra Vinh, 2 of Sa 
Dec and 1 of Binh Phuoc). Incidence rate of S. suis meningitis was twice that of 
Streptococcus pneumoniae meningitis (0.43 vs. 0.20 per 100,000 person-years), which 
is the most common cause of bacterial meningitis in European countries and United 
States (Durand et al. 1993; Gjini et al. 2006). It was also reported as a common cause 
of acute adult bacterial meningitis in other intensive pig rearing countries in Asia, 
such as Thailand and China, but it was a rare cause in European countries, the United 
States and Australia (Table 3-29) (Kay et al. 1995; Suankratay et al. 2004; Willenburg 
et al. 2006; Yu et al. 2006; Tramontana et al. 2008; van de Beek et al. 2008).  
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 This surveillance study was conducted before H. influenzae type b conjugate 
vaccine was introduced to the National Expanded Program on Immunization in June 
2010. This pathogen, which caused 39/150 (26%) of childhood bacterial meningitis 
cases, was the most common pathogen identified in children. This proportion was 
similar to results reported in another study from Ho Chi Minh City in 1990s and in 
other studies in the world before the conjugate vaccine era (Table 3-30). The highest 
incidence rate in children aged less than 5 years was reported in Thua Thien – Hue 
province (6.33 per 100,000 child-years), compared to 3.76 in Dong Thap province and 
1.61 in Dak Lak province. The range of incidence rates among other surveillance 
studies in Asian countries was 0.98 to 28 per 100,000 child-years in children less than 
5 years of age (Shetty et al. 2010). Our incidence rates of H. influenzae type b 
meningitis in children < 5 years of age were lower than the estimated incidence rate in 
Ha Noi City (12 per 100,000 child-years) and in Nha Trang City (18 per 100,000 
child-years) (Anh DD et al. 2006; Anh et al. 2009). These two studies were conducted 
in the urban areas, where transmission rates of H. influenzae type b may be different 
to the rates in the rural areas.  
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Table 3-29 Pathogens of adult bacterial meningitis 
Pathogens, n(%) This study 
(n= 302) 
Viet Nam1
(n=450) 
Singapore2
(n=26) 
Hongkong3 
(n=35) 
Taiwan4
(n=263) 
Malawi5
(n=427) 
UK6
(n=2977) 
Neitherlands7 
(n=696) 
US8 
(n=253) 
S. suis 147 (49) 151 (34) 1 (4) 6 (17) 0 (0) 0 (0) 0 (0) 4 (1) 0 (0) 
S. pneumoniae 35 (12) 81 (18) 4 (15) 7 (20) 64 (24) 275 (64) 1307 (44) 352 (51) 97 (38) 
N. meningitidis 4 (1) 29 (7) 3 (12) 1 (3) 7 (3) 20 (5) 1177 (40) 257 (37) 35 (14) 
H. influenzae 0 (0) 7 (2) 0 (0) 0 (0) 6 (2) 3 (1) 132 (4) 14 (2) 9 (4) 
Listeria spp 0 (0) 0 (0) 2 (8) 2 (6) 6 (2) 0 (0) 127 (4) 30 (4) 29 (11) 
Gram negative bacilli (*) 8 (3) 23 (5) 2 (8) 10 (28) 112 (43) 22 (5) 185 (6) 6 (1) 9 (4) 
Other bacteria (**) 4 (1) 29 (6) 3 (11) 9 (26) 68 (26) 5 (1) 49 (2) 33 (5) 40 (16) 
Unknown pathogens 104 (34) 130 (29) 11 (42) N/A N/A 102 (24) N/A N/A 34 (13) 
(*) E. coli, Klebsiella spp, Acinetobacter spp 
(**) Other Streptococcus spp, Staphylococcus spp, Enterococcus spp. 
(1) (Mai et al. 2008) 
(2) (Chan et al. 2002) 
(3) (Hui et al. 2005) 
(4) (Tang et al. 1999) 
(5) (Scarborough et al. 2007) 
(6) (Gjini et al. 2006) 
(7) (van de Beek et al. 2004) 
(8) (Durand et al. 1993) 
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Table 3-30 Pathogens of paediatric bacterial meningitis before introducing H. influenzae type b conjugate vaccine to EPI# 
Pathogens, n(%) This study 
(n= 150) 
Viet Nam1
(n=86) 
Thailand2
(n=67) 
Saudi Arabia3
(n=38) 
Korea4
(n=276) 
Malawi5
(n=267) 
UK5 
(n=197) 
H. influenzae type b 39 (26) 30 (35) 9 (13) 12 (32) 63 (23) 44 (16) 53 (27) 
S. pneumoniae 37 (25) 24 (28) 1 (2) 13 (34) 91 (33) 62 (23) 22 (11) 
N. meningitidis 6 (4) - 3 (5) 7 (18) 16 (6) 7 (3) 111 (56) 
Other bacteria (*) 9 (6) 11 (13)$ 9 (13) 6 (16) 106 (38) 62 (24) 11 (6) 
Unknown pathogens 59 (39) 21 (24) 45 (67) N/A N/A 92 (34) N/A 
 
(*) E. coli, Klebsiella spp, Acinetobacter spp, Salmonella spp, Staphylococcus spp and Streptococcus spp 
(#) Expanded Program on Immunization 
($) N. meningitidis and other bacteria. 
(1) (Tran et al. 1998) 
(2) (Muangchana et al. 2009) 
(3) (Al-Tawfiq et al. 2009) 
(4) (Cho et al. 2010) 
(5) (Molyneux et al. 2006) 
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3.5.2.2 Viral encephalitis/meningitis 
Diagnosis as well as identifying the causes of viral encephalitis/meningitis is 
one of the greatest challenges facing physicians. Many prospective surveillance 
studies have reported that at least 60% of patients hospitalized with encephalitis had 
no cause identified despite extensive laboratory testing (Glaser et al. 2006; Yong et al. 
2008; Huppatz et al. 2009; Granerod et al. 2010). Our study, which was not an 
exception, focused on the common viral pathogens of encephalitis/ meningitis in Viet 
Nam, such as Japanese encephalitis, Dengue virus and enteroviruses, but the 
proportion with no pathogen identified was approximately 60% of all cases of 
encephalitis/meningitis (Table 3-19) (Ha et al. 1994; Solomon et al. 2000; Tu et al. 
2007).  However, this proportion might be reduced when immune-mediated causes, 
such as acute disseminated encephalomyelitis, N-methyl-D-aspartate (NMDA) 
receptor antibodies and voltage-gated potassium channel (VGKC) antibodies, were 
further investigated (Granerod et al. 2010). The aetiology of viral encephalitis 
/meningitis varies in different geographic settings, especially in the case of 
flaviviruses. Japanese encephalitis virus is the most important cause of encephalitis in 
South-east Asia. It was responsible for 24% of viral encephalitis/meningitis cases and 
over 90% of these cases were reported in children aged <15 years in this study. 
Japanese encephalitis rarely occurs in adults who live in endemic regions because 
serologic surveys have showed that almost everyone was exposed to virus during their 
childhood and is subsequently immune (Solomon 2004). Japanese encephalitis may 
be more common in the north of Viet Nam than in the central and south of Viet Nam. 
It caused 217/421 (50%) of acute encephalitis syndrome cases in five northern 
provinces (Yen NT et al. 2010). The range of incidence rates among the surveillance 
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provinces was 1.03 to 4.34 per 100,000 child-years in children less than 15 years of 
age but the average incidence rates of 4 regions, such as Mekong river delta, South 
East, Central Viet Nam and Central Highlands, were not statistically different (Table 
3-25). Japanese encephalitis is the most common identified cause of encephalitis in 
Vietnamese children. 
 In 2009, over 100,000 dengue cases, which accounted for 40% of the Western 
Pacific Region’s dengue cases, were reported in Viet Nam (WHO 2009). Dengue has 
become one of the most important epidemic diseases in this country. Neurological 
manifestations of dengue infection were reported in 0.5 – 6% of hospitalized dengue 
hemorrhagic fever patients (Hendarto et al. 1992; Solomon et al. 2000; Cam et al. 
2001). Encephalopathy in dengue infection is well recognized but it remains unclear 
whether encephalopathy is caused by direct infection of virus in the central nervous 
system or indirectly via other mechanisms, such as liver failure, cerebral 
hypoperfusion, cerebral oedema and intracranial bleeding. However, detection of 
virus or anti-dengue IgM in the cerebrospinal fluid of a patient with encephalopathy 
after excluding other causes suggests that dengue virus may cause central nervous 
system infection (Varatharaj 2010). In this study, dengue virus, detected by the 
presence of specific IgM in CSF, was the only pathogen in 39/641 suspected viral 
encephalitis/meningitis cases (6.1%), including 25 adults and 14 children. Blood in 
the CSF sample (>5 red blood cells (RBC)/μl), which had the range of 12-38750 
RBCs/μl, was found in 11/39 patients (data not shown). Our result are similar to other 
studies in the dengue endemic region, where the proportion of encephalitis cases 
related to dengue virus ranged from 4.2% to 47% (Solomon et al. 2000; Srey et al. 
2002; Jackson et al. 2008; Le et al. 2010; Soares et al. 2011). Dengue should be 
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considered in patients who present with the clinical features of encephalitis, whether 
or not classical manifestations of dengue are present (Solomon et al. 2000; Varatharaj 
2010). 
 Herpes simplex is one of the most common causes of encephalitis in European 
countries and in the United States, in which it caused 25% to 60% of confirmed viral 
encephalitis cases (Table 3-31). This pathogen was responsible for 6% of suspected 
viral encephalitis/meningitis cases in this study. Herpes simplex encephalitis was 
more common in adults than in children (10% vs. 3% of suspected viral encephalitis/ 
meningitis).  
Enteroviruses were also amongst the most common causes of viral meningitis 
in Europe and North America (Lee et al. 2006; Ihekwaba et al. 2008). In this study, 
these viruses were reported as the second most common pathogen in both adults and 
children. However, 15/20 adult patients, compared to 6/36 paediatric patients, lived in 
Thua Thien – Hue province and 14/15 these adults, compared to none of the children, 
were admitted to Hue Central hospital in the period from June to September 2009 
(Figure 3-4). This means most of adult enteroviruses encephalitis/meningitis cases 
observed in our study might be related to an outbreak in Thua Thien – Hue province 
in the summer of 2009.  
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Table 3-31 Viral pathogens of encephalitis/meningitis 
Pathogens, n(%) This study 
(n= 641) 
Viet Nam1
(n=194)(**) 
Cambodia2 
(n=81) 
Malaysia3
(n=220) 
France4
(n=90) 
UK5
(n=58) 
US6 
(n=170) 
Japanese encephalitis virus (JEV) 153 (24) 50 (26) 16 (9) - (***) - - - 
Dengue virus 37 (6) 9 (5) 5 (6) - - - - 
Enteroviruses 56 (9) 18 (9) 0 (0) 9 (4) 2 (2) 3 (5) 43 (25) 
Herpes simplex 36 (6) 1 (1) 0 (0) 21 (10) 55 (61) 38 (66) 45 (26) 
Varicella-zoster virus - - - 3 (1) 20 (22) 10 (17) 23 (14) 
West Nile virus - - - - 1 (1) - 19 (11) 
Epstein-Barr virus - - - - 3 (3) 1 (2) 17 (10) 
Cytomegalovirus - 1 (1) - 15 (7) 3 (3) - - 
Other causes (*) - 1 (1) 3 (4) 18 (8) 6 (7) 6 (10) 23 (14) 
Unknown pathogen 359 (56) 114 (59) 57 (70) 154 (70) N/A N/A N/A 
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(*) Measles, rabies, HIV, Hepatitis C virus, tick-borne encephalitis, Toscana virus, Influenza A, Human herpesvirus-6, rubella virus, parvovirus 
and JC virus. 
(**) Only patients less than 16 years of age were recruited. 
(***) RNA of JEV was detected in 10 patients’ sera. 
(1) (Le et al. 2010) 
(2) (Srey et al. 2002) 
(3) (Yong et al. 2008) 
(4) (Mailles et al. 2009) 
(5) (Granerod et al. 2010) 
(6) (Glaser et al. 2006) 
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3.5.2.3 Tuberculous meningitis 
Rapid and early diagnosis of tuberculous meningitis is fundamental to patient 
outcome. Physicians face numerous difficulties in establishing a TBM diagnosis, 
including the non-specific manifestations, low sensitivity of Ziehl-Neelsen staining 
and nucleic acid amplification and slowness of culture (Thwaites et al. 2000). To 
diagnose TBM in this study, we applied the consensus case definition of TBM, which 
included clinical, CSF, cerebral imaging information and could be used regardless of 
patient’s age and HIV status (Marais et al. 2010). A commercial real-time PCR test, 
which had a sensitivity of 67% and the specificity of 94% after validation, was used to 
help confirm TBM. Ranking after Streptococcus suis serotype 2 meningitis and 
Japanese encephalitis, TBM, which was confirmed in 49/122 (40%) patients, was the 
third most common cause of CNS infection in Viet Nam. While TBM was the cause 
of 143/357 (40%) adult suspected CNS infection admitted to Hospital for Tropical 
Diseases (HTD), (Thwaites et al. 2002), the overall TBM proportion and its 
proportion stratified for adults and children were 10% (122/1241), 15% (91/617) and 
5% (31/624), respectively in this study. TBM cases made up about 0.2% of total 
tuberculosis cases in the south of Viet Nam (Table 3-32). This is the first report of 
TBM in a context of CNS infection in Vietnamese provincial hospitals. The 
proportion of TBM at HTD was higher than those observed in our study because HTD 
receives TBM cases misdiagnosed as purulent bacterial meningitis from provincial 
hospitals. The protective role of BCG vaccination against TBM in children could 
explain why TBM was less common in children than in adults (Kumar et al. 2005; 
Trunz et al. 2006). 
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Table 3-32 Proportion of TBM in the total cases of tuberculosis in the south of 
Viet Nam 
Province TBM Total TB cases1 Proportion of TBM 
(%, 95%CI) 
Ca Mau 2 1326 0.15 (0.13-0.17) 
Bac Lieu 5 998 0.50 (0.46-0.55) 
Soc Trang 18 3664 0.49 (0.47-0.51) 
Can Tho 3 2004 0.15 (0.13-0.17) 
Dong Thap 5 2801 0.18 (0.16-0.19) 
An Giang 11 9100 0.12 (0.11-0.13) 
Kien Giang 16 5129 0.31 (0.30-0.33) 
Tra Vinh 2 1405 0.14 (0.12-0.16) 
Binh Phuoc 2 864 0.23 (0.20-0.27) 
Total 64 27291 0.23 (0.23-0.24) 
1 Data from Report of Viet Nam National Tuberculosis Control Programme 2008 – 
2009 (MoH 2008; MoH 2009) 
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3.5.2.4 Dual infections in CNS infection: 
Dual infections in CNS infection, such as among members of herpesviruses or 
between a member of this group and a bacterium, were previously reported in both 
immunocompetent and immunocompromised patients by using PCR methods and/or 
intrathecal antibody determinations (Casas et al. 1996; Koskiniemi et al. 1996; Tang 
et al. 1997; Yamamoto et al. 2000; Weinberg et al. 2005; Vianello et al. 2008). In this 
study, we found 20 dual infection cases in 1241 suspected CNS infection patients. 
Most of these cases (18/20 cases) were infected with an endemic virus (Japanese 
encephalitis virus, dengue virus or enteroviruses) and a bacterium. In addition to 118 
CSF samples of patients with suspected TBM according to the case definition, TBM 
PCR test was also done on another 10 CSF samples in which a pathogen had been 
identified, including 6 cases of dengue virus, 2 cases of S. suis serotype 2, 1 case of 
enteroviruses and 1 case of K. pneumoniae. Clinical manifestations and CSF 
parameters of these patients mimicked tuberculous meningitis. Four out of ten patients 
were found to contain M. tuberculosis DNA in their CSF samples (Table 3-10). Dual 
infection of JEV and enteroviruses or H. influenzae type b and enteroviruses was also 
reported in other studies in the South-east Asia (Ooi et al. 2007; Le et al. 2010). Our 
findings emphasize the role of these viruses as a co-infection pathogen in an endemic 
region.  
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3.5.2.5 Limitation of the study: 
According to the report of the Ministry of Health on the HIV/AIDS status in 
Viet Nam, the total number of HIV infected and AIDS patients alive in the country in 
2009 were 160,019 cases and 35,603 cases, respectively (MoH. 2010). Prevalence of 
HIV infection in Viet Nam was 187 cases per 100,000 inhabitants (MoH. 2010). 
Cryptococcus neoformans is one of the most important HIV-related opportunistic 
infections in the South-east Asia, where one third of CNS infection in HIV/AIDS 
patients related to this pathogen (Tansuphasawadikul et al. 1999; Ganiem et al. 2009; 
Park et al. 2009; Le et al. 2010). It can also be found in CNS infection in HIV 
uninfected patients in Viet Nam, in which 57 cases were admitted to Hospital for 
Tropical diseases (HTD) in a period of 10 years (Chau et al. 2010). However, only 
two cryptococcal meningitis cases were reported in our study. The unexpected rarity 
of this fungus could be explained by the limitation of microbiological culture facilities 
at the provincial hospitals or by the fact that lumbar punctures were not performed in 
HIV infected patients at these hospitals. There was only 10/617 (1.6%) HIV infected 
adult patients and none of paediatric patients with HIV infection recruited to study. In 
Viet Nam, attending physicians rarely do lumbar puncture on HIV patients at remote 
provincial hospitals because of their poor prognosis or relative’s refusal. The number 
of TBM patients might be also underestimated because of low HIV prevalence of the 
study sample.  
Another cause of CNS infection, eosinophilic meningitis, might also be under-
reported. Fifty six adult patients with eosinophilic meningitis, who mostly lived in the 
Mekong river delta, were admitted to HTD between January 2002 and December 
2005 (Le et al. 2007). The diagnosis relied on detection of eosinophil granulocytes in 
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CSF samples, but some provincial hospital’s laboratories were unable to differentiate 
these cells from neutrophil granulocytes in CSF samples. 
Confirmation of Japanese encephalitis and dengue encephalitis in our study 
relied on detection of specific IgM antibodies in CSF sample. Some CSF samples 
could have false negative result, especially in the early course of disease, because we 
only collected and tested the CSF samples on admission. 
CNS infection is a serious disease in human, which has high mortality and 
morbidity.  About 30% of patients admitted to hospital with JE die and half of the 
survivors have severe neurological sequelae, such as motor deficits, severe cognitive 
and language impairment (Solomon et al. 2000). In a randomized, double-blind, 
placebo-controlled trial of adjunctive dexamethasone in TBM treatment in Viet Nam, 
199/545 (37%) and 56/545 (10%) of patients were dead or got severe disability nine 
months after treatment, respectively (Thwaites et al. 2004). Apart from the deafness 
of patients, lack of morbidity data (neurological sequelae) is another limitation of this 
study. Hearing loss was documented in 46/149 (31%) of S. suis patients, compared to 
93/151 (62%) in a case-series study in Viet Nam (Mai et al. 2008). The higher rate of 
deafness in this case-series study could be explained by using audiogram testing.  
 Though CNS infection is serious enough to admit patients directly to 
provincial hospitals and most of CSF samples were taken there, this prospective 
hospital-based surveillance study could underestimate the incidence rates of CNS 
infection. Some patients that lived near a neighbouring provincial hospital could be 
admitted to this hospital, instead of to the provincial hospital of their province of 
residence. Some CSF samples may not have been collected because of deaths before 
admission, mild presentation of some viral meningitis cases, contraindications to 
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lumbar puncture procedure and the patients or relative’s refusal for a lumbar puncture. 
The high use of antimicrobial agents in the community prior to admission could also 
decrease the possibility of bacterial isolation in the CSF samples. To overcome the 
limitations, we calculated incidence rates according to home address of patients and 
used real-time PCR method to identify the most common pathogens of bacterial 
meningitis in Viet Nam, such as S. suis serotype 2, S. pneumoniae, H. influenzae type 
b and N. meningitidis. 
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3.6 Conclusions 
This is the first prospective provincial hospital-based surveillance study on the 
aetiology of central nervous system infection across Viet Nam. By using molecular 
diagnostic, serological and culture methods, we identified the pathogens in 640/1241 
(52%) suspected CNS infection cases. The three most common pathogens in children 
were Japanese encephalitis virus, Haemophilus influenzae type b and Streptococcus 
pneumoniae.  These organisms, which caused meningitis or encephalitis in at least 
one third of paediatric patients, could be prevented by implementing vaccination 
programmes with available vaccines in childhood. Meanwhile, Streptococcus suis 
serotype 2 meningitis, an emerging zoonosis in intensive pig-rearing countries, caused 
one fourth (147/617) of adult suspected CNS infection or a half (147/302) of adult 
purulent bacterial meningitis in Viet Nam. It was reported as an endemic pathogen in 
all of surveillance regions as well as in the north of Viet Nam (Wertheim et al. 2009). 
We need more epidemiological studies on risk factors, pathophysiology, treatment 
and prevention of this disease in both humans and pigs. The overall case fatality rate 
of CNS infection was 10%. However, we found that case fatality rate of TBM 
exceeded 30% at the provincial hospitals before TBM diagnosis was established. As 
patient outcome is directly related to early diagnosis and treatment, physicians should 
always think of tuberculous meningitis in the context of CNS infection in developing 
countries. 
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Chapter 4 
Human Streptococcus suis serotype 2 meningitis in Viet Nam 
4.1 Introduction 
Streptococcus suis, a Gram-positive facultatively anaerobic coccus, is a 
commensal in the respiratory, alimentary and genital tracts of swine. It can cause a 
wide range of diseases in pigs, such as meningitis, pneumonia, septicaemia and 
arthritis (Windsor et al. 1975; Gottschalk et al. 2007). According to its capsular 
antigen, thirty five serotypes isolated from pigs have been described, but serotypes 32 
and 34 were recently identified as Streptococcus orisratti by biochemical analysis and 
sequencing (Hill et al. 2005). Among these serotypes, serotype 2 is the most important 
serotype causing invasive diseases in both human and pig (Staats et al. 1997; Lun et 
al. 2007; Wertheim et al. 2009). Since the first human case report of S. suis infection 
in Denmark in 1968, increasing numbers of cases have been reported in many 
European and Asian countries, including the Netherlands, United Kingdom, Hong 
Kong and Thailand (Arends et al. 1988; Walsh et al. 1992; Kay et al. 1995; 
Vilaichone et al. 2002). In Viet Nam, alpha-haemolytic streptococci have been 
reported as a cause of adult bacterial meningitis at Hospital for Tropical Diseases 
(HTD), since 1995. Since then, the stored isolates were identified as Streptococcus 
suis serotype 2. The number of human cases has increased annually in concurrence 
with a significant expansion in the scale of the pig farming industry in Viet Nam both 
in small household and large-scale intensive farming. Around 40% of adults with 
acute bacterial meningitis patients admitted to HTD have been diagnosed with S. suis 
meningitis since the year 2000 (Mai et al. 2008). Only 30% of S. suis meningitis 
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patients lived in Ho Chi Minh City while the remaining lived in other provinces in 
southern Viet Nam. However, the pathogen has only been reported at HTD and at 
another tertiary referral hospital for infectious diseases in Ha Noi (Wertheim et al. 
2009) until to date. Whether S. suis infection is also commonly found in patients in 
other hospitals, and thus can be considered a major public health problem in Viet 
Nam, is unknown. Hence, I conducted a prospective hospital-based surveillance study 
of S. suis infection to determine the incidence rate of S. suis infection, at provincial 
hospitals in central and southern of Viet Nam. 
4.2 Aims 
1. To describe the epidemiological characteristics of Streptococcus suis 
infection, such as age, sex, occupational exposures to pigs, seasonality, 
clinical and laboratory manifestations and outcomes, in central and southern 
Viet Nam. 
2. To calculate the incidence rates of Streptococcus suis infection in each 
province and to compare these with the pig density. 
3. To describe antimicrobial susceptibility of Streptococcus suis strains isolated 
from human blood and cerebrospinal fluid. 
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4.3 Materials and Methods 
Materials and Methods are presented in the Section 2.3.1, 2.4.2, 2.4.5 and 2.5. 
4.4 Results 
Between August 2007 and April 2010, we recruited 1645 patients suspected of 
central nervous system infection at 10 provincial, 2 central and 1 district hospitals in 
the final analysis, including 774 adult patients and 871 paediatric patients, after 
excluding 95 patients whose clinical information was unavailable. S. suis was 
identified in 9 of 95 excluded patients (see Section 3.4). We identified 149 
Streptococcus suis serotype 2 meningitis cases by real-time PCR and culture methods. 
The bacterium was isolated from CSF and/or blood culture samples of 105 patients. 
These strains were reported as Streptococcus spp, Streptococcus group D, alpha or 
gamma haemolytic Streptococcus, Enterococcus faecalis or Enterococcus faecium in 
the provincial hospitals. Only at Hue Central hospital, streptococcal isolates were 
correctly identified as S. suis. In this hospital, identification of strains using APIStrep 
(Biomerieux) was available. CSF and blood cultures of another 44 patients were 
negative, but specific DNA sequence of S. suis serotype 2 was detected in their CSF 
samples by PCR. Two patients had negative result of PCR of the CSF samples 
collected after 7-10 days of admission while S. suis serotype 2 was isolated from their 
CSF samples collected on admission.   
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4.4.1 Characteristics of Streptococcus suis meningitis patients 
4.4.1.1 Epidemiological characteristics of S. suis meningitis patients 
S. suis meningitis predominantly occurred in middle-aged male persons. 
Seventy percent of patients were older than 45 years old and no patient was younger 
than15 years old. The ratio between males and females was 4:1. Underlying diseases 
were reported in 26/149 patients, including alcoholism in 25/149 (17%) patients and 
splenectomy in 1/149 (0.67%) patient. Pig exposures, such as breeding pigs at home, 
slaughtering pigs and eating undercooked blood/organs, were described in 59/149 
(40%) patients. Bacterial meningitis, the most common manifestation of S. suis 
infection, was responsible for 146/149 (98%) cases, and septic shock, the most serious 
manifestation, was reported in 3/149 cases (2%), all at Hue Central hospital (Table 4-
1). 
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Table 4-1 Epidemiological characteristics of S. suis meningitis patients 
Characteristics Patients (n=149) 
Age (years), median (IQR) 53 (42; 60) 
Age groups (years), n (%)  
- <15 0 (0.00) 
- 15 – 29  6 (4.03) 
- 30 – 44 38 (25.50) 
- 45 – 59 64 (42.95) 
- ≥ 60 41 (27.52) 
Male sex, n (%) 118 (79.19) 
Rural, n (%) 118 (79.19) 
Regions, n/x 3 (%)  
- Mekong river delta 75/662 (11.33) 
- Central Viet Nam 70/415 (16.87) 
- Central Highlands 3/142 (2.11) 
- Other (Cambodia and Laos) 1/6 (16.67) 
Ethnicity, n (%)  
- Kinh 136 (91.28) 
- Khmer 12 (8.05) 
- Co Tu 1 (0.67) 
Underlying diseases, n (%)  
- Alcoholism 25 (16.78) 
- Splenectomy 1 (0.67) 
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Pig exposures, n (%)  
- Pigs at home 37 (24.83) 
- Exposures to pigs or pork1 36 (24.16) 
- Eating undercooked pig blood or organs2 26 (17.45) 
- At least one of three above factors 59 (39.60) 
Diagnosis, n (%)  
- Bacterial meningitis 146 (97.99) 
- Septic shock 3 (2.01) 
Duration of hospital stay (days), median (IQR) 19 (14; 23) 
1 Bathing, feeding and slaughtering pigs; cleaning up the piggery and preparing or 
handling blood, organs from pigs 
2 Fresh/undercooked blood, tonsils, tongue, stomach, intestines and uterus. 
3 x is the number of patients recruited in each region. 
4.4.1.2 Seasonality of S. suis meningitis 
The admission characteristics of S. suis meningitis cases followed a seasonal 
distribution (p<0.001), of which the peak month was estimated as July and the 
amplitude of difference (peak month vs. average) was + 70% (95%CI [+34%; 
116%]). A linear time trend analysis of infection showed an increase of 38% per year 
(95%CI [6%; 81%], p=0.018) which remained significant after adjustment for 
overdispersion (p=0.033). However, seasonality seemed to be driven by the admission 
characteristics of Hue Central hospital only. In an analysis for each of the hospitals, 
the test for seasonality was significant for Hue hospital (p<0.001) while it was not 
significant for all other hospitals (p=0.31). A linear time trend analysis of infection in 
Hue, showed an increase of 73% per year (95%CI [12%; 170%], p=0.013) and which 
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remained significant after adjustment for overdispersion (p=0.033). Such trend was 
not observed for other hospitals than Hue (p=0.15) (Figure 4-1). 
 
Figure 4-1 Time distribution of S. suis meningitis admission by hospitals 
 
 Admission of S. suis patients coincided with high air temperature for hospitals 
in North Central Viet Nam (Figure 4-2). 
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Figure 4-2 Admission of S. suis meningitis and monthly mean air temperature in Hue Central hospital 
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4.4.1.3 Clinical and laboratory characteristics of S. suis meningitis 
Patients with S. suis meningitis presented within a median of 3 days of illness 
Over 90% patients had typical manifestations of meningitis, such as fever, headache, 
vomiting and meningeal signs. Ninety eight of 149 patients (66%) were confused on 
admission. Hemorrhagic rash, similar to the rash of meningococcemia, was reported 
in 6/149 (4%) patients. The white cell count of the cerebrospinal fluid, which was 
cloudy in 70% of patients, was greater than 240/μl in 108/145 (75%) of patients and 
the percentage of neutrophiles was greater than 60% in 94/124 (76%) of patients. 
High CSF protein and low CSF glucose were recorded in most of patients. Although 
67/149 (45%) of patients had received antibiotics prior to admission, CSF and/or 
blood culture were positive in 105/149 (70%) patients. For the remaining 30% of 
patients, S. suis infection was confirmed by real-time PCR method (Table 4-2). 
Overall case fatality rate (CFR) was 8% (12/149), but CFR of septic shock 
cases reached 100% (3/3), compared to 9/146 (6%) of meningitis cases. Septic shock 
patients were admitted in 2 or 3 days of illness and none of them received 
antimicrobial treatment prior to admission. Pig exposure was only reported in one 
patient who reported to breed pigs, and who also suffered from alcoholism. Eating 
fresh blood or undercooked pig intestines was not documented in these patients. All of 
them had hemorrhagic rash, altered consciousness and meningitis syndrome. S. suis 
serotype 2 was isolated from CSF samples of 3/3 patients and from blood samples of 
2/3 patients. In addition, 46/149 (31%) patients suffered hearing impairment at 
discharge, of which deafness was recorded in 18/149 (12%) patients. Patients with 
hearing impairment were older than patients without this sequela, 55 years of age 
(median) compared to 50 years of age, respectively (p= 0.012) (Table 4-3). 
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Table 4-2 Clinical and laboratory characteristics of S. suis meningitis patients 
Characteristics 
 
Adult patients  
(n=149) 
Duration of illness (days), median (IQR) 3 (2; 4) 
Clinical manifestations, n (%)  
- Fever 145 (97.32) 
- Headache 139 (93.29) 
- Nausea/Vomiting 107 (71.81) 
- Neck stiffness 130 (87.25) 
- Diarrhea 8 (5.37) 
- Tinnitus  46 (30.87) 
- Deafness 18 (12.08) 
- Altered consciousness 98 (65.77) 
- Convulsion 18 (12.08) 
- Hemiplegia 6 (4.03) 
- Cranial nerve palsy 4 (2.68) 
- Herpes labialis 9 (6.04) 
- Hemorrhagic rash 6 (4.03) 
Laboratory investigations, median (IQR)  
- White blood cells 15400 (11200; 20400) 
o Percentage of neutrophiles 88 (81.5; 91.6) 
o Percentage of lymphocytes 7 (4.3; 10.4) 
- Platelets 
 
159500 (106000; 206500) 
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- Cerebrospinal fluid  
o Cloudy, n (%) 106 (71.14) 
o White cells 882 (240; 3100) 
o Percentage of neutrophiles 85 (63.5; 90) 
o Protein (g/l) 2.15 (1.2; 3.83) 
o Glucose (mmol/l) 0.9 (0.3; 2) 
o Ratio of CSF and blood 
glucose 
0.11 (0.04; 0.25) 
- CSF Gram stain positive, n (%) 43 (28.86) 
- CSF culture positive, n (%) 102 (68.46) 
- CSF PCR positive, n/N (%) 114/116 (98.28) 
- Blood culture positive, n/x (%) 33/90 (36.67) 
No antibiotics prior to admission, n (%) 82 (55.03) 
Outcomes, n (%)  
- Alive 127 (85.23) 
- Died 12 (8.05) 
- Transferred to other hospital 10 (6.71) 
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Table 4-3 Comparison of characteristics of patients with and without hearing 
impairment1 
Characteristics Hearing impairment 
(n= 46) 
Normal hearing 
(n= 83) 
p value 2
Duration of illness 
(days), median (IQR) 
3 (2; 5) 3 (2; 4) 0.207 
No antibiotics prior 
admission, n (%) 
25 (54.35) 49 (59.04) 0.606 
Age (years), median 
(IQR) 
55 (46; 63) 50 (41; 58) 0.012 
Male sex, n (%) 34 (73.91) 67 (80.72) 0.369 
Kinh ethnicity, n (%) 41 (89.13) 78 (93.98) 0.327 
Pig exposures3, n (%) 14 (30.43) 15 (18.07) 0.107 
Eating habit4, n (%) 6 (13.04) 15 (18.07) 0.459 
1 Twenty cases with missing data on hearing impairment were excluded. 
2 Using Chi-square test or Fisher’s exact test (when one or more of the expected count 
is less than 5) for categorical variables and Wilcoxon rank sum test for continuous 
variables. 
3 Pig breeder, butcher, and abattoir worker 
4 Eating fresh blood, pig intestines and uterus. 
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4.4.2 Incidence rate of Streptococcus suis serotype 2 meningitis 
The overall incidence rate of S. suis serotype 2 meningitis was 0.57 per 
100,000 adult person-years. The incidence rate was highest in Thua Thien – Hue 
province with 3.32 per 100,000 adult person-years. It also increased significantly with 
incremental age group. Incidence rate in age group 60+ was 30 times higher than in 
age group 15-29 (1.66 compared to 0.05 per 100,000 person-years) (Table 4-4, 4-5, 4-
6 and 4-7). 
In addition, this study addressed whether the incidence of S. suis infection 
could be related to the development of pig rearing industry in the community. Figure 
4-3 depicts the distribution of S. suis meningitis cases and the corresponding 
provincial pig density on the Viet Nam map. Figure 4-4 shows the incidence rate per 
province and the corresponding provincial pig density. Mapping did not show a clear 
association between a high pig density and incidence rate of S. suis infection. I did not 
find any evidence for an association of the incidence rate of human S. suis infection 
and pig density (p=0.62). Maybe, pig density varies by month but I do not have this 
information, except the mean pig density in a whole year. 
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Table 4-4 The incidence rates of Streptococcus suis serotype 2 meningitis in adult 
population by regions  
Regions Total person-time
of observation 
(× 105 person-
years) 
Adult population (≥  15 years of ages) 
Proportion of 
adult group1 
Number of 
patients 
Incidence rate 
(95%CI) 
Mekong river delta 161.324 0.76 48 0.39 (0.29; 0.52) 
- Ca Mau 12.017 0.75 3 0.33 (0.07; 0.97) 
- Bac Lieu 8.475 0.76 1 0.16 (0.00; 0.87) 
- Soc Trang 25.783 0.75 10 0.52 (0.25; 0.95) 
- Can Tho 11.896 0.78 4 0.43 (0.12; 1.10) 
- Tra Vinh 10.008 0.77 0 - 
- Dong Thap 16.625 0.76 2 0.16 (0.02; 0.57) 
- An Giang 42.918 0.76 5 0.15 (0.05; 0.36) 
- Kien Giang 33.602 0.74 23 0.92 (0.59; 1.39) 
Central Viet Nam 44.826 0.73 55 1.68 (1.27; 2.19) 
- Khanh Hoa 23.090 0.74 3 0.18 (0.04; 0.51) 
- Thua Thien-Hue 21.736 0.72 52 3.32 (2.48; 4.36) 
Central Highlands     
- Dak Lak 34.482 0.69 3 0.13 (0.03; 0.37) 
South East     
- Binh Phuoc 8.580 0.71 0 - 
Overall 249.212 0.74 106 0.57 (0.47; 0.70) 
1 Using data of population by age group from the 2009 Vietnam population and house 
census (Table 2-2) (CP&HCSC 2010) 
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Figure 4-3 Map of human S. suis cases with background pig density data1 
 
1 Pig density was retrieved from Statistical Yearbook of Viet Nam 2009 (GSO 2010) and each 
red dot represents one human S. suis case.  
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Figure 4-4 Map of incidence rate of S. suis infection per province with 
background pig density data1   
 
1 Pig density was retrieved from Statistical Yearbook of Viet Nam 2009 (GSO 2010)  
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Table 4-5 Incidence rate of Streptococcus suis serotype 2 meningitis by age groups and regions (A) 
Regions Total person-time 
of observation 
(× 105 person-
years) 
Age group (years) 
15-29 30-44 
Proportion of 
age group5 
Number 
of 
patients 
Incidence rate 
(95%CI) 
Proportion of 
age group5 
Number 
of 
patients 
Incidence rate 
(95%CI) 
Mekong river delta1 161.324 0.30 2 0.04 (0.01; 0.15) 0.24 17 0.44 (0.26; 0.70) 
Central Viet Nam2 44.826 0.28 2 0.16 (0.02; 0.58) 0.23 8 0.78 (0.33; 1.53) 
Central Highlands3 34.482 0.29 0 - 0.22 0 - 
South East4 8.580 0.30 0 - 0.23 0 - 
Overall 249.212 0.30 4 0.05 (0.01; 0.14) 0.23 25 0.44 (0.28; 0.64) 
1 Ca Mau, Bac Lieu, Soc Trang, Can Tho, Tra Vinh, Dong Thap, An Giang and Kien Giang. 
2 Thua Thien – Hue and Khanh Hoa. 
3 Dak Lak 
4 Binh Phuoc 
5 Applying data of population by age group in the 2009 Vietnam population and house census (Table 2-2) (CP&HCSC 2010) 
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Table 4-6 Incidence rate of Streptococcus suis serotype 2 meningitis by age groups and regions (B) 
Regions Total person-time 
of observation 
(× 105 person-
years) 
Age group (years) 
45-59 60+ 
Proportion of 
age group5 
Number 
of 
patients 
Incidence rate 
(95%CI) 
Proportion of 
age group5 
Number 
of 
patients 
Incidence rate 
(95%CI) 
Mekong river delta1 161.324 0.14 19 0.84 (0.51; 1.31) 0.08 10 0.77 (0.37; 1.42) 
Central Viet Nam2 44.826 0.14 23 3.66 (2.32; 5.50) 0.09 22 5.45 (3.42; 8.26) 
Central Highlands3 34.482 0.12 2 0.48 (0.06; 1.75) 0.06 1 0.48 (0.01; 2.69) 
South East4 8.580 0.13 0 - 0.06 0 - 
Overall 249.212 0.14 44 1.26 (0.92; 1.69) 0.08 33 1.66 (1.14; 2.32) 
1 Ca Mau, Bac Lieu, Soc Trang, Can Tho, Tra Vinh, Dong Thap, An Giang and Kien Giang. 
2 Thua Thien – Hue and Khanh Hoa. 
3 Dak Lak 
4 Binh Phuoc 
5 Applying data of population by age group in the 2009 Vietnam population and house census (Table 2-2) (CP&HCSC 2010) 
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Table 4-7 Comparison of incidence rates of S. suis meningitis across age groups 
Overall 
incidence rate 
Incidence Rate Ratio (IRR) 95% CI of IRR p value 
15-29 1 - - 
30-44 vs. 15-29 8.15 [2.84; 23.42] <0.001 
45-59 vs. 15-29 23.57 [8.47; 65.60] <0.001 
60+ vs. 15-29 30.94 [10.96; 87.33] <0.001 
 
4.4.3 Antimicrobial susceptibility of Streptococcus suis serotype 2 
We received 86/105 Streptococcus suis serotype 2 strains from provincial 
hospitals. S. suis was completely sensitive to penicillin, ceftriaxone, cefepime, 
levofloxacin and vancomycin (Table 4-8). 
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Table 4-8 Antimicrobial susceptibility of S. suis serotype 2 strains isolated from meningitis patients 
Antimicrobial agent 
(number of isolates tested) 
Minimal Inhibitory Concentrations (μg/ml) Resistant strains, n (%) 
Breakpoints1 Range MIC50 2 MIC90 2  
Penicillin (n=86) S ≤ 0.12 0.016 to 0.094 0.047 0.064 0 (0.00) 
Ceftriaxone (n=86) S ≤ 1; R ≥ 4 0.032 to 0.25 0.094 0.125 0 (0.00) 
Cefepime (n=86) S ≤ 1; R ≥ 4 0.016 to 0.094 0.047 0.094 0 (0.00) 
Levofloxacin (n=86) S ≤ 2; R ≥ 8 0.19 to 1.00 0.38 0.38 0 (0.00) 
Vancomycin (n=85) S ≤ 1 0.19 to 0.75 0.25 0.50 0 (0.00) 
Chloramphenicol (n=86) S ≤ 4; R ≥ 16 2 to 64 3 4 4 (4.65) 
Tetracycline (n=86) S ≤ 2; R ≥ 8 1.5 to >256 24 32 81 (94.19) 
Erythromycin (n=86) S ≤ 0.25; R ≥ 1 0.023 to >256 0.064 >256 13 (15.12) 
1 Breakpoints are based on equivalent MIC breakpoints for Streptococcus spp. viridians group (CLSI 2010). R and S mean resistant and 
sensitive. 
2 MIC50 and MIC90 are the MIC values inhibiting growth of 50% and 90% of tested isolates, respectively 
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4.5 Discussion 
4.5.1 Epidemiological characteristics of Streptococcus suis meningitis 
Though Streptococcus suis is a rare cause of purulent bacterial meningitis in 
European and North America countries, it is the second most common pathogen in 
Hong Kong and the most common pathogen in Viet Nam (Hui et al. 2005; Mai et al. 
2008; Wertheim et al. 2009). The overall incidence rate in Vietnamese adult 
population was 0.57 per 100,000 person-years. Assuming that 25% of S. suis patients 
had pig or pork exposure factor (Table 4-1), the estimated incidence rate in the adult 
population without any exposure to pig or pork was 0.43/100,000 person-years (95% 
CI [0.34; 0.54] per 100,000 person-years), compared to 0.09/100,000 and 
0.002/100,000 in Hong Kong and the Netherlands, respectively (Arends et al. 1988; 
Ma et al. 2008). It was more than 5 times that of Hong Kong and 200 times that of the 
Netherlands. This data and other previous case series studies in Viet Nam indicated 
that Streptococcus suis serotype 2 infection is endemic in Viet Nam (Mai et al. 2008; 
Wertheim et al. 2009). No S. suis meningitis cases were detected in 871 children 
presenting with central nervous system infection. Only one case of S. suis meningitis 
has been reported in a Thai child indicating that this infection is extremely rare among 
children (Vilaichone et al. 2002; Mai et al. 2008). The incidence rate increased with 
incremental age in the adult population (Table 4-7) and 75% of patients were older 
than 45 years of age. A higher rate of disease in the elderly was also reported in other 
studies (Wertheim et al. 2009). This observation could be explained by more frequent 
or more intensive exposure to pigs or pork among elderly people compared with 
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children and younger adult, or by decreased immune status and/or a higher rates of 
underlying disease with increase of age (Ma et al. 2008). 
 Similar to other case series, S. suis infection occurred predominantly in male 
sex. The high male-to-female ratio could be explained by the fact that this infection is 
a predominantly an occupational disease (Arends et al. 1988). However, occupational 
exposure to pig or pork was only reported in 24% (36/149) of patients, compared to 
33% (50/151) of another study in Viet Nam and 24% (5/21) of a study in Hong Kong 
(Ma et al. 2008; Mai et al. 2008). While occupational exposure was recorded less than 
40% in Asian studies, it was reported in nearly 90% of European cases (Kay et al. 
1995). This difference could be explained by the underreporting of this risk factor for 
Asian patients, or by the presence of other behavioural or exposure related risk factors 
in the Asian population, such as culinary habits or proximity of pigs within 
households. Mapping of cases and comparison with pig density in each province 
showed that the risk of S. suis infection may be unrelated to pig density in a region. 
Seasonality of S. suis meningitis was not observed in southern provinces. This result 
was similar to a previous report of a large case series at Hospital for Tropical Diseases 
in Ho Chi Minh City (Mai et al. 2008). However, more cases and outbreaks were 
reported in the hottest months of the year in reports from northern Thailand, northern 
Viet Nam and China (Kay et al. 1995; Wangkaew et al. 2006; Yu et al. 2006; Ma et 
al. 2008; Wertheim et al. 2009). Similarly, seasonality of S. suis meningitis was also 
reported in our study at Hue Central hospital, a tertiary hospital of the North Central 
of Viet Nam. The difference between the Southern and the Northern provinces could 
be explained by the large fluctuation of air temperature in the Northern provinces. 
Human S. suis infection tended to occur in parallel with pig diseases in the hottest 
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months of the summer in China (Ma et al. 2008). Stresses, such as crowding, poor 
ventilation, and sudden weather change, predispose pigs to S. suis serotype 2 infection 
(Staats et al. 1997). Moreover, high bacterial load in meat sold at the wet markets 
without being preserved in fridges may be transmitted to human in the summer. 
Hence, pig carriage or contamination of meat in slaughter houses may be a risk at 
higher temperature. 
4.5.2 Clinical manifestations and outcome of S. suis serotype 2 meningitis 
Skin rash usually presents in septic shock syndrome, a life-threatening 
manifestation of S. suis infection, in which case fatality rate exceeded 60% (38/61) in 
Sichuan outbreak, compared to 1% (1/102) of meningitis (Yu et al. 2006). This rash is 
similar to the rash of meningococcemia. The rash of meningococcemia usually occurs 
in children or young adult while that of S. suis infection often present in middle-aged 
patients. Incubation time of septic shock cases was shorter than that of meningitis 
cases in the Sichuan outbreak, 1.6 days compared to 2.2 days respectively (p<0.05) 
(Yu et al. 2006).  The case fatality rate in these studies from provincial hospitals was 
higher than that reported from the Hospital for Tropical Diseases a tertiary referral 
hospital in Ho Chi Minh City (8% vs. 2.6%) (Mai et al. 2008). The reason may be 
related to the high mortality rate of septic shock in this study compared to that of 
meningitis (100% (3/3) vs. 6.2% (9/146)). Septic shock was also an independent risk 
factor for mortality in a Thai study, where 6/8 (75%) septic shock patients died and 
hazard ratio was 22.03 (95% CI, 1.88-158.28) (Wangsomboonsiri et al. 2008). The 
reasons of development of septic shock may be delay of admission or starting 
antimicrobial therapy, high virulence of pathogen and factors related to host status, 
such as decreased immune status and underlying diseases. Fulminant meningococcal 
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septicaemia is characterized by a rapid proliferation of meningococci in the 
circulation, resulting in very high concentration of bacteria (105–108/ml) and 
meningococcal endotoxin (101–103 endotoxin units/ml)in blood, compared to low 
concentration of meningococci (<103/ml) and endotoxin (< 3 endotoxin units/ml) in 
plasma of meningitis patients (Stephens et al. 2007). 
Apart from the high rate of hearing loss, signs and symptoms of S. suis 
meningitis could not be differentiated from purulent bacterial meningitis caused by 
other bacteria (Table 4-9). Hearing loss ranged from 30% to 90% in different studies 
depending on the proportion of meningitis cases in the study sample (Walsh et al. 
1992; Mai et al. 2008; Rusmeechan et al. 2008). In a series of 41 cases from Chiang 
Mai University hospital, 30.7% (4/13) of meningitis cases and none of 16 infective 
endocarditis cases developed hearing loss (Wangkaew et al. 2006). Animal 
experiments demonstrated suppurative labyrinthitis, with the bacteria invading the 
perilymph via the cochlear aqueduct (Kay 1991). This hypothesis was indirectly 
confirmed in human S. suis meningitis cases by computed tomography and magnetic 
resonance imaging scans of the inner ears of a Thai patient (Navacharoen et al. 2009). 
In summary, S. suis meningitis should be suspected in any Vietnamese adult with 
bacterial meningitis regardless of occupational exposure to pigs or pork.  
4.5.3 Antimicrobial susceptibility of Streptococcus suis serotype 2 strains 
Streptococcus suis serotype 2 strains isolated from humans are generally 
susceptible to antimicrobial agents used to treat purulent bacterial meningitis, such as 
penicillin, ampicillin, ceftriaxone and vancomycin (Wangkaew et al. 2006; Ma et al. 
2008; Mai et al. 2008; Hoa et al. 2011). However, one strain isolated from a Thai 
patient with peritonitis was reported as penicillin resistant with MIC>32 μg/ml 
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(Vilaichone et al. 2002). The antimicrobial susceptibility rates of our strains collected 
in the period 2008-2010, were similar to the rates observed in the strains collected at 
Hospital for Tropical Diseases in 2004-2008, except that the chloramphenicol 
resistance rate was lower in our study (4.65% vs.13%) (Hoa et al. 2011). The use of 
chloramphenicol in agriculture has been banned in Vietnam since 2003. However, 
other amphenicols (such as florfenicol) are still allowed to use in agriculture and 
animal husbandry in Vietnam. It is also possible that the chloramphenicol resistance 
determinants are under co-selection in strains that are resistant to tetracyclines and 
macrolides, which currently approved for veterinary use in the prevention and 
treatment of infections (Hoa et al. 2011). 
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Table 4-9 Clinical manifestations and outcome of S.suis infection 
Characteristics 
 
This study  
(n=149) 
HTD, Viet Nam1
(n=151) 
NHTD, Viet 
Nam2 (n=50) 
Thailand3
(n=41) 
UK4 
(n=35) 
Duration of illness (days), median (IQR) 3 (2; 4) 4 (3;5) 4 - - 
Clinical manifestations, n (%)      
- Fever 145 (97.32) 148 (98.01) 50 (100.00) 39 (95.12) 17/20 (85.00) 
- Headache 139 (93.29) 142 (94.04) 46 (92.00) 40 (97.56) - 
- Nausea/Vomiting 107 (71.81) 100 (66.23) - - - 
- Neck stiffness 130 (87.25) 142 (94.04) 44 (88.00) 39 (95.12) 17/20 (85.00) 
- Diarrhea 8 (5.37) 9 (5.96) - - - 
- Hearing loss  46 (30.87) 93/140 (66.43) 16 (32.00) 38 (92.68) 10/28 (35.71) 
- Altered consciousness 98 (65.77) 104 (68.87) 23 (46.00) 22 (53.66) - 
- Hemiplegia 6 (4.03) 15 (9.93) - 1 (2.44) - 
- Cranial nerve palsy 4 (2.68) 13 (8.61) - 2 (4.88) - 
- Hemorrhagic skin rash 4 (2.68) 9 (5.96) 7 (14.00) 0 (0) - 
Laboratory investigations, median       
- White blood cells 15,400 16,800 17,9005 - - 
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- Platelets 159,500 159,000 169,8005 - - 
- Cerebrospinal fluid      
o White cells 882 2,100 3,2535 - - 
o Percentage neutrophiles 85 84 - - - 
o Protein (g/l) 2.15 2.06 1.705 - - 
o Ratio of CSF and blood 
glucose 
0.11 0.14 - - - 
- CSF culture positive, n (%) 102 (68.46) 115 (76.16) 32(64.00) 37 (90.24) - 
Diagnosis      
- Bacterial meningitis, n (%) 146 (97.99) 149 (98.68) 44 (88.00) 41 (100.00) 18/20 (90.00) 
- Septic shock, n (%) 3 (2.01) 2 (1.32) 6 (12.00) - - 
Died, n(%) 12 (8.05) 4 (2.65) 3 (6.00) 0 (0) 4 (11.43) 
1 (Mai et al. 2008) 
2 (Wertheim et al. 2009) 
3 (Rusmeechan et al. 2008) 
4 (Walsh et al. 1992) 
5 Mean was presented
 
  
217
4.5.4 Limitation of study 
Though most human Streptococcus suis infection cases are caused by S. suis 
serotype 2, other serotypes were also reported as a pathogen of meningitis or sepsis, 
such as serotype 4 (Arends et al. 1988), serotype 14 (Mai et al. 2008; Haleis et al. 
2009; Kerdsin et al. 2009) and serotype 16 (Nghia et al. 2008). Real-time PCR test is 
a sensitive tool in surveillance of S. suis meningitis, especially when antibiotics had 
been used prior to the withdrawal of CSF sample (Mai et al. 2008). However, the PCR 
test targeted a specific DNA sequence of serotype 2 and this would miss patients 
infected with other serotypes. 
 Both classical microbiological culture and diagnostic PCR was used for 
detecting S. suis cases, but the incidence rate could be still underestimated for a 
variety of reasons, including deaths prior to admission, primary presentation other 
than meningitis, e.g. sepsis syndrome, or because of the presence of a contraindication 
to lumbar puncture procedure. 
 Finally, there was not data on the number of people who are pig breeders, 
abattoir workers or butchers in Viet Nam. Therefore, it was not possible to calculate 
the incidence rates of S. suis infection for these important groups. 
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4.6 Conclusions 
This study was the first prospective surveillance study of Streptococus suis 
meningitis in the Southeast Asia area. S. suis serotype 2 meningitis cases were 
reported in most of surveillance provinces in central and southern Viet Nam. 
Seasonality of this infection was documented in the North Central of Viet Nam, but 
not in southern Viet Nam. The overall incidence rate in adult population was 0.57 per 
100,000 person-years. The estimated incidence rate among the general adult 
population was more than 5 times that of Hong Kong and 200 times that of the 
Netherlands.  
S. suis infection is a striking public health problem in Viet Nam associated 
with substantial mortality and morbidity. Occupational exposure to pig or pork was 
only recorded in 25% of patients. Hence, there was a need to conduct an 
epidemiological study to identify additional risk factors in order to advise on 
preventative measures for Streptococcus suis infection in Viet Nam. 
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Chapter 5 
Risk factors for Streptococcus suis infection in Viet Nam 
5.1 Introduction 
The importance of zoonotic emerging infections is increasingly recognized, as 
illustrated by outbreaks of SARS coronavirus and the ongoing threat of human 
infections with avian influenza H5N1 virus. It is essential to understand transmission 
dynamics and risk factors for infection, in order to design effective strategies to 
contain and prevent the spread of zoonotic diseases (Ma et al. 2009). Streptococcus 
suis infection is an emerging zoonotic infectious disease, which is increasingly 
reported in Southeast Asia and China. In Viet Nam, S. suis infection was first reported 
in 1996 and the number of human cases has increased annually, coinciding with a 
significant expansion in the scale of the pig farming industry in Viet Nam both in 
small household and large scale intensive farming. Among approximately 100 adult 
patients admitted with acute bacterial meningitis to the Hospital for Tropical Diseases 
Ho Chi Minh City each year, around 40% will be diagnosed with S. suis meningitis, 
which is more than Streptococcus pneumoniae and Neisseria meningitidis combined. 
Thus, the disease can be considered endemic in Viet Nam (Nguyen et al. 2007; Mai et 
al. 2008; Wertheim et al. 2009). To date little is known of the risk factors underlying 
the disease or the portals of entry in humans. From small case series, the reported risk 
factor included occupational exposure, such as in slaughter house workers, butchers, 
pig breeders, meat processing and pig transportation workers. It is hypothesized that 
patients may be infected through minor cuts or abrasions on their skin (Arends et al. 
1988; Yu et al. 2006). However, although an occupational exposure to pigs or pork 
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was documented in 88% of the European patients described, it was reported in only 
up to 42% of the Asian cases (Kay et al. 1995; Mai et al. 2008). I hypothesised that 
there may be other behavioural or exposure related risk factors in Asian populations, 
such as culinary habits, or close proximity of pigs within households, and more 
intensive exposure to pigs or pork meat in the Asian context than is usual in European 
populations. Hence I conducted a prospective case-control study to identify the risk 
factors of S. suis infection in Viet Nam. 
5.2 Aims 
To identify risk factors of Streptococcus suis infection in Vietnam 
5.3 Materials and Methods 
Materials and Methods are described in Section 2.3.2, 2.4.2, 2.4.3.2, 2.4.4, 
2.4.5 and 2.5 
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5.4 Results 
Between May 2006 and June 2009, a total of 722 patients with suspected CNS 
infections or severe malaria were admitted to HTD. S. suis meningitis was diagnosed 
in 108 patients. Seven cases were excluded as they did not meet the inclusion criteria 
(HIV positive in 3 cases and prolonged coma over 14 days in 1 case), were diagnosed 
as tuberculous meningitis (2 cases), or were unable to communicate due to language 
differences (one Cambodian case). Another 311 patients, including 106 non-S. suis 
bacterial meningitis patients, 103 viral encephalitis/meningitis patients, 49 
tuberculous meningitis patients, 16 eosinophilic meningitis patients, 6 cryptococcal 
meningitis patients, 8 severe malaria patients and 23 other patients, were excluded 
because of death (37 cases), prolonged coma (72 cases), unconfirmed bacterial 
meningitis (80 cases), transfer to other hospitals (61 cases), use of antimicrobial 
agents more than 2 days in case of suspected viral encephalitis/meningitis (38 cases), 
and absence of diagnosis of CNS infection (23 cases). It was not possible to recruit 
community controls at the residency of one S. suis case because of the distance from 
the study site (Central Viet Nam, 800 kms from Ho Chi Minh City). During the period 
of recruitment we therefore included 101 cases of confirmed S. suis meningitis, 303 
hospital controls and 300 community controls for analysis (Figure 5-1). 
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Figure 5-1 Flow diagram of inclusion of study participants1 
 
 
 
 
 
 
 
 
 
  
                                                     
1 Reasons for exclusions of cases: HIV (+) (3), transfer to other hospital because of 
presumed tuberculous meningitis (2), confusion more than 14 days after admission (1), 
language differences precluding interview (1). 
Reasons for exclusion of controls: death (37), prolonged coma (72), unconfirmed bacterial 
meningitis (80), transfer to other hospitals (61), use of antimicrobial agents for more than 2 
days in case of suspected viral encephalitis/meningitis (38), and absence of diagnosis of CNS 
infection (23). For one case, community controls could not be included because of too long 
distance of community to study site. 
 
Admitted to CNS infection 
ward from 05/2006 to 06/2009 
(n=722) 
Excluded (n=318) 
106  Bacterial meningitis 
(80 unconfirmed and 26 confirmed) 
  07 Streptococcus suis serotype 2 
103  Viral encephalitis/meningitis 
  49  Tuberculous meningitis 
  16  Eosinophilic meningitis 
  08  Severe malaria 
  06  Cryptococcal meningitis 
  23  Others 
303 hospital controls 
110  Severe malaria 
  84 Viral encephalitis/meningitis 
  49 Bacterial meningitis 
 - 17 S. pneumoniae 
 - 10 N. meningitidis 
 - 05 Streptococcus spp 
 - 07 Others 
  37 Eosinophilic meningitis 
  22 Cryptococcal meningitis 
  01 Typhoid fever 
101 cases S. suis 
- 97 serotype 2 
- 03 serotype 14 
- 01 untypeable 
300 community controls 
Total recruited 
(n=404) 
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5.4.1 Characteristics of the participants 
S. suis infection occurred sporadically throughout the year without any clear 
seasonality (Figure 5-2). Clustering of cases was not observed.  
Figure 5-2 Distribution of Streptococcus suis meningitis cases and mean air 
temperature of southern Viet Nam in months during the study period (2006-
2009)(GSO 2009) 
 
 
 
Ninety-seven patients (96%) were infected with S. suis serotype 2 while only 
four patients (4%) were infected with other serotypes, including serotype 14 (3 cases) 
and untypeable serotype (1 case). S. suis cases were predominantly male (82%) and 
from a rural residence (81%) with a median (IQR) age of 50 (41-59) years. A high 
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proportion of cases had an occupation related to pigs (21%), other exposure to pigs 
(46%) or reported eating of “high risk” dishes in the last two weeks (48%). Except for 
fresh blood, other “high risk” dishes were mostly undercooked foods. Exposures to 
pigs/pork or eating “high risk” dishes were reported in 72/101 S. suis cases (71.29%), 
91/303 hospital controls (30.03%) and 84/300 community controls (28%). Twenty-six 
S. suis cases (25.74%), compared to 52 hospital controls (17.16%) and 29 community 
controls (9.67%), only ate these “high risk” dishes without any other exposure to pigs 
or pork. Hospital and community controls were more frequently female and 
(unmatched) hospital controls were significantly younger, with a higher proportion of 
urban residence (Table 5-1). I further analyzed the age distribution of cases, hospital 
controls and non-S. suis bacterial meningitis patients in the hospital control group 
(Table 5-2).  Nearly 70% of S. suis meningitis patients were older than 45 years old 
while only 25% of non-S. suis meningitis patients and 20% of hospital control group 
belonged to this age group. The 49 hospital controls with bacterial meningitis (not S. 
suis) were significantly younger than S. suis cases with median (IQR) age of 27 (23-
45) compared to 50 (41-59) years (p<0.001). 
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Table 5-1 Characteristics of Streptococcus suis cases and controls 
Characteristics Cases 
(n=101) 
Hospital 
controls 
(n=303) 
Community 
controls 
(n=300) 
Sex,  n(%) 
- Male 
- Female 
 
83 (82.18) 
18 (17.82) 
 
202 (66.67) 
101 (33.33) 
 
169 (56.33) 
131 (43.67) 
Residence, n(%) 
- Rural 
- Urban 
 
82 (81.19) 
19 (18.81) 
 
193 (63.70) 
110 (36.30) 
 
243 (81.00) 
57 (19.00) 
Age (years), median (interquartile 
range) 
50 (41,59) 27 (20,40) 50 (41,59) 
Occupations related to pigs(1), 
n(%) 
21 (20.79) 8 (2.64) 8 (2.67) 
Education level, n(%) 
- Primary 
- Secondary “level 2” 
- Secondary “level 3” 
- University 
- Illiterate 
 
52 (51.49) 
30 (29.70) 
11 (10.89) 
1 (0.99) 
6 (5.94) 
 
96 (31.68) 
134 (44.22) 
40 (13.20) 
21 (6.93) 
12 (3.96) 
 
175 (58.33) 
73 (24.33) 
30 (10) 
2 (0.67) 
19 (6.33) 
    
Religion 
- Buddhism 
- Catholicism 
- Protestant 
- Cao Dai 
- Other 
- No 
 
64 (63.37) 
12 (11.88) 
1 (0.99) 
7 (6.93) 
2 (1.98) 
15 (14.95) 
 
160 (52.81) 
42 (13.86) 
4 (1.32) 
17 (5.61) 
1 (0.33) 
77 (25.41) 
 
181 (60.33) 
31 (10.33) 
0 
29 (9.67) 
6 (2) 
53 (17.67) 
Ethnic background 
- Kinh 
- Khmer 
 
99 (98.02) 
1 (0.99) 
 
287 (94.72) 
4 (1.32) 
 
298 (99.33) 
2 (0.67) 
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- Chinese 
- Other 
1 (0.99) 
0 
4 (1.32) 
8 (2.64) 
0 
0 
Medical history, n(%) 
- Diabetes mellitus 
- Alcoholism 
- Splenectomy 
 
3 (2.97) 
14 (13.86) 
1 (0.99) 
 
3 (0.99) 
18 (5.94) 
0 
 
4 (1.33) 
20 (6.67) 
0 
Skin injuries, n(%) 33 (32.67) 18 (5.94) 11 (3.67) 
Breeding pigs at home, n(%) 23 (22.77) 33 (10.89) 41 (13.67) 
Any exposure to pigs/pork in the 
last 2 weeks, n(%) 
- With skin injuries 
- Without skin injuries 
46 (45.54) 
 
20 (19.80) 
26 (25.74) 
39 (12.87) 
 
5 (1.65) 
34 (11.22) 
55 (18.33) 
 
2 (0.67) 
53 (17.67) 
Eating any “high risk” dish in the 
last 2 weeks (2) 
- Fresh pig blood 
- Tonsils/tongue 
- Stomach/intestines 
- Uterus 
- Undercooked pig blood 
48 (47.52) 
 
5 (4.95) 
19 (18.81) 
45 (44.55) 
8 (7.92) 
11 (10.89) 
66 (21.78) 
 
5 (1.65) 
29 (9.57) 
53 (17.49) 
8 (2.64) 
18 (5.94) 
48 (16.00) 
 
5 (1.67) 
25 (8.33) 
42 (14) 
13 (4.33) 
5 (1.67) 
Only eating “high risk” dishes 
(without any other exposure to 
pigs/pork) 
26 (25.74) 52 (17.16) 29 (9.67) 
Ill pigs at home in the last 4 weeks, 
x/n (%) 
10/23 (43.48) 1/33 (3.03) 0/40 (0) 
Pigs at home carrying S. suis 
serotype 2 (confirmed by PCR), 
x/n (3) (%) 
9/22 (40.91) 3/13 (23.08) 5/28 (17.86) 
(1) Butcher, pig breeder, slaughterer, roaster, meat transporter, meat processing, 
veterinarian and cook 
(2) Fresh pig blood, tonsils, tongue, stomach, intestines, uterus, unwell-cooked blood 
(3) n was the number of participant’s houses where the pigs’ samples were taken 
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Table 5-2 Age distribution of Streptococcus suis cases and hospital controls  
Age groups Cases Hospital controls BM (1) (not S. suis) in 
hospital controls 
<30 5 (4.95) 173 (57.10) 27 (55.10) 
30 – 44 29 (28.71) 78 (25.74) 9 (18.37) 
45 – 59 45 (44.55) 33 (10.89) 8 (16.33) 
60 – 74 15 (14.85) 16 (5.28) 3 (6.12) 
75+ 7 (6.93) 3 (0.99) 2 (4.08) 
(1) Bacterial meningitis 
 
5.4.2 Analysis of risk factors 
Occupations related to pigs, breeding pigs at home, exposures to pigs or pork 
with skin injuries, eating “high risk” dishes in the last 2 weeks and having ill pigs at 
home in the last 4 weeks were associated with S. suis meningitis, after adjustment for 
potential confounders (residency, age and sex) (Table 5-3 and 5-4). Alcoholism was 
significantly associated with S. suis without adjustment (crude odd ratio [OR] in 
hospital control group, 2.55 and 95% confidence interval [CI], 1.22 to 5.33 and crude 
OR in community control group, 2.50 and 95%CI, 1.15 to 5.45) but the association 
disappeared after adjustment. 
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Table 5-3 Risk factors of Streptococcus suis infection on univariate analysis 
(Cases versus Hospital controls) 
Exposures Cases versus Hospital controls 
OR (1) 
(95%CI) 
p value OR(2) 
(95%CI) 
p value 
Occupations related to 
pigs 
9.68  
(4.13-22.67) 
<0.001 7.51  
(2.85-19.82) 
<0.001 
Medical history 
- Diabetes mellitus 
 
 
- Alcoholism 
 
3.06  
(0.61-15.41) 
 
2.55  
(1.22-5.33) 
 
0.175 
 
 
0.013 
 
0.82  
(0.13-5.23) 
 
1.31  
(0.54-3.16) 
 
0.830 
 
 
0.547 
Skin injuries 7.68  
(4.08-14.46) 
<0.001 8.16  
(3.72-17.92) 
<0.001 
Breeding pigs at home 2.41  
(1.34-4.35) 
0.003 2.34  
(1.09-5.00) 
0.028 
Any exposure to pigs/pork 
in the last 2 weeks 
 
- With skin injuries 
 
 
- Without skin injuries 
5.66  
(3.38-9.49) 
 
14.72 
(5.36-40.42) 
 
2.74  
(1.55-4.86) 
<0.001 
 
 
<0.001 
 
 
0.001 
4.69  
(2.43-9.07) 
 
12.16  
(3.74-39.50) 
 
2.06  
(0.99-4.27) 
<0.001 
 
 
<0.001 
 
 
0.052 
Eating any “high risk” 
dish in the last 2 weeks 
3.25 
(2.02-5.24) 
<0.001 2.48  
(1.35-4.52) 
0.003 
Ill pigs at home in the last 
4 weeks (3) 
24.62 
(2.85-212.24) 
0.004 30.10  
(2.72-333.64) 
0.006 
Pigs at home with S. suis 
serotype 2 (confirmed by 
PCR)(4) 
2.31 
(0.49-10.82) 
0.289 7.83  
(0.68-90.19) 
0.099 
(1) Crude OR based on logistic regression. 
(2) Adjusted for age, sex and rural/urban residence, using logistic regression. 
(3) Only individuals with pigs at home were analyzed.  
(4) Only individuals who had pig swab samples taken at their houses were analyzed.  
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Table 5-4 Risk factors of Streptococcus suis infection on univariate analysis 
(Cases versus Community controls) 
 
Exposures Cases versus Community controls 
OR (1) 
(95%CI) 
p value OR(2) 
(95%CI) 
p value 
Occupations related to 
pigs 
11.50 
 (4.31-30.65) 
<0.001 11.01  
(4.03-30.12) 
<0.001 
Medical history 
- Diabetes mellitus 
 
- Alcoholism 
 
2.25  
(0.50-10.05) 
 
2.50  
(1.15-5.45) 
 
0.288 
 
 
0.021 
 
3.75  
(0.75-18.73) 
 
1.48  
(0.63-3.31) 
 
0.107 
 
 
0.381 
Skin injuries 22.09  
(7.79-62.64) 
<0.001 22.30  
(7.55-65.84) 
<0.001 
Breeding pigs at home 1.95  
(1.04-3.65) 
0.036 1.99  
(1.04-3.80) 
0.036 
Any exposure to 
pigs/pork in the last 2 
weeks 
- With skin injuries 
 
- Without skin 
injuries 
4.51  
(2.55-7.97) 
 
 
30 
(7.01-128.35) 
 
1.66 
(0.92-3.00) 
<0.001 
 
 
 
<0.001 
 
 
0.090 
4.16  
(2.30-7.52) 
 
 
26.95  
(6.14-118.23) 
 
1.57  
(0.85-2.91) 
<0.001 
 
 
 
<0.001 
 
 
0.152 
Eating any “high risk” 
dish in the last 2 weeks 
6.00 
(3.33-10.81) 
<0.001 4.38  
(2.72-8.08) 
<0.001 
Ill pigs at home in the 
last 4 weeks (3) 
- - - - 
Pigs at home with S. 
suis serotype 2 
(confirmed by PCR)(4) 
- - - - 
(1) Crude OR conditional logistic regression. 
(2) Adjusted for sex (matched for age and residence), using conditional logistic 
regression. 
(3) Only individuals with pigs at home were analyzed. OR could not be analyzed for 
community controls because none of them reported ill pigs at home 
(4) Only individuals who had pig swab samples taken at their houses were analyzed. 
OR could not be analyzed for community controls because there was no discordant 
pair included in the analysis. 
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S. suis infection was independently associated with occupations related to 
pigs, exposures to pigs or pork in the presence of skin injuries in the 2 weeks prior to 
infection, and eating “high risk” dishes in the 2 weeks prior to infection after 
multivariate analysis. These associations were found in comparisons of cases with the 
hospital control group as well as with the community control group. Breeding pigs at 
home, diabetes mellitus, alcoholism or exposure to pigs or pork without skin injuries 
were not associated with S. suis infection in multivariate analysis (Table 5-5). In a 
sensitivity analysis, which included only male cases and controls, exactly the same 
risk factors were significant with similar odds ratios as in the main analysis. Risk 
factors identified by multivariate analysis of male cases and controls from either 
control group included eating “high risk” dishes (OR1=3.46; 95%CI=[1.65-7.28] and 
OR2=4.79; 95%CI=[2.02-11.40]), occupations related to pigs (OR1=6.33; 
95%CI=[1.55-25.79] and OR2=7.46; 95%CI=[1.56-35.74]), and exposures to pigs or 
pork in the presence of skin injuries (OR1=5.81; 95%CI=[1.07-31.48] and OR2=7.11; 
95%CI=[1.00-50.54]). 
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Table 5-5 Risk factors of Streptococcus suis infection - multivariate analysis 
Exposure Cases versus  
Hospital controls 
Cases versus Community 
controls 
OR1 (95%CI) p 
value 
OR2 (95%CI) p 
value 
Occupations related to pigs 3.84 (1.32-11.11) 0.013 5.52 (1.49-20.39) 0.010 
Medical history 
- Diabetes mellitus 
 
- Alcoholism 
 
1.10 (0.17-7.31) 
 
1.02 (0.38-2.73) 
 
0.918 
 
0.969 
 
4.11 (0.78-21.68) 
 
0.72 (0.24-2.14) 
 
0.095 
 
0.553 
Breeding pigs at home 1.02 (0.39-2.69) 0.965 0.83 (0.34-2.03) 0.681 
Any exposure to pigs/pork 
in the last 2 weeks 
- With skin injuries 
 
- Without skin injuries 
 
 
7.48 (1.97-28.44) 
 
2.15 (0.88-5.24) 
 
 
0.003 
 
0.092 
 
 
15.96 (2.97-85.72) 
 
1.14 (0.49-2.69) 
 
 
0.001 
 
0.757 
Eating any “high risk” dish 
in the last 2 weeks 
2.22 (1.15-4.28) 0.017 4.44 (2.15-9.15) <0.001
Rural 2.39 (1.13-5.04) 0.022 - - 
Age (by +10 years) 2.59 (2.04-3.29) <0.001 - - 
Male sex 4.47 (1.88-10.64) 0.001 3.53 (1.59-7.82) 0.002 
 
OR1: Odd ratio between cases and hospital controls 
OR2: Odd ratio between cases and community controls 
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5.4.3 Carriage of S. suis serotype 2 in pigs 
We collected 571 pig swab samples from pigs present around the house of 22 
of 23 cases, 28 of 41 community controls and 13 out of 33 hospital controls 
respectively, who kept pigs around the house (Table 5-1). Median of herd size was 7 
pigs (range, 1 to 50) and S. suis serotype 2 was detected in 9 (41%) case group herds, 
3 (23%) hospital control group herds, and 5 (18%) matched community control group 
herds. Differences between case group and hospital control group were not 
statistically significant. The odd ratio could not be analyzed for community controls 
because there was no discordant pair included in the analysis. (Table 5-3 and 5-4). 
5.5 Discussion 
We conducted the largest prospective epidemiological assessment of risk 
factors of S. suis infection globally. In addition to the previously suggested risk 
factors, such as occupational exposure and contact with pigs or pork without skin 
protection, we identified the ingestion of food with a high risk of contamination with 
S. suis serotype 2 to be an important risk factor for S. suis serotype 2 meningitis. To 
investigate eating habits as a risk factor of S. suis infection, we focused on potential 
“high risk” dishes common in Viet Nam. These include fresh or under-cooked blood, 
tonsils, tongue, stomach, intestines and uterus. Such food items typically are 
undercooked when eaten as a main dish (as opposed to as components of well cooked 
main dishes such as rice or noodle soups), as was generally the case in our patients. 
By multivariate analysis including all potential risk factors and confounding factors, 
we demonstrated that eating these “high risk” dishes in the 2 weeks prior to admission 
was a significant risk factor for this infection with OR1, 2.22 (95%CI, 1.15-4.28) and 
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OR2, 4.44 (95%CI, 2.15-9.15). Eating habits were also confirmed as a risk factor in a 
case-control study conducted in Phayao province, Thailand. In this outbreak, patients 
attended a funeral ceremony, where fresh pig blood and raw pork were served. In the 
multivariate analysis, only eating blood remained statistically significant with an 
adjusted OR of 24.8 (95%CI, 1.46-423.53). However, the sample size of this study 
was small with 9 infected individuals and 36 controls (Khadthasrima et al. 2009).  A 
history of raw pork or uncooked pig blood consumption prior to illness was reported 
in 25/40 patients (62.5%), while a history of direct skin contact with pigs or raw pork 
products was only recorded in 10/40 patients (25%), in another study also conducted 
in northern Thailand (Navacharoen et al. 2009). Entry of S. suis through 
gastrointestinal tract might explain why diarrhoea was one of the presenting 
symptoms documented in 13/61 (21%) of patients from Hong Kong (Kay et al. 1995). 
However, eating pork was not associated with S. suis cases in a matched case-control 
study conducted during the outbreak in Sichuan province in 2005 (Yu et al. 2005). S. 
suis lives as normal flora in the upper respiratory, gastrointestinal and genital tract of 
pigs and can cause invasive disease in pigs. Pork and pig’s organs can also be 
contaminated in slaughter houses. S. suis was isolated from 7 out of 117 (6.1%) of 
raw pork meat samples from 3 out of 6 wet markets in 6 districts in Hong Kong (Ip et 
al. 2007). There may be a high bacterial load in food items that are kept at high 
ambient temperatures in the tropics for example when being sold in the markets. 
Therefore, patients may be infected with S. suis through the gastrointestinal tract if the 
“high risk” dishes are served as raw or under-cooked food.  
Reports from China, Thailand and the northern provinces of Viet Nam, 
suggested S. suis infections tend to present in the summer or the rainy season 
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potentially linked with a higher incidence of disease in pigs due to high temperature 
and humidity (Kay et al. 1995; Huang et al. 2005; Wangkaew et al. 2006; Yu et al. 
2006; Navacharoen et al. 2009; Wertheim et al. 2009). However in our study seasonal 
variation was not observed. (Figure 5-6). 
I found that age of S. suis meningitis patients was higher than that of patients 
with bacterial meningitis caused by other bacteria and that high age was associated 
with increased risk of infection with S. suis. In contrast, paediatric infections with S. 
suis are extremely rare, presumably related to a lack of exposure associated with 
increased risk of S. suis infection, in children. Breeding as well as slaughtering pigs 
are the hard works which are more suitable for males than females. Moreover, eating 
the “high risk” dishes, such as fresh blood and raw or undercooked pork, usually 
reported in adult males. These reasons could explain why high male-to-female ratio 
was documented in human S. suis infection. 
The association between human S. suis infection and occupational exposures 
to pigs or pork has been reported since 1968. Most of these reports have been in pig 
breeders or abattoir workers (Arends et al. 1988; Walsh et al. 1992). In The 
Netherlands, the risk of S. suis meningitis among these individuals was estimated to 
be 3/100,000 people. This risk was 1500 times higher than that of persons not 
working in the pork industry (Arends et al. 1988). The annual incidence of S. suis 
infection among the general population in Hong Kong was calculated as 0.09/100,000 
people while this incidence among occupational group was reported to be 32/100,000 
(Ma et al. 2008). In Viet Nam, the proportion of patients reported to have 
occupational exposures was lower than reported in European patients but it remained 
an important independent risk factor with OR1, 3.84 (95% CI, 1.32-11.11) and OR2, 
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5.52 (95% CI, 1.49-20.39). Risk of infection may be different in different types of 
exposure. A matched case-control study was conducted in the Sichuan outbreak, 
including 29 cases and 147 controls. The authors found that slaughtering (OR, 11.978; 
95%CI, 3.335-42.756) and carcass cutting and processing (OR, 3.008; 95%CI, 1.022-
8.849) sick or dead pigs were associated with S. suis cases (Yu et al. 2005). 
A number of reports have linked skin injuries as a factor in acquisition of 
infection in individuals in direct contact with pigs or pork. Significant skin injury, 
sometimes with signs and symptoms of bacterial infection, was evident in 5 out of 35 
(14%) of people with S. suis in the UK, 4 out of 15 cases (16%) in Hong Kong and 
104 out of 215 cases (48%) in Sichuan province’s outbreak (Walsh et al. 1992; Kay et 
al. 1995; Yu et al. 2006). In this study, skin injuries were reported in 33/101 (33%) of 
S. suis patients compared to 18/303 (6%) of hospital controls and 11/300 (4%) of 
community controls (Table 5-5). These often relatively minor skin injuries may allow 
direct entry of the bacteria in people with direct contact with infected pigs or pork. 
Contact with pigs within the last two weeks and skin lesions was associated with a 
significant high risk of infection with OR1, 7.48 (95%CI, 1.97-28.44) and OR2, 15.96 
(95%CI, 2.97-85.72) (Table 5-9). Skin injuries were most often recorded in slaughter 
house workers, cooks and housewives involved in processing meat. Skin protection, 
including gloves, hand washing and exclusion of people with obvious skin lesions 
from direct contact with pigs and pork meat may help to reduce the incidence of the 
disease. 
Pig carriage of S. suis serotype 2 was higher in the case group than in hospital 
control and in community control groups but it was not statistically significant. This 
condition reflected the bacteria as a common commensal or pathogen for pigs. 
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Nevertheless, information on the prevalence of sick pigs at the participant’s house 
may have been underestimated, especially in the community control group. Patients 
and their relatives may have been reluctant to admit to having sick pigs at home for 
fears of losing their pigs to the veterinary authorities or not being able to sell their 
stock at a good price. We were unable to take pig samples immediately after the 
patient was admitted to HTD, as there was an inevitable delay until we could travel to 
their home. The median time to conduct the home visit was 22 days (IQR, 18-32) 
after admission. It is possible that in this gap the pigs we surveyed in the home were 
not the same pigs that may have lead to the infection that caused the admission. 
5.6 Conclusions 
In conclusion, S. suis is an important and emerging public health issue in Asia 
and one with the potential for both endemic transmission and for explosive epidemics. 
I identified risk factors for S. suis infection which can be addressed in health 
education programs targeted at individuals and communities at risk, focusing on skin 
protection for those in direct contact with pigs or pork and avoiding eating raw or 
under-cooked pig products.  
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Chapter 6 
Human carriage of Streptococcus suis serotype 2 
6.1 Introduction 
S. suis can be a commensal or pathogen for a wide range of mammalian 
species, such as cattle, sheep, goats, horse, cat, dog, and particularly pigs (Staats et al. 
1997). Pigs harbour S. suis in their tonsils and multiple serotypes and untypeable 
strains may be present in a single herd and even within the same animal (Martinez et 
al. 2002; Marois et al. 2007). The bacteria have also been recovered from the nasal 
cavity, reproductive, and alimentary tract of subclinical carriers (Robertson et al. 
1989; Brisebois et al. 1990; Gottschalk et al. 2000). Tonsillar swab cultures from live 
pigs indicated that carrier rates of S. suis serotype 2 in herds vary from 0 to 100% 
(Mwaniki et al. 1994). Carriers of S. suis serotype 2 are infectious to other pigs and 
are significant in transmission of pathogenic strains via close contact or exposure to 
the pathogen in aerosol form (Staats et al. 1997; Madsen et al. 2001; Huang et al. 
2005). In humans, S. suis causes a systemic infection that affects several organ 
systems, such as bacterial meningitis, streptococcal toxic shock syndrome, arthritis 
and bacterial endocarditis (Lun et al. 2007; Wertheim et al. 2009). As mentioned 
before, this zoonosis is considered an occupational disease and the common 
occupations at risk are pig breeder, abattoir worker, those involved in meat processing 
and meat transport, butcher, and cooks (Arends et al. 1988; Walsh et al. 1992; Kay et 
al. 1995). It is hypothesized that patients may be infected through minor cuts or 
abrasions on their skin (Arends et al. 1988; Yu et al. 2006). However, although 
occupational exposure to pigs or pork was documented in 88% of the European 
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patients described, it was reported in only up to 42% of the Asian cases (Kay et al. 
1995; Mai et al. 2008). Significant skin injury was only evident in 5 out of 35 (14%) 
of people with S. suis in the UK, 4 out of 15 cases (16%) in Hong Kong and 104 out 
of 215 cases (48%) in Sichuan province’s outbreak (Walsh et al. 1992; Kay et al. 
1995; Yu et al. 2006). Whilst it is known that pigs can carry S. suis asymptomatically, 
it is not known if there is asymptomatic carriage of S. suis in the respiratory or 
gastrointestinal tract of humans, which may lead to person-to-person transmission or 
potentially to infection. S. suis was cultured from pharyngeal swabs from 7 of 132 
(5%) German workers in pig slaughterhouses and pork dissecting and processing 
industry but was not isolated from 130 controls from the same geographic area. 
Carriage was confirmed in all four cases where repeat samples were available 
(Strangmann et al. 2002). Hence, I conducted a study to identify human carriage of 
Streptococcus suis serotype 2 in the upper respiratory and gastrointestinal tract. As 
detection of potential carriage in cases and hospital controls could be affected by their 
antimicrobial treatment, household members were also studied for carriage of S. suis 
serotype 2 since if carriage and associated transmission were to occur, household 
members of carriers are the most likely to become positive. 
 
6.2 Aims 
1. To describe pig exposures and human carriage of S. suis serotype 2 in patients 
with meningitis caused by S. suis serotype 2 and controls. 
2. To describe pig exposure and human carriage of S. suis serotype 2 in 
household members of cases and controls. 
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6.3 Materials and Methods 
Materials and Methods are presented in Section 2.3.2, 2.4.3.1, 2.4.5 and 2.5. 
6.4 Results 
A total of 722 patients with suspected CNS infection or severe malaria, were 
admitted to HTD between May 2006 and June 2009. Three hundred and eighteen 
patients were excluded because they did not fulfill the inclusion criteria for the case-
control study, such as death within 14 days, prolonged coma, unconfirmed bacterial 
meningitis, transfer to other hospitals and use of antimicrobial agents more than 2 
days in case of suspected viral encephalitis/meningitis (Table 5-1 and Table 5-2). 
During this period, 101 patients with confirmed S. suis meningitis were recruited, 303 
hospital controls and 300 community controls. Two hundred and five household 
members of S. suis cases, and 291 and 424 hospital controls and community controls, 
respectively were recruited. It was not possible to take throat and rectal swab samples 
of one patient in the hospital control group and another person in the community 
control group because they refused sampling. The number of second samples was 
lower than of the first samples because patients’ hospitalized duration was less than 
10 days or the community controls and household members were absent at the second 
visit (Figure 6-1). 
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Figure 6-1: Flow diagram of inclusion of study participants2 
                                                     
2 T1, R1: First throat (T) and rectal (R) swab sample, taken on hospital admission or on the first household visit 
  T2, R2: Second throat (T) and rectal (R) swab sample, taken after admission 10-14 days or on the second  household visit (12-16 days after the first visit) 
Admitted to CNS infection ward 
from 05/2006 to 06/2009 
(n=722) 
Excluded (n=318) 
Total recruited 
(n=404) 
 
101 cases S. suis 
T1 : 101 samples    R1 : 101 samples 
T2 : 101 samples    R2 : 101 samples 
303 hospital controls 
T1 : 302 samples    R1 : 302 samples 
T2 : 287 samples    R2 : 287 samples 
300 community controls 
T1 : 299 samples    R1 : 298 samples 
T2 : 275 samples    R2 : 275 samples 
424 household members 
T1 : 424 samples    R1 : 422 samples 
T2 : 346 samples    R2 : 346 samples 
205 household members 
T1 : 205 samples    R1 : 204 samples 
T2 : 184 samples    R2 : 183 samples 
291 household members 
T1 : 291 samples    R1 : 291 samples 
T2 : 211 samples    R2 : 211 samples 
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6.4.1 Pig exposure and carriage results of case and control groups 
Pigs or pork exposure was reported more frequently in the case group than in 
the hospital and community control groups. Nearly 20% of cases had occupations 
related to pigs or pork, but only 2-3% of hospital or community controls had such 
occupations. Similarly, contacts with pigs or pork in the last 2 weeks were recorded in 
45% of cases, compared to 13% and 18% of hospital controls and community 
controls, respectively. Eating the “high risk” dishes in previous 2 weeks, such as fresh 
blood, undercooked pig’s intestines and stomach, was also documented in nearly 50% 
of case group and 15-20% of control groups. However, the proportion of cases and 
controls in the two control groups who reported breeding pigs at home was not 
significantly different, 20% compared to 11-14% (Table 6-1). 
Table 6-1 Exposure to pigs or pig products of cases and controls and PCR results 
of their throat and rectal swab samples 
Characteristics Cases 
(n=101) 
Hospital 
controls 
(n=303) 
Community 
controls 
(n=300) 
Occupations, n (%) 
- Butcher 
- Pig breeder 
- Slaughterer/pig’s 
roaster 
- Meat transporter 
- Meat processing 
 
5 (4.95) 
6 (5.94) 
7 (6.93) 
 
1 (0.99) 
1 (0.99) 
 
2 (0.66) 
2 (0.66) 
0 (0) 
 
0 (0) 
0 (0) 
 
0 (0) 
6 (2) 
1 (0.33) 
 
0 (0) 
0 (0) 
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- Veterinarian 
- Cook 
- No occupational 
exposure to pigs  
1 (0.99) 
0 (0) 
80 (79.21) 
0 (0) 
4 (1.32) 
295 (97.36) 
0 (0) 
1 (0.33) 
292 (97.33) 
Pigs at home, n (%) 23 (22.77) 33 (10.89) 41 (13.67) 
Contact with pigs/pork in the last 
2 weeks, n (%) 
- Bathing pigs 
- Feeding 
- Cleaning up piggery 
- Slaughtering 
- Contact blood/pig’s 
organs 
- Visiting pig’s farm  
46 (45.54) 
 
18 (17.82) 
19 (18.81) 
19 (18.81) 
13 (12.87) 
30 (29.70) 
 
17 (16.83) 
39 (12.87) 
 
17 (5.61) 
18 (5.94) 
13 (4.29) 
0 (0) 
7 (2.31) 
 
17 (5.61) 
55 (18.33) 
 
30 (10) 
29 (9.67) 
25 (8.33) 
1 (0.33) 
18 (6) 
 
16 (5.33) 
Eating “high risk” dishes in the 
last 2 weeks, n (%) 
- Fresh blood 
- Pig tonsils/tongue 
- Pig intestines/stomach 
- Pig uterus 
- Undercooked blood 
48 (47.56) 
 
5 (4.95) 
19 (18.81) 
45 (44.55) 
8 (7.92) 
11 (10.89) 
66 (21.78) 
 
5 (1.65) 
29 (9.57) 
53 (17.49) 
8 (2.64) 
18 (5.94) 
48 (16) 
 
5 (1.67) 
25 (8.33) 
42 (14) 
13 (4.33) 
5 (1.67) 
Positive throat/rectal swab 
samples by PCR, x/n (%) 
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- 1st throat swab  
- 1st rectal swab  
- 2nd throat swab  
- 2nd rectal swab  
1/101 (0.99) 
5/101 (4.95) 
0/101 (0) 
1/101 (0.99) 
0/302 (0) 
0/302 (0) 
0/287 (0) 
0/287 (0) 
0/299 (0) 
0/298 (0) 
0/275 (0) 
0/275 (0) 
 
S. suis serotype 2 was detected in the throat or rectal swab samples of six S. 
suis serotype 2 meningitis patients by PCR. One patient had a positive throat swab 
sample on admission day and one other patient had two positive rectal swab samples, 
one on admission day and one 8 days later. The remaining patients only had positive 
rectal swab samples on admission day (Table 6-1). S. suis serotype 2 was cultured 
from the throat swab sample and one of the rectal swab samples. All of the patients 
with PCR positive swab samples were male, middle-aged persons and lived in the 
Mekong river delta of southern Viet Nam. None of them had a history of splenectomy 
or diabetes mellitus but for two patients alcoholism was reported. Three of these six 
patients had pigs at home. No illness was reported in these pigs in the last 4 weeks 
prior to presentation of the patients and the PCR results of pig tonsil swab samples 
were negative indicating that these pigs did not carry S. suis serotype 2 in their tonsils. 
None of these patients had skin injuries. Three patients had eaten pig intestines within 
the two weeks prior to admission. Of these three patients, the throat swab sample was 
positive in one patient and rectal swab samples were positive in the two others. One of 
these two patients had two PCR positive rectal swab samples on separate occasions. S. 
suis serotype 2 was cultured from the first sample (Table 6-2). 
It was not possible to detect DNA of S. suis serotype 2 in the throat and rectal 
swab samples of 601 hospital and community controls. 
244 
 
Table 6-2 Epidemiological characteristics of six patients with S. suis serotype 2 
detected in throat swab or rectal swab samples by PCR 
Characteristics Patients with PCR positive swab samples 
(n=6) 
Male sex, n (%) 6 (100) 
Age (years), median (range) 54.5 (40,79) 
Rural residency  5 (83.33) 
History of splenectomy 0 (0) 
Alcoholism 2 (33.33) 
Diabetes mellitus 0 (0) 
Occupation related to pigs 1 1 (16.67) 
Breeding pigs at home 3 (50) 
Contact with pigs/pork in the 
previous 2 weeks 2 
2 (33.33) 
Eating “high risk” dishes in the 
previous 2 weeks 3 
3 (50) 
Contact with pigs/pork or eating 
“high risk” dishes in the previous 
2 weeks 
5 (83.33) 
Skin injuries 0 (0) 
1 Butcher, slaughterer, pig’s breeder, meat transporter, vet, cook and meat process 
2  Bathing, feeding, cleaning up piggery, slaughtering, direct contact blood/pig’s 
organs and visiting pig’s farm 
3 Fresh blood, undercooked tonsils/tongue, intestines, stomach and uterus 
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Patients with PCR positive swab samples had a short history of illness with a 
median of 4 days. Five of six patients had altered level of consciousness but none of 
them got seizures. Gastrointestinal symptoms were common, including vomiting in 5 
of 6 patients and diarrhoea in 2 of 6 patients but none had gastrointestinal bleeding. 
Four of six patients had low blood platelet count (<100,000/μl) and two patients 
suffered from skin haemorrhages. One or two doses of intravenous ceftriaxone or 
cefotaxime were given to 3 patients before admission and antibiotic treatment was not 
recorded in 2 other patients. However, S. suis serotype 2 was cultured from blood in 4 
patients and from CSF in 5 patients (Table 6.3). 
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Table 6-3 Clinical manifestations of six patients with S. suis serotype 2 detected 
in throat swab or rectal swab samples by PCR 
Characteristics Patients with PCR positive swab samples 
 (n=6) 
Days of illness (before admission), 
median (range) 
4 (2,8) 
Confusion 5 (88.33) 
Glasgow Coma Scale (GCS), 
median (range) 
12 (9,15) 
Seizures 0 (0) 
Vomiting 5 (88.33) 
Diarrhoea 2 (33.33) 
Gastrointestinal haemorrhage 0 (0) 
Skin haemorrhages 2 (33.33) 
Platelet count (x103/μl), median 
(range) 
51.65 (20.3, 210) 
No antibiotic therapy before 
admission 1 
1 (16.67) 
S. suis serotype 2 cultured from 
blood 
4 (66.67) 
S. suis serotype 2 cultured from 
cerebrospinal fluid (CSF) 
5 (83.33) 
S.suis serotype 2 detected in CSF 
by real-time PCR 2 
5 (83.33) 
1 Antibiotic therapy before admission was not reported clearly in 2 patients and these 
patients were assigned as “unknown”. 
2 Real-time PCR was not done in one patient because his CSF sample was not sent for 
PCR but S. suis serotype 2 was cultured from CSF and blood of this patient. 
  
247 
 
6.4.2 Pig exposure and carriage results of household members of case and 
control groups 
A total of 3318 throat and rectal swab samples were collected from 205, 291 
and 424 household members of cases, hospital controls and community controls, 
respectively. Nearly fifty percent of these household members were farmers or 
housewives. Occupations related to pigs or pork in this group included predominantly 
butcher, pig breeder or cook but relative frequencies were below 5%. Some of the 
household members had direct contact with pigs or pork and all of the household 
members of S. suis patients had direct contact with patients, such as living in the same 
house or taking care of the patient. However, DNA of S. suis serotype 2 was not 
detected in any of the swab samples of these household members (Table 6-4). 
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Table 6-4 Characteristics of household members and PCR results of their throat 
swab and rectal swab samples 
Characteristics House hold members 
Case group 
(n=205) 
Hospital 
control group 
(n=291) 
Community 
control group 
(n=424) 
Age (years), median 
(interquartile range) 
36  
(24,50) 
41  
(29,49) 
39  
(25,51) 
Occupations, n (%) 
- Butcher 
- Pig breeder 
- Slaughterer 
- Cook (related to pork) 
- Housewife 
- Farmer 
- Others (unrelated to 
pigs/pork) 
- Unknown job 
 
10 (4.88) 
5 (2.44) 
3 (1.46) 
7 (3.41) 
26 (12.68) 
53 (25.85) 
100 (48.78) 
 
1 (0.49) 
 
1 (0.34) 
2 (0.69) 
0 (0) 
3 (1.03) 
54 (18.26) 
112 (38.69) 
111 (38.24) 
 
8 (2.75) 
 
2 (0.47) 
5 (1.18) 
0(0) 
11 (2.59) 
78 (18.40) 
151 (35.61) 
175 (41.27) 
 
2 (0.47) 
Pigs at home, n (%) 54 (26.34) 44 (15.12) 59 (13.92) 
PCR positive throat/rectal 
swab samples, x/n (%) 
- 1st throat swab  
- 1st rectal swab 
- 2ndthroat swab 
- 2nd rectal swab 
 
 
0/205 (0) 
0/204 (0) 
0/184 (0) 
0/183 (0) 
 
 
0/291 (0) 
0/291 (0) 
0/211 (0) 
0/211 (0) 
 
 
0/424 (0) 
0/422 (0) 
0/346 (0) 
0/346 (0) 
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6.5 Discussion 
Though asymptomatic carriage is common in healthy pigs, it is unknown 
whether there is asymptomatic human carriage of S. suis. All common human 
pathogens causing bacterial meningitis are typically carried, either in the upper 
respiratory tract (S. pneumoniae, H. influenza type b and N. meningitides) or in the 
intestine or vagina (E. coli, Listeria spp and Streptococcus group B). All of these 
bacteria are encapsulated microorganism like S. suis. If human carriage of S. suis 
occurred, this would be very important to know as it may play a role in the routes of 
transmission, the risk of infection and evolution of the bacteria. 
In this study, it was not possible to demonstrate S. suis serotype 2 carriage in 
1521 healthy persons or patients without S. suis infection, including those with pig 
exposures such as abattoir worker, butcher and pig breeder. This finding indicates that 
humans are either not asymptomatic carriers of S. suis serotype 2 or it is extremely 
uncommon. In contrast, the nasopharyngeal carriage rate of S. suis in a high risk 
group, consisting of butchers, abattoir workers and meat processors, was 7 out of 132 
(5.3%), while none of those without contact with pigs or pork were found to be 
carriers, in one study in Germany (Strangmann et al. 2002). However, the serotype of 
these S. suis strains was not reported in this study. In this study I only tested for the 
presence of serotype 2 strains as this is by far the predominant serotype causing 
disease in humans. There are other serotypes in pigs that could potentially be 
transmitted to and be carried by humans who are continuously exposed to pigs or their 
products, and carriage of such strains in the German population at high risk may 
explain differences in carriage rates observed.  
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In addition, enzyme linked immunosorbent assay (ELISA) was used to 
investigate the prevalence of antibodies to S. suis serotype 2 in sera of different 
occupational groups in New Zealand. In 9 of 96 (9.3%) dairy farmers, 11 of 107 
(10.3%) meat inspectors, 15 of 70 (21.4%) pig farmers, and none of 16 veterinary 
students, antibodies against S. suis serotype 2 were detected (Robertson et al. 1989). 
In a study in the US, antibodies against S. suis serotype 2 were found in 7 out of 73 
(9.6%) swine workers compared with 1 out of 67 (1.5%) of non-swine exposed 
participants. All of the positive cases had worked and lived in swine farms for over 10 
years (Smith et al. 2008). Subclinical infection, rather than human carriage, with S. 
suis serotype 2 may occur in those with direct contact with pigs or pork, as suggested 
by these serological test results. However, these data should be regarded with caution 
because no standardized serological test to detect S. suis antibodies in humans or pigs 
exists, and the ELISA test used may detect cross reactivity with other antigens 
(Gottschalk et al. 2007). Further evidence for the absence of human carriage of S. suis 
serotype 2 in their respiratory and alimentary tract is the antimicrobial susceptibility 
of S. suis serotype 2 strains isolated from human. All of S. suis strains isolated from 
patients in Viet Nam, where antibiotic drugs can be bought without prescription, were 
totally susceptible to penicillin and ceftriaxone (Mai et al. 2008; Wertheim et al. 
2009; Hoa et al. 2011).  
Eating pig intestines in the few days prior to admission was reported in 3 of 6 
patients with a PCR positive throat or rectal swab, two of which were also culture 
positive. Only one patient had a PCR positive throat swab sample and the bacteria 
were also isolated from this sample. He did not have any exposure to pigs or pork in 
the last 2 weeks, except eating undercooked pig’s intestines in a wedding party two 
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days before admission. Taken together, rather than indicating human carriage of S. 
suis serotype 2, our results strengthen the hypothesis that the gastrointestinal tract 
may be a route of entry for S. suis serotype 2, for at least a proportion of patients. 
6.6 Conclusions 
After carefully investigating 1622 healthy persons or patients with or without 
S. suis serotype 2 infection, it was not possible to demonstrate asymptomatic carriage 
of S. suis serotype 2 in the respiratory or gastrointestinal tract of humans, with the 
exception of one patient in whom carriage cannot be excluded since consecutive rectal 
swab samples were PCR positive. These findings may reinforce the evidence for the 
alimentary tract as a route of entry of S. suis serotype 2 in the Asian population. 
 
 
 
 
 
 
 
 
  
252 
 
Chapter 7 
Discussion 
Central nervous system infection is a serious and life-threatening disease with 
high morbidity and mortality in developing countries. An increasing number of 
reports related to Streptococcus suis meningitis have appeared in the recent years, 
especially after the explosive outbreak of this infection in Sichuan province of China, 
raising the alarm about an emerging zoonotic disease in Southeast Asia (Gottschalk et 
al. 2010). Two case series from the Hospital for Tropical Diseases (HTD) in Ho Chi 
Minh City and the National Hospital for Tropical Diseases (NHTD) in Ha Noi 
showed that S. suis is the most important cause of purulent bacterial meningitis in 
adults in these tertiary referral hospitals (Mai et al. 2008; Wertheim et al. 2009). 
However, we did not have any information on the incidence and characteristics of S. 
suis meningitis in other, provincial, hospitals in Viet Nam. In addition, we were 
uninformed about the important risk factors of this infection in the Vietnamese 
population, with the exception of occupational exposure to pigs or pork, which was 
documented in 30% of patients in prior studies (Mai et al. 2008).  
This thesis focused on the epidemiology of S. suis serotype 2 infection in Viet 
Nam and aimed to address the following questions: 
1. Is human S. suis serotype 2 infection endemic across Viet Nam? 
2. What are the epidemiological characteristics of human S. suis serotype 2 
infection in Viet Nam, including incidence rate of disease, seasonality, and 
antimicrobial susceptibility of bacterial strains isolated from humans? 
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3. What are the main risk factors of human S. suis serotype 2 infection in Viet 
Nam? 
4. Is there any human carriage of S. suis serotype 2 in the respiratory and 
alimentary tracts? 
The extent to which these questions have been answered will now be discussed. 
7.1 Human endemic disease in Viet Nam  
S. suis infection in humans is sporadically reported in Western countries and 
may be underreported in China and Southeast Asian countries. Apart from the 
outbreaks in Jiangsu and Sichuan provinces in 1998 and 2005, any information about 
this infection in China is lacking. With the exception of reports from Thailand and 
Viet Nam, S. suis infection cases in other Southeast Asia countries, including Laos, 
Cambodia, Myanmar, Philippine, Brunei, Indonesia, Malaysia and Singapore, are 
rarely published in English literature. The reasons for this may be the really low 
incidence rate in the Muslim countries (Brunei, Indonesia and Malaysia) or the 
limitation of microbiological laboratories in isolating and identifying bacterial strains 
from cerebrospinal fluid and blood. In my opinion, the latter reason is probably the 
most important. Prior to this prospective surveillance study (01SS study) S. suis 
meningitis had never been reported from 2 central hospitals (Hue and Can Tho), 10 
provincial hospitals (Ca Mau, Bac Lieu, Soc Trang, Tra Vinh, Dong Thap, An Giang, 
Kien Giang, Binh Phuoc, Dak Lak, Khanh Hoa) and 1 district hospital (Sa Dec). 
Following this study, S. suis meningitis cases has now been documented at all of the 
surveyed sites by using standard culture and real-time PCR methods. This pathogen 
was the most common cause of adult CNS infection as well as adult bacterial 
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meningitis (BM) in these hospitals, which accounted for 25% and 50% of cases, 
respectively. Similarly, S. suis infection was also confirmed in 151 of 450 (34%) of 
BM patients in another previous case series at HTD from 1996 to 2005, and in 108 of 
268 (41%) of BM patients in our case-control study (EN study) at HTD from 2006-
2009 (chapter 5), and in 50 of 57 (88%) of culture or PCR confirmed BM patients at 
NHTD in 2007 (Mai et al. 2008; Wertheim et al. 2009). Moreover, S. suis meningitis 
consistently accounted for at least 40% of bacterial meningitis cases at HTD in the 
period of 2000 – 2005 (Mai et al. 2008). Given the above evidence, it can be 
concluded that human S. suis infection is really an endemic disease in Viet Nam, with 
an incidence rate of 0.57 per 100,000 adult person-years. The incidence rate in the 
general Vietnamese population was 5 times higher than that of Hong Kong and 200 
times higher than that of The Netherlands. S. suis infection is a public health problem 
which requires interventions in Viet Nam.  
7.2 Epidemiological characteristics of human S. suis infection in Viet Nam 
The majority of human S. suis cases reported in European countries 
sporadically occurred without any obvious seasonal pattern (Arends et al. 1988; 
Walsh et al. 1992). Other reports from the south of Viet Nam, including our case-
control study, documented similar observations (Figure 5-2) (Mai et al. 2008). 
However, human infection cases tended to occur mainly during the summer or the 
rainy season in most of case series from China, Hong Kong, northern Thailand and 
northern Viet Nam (Kay et al. 1995; Wangkaew et al. 2006; Yu et al. 2006; Ma et al. 
2008; Wertheim et al. 2009). In our prospective surveillance study, we found that the 
incidence of S. suis cases had a seasonal pattern in Hue Central hospital, but not in the 
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other hospitals which were located in the south of Viet Nam (Figure 4-1 and 4-2). As 
is shown in Figure 4-2, S. suis cases tended to occur when the mean air temperature 
was higher than 270C in Hue Central hospital. The lack of an obvious seasonal pattern 
of infection in the south of Viet Nam, (Figure 5-2), may be due to the fact that mean 
air temperatures are rarely below 260C in this geographical area with a tropical 
climate. S. suis infections tend to present in the summer or the rainy season, 
potentially linked with a higher incidence of disease in pigs due to high temperature 
and humidity (Kay et al. 1995; Huang et al. 2005; Wangkaew et al. 2006; Yu et al. 
2006; Navacharoen et al. 2009; Wertheim et al. 2009). S. suis can survive better in the 
environment at higher temperatures and humidity (Staats et al. 1997). Pork may be 
contaminated after environmental contamination of S. suis in slaughterhouses or 
markets. S. suis was isolated from raw pork samples obtained from wet markets in 
Hong Kong (Ip et al. 2007). Potentially more important, pork which is colonized by S. 
suis as a result of pig carriage state, may acquire high bacterial load in pork sold at the 
markets in the condition of high temperature and humidity. In addition, sudden 
weather change, such as can be observed in the north of Viet Nam, can precipitate S. 
suis infection in pigs (Staats et al. 1997), potentially resulting in an increased sale of 
infected pork as farmers seek to sell pigs and pork before they loose their livelihoods. 
 The association between human S. suis infection and occupational exposures 
to pigs or pork was first suggested in 1968 (Arends et al. 1988; Walsh et al. 1992). 
However, exposure to pigs or pork was present in only 36/149 (24%) of patients in the 
01SS study and in 46/101 (45%) of S. suis patients in the EN study, where the patients 
were carefully interviewed by two dedicated research nurses. Occupational exposure 
to pigs or pork was also reported in less than 50% of patients in another Asian case 
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series while the rate was nearly 90% in European patients (Kay et al. 1995; Mai et al. 
2008). I hypothesized that consuming uncooked or partially cooked pork products 
maybe a risk factor for S. suis infection. Local culinary delights such as undercooked 
pig tonsils, intestines, uterus, and fresh pig blood, may also represent important 
sources of infection. In the case-control study, I provided evidence that local culinary 
habits were indeed a risk factor of S. suis infection in Viet Nam. In addition, S. suis 
serotype 2 DNA was detected in the rectal swab samples of five S. suis meningitis 
patients and three of these patients had eaten pig intestines in the two week prior to 
sampling. In addition, S. suis was cultured from two of these patients. Taken together, 
our results strengthen the hypothesis that the gastrointestinal tract may be a route of 
entry of S. suis serotype 2 for at least a proportion of patients. Whilst I am aware that 
epidemiological evidence does not directly prove a causal relationship, I consider this 
novel finding one of the most striking results of my thesis. These results are also 
supported by an outbreak investigation in Thailand, where S. suis infection in 
attendants of a funeral banquet was significantly associated with the consumption of 
raw pig blood. Clearly, more research is needed to establish this causal relationship. 
In this thesis, a real-time PCR test was used to detect S. suis serotype 2 DNA 
in the CSF samples as well as in swab samples, which was more sensitive than culture 
method and had a detection limit of 1-5 colony forming units per reaction in a 
previous validation (Nga et al. 2011). Approximately, 30% (44/149) of S. suis cases in 
the 01SS study were only confirmed by PCR test, compared to 36/151 (24%) in a 
previous study at HTD and 11/41 (26%) in another study performed at NHTD in Ha 
Noi (Mai et al. 2008; Wertheim et al. 2009). Real-time PCR method is an effective 
procedure in surveillance of S. suis serotype 2 meningitis in developing countries, 
257 
 
where bacteriological culture facilities are limited and the use of antibiotics prior to 
admission is common. However, the cost of this method can be an obstacle for 
applying in the poor countries. 
It has been reported that S. suis infection is extremely rare in children because 
of the absence of occupational exposure to pigs or pork (Gottschalk et al. 2007). In 
addition, children rarely eat fresh blood and raw or undercooked pork, which can be a 
potential source of infection. Despite using direct culture and sensitive PCR, it was 
not possible to detect any paediatric case of S. suis infection from 871 CSF samples.  
 Although asymptomatic carriage of S. suis is common in healthy pigs, it is 
unknown whether humans asymptomatically carry the bacteria. Human carriage could 
potentially contribute to an increased risk of infection, and to the possibility of 
person-to-person transmission. It was not possible to detect any S. suis serotype 2 
DNA from the throat and rectal swab samples of 1521 healthy persons and non-S. suis 
infected patients, including those with pig exposures such as abattoir worker, butcher 
and pig breeders. This finding indicates that human carriage of S. suis serotype 2 must 
be extremely uncommon in this study population. I cannot exclude the possibility that 
other serotypes might be carried as the detection was limited to serotype 2. However, 
since 95% of culture confirmed S. suis infection is caused by serotype 2, such carriage 
is unlikely to contribute to any important morbidity.  
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7.3 Conclusions and future directions 
I have the following conclusions on the epidemiology of S. suis serotype 2 
infection in Viet Nam: 
1. S. suis serotype 2 infection is an endemic disease in Viet Nam, which is 
responsible for 49% of cases of adult purulent bacterial meningitis with an 
average incidence rate of 0.57 per 100,000 adult person-years (95% CI, 0.47-
0.70). 
2. A seasonal pattern of S. suis serotype 2 meningitis was documented in the 
North Central Viet Nam, but not in Southern Viet Nam. 
3. I identified risk factors for S. suis infection which can be addressed in health 
education programs targeted at individuals and communities at risk, focusing 
on skin protection for those in direct contact with pigs or pork and avoiding 
eating raw or under-cooked pig products. 
4. Human carriage of S. suis serotype 2 was not found in the Vietnamese 
population. 
I also propose following my thesis future directions in S. suis infection research in 
Viet Nam: 
1. In order to prevent human S. suis infection, we should conduct health 
education programs focused on the important risk factors at communities at 
risk, such as Thua Thien – Hue province in Central Viet Nam or Soc Trang 
and Kien Giang provinces in Mekong River Delta. 
2. Septic shock in S. suis infection was rarely reported in southern Viet Nam, but 
it was not an uncommon manifestation in the north of the country. Are there 
any differences in host or bacterial genetics, immune status, exposure factors, 
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or in treatment delay between septic shock patients and meningitis patients? A 
study focused on comparison of these characteristics as well as comparing 
virulence factors of the strains isolated in the north with the strains isolated in 
the south, needs to be done. 
3. Seventy percent of patients were older than 45 years and the incidence rate 
increased with the incremental of age. Why is S. suis infection more common 
in middle-aged and elderly persons? Does the exposure to pigs peak in this age 
group or are there decreases in the immune status in the elderly or is the 
presence of underlying diseases important in increasing the susceptibility to S. 
suis infection in this group? 
4. Investigating the prevalence of S. suis contamination in food items, such as 
fresh blood, intestines and uterus, in the restaurants and wet markets could 
provide support for the hypothesis of local eating habits as a risk factor for 
infection. 
5. Isolation and identification of S. suis are not available in every provincial 
hospital in Viet Nam. A diagnostic algorithm for S. suis meningitis based on 
clinical manifestations and CSF parameters (without the need of bacterial 
identification) would be useful. In addition, we need to enhance the capacity in 
bacteriology to establish a diagnosis of S. suis infection and to monitor the 
incidence of disease and the antimicrobial susceptibility of the isolates. 
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Appendix A 
The prospective surveillance study of CNS infection in the Central, 
Central Highlands and South of Viet Nam (01SS study) 
I. Case record forms: 
a. Adult patient: 
DATA FORM 
         Study number: 
         Hospital number: 
 
GENERAL INFORMATION 
 
1. Initials:/__/__/__/ Age: ............... Sex: Male / Female 
2. Address ....................................... Commune: ........................................................ 
    District: ....................................... Province: .......................................................... 
    Rural / Urban 
3. Occupation: ............................................................................................................ 
4. Ethnic groups: ........................................................................................................ 
5. Date of admission (DD/MM/YYYY): /___/___/________/ 
6. Reason of admission: ............................................................................................. 
 
UNDERLYING DISEASES or PAST MEDICAL HISTORY 
7. Underlying diseases or past medical history: (Yes: Y; No: N; Unknown: U) 
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• Diabetes   Y / N / U 
• Otitis   Y / N / U 
• Head trauma   Y / N / U 
• Heart diseases  Y / N / U 
• Alcoholic  Y / N / U 
• Splenectomy  Y / N / U 
• Bacterial meningitis Y / N / U 
• Valvular heart diseases Y/N / U 
• Others: ............................................................................................................ 
 
PIG EXPOSURE 
8. In patient’s family, is there anybody that has job related to pigs? Y / N / U 
• Pig breeder   
• Butcher   
• Slaughterer   
• Meat processor  
• Meat transporter   
• Pork roaster   
• Waiter    
• Veterinary inspector  
9. Does the patient have any pigs at home?    Y / N / U 
10. Have his/her pigs had any diseases in the last 4 weeks?   Y / N / U 
11. If yes, describe: 
• Fever    
• Arthritis   
• Neurological problems 
• Cough    
• Sudden death   
• Miscarriage   
• Unknown   
• Others: ………………… 
12. Has the patient done any of the work below during the last 2 weeks? 
• Bathe the pigs          
• Feed pigs          
• Clean up the piggery         
• Slaughter pigs          
• Prepare/handle pig blood    
• Prepare/handle raw pork     
• Contact with pig’s organs  
• Cook pork         
• Not done         
• Unknown         
• Others: ……………………
13. Which dishes did patient take in the last 2 weeks (especially when drinking)? 
• Pig’s blood curds          
• Duck’s blood curds          
• Undercooked  pig’s blood   
• Pig tonsils or tongue          
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• Pig stomach or intestines     
• Pig uterus            
• Not eat             
• Unknown            
 
CLINICAL MANIFESTATIONS ON ADMISSION 
14. Days of illness: ………….days 
15. Antimicrobial therapy before admission? Yes/No/Unknown 
      If yes, could you describe: 
…………………………………………………………………………………………
………………………………………………………………………………………… 
16 Vital signs: 
• Pulse:   /minute 
• Temperature:  0C 
• Blood pressure:      /       mmHg 
• Breath rate:  /minute 
17. Glasgow Coma Scale:  E M V = 
18. Clinical manifestations: 
• Fever    Y / N / U 
• Chills/rigors  Y / N / U 
• Headache  Y / N / U 
• Nausea/vomiting Y / N / U 
• Diarrhoea  Y / N / U 
• Dizziness  Y / N / U 
• Tinnitus  Y / N / U 
• Deafness  Y / N / U 
• Delirium  Y / N / U 
• Confusion  Y / N / U 
• Unconscious  Y / N / U 
• Seizures  Y / N / U 
• Gastrointestinal  
haemorrhage  Y / N / U 
• Other haemorrhages Y / N / U 
………………………………
……………………………… 
• Acrocyanosis/ 
Necrosis   Y / N / U 
• Rash   Y / N / U 
………………………………
……………………………… 
• Jaundice  Y / N / U 
• Hepatomegaly  Y / N / U 
• Urine retention Y / N / U 
• Meningeal signs Y / N / U 
• Hemiplegia  Y / N / U 
• Paraplegia  Y / N / U 
• Cranial nerve palsy Y / N / U 
• Herpes labial  Y / N / U 
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• Arthritis  Y / N / U 
………………………………
……………………………… 
• Ear drum: 
L Normal/ Abnormal 
R Normal/ Abnormal 
• Heart exam:
 Normal/Abnormal 
………………………………
……………………………… 
• Lung exam: 
 Normal/ Abnormal 
………………………………
……………………………… 
• Skin lesions  Y / N / U 
………………………………
………………………………
………………………………
……………………………… 
 
LABORATORY FINDINGS ON ADMISSION 
19. CBC 
WBC ............../µl (N ..............%, L ................%, M ...............%, E ................%) 
Hb ...................g/dl, Hct..........% 
Plt .................../ µl 
20. Liver function tests: 
SGOT .............U/l, SGPT .............U/l, Bilirubin total  ..............µmol/l 
21. Renal function tests: 
BUN  ..............mmol/l, Creatinine  ................µmol/l 
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22. CSF: 
Date 
    
Color…     
Opening pressure     
Cell count 
+ WC (N/L) 
 
+ RC 
    
Protein     
Glucose 
(CSF/blood) 
    
Lactate 
(CSF/blood) 
    
Gram stain     
Culture     
PCR     
ELISA     
 
23. CSF culture and antibiogram: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
24. Blood culture and antibiogram: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
  
280 
 
25. Chest X-ray: Normal / Abnormal / Not done 
…………………………………………………………………………………………
………………………………………………………………………………………… 
26. Cranial CT Scan/MRI: Normal / Abnormal / Not done 
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
TREATMENT AND OUTCOME 
27. Final diagnosis:  .......................................................................................................  
28. Dexamethasone:   Y / N / U 
29. Antimicrobial therapy: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
30. Hearing status on discharge: 
• Tinnitus   Y / N / U 
• Hearing loss   Y / N / U 
• Deaf (completely)  Y / N / U 
31. Other sequelae: 
………………………………………………………………………………………… 
32. Outcome: 
• Survival  
• Died   
• Transferred  
• Unknown  
31. Duration of staying in hospital: ……………………… day(s). 
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b. Paediatric patient: 
DATA FORM 
         Study number: 
         Hospital number: 
 
GENERAL INFORMATION 
 
1. Initials:/__/__/__/ Age: ...............(yrs)  ..................(months) Sex: Male / Female 
2. Address ....................................... Commune: ........................................................ 
    District: ....................................... Province: .......................................................... 
    Rural / Urban 
3. Occupation: ............................................................................................................ 
4. Ethnic groups: ........................................................................................................ 
5. Date of admission (DD/MM/YYYY): /___/___/________/ 
6. Reason of admission: ............................................................................................. 
 
UNDERLYING DISEASES or PAST MEDICAL HISTORY 
7. Underlying diseases or past medical history: (Yes: Y; No: N; Unknown: U) 
• Diabetes   Y / N / U 
• Otitis/ Sinusitis Y / N / U 
• Head trauma   Y / N / U 
• Heart diseases  Y / N / U 
• Mother had fever  
on delivery  Y / N / U 
• Splenectomy  Y / N / U 
• Bacterial meningitis Y / N / U 
• Valvular heart diseases/ 
congenital heart diseases  
    Y / N / U 
• Others: ............................................................................................................ 
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8. Vaccination: (Code: 0: none; 9: unknown) 
 
Type of vaccines Total doses 
0: none; 9: unknown 
Age of the last dose 
99: unknown 
Notes 
H. influenzae type b    
N. meningitidis    
S. pneumoniae    
Measles    
Mumps    
Rubella    
Chickenpox    
Sabin    
JE vaccine    
 
9. HIV: Positive/ Negative/ Unknown 
 
PIG EXPOSURE 
10. In patient’s family, is there anybody that has job related to pigs? Y / N / U 
• Pig breeder   
• Butcher   
• Slaughterer   
• Meat processor  
• Meat transporter   
• Pork roaster   
• Waiter    
• Veterinary inspector  
11. Does the patient have any pigs at home?    Y / N / U 
12. Have his/her pigs had any diseases in the last 4 weeks?   Y / N / U 
13. If yes, describe: 
• Fever    
• Arthritis   
• Neurological problems 
• Cough    
• Sudden death   
• Miscarriage   
• Unknown   
• Others: ………………… 
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14. Has the patient done any of the work below during the last 2 weeks? 
• Bathe the pigs          
• Feed pigs          
• Clean up the piggery         
• Slaughter pigs          
• Prepare/handle pig blood    
• Prepare/handle raw pork     
• Contact with pig’s organs  
• Cook pork         
• Not done         
• Unknown         
• Others: ……………………
15. Which dishes did patient take in the last 2 weeks (especially when drinking)? 
• Pig’s blood curds          
• Duck’s blood curds          
• Undercooked  pig’s blood   
• Pig tonsils or tongue          
• Pig stomach or intestines     
• Pig uterus            
• Not eat             
• Unknown            
 
 
CLINICAL MANIFESTATIONS ON ADMISSION 
16. Days of illness: ………….days 
17. Antimicrobial therapy before admission? Yes/No/Unknown 
      If yes, could you describe: 
…………………………………………………………………………………………
………………………………………………………………………………………… 
18 Vital signs: 
• Pulse:   /minute 
• Temperature:  0C 
• Blood pressure:      /       mmHg 
• Breath rate:  /minute 
 
19. Glasgow Coma Scale (if child ≥ 3 year-old):  E M V = 
      Blantyre Coma Scale (if child < 3 year-old):  E M V = 
  
284 
 
 
Glasgow Coma Scale Blantyre Coma Scale 
Eye opening (E) 
Spontaneous                                             4 
To speech                                                 3 
To pain                                                     2 
None                                                        1 
Eye movement (E) 
Watches or follows                                 1 
Fails to watch or follow                          0
Motor response (M) 
Obeys commands                                    6 
Localizes pain                                         5 
Withdrawal                                             4 
Flexor response                                      3 
Extension                                                2 
None                                                       1 
Best motor response (M) 
Localizes painful stimulus                      2 
Withdraws limb from painful stimulus  1 
No response                                            0 
 
Verbal response (V) 
Oriented                                                  5 
Confused                                                 4 
Inappropriate                                           3 
Incomprehensible                                    2 
None                                                        1 
Best verbal response (V) 
Cries appropriately with pain                 2 
Moan or abnormal cry with pain            1 
No vocal response to pain                      0 
 
20. Clinical manifestations: 
• Fever    Y / N / U 
• Chills/rigors  Y / N / U 
• Headache  Y / N / U 
• Nausea/vomiting Y / N / U 
• Diarrhoea  Y / N / U 
• Dizziness  Y / N / U 
• Anorexia  Y / N / U 
• Bulging fontanelle Y / N / U 
• Lethargy  Y / N / U 
• Delirium  Y / N / U 
• Confusion  Y / N / U 
• Unconscious  Y / N / U 
• Seizures  Y / N / U 
• Gastrointestinal  
haemorrhage  Y / N / U 
• Other haemorrhages Y / N / U 
………………………………
………………………………. 
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• Acrocyanosis/ 
Necrosis  Y / N / U 
• Rash   Y / N / U 
………………………………
……………………………… 
• Jaundice  Y / N / U 
• Hepatomegaly  Y / N / U 
• Urine retention Y / N / U 
• Meningeal signs Y / N / U 
• Hemiplegia  Y / N / U 
• Paraplegia  Y / N / U 
• Cranial nerve palsy Y / N / U 
• Herpes labial  Y / N / U 
• Arthritis  Y / N / U 
………………………………
……………………………… 
• Ear drum: 
L Normal/ Abnormal 
R Normal/ Abnormal 
• Heart exam:  
Normal/ Abnormal 
………………………………
……………………………… 
• Lung exam:  
Normal/ Abnormal 
………………………………
……………………………… 
  
LABORATORY FINDINGS ON ADMISSION 
21. CBC 
WBC ............../µl (N ..............%, L ................%, M ...............%, E ................%) 
Hb ...................g/dl, Hct..........% 
Plt .................../ µl 
22. Liver function tests: 
SGOT .............U/l, SGPT .............U/l, Bilirubin total  ..............µmol/l 
23. Renal function tests: 
BUN  ..............mmol/l, Creatinine  ................µmol/l 
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24. CSF: 
Date 
    
Colour…     
Opening pressure     
Cell count 
+ WC (N/L) 
 
+ RC 
    
Protein     
Glucose 
(CSF/blood) 
    
Lactate 
(CSF/blood) 
    
Gram stain     
Culture     
PCR     
ELISA     
 
25. CSF culture and antibiogram: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
26. Blood culture and antibiogram: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
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27. Chest X-ray: Normal / Abnormal / Not done 
…………………………………………………………………………………………
………………………………………………………………………………………… 
26. Cranial CT Scan/MRI: Normal / Abnormal / Not done 
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
TREATMENT AND OUTCOME 
27. Final diagnosis:  .......................................................................................................  
28. Dexamethasone:   Y / N / U 
29. Antimicrobial therapy: 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
30. Hearing status on discharge: 
• Tinnitus   Y / N / U 
• Hearing loss   Y / N / U 
• Deaf (completely)  Y / N / U 
31. Other sequelae: 
………………………………………………………………………………………… 
32. Outcome: 
• Survival  
• Died   
• Transferred  
• Unknown  
31. Duration of staying in hospital: ……………………… day(s). 
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II. Participant Information sheets and Consent forms: 
a. Adult patient: 
Hospital for Tropical Diseases 
190 Ben Ham Tu, District 5 
Ho Chi Minh City, Viet Nam 
 
Hospital for Tropical Diseases: 08. 8380302 
Contact physicians: Dr Ho Dang Trung Nghia:  0918500638 
 
Patient information sheet 
Oxtrec No.: 01 08 
 
A study of causes of infection in southern and central Viet Nam 
 
You are being invited to take part in a research study on the causes of Central 
Nervous System infections because you may have an infection of your Central 
Nervous System. Please read this information sheet carefully or have someone read it 
for you. You will be given a copy of this form to keep. 
 
What is the reason for doing the study? 
Central nervous system infection is a serious and life-threatening disease. The relative 
frequencies of the cause of meningitis/encephalitis have varied with periods of time, 
location, age, underlying medical and/or surgical conditions of patients. In Viet Nam, 
we have little information about why people get meningitis/encephalitis. We would 
like to get more information by studying patients with CNS infection. Your 
participation in this study does not have direct benefit for you now, but may have 
benefit for patients in the future. You can withdraw from this study at any time if you 
choose to. 
What will happen if I take part in the study? 
You will be given treatment for the disease, for which you have been admitted to the 
hospital, whether or not you decide to take part in the study. 
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What tests will be done? 
A lumbar puncture will be done to collect some cerebrospinal fluid (CSF), this is fluid 
in your back, for meningitis/encephalitis diagnosis as part of standard clinical care. 
One millilitre of your CSF will be used to detect bacteria or viruses using molecular 
techniques. All samples will be labelled with a study number rather than your name, 
to protect your identity. Samples will be tested and stored indefinitely in a freezer at 
the Oxford University Clinical Research Unit, Hospital for Tropical Diseases. Further 
tests for detection of bacteria or viruses on stored samples, may be undertaken in the 
future to improve our understanding of the disease. We will not perform any analysis 
related to human genetics on your sample. 
 
Risks 
There are very few risks to you from being in the study. Collecting of the fluid from 
your back will hurt for a moment and may leave a bruise. This is part of your normal 
clinical care. 
 
Confidentiality 
Information about you will be kept confidential and will not be made available to 
anyone who is not connected with the study without your consent.  
 
Cost 
You will not have to pay for anything other than the normal cost of routine inpatient 
care. All tests related to the study will be paid for. 
 
Questions 
If you have any other questions about the study please contact: 
Doctor’s name: Dr Ho Dung Trung Nghia 
Telephone number: 0918500638 
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CONSENT FORM 
 
A study of causes of infection in southern and central Viet Nam  
Oxtrec No. 01 08 
Consent from patient 
  
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree to take part. I know that I can withdraw at any time if I 
choose to. 
 
I also agree to the indefinite storage of my cerebrospinal fluid for further tests 
to detect bacteria or viruses at a later date.  
 
Name of patient: _____________________________Signature: _________________ 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
 
If the patient gives verbal consent to take part in the study, but is unable to sign, the 
physician can record the consent here: 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
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Consent from relative 
 
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree for my relative ___________________________to take part. 
 I also agree to the indefinite storage of my relative’s cerebrospinal fluid for 
further tests related to the cause of infection at a later date.  
 
Name of relative: _____________________________Signature: _________________ 
Relationship to patient: _________________________ 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
 
Consent from two independent physicians 
If the patient is unconscious, two independent doctors approached to act as proxy for 
relatives should not be involved in the study and also that proper consent will be 
sought as and when the patients recovers consciousness. 
 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
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b. Paediatric patient: 
Hospital for Tropical Diseases 
190 Ben Ham TU, District 5 
Ho Chi Minh City, Viet Nam 
 
Hospital for Tropical Diseases: 08. 8380302 
Contact physicians: Dr Ho Dang Trung Nghia:  0918500638 
 
Patient information sheet (children) 
Oxtrec No.: 01 08 
 
A study of causes of infection in southern and central Viet Nam 
 
Your child is being invited to take part in a research study on the causes of Central 
Nervous System infection. Please read this information sheet carefully or have 
someone read it for you. You will be given a copy of this form to keep. 
 
What is the reason for doing the study? 
We are asking to enroll your child in a study to find out what caused her/his illness 
(meningitis or encephalitis). We want to find out what causes this disease in Viet 
Nam. Meningitis and encephalitis are common diseases in Viet Nam, and we often do 
not know the cause or how to treat the disease. We hope this work will help us 
understand the disease, to prevent it happening and we hope to plan the best treatment 
for this disease for future generations of people in Vietnam. Your participation in this 
study does not have direct benefit for you now, but may have benefit for patients in 
the future. You can withdraw from this study at any time if you choose to. 
What will happen if my child takes part in the study? 
Your child will be given treatment for the disease, for which he/she has been admitted 
to the hospital, whether or not you decide to enroll in the study. 
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What tests will be done? 
A lumbar puncture will be done to collect some cerebrospinal fluid (CSF), this is fluid 
in the back, for meningitis/encephalitis diagnosis as part of standard clinical care. One 
millilitre of the CSF will be used to detect bacteria or viruses using molecular 
techniques. All samples will be labelled with a study number rather than your child’s 
name, to protect her/his identity. Samples will be tested and stored indefinitely in a 
freezer at the Oxford University Clinical Research Unit, Hospital for Tropical 
Diseases. Further tests for detection of bacteria or viruses on stored samples, may be 
undertaken in the future to improve our understanding of the disease. We will not 
perform any analysis related to human genetics on the sample. 
 
Risks 
There are very few risks to your child from being in our study. Collecting the fluid 
from their back will hurt for a moment and may leave a bruise. This is part of normal 
clinical care 
 
Confidentiality 
Information about your child will be kept confidential and will not be made available 
to anyone who is not connected with the study without your consent.  
 
Cost 
You will not have to pay for anything other than the normal cost of routine inpatient 
care. All tests related to the study will be paid for. 
 
Questions 
If you have any other questions about the study please contact: 
Doctor’s name: Dr Ho Dung Trung Nghia 
Telephone number: 0918500638 
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CONSENT FORM (children) 
 
A study of causes of infection in southern and central Viet Nam  
Oxtrec No. 01 08 
Consent from parent/caretaker 
 
I have read and understood the information sheet. 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree for my child ___________________________________ 
to take part. 
I also agree to the indefinite storage of my child’s cerebrospinal fluid for 
further tests related to the cause of infection at a later date.  
 
Name of parent/caretaker: ______________________Signature: _________________ 
Relationship to patient:__________________________________________________ 
Name of physician: ___________________________Signature: _________________ 
Date: ______________________ 
 
If the parent/caretaker gives verbal consent to take part in the study, but is unable to 
sign, the physician can record the consent here: 
Name of physician: __________________________ Signature: _________________ 
Date: ______________________ 
Consent from two independent physician 
If the patient is unconscious, two independent doctors approached to act as proxy for 
relatives should not be involved in the study and also that proper consent will be 
sought as and when the patients recovers consciousness. 
 
Name of physician: ________________________Signature: _________________ 
Date: ______________________ 
Name of physician: ________________________Signature: _________________ 
Date: ______________________ 
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III. The ethical approvals: 
a. HTD’s approval: 
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b. OXTREC’s approval: 
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Appendix B 
Case-control study to identify risk factors of S. suis infection 
 in Viet Nam (EN study) 
I. Case record forms: 
a. Questionnaire: 
 
 
QUESTIONNAIRE 
 
 
1. GENERAL INFORMATION: 
 
 
N0 Question Answer 
101 What’s your name? Initials /__/__/__/ 
 
102 What’s your address? 
 
 
 
 
District  
Province 
Rural l 
Urban 2
103 How long have you lived here? <4 weeks 
≥4 weeks 
1 
2 
 
N0 Question Answer Code Other 
104 How old are you? ………years  Validated by ID 
card: yes/no 
105 Sex Male 
Female 
1 
2 
 
106 What is your principal 
occupation? 
……………………………. 
No job 
No answer 
 
98 
99 
 
107 What is your secondary 
occupation? 
……………………………... 
No job 
No answer 
 
98 
99 
 
Did you suffer from meningitis during the last year? Study number: EN  
Hospital number:   
Name interviewer: 
Date: 
Time:    until 
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108 What is your education level? Primary 
Secondary “level 2” 
Secondary “level 3” 
University 
Illiterate 
Unknown 
No answer 
1 
2 
3 
4 
5 
98 
99 
 
109 What is your religion? Buddhism 
Catholicism 
Christianity 
Cao dai 
Other (specify)…………….. 
No religion 
Unknown 
No answer 
1 
2 
3 
4 
5 
6 
98 
99 
 
110 What is your ethnic 
background? 
Kinh 
 Khmer 
Chinese 
Other (specify)…………….. 
Unknown 
No answer 
1 
2 
3 
4 
98 
99 
 
111 Are you married? Single 
Married 
Divorce/Separated 
No answer 
1 
2 
3 
99 
 
112 How many persons live in your 
house? 
< 15 year-old………… 
≥ 15 year-old………… 
no answer 
 
 
99 
 
113 In your family, is there anybody 
that has job related to pigs? (Pig 
breeder, butcher, abattoir 
worker, meat transporter, 
waiter, cook, pork roaster, meat 
processor, veterinary inspector, 
housewife…) 
Yes 
No 
Unknown 
No answer 
If yes, 
specify……………………
…………………………… 
1 
2 
98 
99 
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114 How much do you earn a month 
(your income)? 
VND…………..………… 
Unknown 
No answer 
 
98 
99 
 
115 Do you own …?  
TV 
Motorbike 
Car 
House category 1-3 
House category 4 
Thatched house 
None of the above 
No answer 
Yes No  
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
Multiple 
answers 
possible 
3 
99 
 
 
 
2. MEDICAL HISTORY: 
201 Have you had any diseases? 
(except for current illness) 
 
Yes 
No 
If yes, specify…………… 
…………………………... 
Unknown 
No answer
1 
2 
 
 
98 
99 
 
202 Have you ever been 
hospitalized? (except for 
current hospitalization) 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
If yes, for 
which 
diseases? 
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203 
 
Which diseases/conditions did 
you have or are you still 
suffering from? 
 
 
 
 
Diseases/conditions  V* Time frame* 
Nothing 
Bacterial meningitis 
Diabetes mellitus 
 Malignancy 
 Valvular heart diseases 
Hydrocephalus 
Splenectomy 
Alcoholic 
…………………………… 
……………………………
0 
1 
2 
3 
4 
5 
6 
7 
  
V*: Validated by hospital records : yes(1)/no(2) for each illness 
Time frame*: Time frame for each illness: when and how long 
204 Are you using any medication 
(in the last 4 weeks, at least 2 
days per week)? 
Drugs Yes No 
Validated by 
hospital records or 
direct inspection 
 Steroids 
Antibiotics 
…………………… 
…………………… 
No treatment 
Unknown 
No answer
1 
1 
1 
1 
2 
2 
2 
2 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
 
 
 
 0 
98 
99 
 
 
205 Have you had any disease in the 
last 2 weeks? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
206 If yes, could you describe 
diseases/ symptoms/ signs? 
Common cold/Flu 
Diarrhoea 
Otorrhea/Otalgia 
Extraction of your teeth 
Other (specify)………….. 
……………………………
1 
2 
3 
4 
5 
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207 Have you had any skin injury 
(cut, burn…) in the last 2 
weeks? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
208 If yes, describe your skin 
injuries? 
• Location (all) 
• Extend 
• Open/closed 
……………………………
…………………………… 
……………………………
…………………………… 
……………………………
…………………………… 
……………………………
……………………………
 
209 Have you had any head injury? 
(in the last 2 weeks) 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
 
3. CONTACT WITH PIGS: 
301 Do you have any pigs at home, 
now or in the last 6 months? 
Yes 
No 
Unknown 
No answer 
1 
2 
98 
99 
If No, go to 
Q308 
302 How many pigs do you have at 
home? 
………pigs 
Unknown 
No answer
 
98 
99 
 
303 How long have you kept them 
at home? 
………months 
Unknown 
No answer
 
98 
99 
 
 
 
304 Where do you keep your pigs? In piggery 
Let wander 
Unknown 
 No answer
1 
2 
98 
99 
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305 Why do you breed pigs? 
 
 
 
Reproduction 
Selling 
Eating 
Unknown 
No answer
Yes No  
1 
1 
1 
2 
2 
2 
98 
99 
306 Have your pigs had any 
diseases in the last 4 weeks? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
307 If yes, describe?  
Fever 
Arthritis 
Neurological problems 
Cough 
Sudden death 
Miscarriage 
Unknown 
No answer
Yes No  
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
98 
99 
308 Have you done any of the work 
below during the last 2 weeks? 
 
 
To bathe your pigs 
To feed pigs 
To clean up the piggery 
 slaughter pigs 
prepare/handle pig blood 
prepare/handle raw pork 
cook pork 
Unknown 
No answer
Yes No Frequency 
(times/week), 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
 
98 
99 
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309 Do your neighbours have any 
pigs? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
310 Did you visit a pig farm or a 
house that has some pigs in the 
last 2 weeks? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
311 Did you have contact with pork 
blood or other pig’s organs in 
the last 2 week? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
312 If yes, describe? ……………………….. 
……………………….. 
………………………..
 Frequency 
(times/week) 
313 Other contact with pigs in the 
last 2 weeks? 
Hunting wild boar 
Other (specify)………… 
……………………….. 
………………………..
1 
2 
 
314 Have you had any animals at 
home in the last 2 weeks? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
315 If yes, what kind of animal?  
Dog 
Cat 
Cow 
Chicken 
Duck 
Other…………… 
Unknown 
No answer
Yes No  
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
98 
99 
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4. EATING HABITS AND SANITARY 
401 Do you eat pork? Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
402 How many times do you eat 
pork each week? 
…………times 
Unknown 
No answer
 
98 
99 
 
403 Which dishes? Dishes Yes No Frequency 
(times/week) 
Duck/Pig’s blood curds 
Fermented pork roll 
Pork meat 
Pig tonsils/tongue 
Pig stomach or intestines 
Pig uterus 
Meat of wild boar 
Other 
………………….. 
Unknown 
No answer
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
 
 
98 
99 
404 Do you drink beer/wine? Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
If No, go to 
question 408 
405 If Yes, could you describe? 
 
 
 
* Beer 
 
* Wine 
 
 
Frequency  
times/week 
How much? 
(ml/each 
time) 
How long? (years) 
 
  
  
* Unknown: 98, No answer: 99 
  
 305
406 Where do you usually drink 
beer/wine? 
Where Yes No  
At home 
In the restaurant
1 
1 
2 
2 
 
 
407 Which dishes do you usually 
take when drinking? 
Dishes Yes No  
Pork meat 
Beef meat 
Pig’s blood curds 
Duck’s blood curds 
Pig tonsils/tongue 
Pig stomach 
Pig uterus 
Meat of wild boar 
…………………. 
…………………. 
Unknown 
No answer
1 
1 
1 
1 
1 
1 
1 
1 
 
 
2 
2 
2 
2 
2 
2 
2 
2 
 
98 
99 
 
408 Do you usually smoke? Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
409 If yes, do you usually smoke 
when you contact* with pig? 
(contact*: To bathe your pigs, 
to feed pigs, to clean up the 
piggery, slaughter pigs, 
prepare/handle pig blood, 
prepare/handle raw pork, cook 
pork). 
 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
410 Do you wash your hands after 
going to the toilet? 
Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
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411 Do you wash your hands before 
and after preparing meals? 
 Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
 
412 Which sources of water do you 
use in your house for drinking? 
Sources of water Yes No Multiple 
answers 
possible 
Tap-water 
Water from the well 
Rain water 
Water from the river 
Water from the pond/lake 
 
Unknown 
No answer
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
 
 
98 
99 
 
 
413 Does your house have a toilet? Yes 
No 
Unknown 
No answer
1 
2 
98 
99 
 
414 Where do you and your family 
defecate? 
 
Toilet 
In the field 
In the river 
In the fish pond/lake 
 
 
Unknown 
No answer
Yes No  
1 
1 
1 
1 
 
 
2 
2 
2 
2 
 
98 
99 
 
 
This is the end of the interview. Thank you for your time answering these questions. 
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b. Data form: 
DATA FORM 
 
Study number: EN 
Hospital number: 
GENERAL INFORMATIONS 
1. Name: .......................................................................................... Age: ................ 
2. Sex:  (Male= 1, Female= 2) 
3. Address: ................................................................... Commune: ......................... 
District: .................................................................... Province: ............................ 
 (Rural=1, Urban=2) 
4. Occupation: .......................................................................................................... 
5. Ethnic groups: ...................................................................................................... 
6. Date of admission: ............................................................................................... 
7. Reason of admission: ........................................................................................... 
 
UNDERLYING DISEASES or PAST MEDICAL HISTORY 
8. Did the patient have any underlying diseases or past medical history?  
(Yes=1, No=2, Unknown=99) 
Diabetes   
Otitis    
Head trauma   
Heart diseases  
Alcoholic   
Splenectomy   
Pig exposure   
9. Others, could you describe? ................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
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CLINICAL MANIFESTATIONS ON ADMISSION 
10. Days of illness: ............................. days. 
11. Antimicrobial therapy before admission?   
(Yes=1, No=2, Unknown=99) 
If yes, could you describe?................................................................................... 
 ............................................................................................................................. 
 ............................................................................................................................. 
12. Vital signs: 
Date               
400C 
 
T 
 
360C 
              
              
              
              
              
Pulse               
BP               
RR               
Urine  
Output 
              
GCS               
 
13. GCS on admission: E     M      V        = 
Question 14 - 42, (Yes=1, No=2, Unknown=99) 
14. Fever     
15. Chills, rigors:    
16. Headache:    
17. Nausea/Vomiting:   
18. Diarrhoea:    
19. Dizziness:   
20. Tinnitus:   
 R/L/Both sides 
21. Delirium:   
22. Confusion:   
23. Unconscious:  
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24. Seizures:  if yes, describe .............................................................................. 
25. Gastrointestinal haemorrhage:  
26. Other haemorrhages: , if yes, describe .......................................................... 
27. Acrocyanosis:  
28. Ischemic necrosis of peripheral tissues:  
29. Rash: , if yes, describe rash including location: ............................................ 
 ............................................................................................................................. 
30. Skin injuries: , if yes, describe lesions including location: ........................... 
 ............................................................................................................................. 
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31. Jaundice:  
32. Hepatomegaly:  
33. Urine retention:  
34. Neck stiffness:  
35. Kernig’s sign:  
36. Brudzinski’s sign:  
37. Focal neurological findings:  if yes, describe ................................................ 
38. Abnormal cranial nerve:  if yes, describe ...................................................... 
39. Papilledema:  
40. Deafness:  R/L/Both sides 
41. Herpes labial:  
42. Arthritis: , if yes, describe ............................................................................. 
43. Ear drum: (Normal=1, Abnormal=2) 
R         L   
44. Heart exam: (Normal=1, Abnormal=2) ......................................................... 
45. Lung exam: (Normal=1, Abnormal=2) ......................................................... 
46. Teeth condition:  .................................................................................................. 
47. Other symptoms: .................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
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48. Complications:  
Septic shock = 1 DIC = 2 ARDS = 3 Renal failure = 4
 None = 0 
Other ………………………………………………………………………… 
 
LABORATORY FINDINGS ON ADMISSION 
49. CBC 
WBC .................................. /µl (N ........ %, L .......... %, M ......... %, E .......... %) 
Hb…………………g/dl, Hct ................ % 
Plt ....................................... / µl 
50. Liver function tests: 
SGOT .............. U/l, SGPT .................... U/l, Bilirubintotal .................... µmol/l 
51. Renal function tests: 
BUN ................ µmol/l, Creatinine……………………… µmol/l 
52. DIC tests: 
TT .................... , PT ....................., Fibrinogen ..................., TCK....................... 
53. Blood gases: 
pH .................... PaCO2 ................. PaO2 ............................. HCO-3 ...............................  
Conclusion: 
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54. CSF: 
Date     
Colour…     
OP     
Cell count 
+ WC (N/L) 
 
+ RC 
    
Protein     
Glucose 
(CSF/blood) 
    
Lactate 
(CSF/Blood) 
    
Gram stain/ 
AFB/ India ink 
    
Culture     
PCR     
 
55. CSF culture and antibiogram: 
 ............................................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
56. Blood culture and antibiogram: 
 ............................................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
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57. Throat and rectal swabs (PCR): 
 
Samples Date PCR results Other 
Throat swab I    
Throat swab II    
Rectal swab I    
Rectal swab II    
 
TREATMENT AND OUTCOME 
58. Final diagnosis:  ................................................................................................... 
 ............................................................................................................................. 
59. Dexamethasone: (Yes=1, No=2, Unknown=99) 
60. Antimicrobial therapy: 
 ............................................................................................................................. 
 ............................................................................................................................. 
 ............................................................................................................................. 
61. Hemofiltration:  (Yes=1, No=2, Unknown=99) 
62. Mechanical ventilation:  (Yes=1, No=2, Unknown=99) 
63. Outcome:  (Survival=1, Died=2, Transferred=3, Unknown=99) 
64. Considered mentally normal by medical staff:  (Normal=1, Personality 
difference=2, Moderately abnormal=3, Severely abnormal=4) 
65. Understanding:  (Same as before illness=1, Reduce=2, None=3) 
66. Able to sit:  (Independent=1, With help=2, Not at all = 3) 
67. Able to stand:  (Independent=1, With help=2, Not at all = 3) 
68. Able to walk:  (Independent=1, With help=2, Not at all = 3) 
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69. Power:  
R arm:             /5                         L arm:            /5 
R leg:              /5                          L leg:             /5 
70. Cerebellar syndrome: 
Gait:  (Normal=1, Abnormal=2) 
Finger nose test  (Normal=1, Abnormal=2) 
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II. Participant Information sheets and Consent forms: 
a. Patient: 
 Hospital for Tropical Diseases 
190 Ben Ham TU, District 5 
Ho Chi Minh City, Viet Nam 
 
Hospital for Tropical Diseases: 8. 8380302 
Contact physicians: Dr Ho Dung Trung Nghia:  0918500638 
Dr Constance Schultsz: 8. 9237954 
 
Patient information sheet 
Oxtrec No.:012-06 
 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicaemia in adults in southern Viet Nam 
 
You are being invited to take part in a research study of Streptococcus suis infection. 
Please read this information sheet carefully or have someone read it for you. You will 
be given a copy of this form to keep. 
 
What is the reason for doing the study? 
 
Streptococcus suis meningitis is an important disease in Viet Nam. We know that pigs 
can carry Streptococcus suis in their body and that they can become ill due to 
infection with Streptococcus suis. At this time, we have little information on how 
humans get infected with Streptococcus suis and what measures we can take to 
prevent infection. We would like to get more information by studying patients with 
Streptococcus suis infection, patients with other infections, and healthy people, and 
compare the results. Your participation in this study does not have direct benefit for 
you now, but may have benefit for patients in the future. You can withdraw from this 
study at any time if you choose to. 
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What will happen if I take part in the study? 
• You will be given treatment for the disease, for which you have been admitted 
to the hospital, whether or not you decide to take part in the study. 
• You will be asked a number of questions, using a questionnaire. It takes you 
about 15 minutes. We will ask you these questions when you are fully 
conscious and capable of answering any questions. 
 
What tests will be done? 
• You will have 2 throat swabs taken to detect the presence or absence of 
Streptococcus suis in your throat. The first sample will be taken after giving 
consent to participate in the study, and the second 14 days after admission or 
at discharge. 
• You will have 2 stool samples or rectal swabs, whichever you prefer, taken to 
detect the presence or absence of Streptococcus suis in your large intestine. 
The first sample will be taken after giving consent to participate in the study, 
and the second 14 days after admission or at discharge. 
• You will be taken 10 ml blood  
o to detect if your body has produced antibodies against Streptococcus 
suis  
o to assess whether certain people are genetically susceptible to this 
disease. 
• If you have pigs at home, we will take throat swab samples from some of the 
piglets or pigs to detect the presence of Streptococcus suis in your pigs. 
• We will ask 3 of your adult household members to also participate in this 
study by supplying swab samples. 
 
Taking a throat or rectal swab sample can be a little uncomfortable. Taking blood may 
cause a little pain and a bruise.  
Taking a throat swab sample from a piglet or pig causes a little stress for the animal. 
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All samples will be labelled with a study number rather than your name, to protect 
your identity. Samples will be tested and stored indefinitely in a freezer at the Oxford 
University Clinical Research Unit, Hospital for Tropical Diseases. Further tests on 
stored samples, including studies on your DNA (your genetic make up), may be 
undertaken in the future to improve our understanding of the disease. 
 
If we detect Streptococcus suis in any of the samples, we will inform you by mail. At 
the moment we think that this does not require any additional treatment. 
 
Confidentiality 
Information about you will be kept confidential and will not be made available to 
anyone who is not connected with the study without your consent.  
 
Cost 
You will not have to pay for anything other than the normal cost of routine inpatient 
care. All tests related to the study will be paid for. 
 
Questions 
If you have any other questions about the study please contact: 
Doctor’s name: Dr Ho Dung Trung Nghia 
Telephone number: 0918500638 
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CONSENT FORM 
 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicaemia in adults in southern Viet Nam 
Oxtrec No. 012-06 
 
Consent from patient 
  
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree to take part. I know that I can withdraw at any time if I 
choose to. 
 
I also agree to the indefinite storage of my swab samples and blood for further 
tests, including genetic tests, related to Streptococcus suis infection, at a later 
date.  
 
I also agree to have throat swab samples taken from some of the pigs in my 
household to detect the presence of Streptococcus suis. 
 
 
Name of patient: ____________________________ Signature: _________________ 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
 
 
If the patient gives verbal consent to take part in the study, but is unable to sign, the 
physician can record the consent here: 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
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Consent from relative 
 
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree for my relative ___________________________to take part. 
 
I also agree to the indefinite storage of my relative’s swab samples and blood 
for further tests related to Streptococcus suis infection at a later date.  
 
I also agree to have throat swab samples taken from some of the pigs in my 
relative’s household to detect the presence of Streptococcus suis. 
 
Name of relative: ___________________________ Signature: _________________ 
Relationship to patient: _________________________________________________ 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
 
Consent from two independent physicians 
If the patient is unconscious, two independent doctors may decide to enter the patient 
into the study. 
 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
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b. Healthy control: 
Hospital for Tropical Diseases 
190 Ben Ham TU, District 5 
Ho Chi Minh City, Viet Nam 
 
Hospital for Tropical Diseases: 8. 8380302 
Contact physicians: Dr Ho Dung Trung Nghia:  0918500638 
Dr Constance Schultsz: 8. 9237954 
 
Healthy control information sheet 
Oxtrec No.:012-06 
 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicaemia in adults in southern Viet Nam 
 
You are being invited to take part in a research study of Streptococcus suis infection. 
Please read this information sheet carefully or have someone read it for you. You will 
be given a copy of this form to keep. 
 
What is the reason for doing the study? 
Streptococcus suis meningitis is an important disease in Viet Nam. We know that pigs 
can carry Streptococcus suis in their body and that they can become ill due to 
infection with Streptococcus suis. At this time, we have little information on how 
humans get infected with Streptococcus suis and what measures we can take to 
prevent infection. We would like to get more information by studying patients with 
Streptococcus suis infection, patients with other infections, and healthy people, and 
compare the results. We would like to invite you to be one of the healthy people 
participating in this study. Your participation in this study does not have direct benefit 
for you now, but may have benefit for patients in the future. You can withdraw from 
this study at any time if you choose to. 
 
  
  321
What will happen if I take part in the study? 
• You will be asked a number of questions, using a questionnaire. It takes you 
about 15 minutes. 
 
What tests will be done? 
• You will have 2 throat swabs taken to detect the presence or absence of 
Streptococcus suis in your throat. The first sample will be taken after giving 
consent to participate in the study, and the second 14 days later. 
• You will have 2 stool samples or rectal swabs, whichever you prefer, taken to 
detect the presence or absence of Streptococcus suis in your large intestine. 
The first sample will be taken after giving consent to participate in the study, 
and the second 14 days later. 
• You will be taken 10 ml blood  
o to detect if your body has produced antibodies against Streptococcus 
suis  
o to assess whether certain people are genetically susceptible to this 
disease. 
• If you have pigs at home, we will take throat swab samples from some of the 
piglets to detect the presence of Streptococcus suis in your pigs. 
• We will ask 3 of your adult household members to also participate in this 
study by supplying swab samples. 
 
Taking a throat or rectal swab sample can be a little uncomfortable. Taking blood may 
cause a little pain and a bruise.  
 
Taking a throat swab sample from a piglet or pig causes a little stress for the animal. 
 
All samples will be labelled with a study number rather than your name, to protect 
your identity. Samples will be tested and stored indefinitely in a freezer at the Oxford 
University Clinical Research Unit, Hospital for Tropical Diseases. Further tests on 
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stored samples, including studies of your DNA (your genetic make up), may be 
undertaken in the future to improve our understanding of the disease. 
If we detect Streptococcus suis in any of the samples, we will inform you by mail. At 
the moment we think that this does not require any treatment. 
 
Confidentiality 
Information about you will be kept confidential and will not be made available to 
anyone who is not connected with the study without your consent.  
 
Questions 
If you have any other questions about the study please contact: 
Doctor’s name: Dr Ho Dung Trung Nghia 
Telephone number: 0918500638 
 
 
  323
CONSENT FORM 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicaemia in adults in southern Viet Nam 
Oxtrec No. 012-06 
 
Consent from healthy control  
 
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree to take part. I know that I can withdraw at any time if I 
choose to. 
 
I also agree to the indefinite storage of my swab samples and blood, for further 
tests, including genetic tests, related to Streptococcus suis infection, at a later 
date. 
 
I also agree to have throat swab samples taken from some of the pigs in my 
household to detect the presence of Streptoccus suis. 
 
Name of control: ___________________________ Signature: _________________ 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
 
If the control gives verbal consent to take part in the study, but is unable to sign, the 
physician can record the consent here: 
 
As the investigator I confirm that the participant named below has been given the 
Information Sheet and has verbally agreed to participate in the study.   
Name of control: _____________________________________ 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
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c. Household member: 
Hospital for Tropical Diseases 
190 Ben Ham TU, District 5 
Ho Chi Minh City, Viet Nam 
 
Hospital for Tropical Diseases: 8. 8380302 
Contact physicians: Dr Ho Dung Trung Nghia:  0918500638 
Dr Constance Schultsz: 8. 9237954 
 
Information sheet 
(household members) 
Oxtrec No.:012-06 
 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicaemia in adults in southern Viet Nam 
 
You are being invited to take part in a research study of Streptococcus suis infection. 
Please read this information sheet carefully or have someone read it for you. You will 
be given a copy of this form to keep. 
 
What is the reason for doing the study? 
Streptococcus suis meningitis is an important disease in Viet Nam. We know that pigs 
can carry Streptococcus suis in their body and that they can become ill due to 
infection with Streptococcus suis. At this time, we have little information on how 
humans get infected with Streptococcus suis and what measures we can take to 
prevent infection. We would like to get more information by studying patients with 
Streptococcus suis infection, patients with other infections, and healthy people, and 
compare the results. We would also like to know if healthy individuals carry S. suis 
without any symptoms and if the presence of such carriers in the household increases 
the risk of infection. We would like to invite you to be one of those healthy household 
members participating in this study. Your participation in this study does not have 
direct benefit for you now, but may have benefit for patients in the future. You can 
withdraw from this study at any time if you choose to.  
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What will happen if I take part in the study? 
• You will have 2 throat swabs taken, the first after giving consent during our 
first visit and the second 14 days later, to detect the presence of Streptococcus 
suis in your throat. 
• You will have 2 stool samples or rectal swabs taken, whichever you prefer, the 
first after giving consent during our first visit and the second 14 days later, to 
detect the presence of Streptococcus suis in your large intestine. 
 
Taking a throat or rectal swab sample can be a little uncomfortable.  
All samples will be labelled with a study number rather than your name, to protect 
your identity. Samples will be tested and stored indefinitely in a freezer at the Oxford 
University Clinical Research Unit, Hospital for Tropical Diseases.  
 
Further tests on stored samples may be undertaken in the future to improve our 
understanding of the disease. 
 
If we detect Streptococcus suis in any of the samples, we will inform you by mail. At 
the moment we think that this does not require any treatment. 
 
Confidentiality 
Information about you will be kept confidential and will not be made available to 
anyone who is not connected with the study without your consent.  
 
Questions 
If you have any other questions about the study please contact: 
Doctor’s name: Dr Ho Dung Trung Nghia  
Telephone number: 0918500638 
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CONSENT FORM 
 
A case-control study to identify risk-factors for Streptococcus suis meningitis and 
septicemia in adults in southern Viet Nam 
Oxtrec No. 012-06 
 
Consent from household member 
 
I have read and understood the information sheet. 
 
I have been fully informed of the possible risks and benefits of taking part in 
this study, and agree to take part. I know that I can withdraw at any time if I 
choose to. 
 
I also agree to the indefinite storage of my swab samples for further tests 
related to Streptococcus suis infection at a later date.  
 
Name of household member: ___________________ Signature: _________________ 
Name of physician: ___________________________ Signature: ________________ 
Date: ______________________ 
 
If the household member gives verbal consent to take part in the study, but is unable 
to sign, the physician can record the consent here. 
 
As the investigator I confirm that the participant named below has been given the 
Information Sheet and has verbally agreed to participate in the study.   
 
Name of household member: ______________________________ 
Name of physician: _________________________ Signature: _________________ 
Date: ______________________ 
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III. Ethical approvals: 
a. HTD’s approval: 
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b. OXTREC’s approval: 
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Abstract
Background: Streptococcus suis infection, an emerging zoonosis, is an increasing public health problem across South East
Asia and the most common cause of acute bacterial meningitis in adults in Vietnam. Little is known of the risk factors
underlying the disease.
Methods and Findings: A case-control study with appropriate hospital and matched community controls for each patient
was conducted between May 2006 and June 2009. Potential risk factors were assessed using a standardized questionnaire
and investigation of throat and rectal S. suis carriage in cases, controls and their pigs, using real-time PCR and culture of
swab samples. We recruited 101 cases of S. suis meningitis, 303 hospital controls and 300 community controls. By
multivariate analysis, risk factors identified for S. suis infection as compared to either control group included eating ‘‘high
risk’’ dishes, including such dishes as undercooked pig blood and pig intestine (OR1 = 2.22; 95%CI = [1.15–4.28] and
OR2 = 4.44; 95%CI = [2.15–9.15]), occupations related to pigs (OR1 = 3.84; 95%CI = [1.32–11.11] and OR2 = 5.52; 95%CI = [1.49–
20.39]), and exposures to pigs or pork in the presence of skin injuries (OR1 = 7.48; 95%CI = [1.97–28.44] and OR2 = 15.96;
95%CI = [2.97–85.72]). S. suis specific DNA was detected in rectal and throat swabs of 6 patients and was cultured from 2
rectal samples, but was not detected in such samples of 1522 healthy individuals or patients without S. suis infection.
Conclusions: This case control study, the largest prospective epidemiological assessment of this disease, has identified the
most important risk factors associated with S. suis bacterial meningitis to be eating ‘high risk’ dishes popular in parts of Asia,
occupational exposure to pigs and pig products, and preparation of pork in the presence of skin lesions. These risk factors
can be addressed in public health campaigns aimed at preventing S. suis infection.
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Introduction
The importance of zoonotic emerging infections is increasingly
recognized, as illustrated by outbreaks of SARS coronavirus and
the ongoing threat of human infections with avian influenza H5N1
virus. It is essential to understand transmission dynamics and risk
factors for infection, in order to design effective strategies to
contain and prevent the spread of zoonotic diseases [1].
Streptococcus suis infection is an emerging zoonotic infectious
disease, which is increasingly reported in Asia. It has become an
important threat for human health, illustrated by the explosive
outbreak in Sichuan Province China associated with at least 215
cases and 39 deaths in 2005 [2]. In Vietnam, S. suis infection was
first reported in 1996 and the number of human cases has
increased annually. In Ho Chi Minh City and Hanoi, it causes
approximately 40% of all adult acute bacterial meningitis cases.
This is more than Streptococcus pneumoniae and Neisseria meningitidis
combined [3,4,5].
S. suis is a Gram-positive, facultatively anaerobic coccus, which
can be a commensal or pathogen for a wide range of mammalian
species, particularly pigs. The natural habitat of S. suis in pigs is the
upper respiratory-, the genital- and alimentary tracts. Based on
differences in antigenic properties of the polysaccharide capsule,
33 serotypes have been distinguished to date, among which
serotype 2 is most commonly associated with invasive disease in
both pigs and humans. To date little is known of the risk factors
underlying the disease or the portals of entry in humans. From
small case series, the reported risk factor included occupational
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exposure, such as in slaughter house workers, butchers, and pig
breeders, meat processing, and pig transport. It is hypothesized
that patients may be infected through minor cuts or abrasions on
their skin [2,6]. However, whilst occupational exposure to pigs or
pork was documented in 88% of the European patients described,
it was reported in less than 50% of Asian cases [4,7], suggesting the
contribution of other behavioural or exposure related risk factors
in Asian populations, such as culinary habits or close proximity of
pigs within households. In addition, whilst it is known that pigs can
carry S. suis asymptomatically, it is not known if there is
asymptomatic carriage of S. suis in humans, which could poten-
tially contribute to an increased risk of infection, and to the
possibilitiy of person-to-person transmission. We conducted a
prospective case-control study to identify the risk factors of S. suis
infection in Viet Nam.
Methods
Ethical approval
The study was approved by the Scientific and Ethics Committee
of the Hospital for Tropical diseases and the University of Oxford
Tropical Research Ethics Committee (OXTREC 012-06).
Study design and setting
This study was designed as a case-control study, including
patients with invasive S. suis infection, an unmatched hospital
control group and a community control group matched by
residency and age, at a ratio of 1:3. The study was conducted at
the Hospital for Tropical Diseases (HTD), a tertiary referral
hospital of infectious diseases in the south of Viet Nam, between
May 2006 and June 2009. The recruitment of cases and hospital
control groups took place at the dedicated Central Nervous
System (CNS) infectious disease ward at HTD. Community
controls were recruited according to the residency of the cases in
the south of Viet Nam, mainly in Ho Chi Minh City and the
provinces of the Mekong River Delta.
Participants
Consecutive patients admitted with signs and symptoms
consistent with central nervous system (CNS) infection were
eligible for the study (Table 1). When S. suis infection was
confirmed, patients were included as cases. After inclusion of a
patient as a case, the next three consecutive patients admitted to
the ward who met the inclusion criteria were included as hospital
controls. Three community controls, matched for age (within a 10
year age range), were randomly identified from a list of eligible
households available at the health center in the community of
residence of the case, by using random number tables (Figure 1).
Written informed consent was obtained from all patients and
controls or their care takers.
Assessment of risk factors
Risk factors were assessed using a standardized questionnaire.
This questionnaire was developed in Vietnamese and validated at
HTD and consisted of four parts; socio-demographic and cultural
factors, medical history, potential exposure to pigs or pork and
culinary habits and hygiene measures. We hypothesized that
consumption of ‘‘high risk’’ food dishes (Table 2), potentially
contaminated with S. suis, could function as a source of infection.
The majority of the questions were ‘‘closed questions’’ but ‘‘open
questions’’ which allowed participants to explain in their own
words were also included. Patients and hospital controls were
interviewed when they were fully conscious. The questionnaire
was filled in by structured interview, which was carried out by one
of two research nurses on the ward for cases and hospital controls,
or at the residency of community controls. The interviewers were
blinded towards the diagnosis of the patient in the case and
hospital control groups.
Collection of swabs for detection of S. suis serotype 2
carriage
From all patients and controls, throat and rectal swab samples
were taken on admission or at the community visit and a second set
of swab samples was taken ten to fourteen days later. As detection of
potential carriage in cases and hospital controls could be affected by
their antimicrobial treatment, household members were also studied
for carriage of S. suis serotype 2 since if carriage and associated
transmission were to occur, household members of carriers are the
most likely to become positive. Adult household members, defined
as any adult (at least 15 years old) who resided for at least 50% of the
Table 1. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Cases: Did not provide informed consent.
At least 15 year-old Recent history of bacterial meningitis (,1 year before admission).
Streptococcus suis meningitis or sepsis confirmed by
blood culture, CSF culture, or CSF real-time PCR
Did not regain full consciousness (GCS 15) within 14 days after admission.
Admitted to CNS disease ward Transferred to other hospitals within 7 days after admission
Hospital controls: HIV positive.
At least 15 year-old
Confirmed bacterial meningitis (not S. suis), eosinophilic meningitis, cryptococcal
meningitis, viral encephalitis/meningitis* or malaria (confirmed by blood smear)
Admitted to CNS disease ward
Community controls:
Living in the same commune as case for at least 4 weeks until inclusion of case
Age matched with case (10 years range)
(*) Viral encephalitis/meningitis was diagnosed on the basis of confirmation by positive diagnostic PCR or serology of CSF sample, or if the patient completely regained
consciousness during treatment with antimicrobial agents for a duration of 48 hours or less.
doi:10.1371/journal.pone.0017604.t001
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week in the same house as the case or control, were identified either
at the HTD, when taking care of a case or hospital control, or
during the household visits. From each household, we choose a
maximum of three adult household members from whom we took
throat and rectal swabs in the same way as for the cases and
controls, following written informed consent.
For all cases and controls who reported exposure to pigs at
home, sampling of the pigs was performed in collaboration with
the Sub-department of Animal Health of Ho Chi Minh City. Swab
samples were taken from all pigs present (except pregnant sows to
avoid stress-induced miscarriage) within 4 weeks of admission of
the patient, or at the second visit to the community controls.
Microbiological investigations
Culture of blood and cerebrospinal fluid was performed in the
microbiology laboratory of the HTD using standard culture
Figure 1. Flow diagram of recruitment of cases and controls. *Study nurses were unaware of case or control status of patients. ** Eligible
households were defined as households in the same commune as a case.
doi:10.1371/journal.pone.0017604.g001
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methods. Blood samples were taken on admission for all patients
and blood cultures were performed using the BD BACTECH 9050
blood culture system. S. suis was identified on the basis of colony
morphology, negative catalase reaction, optochin resistance, and
by APIStrep (Biomerieux, France) and subsequently serotyped
(Statens Serum Institute, Denmark).
Swab samples were inoculated in transport medium (TRANS-
WABSH, UK) at the site, and transferred to the laboratory at
HTD or stored at 4uC until transfer within 48 hours. Samples
were inoculated into selective Todd-Hewitt broth (OXOID, UK),
containing Streptococcal Selective Reagent (Oxoid) and crystal
violet [8] and incubated overnight at 37uC, followed by real-time
PCR for detection of S. suis serotype 2. Positive samples were
cultured to retrieve S. suis isolates.
We used an internally controlled real-time PCR for detection of
S. pneumoniae, H. influenzae type b, N. meningitidis and S. suis serotype
2 in CSF samples [4,8,9,10]. The real-time PCR for detection of S.
suis serotype 2 was also used on swab cultures. Previous validation
of this PCR demonstrated a detection limit of 1–5 colony forming
units per reaction [10].
After bacterial lysis, DNA was extracted using the EasyMag
extraction system (BioMerieux, Ho Chi Minh City, Vietnam),
according to manufacturer’s instructions and subjected to consecu-
tive monoplex PCR reactions (CSF samples).
Sample size
Demographic data obtained during a randomized study on the
efficacy of adjunct dexamethasone for the treatment of acute
bacterial meningitis showed that 59/226 (26%) of the non-S. suis
patients had potential occupational exposure to pigs compared to
46/78 (59%) of S. suis meningitis patients [3], corresponding to an
odds ratio of 4. We decided on a target sample size of 100 cases
(and 300 matched controls), corresponding to a recruitment period
of approximately 4 years and a target odds ratio for 80% power of
2.1 assuming a probability of exposure in controls of 0.25 and a
correlation coefficient for exposure between matched cases and
controls of at most 0.2. With 100 cases, we also expected to fit
reliable multivariate models with up to 10 covariates without over
fitting the data [11].
Statistical methods
All variables of interest were summarized by group (case,
hospital, or community control). Categorical variables were
summarized as number and percent (%). Continuous variables
were summarized as median and interquartile range (IQR). To
assess univariate associations of S. suis with potential risk factors in
hospital controls, we used both logistic regression without any
adjustment for covariates and with adjustment for sex, age, and
living in a rural or urban area. We used conditional logistic
regression for the matched community controls and these analyses
were performed with and without additional adjustment for sex (in
addition to the matched variables age and place of living). In a
multivariate analysis of potential risk factors of main interest, all
potential risk factors plus the potential confounders (e.g. age, sex,
place of living) were jointly included in a logistic (hospital controls)
or conditional logistic (community controls) regression model. No
model selection such as backwards elimination was performed. We
included separate effects of exposure to pigs or pork depending on
whether the individual had skin injuries or not. S. suis infection
occurred predominantly in males but controls were not matched
by gender. As a sensitivity analysis, we therefore repeated the
multivariate analysis including only male cases and controls. All
analyses were performed with Stata version 10.1 (StataCorp)
software.
Results
Between May 2006 and June 2009, 722 patients with suspected
CNS infections or severe malaria were admitted to HTD. S. suis
meningitis was diagnosed in 108 patients. Seven cases were
excluded as they did not meet the inclusion criteria. We also
excluded 311 other patients as they did not meet the inclusion
criteria for hospital controls (Figure 2). It was not possible to
recruit community controls at the residency of one S. suis case
because of the distance from the study site (Central Viet Nam,
800 kms from Ho Chi Minh City). During the period of
recruitment we therefore included 101 cases of confirmed S. suis
meningitis, 303 hospital controls and 300 community controls for
analysis (Figure 2).
Table 2. Definitions.
Occupational exposures: at least one of the following occupations
Butcher
Pig breeder
Slaughterer
Meat transporter
Meat processing
Veterinarian
Cook
Contact with pigs/pork: at least one of the following contacts
Bathe pigs
Feed pigs
Clean up the piggery
Slaughter pigs
Prepare or handle blood, organs from pigs
Visit a pig farm in the last 2 weeks
‘‘High risk’’ dishes:
Pig/duck fresh blood
Pig tonsils/tongue
Pig stomach/intestines
Pigs uterus
Under-cooked pig blood
Skin injuries:
Patients were checked by nurses and doctors for skin injuries
on forearms, hands and feet. Injuries were defined as lesions
with signs of disruption of skin integrity.
Underlying diseases:
alcoholism, diabetes mellitus and splenectomy.
Alcoholism:
A person drinking beer .1500 ml/day or
wine .250 ml/day in at least 5 days/week (Wine = SPIRIT 30–40u)
Household exposure to pigs:
breeding any number of pigs at home.
Confirmed carriage:
A person with 2 PCR positive swab samples on
two separate occasions, at least 10–14 days in between
Possible carriage:
A person with 1 PCR positive swab sample
doi:10.1371/journal.pone.0017604.t002
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Characteristics of the participants
S. suis infection occurred sporadically throughout the year
without any clear seasonality (Figure 3). Clustering of cases was not
observed. Ninety-seven patients (96%) were infected with S. suis
serotype 2 while only four patients (4%) were infected with other
serotypes, including serotype 14 (3 cases) and untypeable serotype
(1 case). S. suis cases were predominantly male (82%) and from a
rural residence (81%) with a median (IQR) age of 50 (41–59) years.
Twenty-one percent of cases had an occupation related to pigs,
other exposure to pigs (46%), or reported eating ‘‘high risk’’ dishes
in the two weeks prior to admission (48%). Hospital and
community controls were more frequently female and (un-
matched) hospital controls were significantly younger, with a
higher proportion of urban residence (Table 3). We further
analyzed the age distribution of cases, hospital controls and non-S.
suis bacterial meningitis patients amongst the hospital controls.
Nearly 70% of S. suis meningitis patients were older than 45 years,
while only 25% of non-S. suis meningitis patients and 20% of all
hospital controls belonged to this age group (Table 4). The 49
hospital controls with bacterial meningitis (not S. suis) were
significantly younger than S. suis cases with median (IQR) age of
27 (23–45) compared to 50 (41–59) years (p,0.001).
Figure 2. Flow diagram of inclusion of study participants. #Reasons for exclusions of cases: HIV (+) (3), transfer to other hospital because
of presumed tuberculous meningitis (2), confusion more than 14 days after admission (1), language differences precluding interview (1). #Reasons
for exclusion of controls: death (37), prolonged coma (72), unconfirmed bacterial meningitis (80), transfer to other hospitals (61), use of
antimicrobial agents for more than 2 days in case of suspected viral encephalitis/meningitis (38), and absence of diagnosis of CNS infection (23). For
one case, community controls could not be included because of too long distance of community to study site.
doi:10.1371/journal.pone.0017604.g002
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Analysis of risk factors
Occupations related to pigs, breeding pigs at home, exposures
to pigs or pork with skin injuries, eating ‘‘high risk’’ dishes in the
last 2 weeks and having ill pigs at home in the last 4 weeks were
associated with S. suis meningitis, after adjustment for residency,
age and sex (Table 5). S. suis infection was independently
associated with occupations related to pigs, exposures to pigs or
pork in the presence of skin injuries in the 2 weeks prior to
infection, and eating ‘‘high risk’’ dishes in the 2 weeks prior to
infection after multivariate analysis. These associations were found
in comparisons of cases with the hospital control group as well as
with the community control group. Breeding pigs at home,
diabetes mellitus, alcoholism or exposure to pigs or pork without
skin injuries were not associated with S. suis infection in
multivariate analysis (Table 6). In a sensitivity analysis, which
included only male cases and controls, exactly the same risk factors
were significant with similar odds ratios as in the main analysis.
Risk factors identified by multivariate analysis of male cases and
controls from either control group included eating ‘‘high risk’’
dishes (OR1=3.46; 95%CI= [1.65–7.28] and OR2=4.79;
95%CI= [2.02–11.40]), occupations related to pigs (OR1= 6.33;
95%CI= [1.55–25.79] and OR2= 7.46; 95%CI= [1.56–35.74]),
and exposures to pigs or pork in the presence of skin injuries
(OR1= 5.81; 95%CI= [1.07–31.48] and OR2=7.11; 95%CI=
[1.00–50.54]).
‘‘High risk’’ dishes predominantly consisted of undercooked
food (Table 3). Exposure to pigs or pork in the presence of skin
injuries, eating ‘‘high risk’’ dishes, or both, were reported in 72/
101 S. suis cases (71.3%), 91/303 hospital controls (30%) and 84/
300 community controls (28%). For 26 S. suis cases (25.7%),
compared to 52 hospital controls (17.2%) and 29 community
controls (9.7%), eating these ‘‘high risk’’ dishes was the only risk
factor reported.
Human carriage
To investigate potential carriage of S. suis serotype 2, 197
throat swab samples and 197 rectal swab samples were taken
from 101 S. suis patients (Table 7). Six patients had PCR positive
results, including one throat sample and six rectal samples. S. suis
serotype 2 was cultured from this throat sample and from one of
these rectal samples. Three of these six patients had pigs at home.
No illness was reported in the last 4 weeks in these pigs, and the
PCR results of pig tonsil swab samples were negative. None of
these patients had skin injuries. Three patients had eaten pig
intestines prior to admission. Of these, the throat swab sample
was positive in one patient and rectal swab samples were positive
in the two others. One patient, who had eaten pig intestines two
days before admission, had two PCR positive rectal swab samples
on separate occasions. S. suis serotype 2 was cultured from the
first sample.
We collected 1162 throat and rectal swab samples from the 303
hospital controls and 4492 throat and rectal swab samples from
healthy persons, including 300 community controls and 920
household members of cases, hospital controls and community
controls. In none of these samples was S. suis serotype 2 detected.
(Table 7).
Pig carriage
We collected 571 pig swab samples from pigs present around
the house of 22 of 23 cases, 28 of 41 community controls and 13 of
Figure 3. Distribution of Streptococcus suis meningitis cases during the study period. Distribution of Streptococcus suis meningitis cases
and mean air temperature of southern Viet Nam in months during the study period (2006–2009) [17].
doi:10.1371/journal.pone.0017604.g003
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33 hospital controls respectively, who kept pigs around the house
(Table 3). The median herd size was 7 pigs (range, 1 to 50). S. suis
serotype 2 was detected in 9 (41%) case group herds, 3 (23%)
hospital control group herds, and 5 (18%) matched community
control group herds. Differences between case group and control
groups were not statistically significant (Table 5).
Table 3. Characteristics of Streptococcus suis cases and controls.
Characteristics
Cases
(n=101)
Hospital controls
(n=303)
Community controls
(n=300)
Sex, n(%)
Male 83 (82.2) 202 (66.7) 169 (56.3)
Female 18 (17.8) 101 (33.3) 131 (43.7)
Residence, n(%)
Rural 82 (81.2) 193 (63.7) 243 (81)
Urban 19 (18.8) 110 (36.3) 57 (19)
Age (years), median (interquartile range) 50 (41,59) 27 (20,40) 50 (41,6)
Occupations related to pigs(1), n(%) 21 (20.79) 8 (2.64) 8 (2.7)
Education level, n(%)
Primary 52 (51.5) 96 (31.7) 175 (58.3)
Secondary ‘‘level 2’’ 30 (29.7) 134 (44.2) 73 (24.3)
Secondary ‘‘level 3’’ 11 (10.9) 40 (13.2) 30 (10)
University 1 (1) 21 (6.9) 2 (0.7)
Illiterate 6 (5.9) 12 (4) 19 (6.3)
Religion
Buddhism 64 (63.4) 160 (52.8) 181 (60.3)
Catholicism 12 (11.8) 42 (13.9) 31 (10.3)
Christianity 1 (1) 4 (1.3) 0
Cao Dai 7 (7) 17 (5.6) 29 (9.7)
Other 2 (2) 1 (0.3) 6 (2)
No 15 (15) 77 (25.4) 53 (17.7)
Ethnic backgroun
Kinh 99 (98.0) 287 (94.7) 298 (99.3)
Khmer 1 (1) 4 (1.3) 2 (0.7)
Chinese 1 (1) 4 (1.3) 0
Other 0 8 (2.6) 0
Medical history, n(%)
Diabetes mellitus 3 (3) 3 (1) 4 (1.3)
Alcoholism 14 (13.9) 18 (5.9) 20 (6.7)
Splenectomy 1 (1 0 0
Skin injuries, n(%) 33 (32.7) 18 (5.9) 11 (3.7)
Breeding pigs at home, n(%) 23 (22.8) 33 (10.9) 41 (13.7)
Any exposure to pigs/pork in the last 2 weeks, n(%) 46 (45.5) 39 (12.9) 55 (18.3)
With skin injuries 20 (19.8) 5 (1.7) 2 (0.7)
Without skin injuries 26 (25.7) 34 (11.2) 53 (17.7)
Eating any ‘‘high risk’’ dish in the last 2 weeks 48 (47.5) 66 (21.8) 48 (16.)
Fresh pig blood 5 (5) 5 (1.7) 5 (1.7)
Tonsils/tongue 19 (18.8) 29 (9.6) 25 (8.3)
Stomach/intestines 45 (44.6) 53 (17.5) 42 (14)
Uterus 8 (7.9) 8 (2.6) 13 (4.3)
Undercooked pig blood 11 (10.9) 18 (5.9) 5 (1.7)
Ill pigs at home in the last 4 weeks, x/n (%) 10/23 (43.5) 1/33 (3.0) 0/40 (0)
Pigs at home with S. suis serotype
2 (confirmed by PCR), x/n(2) (%)
9/22 (40.9) 3/13 (23.1) 5/28 (17.9)
(1)Butcher, pig breeder, slaughterer, roaster, meat transporter, meat processing, veterinarian and cook.
(2)Number of households with any number of PCR positive pig swab samples/ number of households where pigs where present and samples were taken.
doi:10.1371/journal.pone.0017604.t003
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Discussion
We conducted the largest prospective epidemiological assess-
ment of risk factors of S. suis infection globally. In addition to the
previously suggested risk factors, occupational exposure and
contact with pigs or pork without skin protection, we identified
the ingestion of food with a high risk of contamination with S.
suis serotype 2 to be an important risk factor for S. suis
meningitis. To investigate eating habits as a risk factor of S. suis
infection, we focused on potential ‘‘high risk’’ dishes common in
Vietnam. These include fresh or under-cooked blood, tonsils,
tongue, stomach, intestines and uterus. Such food items typically
are undercooked when eaten as a main dish (as opposed to as
components of well cooked main dishes such as rice or noodle
soups), as was generally the case in our patients. By multivariate
analysis, we demonstrated that eating these ‘‘high risk’’ dishes in
the 2 weeks prior to admission was a significant risk factor for
this infection. Eating habits were also confirmed as a risk factor
during a relatively small S. suis outbreak in Thailand, associated
with consumption of fresh pig blood. [12]. Eating pork was not
associated with S. suis cases in a matched case-control study
conducted during the outbreak in Sichuan province in 2005
[13]. S. suis lives as normal flora in the respiratory, gastrointes-
tinal and genital tract of pigs and can cause invasive disease in
Table 4. Age distribution of Streptococcus suis cases and hospital controls.
Age groups Cases Hospital controls BM(1) (not S. suis) in hospital controls
,30 5 (5) 173 (57.1) 27 (55.1)
30–44 29 (28.7) 78 (25.7) 9 (18.4)
45–59 45 (44.6) 33 (10.9) 8 (16.3)
60–74 15 (14.9) 16 (5.3) 3 (6.1)
75+ 7 (6.9) 3 (1) 2 (4.1)
(1)Bacterial meningitis.
doi:10.1371/journal.pone.0017604.t004
Table 5. Risk factors of Streptococcus suis infection on univariate analysis.
Exposure Cases versus Hospital controls Cases versus Community controls
OR(1) (95%CI) p value OR(2) (95%CI) p value OR(1) (95%CI) p value OR(3) (95%CI) p value
Occupations related
to pigs
9.68
(4.13–22.67)
,0.001 7.51
(2.85–19.82)
,0.001 11.50
(4.31–30.65)
,0.001 11.01
(4.03–30.12)
,0.001
Medical history
Diabetes mellitus 3.06
(0.61–15.41)
0.175 0.82
(0.13–5.23)
0.830 2.25
(0.50–10.05)
0.288 3.75
(0.75–18.73)
0.107
Alcoholism 2.55
(1.22–5.33)
0.013 1.31
(0.54–3.16)
0.547 2.50
(1.15–5.45)
0.021 1.48
(0.63–3.31)
0.381
Skin injuries 7.68
(4.08–14.46)
,0.001 8.16
(3.72–17.92)
,0.001 22.09
(7.79–62.64)
,0.001 22.30
(7.55–65.84)
,0.001
Breeding pigs
at home
2.41
(1.34–4.35)
0.003 2.34
(1.09–5.00)
0.028 1.95
(1.04–3.65)
0.036 1.99
(1.04–3.80)
0.036
Any exposure to pigs/pork
in the last 2 weeks
5.66
(3.38–9.49)
,0.001 4.69
(2.43–9.07)
,0.001 4.51
(2.55–7.97)
,0.001 4.16
(2.30–7.52)
,0.001
With skin injuries 14.72
(5.36–40.42)
,0.001 12.16
(3.74–39.50)
,0.001 30
(7.01–128.35)
,0.001 26.95
(6.14–118.23)
,0.001
Without skin injuries 2.74
(1.55–4.86)
0.001 2.06
(0.99–4.27)
0.052 1.66
(0.92–3.00)
0.090 1.57
(0.85–2.91)
0.152
Eating any ‘‘high risk’’
dish in the last 2 weeks
3.25
(2.02–5.24)
,0.001 2.48
(1.35–4.52)
0.003 6.00
(3.33–10.81)
,0.001 4.38
(2.72–8.08)
,0.001
Ill pigs at home in
the last 4 weeks(4)
24.62
(2.85–212.24)
0.004 30.10
(2.72–333.64)
0.006 - - - -
Pigs at home with S. suis
serotype 2 (confirmed
by PCR)(5)
2.31
(0.49–10.82)
0.289 7.83
(0.68–90.19)
0.099 - - - -
(1)Crude OR based on logistic (hospital controls) or conditional logistic regression (community controls).
(2)Adjusted for age, sex and rural/urban residence, using logistic regression.
(3)Adjusted for sex (matched for age and residence), using conditional logistic regression.
(4)Only individuals with pigs at home were analyzed. OR could not be analyzed for community controls because none of them reported ill pigs at home.
(5)Only individuals who had pig swab samples at their houses were analyzed. OR could not be analyzed for community controls because there was no discordant pairs
included in the analysis.
doi:10.1371/journal.pone.0017604.t005
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pigs. S. suis was isolated from raw pork samples obtained from
markets in Hong Kong [14]. There may be a high bacterial load
in food items that are kept at high ambient temperatures.
Therefore, patients may be infected with S. suis through
gastrointestinal tract if the ‘‘high risk’’ dishes are served as raw
or under-cooked food.
We observed that the mean age of S. suis meningitis patients was
significantly higher than the age of patients with bacterial
meningitis caused by other bacteria, and that high age was
associated with increased risk of infection with S. suis. In contrast,
pediatric infections with S. suis are extremely rare, presumably
related to a lack of exposure associated with increased risk of S. suis
infection, in children.
The association between human S. suis infection and occupa-
tional exposures to pigs or pork has been reported in Europe and
Asia since 1968 [6,15,16]. In Vietnam, the proportion of patients
reported to have occupational exposures was lower than reported
in European patients but it remained an important independent
risk factor. Slaughtering and processing sick or dead pigs were also
associated with S. suis infection in a case-control study conducted
during the Sichuan outbreak [13].
Significant skin injury was evident in 5/35 (14%) of people with
S. suis in the UK, 4/15 cases (16%) in Hong Kong and 104/215
cases (48%) in Sichuan province’s outbreak [2,7,15]. In our study,
skin injuries were reported in 33/101 (33%) of S. suis patients
compared to 18/303 (6%) of hospital controls and 11/300 (4%) of
community controls (Table 3). These minor skin injuries may
allow direct entry of the bacteria in people with direct contact with
infected pigs or pork. Contact with pigs within the last two weeks
in the presence of skin lesions was associated with a significant high
risk of infection (Table 6). Skin injuries were most often recorded
in slaughter house workers, cooks and housewives involved in
processing meat. Skin protection, including gloves, hand washing
and exclusion of people with obvious skin lesions from direct
contact with pigs and pork meat, may help to reduce the incidence
of the disease.
We were unable to demonstrate S. suis serotype 2 carriage in
1522 healthy persons or patients without S. suis infection, including
those with pig exposures. In contrast, 6/101 (6%) of patients had
PCR positive swab samples, a rate similar to what was found in
slaughterhouse workers in Germany [16]. Eating pig intestines in
the few days prior to admission was reported in 3/6 of the patients
with a PCR positive throat or rectal swab, two of which were also
culture positive. Taken together, rather than indicating human
carriage of S. suis serotype 2, our results strengthen the hypothesis
that the gastrointestinal tract may be a route of entry for at least a
proportion of patients.
In conclusion, S. suis is an important and emerging public health
issue in Asia and one with the potential for both endemic
transmission and for explosive epidemics. We identified risk factors
for S. suis infection which can be addressed in health education
programs targeted at individuals and communities at risk, focusing
on skin protection for those in direct contact with pigs or pork and
avoiding eating raw or under-cooked pig products.
Table 6. Risk factors of Streptococcus suis infection - multivariate analysis.
Exposure Cases versus Hospital controls Cases versus Community controls
OR (95%CI) p value OR (95%CI) p value
Occupations related to pigs 3.84 (1.32–11.11) 0.013 5.52 (1.49–20.39) 0.010
Medical history
Diabetes mellitus 1.10 (0.17–7.31) 0.918 4.11 (0.78–21.68) 0.095
Alcoholism 1.02 (0.38–2.73) 0.969 0.72 (0.24–2.14) 0.553
Breeding pigs at home 1.02 (0.39–2.69) 0.965 0.83 (0.34–2.03) 0.681
Any exposure to pigs/pork in the last 2 weeks
With skin injuries 7.48 (1.97–28.44) 0.003 15.96 (2.97–85.72) 0.001
Without skin injuries 2.15 (0.88–5.24) 0.092 1.14 (0.49–2.69) 0.757
Eating any ‘‘high risk’’ dish in the last 2 weeks 2.22 (1.15–4.28) 0.017 4.44 (2.15–9.15) ,0.001
Rural 2.39 (1.13–5.04) 0.022 - -
Age (by +10 years) 2.59 (2.04–3.29) ,0.001 - -
Male sex 4.47 (1.88–10.64) 0.001 3.53 (1.59–7.82) 0.002
doi:10.1371/journal.pone.0017604.t006
Table 7. Results of Streptococcus suis serotype 2 PCR of throat and rectal swabs.(1)
Samples Cases HM(2)/cases Hospital controls
HM/hospital
controls
Community
controls HM/community controls
1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd
Throat 1/101 0/96 0/205 0/182 0/302 0/279 0/291 0/212 0/300 0/291 0/424 0/347
Rectum 5/101 1/96 0/204 0/181 0/302 0/279 0/291 0/211 0/300 0/291 0/422 0/340
(1)Number positive/total number tested (each person had 2 samples taken on 2 separate occasions with a minimum of 10–14 days in between).
(2)Household members.
doi:10.1371/journal.pone.0017604.t007
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Abstract
Streptococcus suis serotype 2 is an emerging zoonotic pathogen and is the main cause of acute bacterial meningitis in adult patients in
Vietnam. We developed an internally controlled real-time PCR for detection of S. suis serotype 2 in cerebrospinal fluid (CSF) samples
targeted at the cps2J gene. Sensitivity and specificity in culture-confirmed clinical samples were 100%. The PCR detected S. suis serotype 2
infection in 101 of 238 (42.4%) prospectively collected CSF samples, of which 55 (23%) were culture positive. Culture-negative but PCR-
positive CSF samples were significantly associated with the use of antimicrobial agents before admission. S. suis serotype 2 infection was
more common than infections with Streptococcus pneumoniae and Neisseria meningitidis combined. Our results strikingly illustrate the
additional diagnostic value of PCR in patients who are pretreated with antimicrobial agents and demonstrate the extremely high prevalence of
S. suis infections among Vietnamese adult patients with bacterial meningitis.
© 2011 Elsevier Inc. All rights reserved.
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1. Introduction
Streptococcus suis is an emerging zoonotic human
pathogen. S. suis infection is acquired through exposure to
contaminated pigs or pig meat. Healthy pigs can carry
multiple serotypes of S. suis in their nasal cavities, tonsils,
and upper respiratory, genital, and alimentary tracts. Based
on differences in antigenic properties of the polysaccharide
capsule, 33 serotypes have been distinguished to date, of
which only a limited number are responsible for infections in
pigs, including serotypes 1 to 9 and 14. Serotype 2 is
considered to be the most pathogenic for both humans and
pigs and is the single most common serotype found in human
infection (Gottschalk et al., 2007).
Over the past few years, the number of reported S. suis
infections in humans has increased substantially, with most
cases originating in Southeast Asia where there is a high density
of pigs. Increased awareness, particularly following the
occurrence of an outbreak of human and pig infection in the
Sichuan province in China in 2005, has likely contributed to
this increase in reported human infections (Tang et al., 2006; Ye
et al., 2006). Meningitis and septicemia are the most common
clinical manifestations of human S. suis infection; hearing loss
is a frequent complication (Wertheim et al., 2009a).
Although S. suis can be cultured from cerebrospinal fluid
(CSF) or blood samples with use of standard microbiological
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techniques, infection often goes undiagnosed or positive
cultures are misidentified as Streptococcus species, alpha-
hemolytic or viridans streptococci, Enterococcus faecalis,
Aerococcus viridans, or Streptococcus pneumoniae (Donsa-
kul et al., 2003; Lutticken et al., 1986). Furthermore, culture
results can be negative as a result of antibiotic use before the
collection of specimens.
During a randomized placebo-controlled clinical trial on
the adjuvant use of dexamethasone in adult patients with
bacterial meningitis, carried out at the Hospital for
Tropical Diseases in Ho Chi Minh City, Vietnam, S. suis
serotype 2 was found to be the most common pathogen
isolated from CSF cultures (Nguyen et al., 2007). As up to
60% of patients had used antimicrobial agents before
submission to the hospital, and culture results were
negative for 50% of patients (Nguyen et al., 2007), an
internally controlled diagnostic real-time PCR was set up
for detection of S. suis serotype 2 to further study the
importance of this pathogen in patients with bacterial
meningitis in this region. Here we report the design of this
method and its prospective evaluation.
2. Materials and methods
2.1. Sample collection
This study was performed at the Hospital for Tropical
Diseases, a tertiary referral hospital for infectious diseases.
CSF samples were collected and stored as part of a
randomized placebo-controlled clinical trial carried out at
the Hospital for Tropical Diseases between November
1996 and May 2005 (Nguyen et al., 2007). CSF samples
were sent for biochemical and microbiological investiga-
tions, and an aliquot was stored at −70 °C in a dedicated
freezer on the ward. These samples were studied
retrospectively. CSF samples were prospectively collected
from all consecutive adult patients (age ≥15 years)
presenting with fever and neck stiffness and/or altered
consciousness at the Hospital for Tropical Diseases from
May 2006 until June 2009, and were aliquoted immedi-
ately after lumbar puncture on the ward. Aliquots were
sent to the biochemistry and microbiology laboratories for
immediate processing and analyses. A separate aliquot was
sent to the molecular diagnostics laboratory, where
samples where stored for a maximum of 48 h at −70 °C
until testing (prospective study). Standard measures for
prevention of PCR contamination are operational at the
molecular diagnostic laboratory, including a unidirectional
workflow in physically separated laboratories for reagent
preparation, nucleic acid extraction, and amplification and
analysis, respectively.
Demographic, clinical, and laboratory data were recorded
for all patients. The study was approved by the ethical review
boards of the Hospital for Tropical Diseases and the
University of Oxford (OXTREC).
2.2. Bacterial culture
All CSF samples were spun down and a Gram stain was
made. The pellet was inoculated on blood and chocolate agar
plates and in brain heart infusion broth for enrichment. Plates
were incubated at 37 °C in 5% CO2 for 18 h. The broth was
incubated aerobically and subcultured if growth was present.
Bacteria were identified using standard identification meth-
ods. S. suiswas identified on the basis of colony morphology,
negative catalase reaction, optochin resistance, and APIStrep
(Biomerieux, Ho Chi Minh City, Vietnam). Serotyping was
performed by slide agglutination with use of specific antisera
(Statens Serum Institute, Copenhagen, Denmark).
Blood culture was performed using the BACTEC 9050
system, and positive culture results were identified as
described above.
2.3. Primers and probes
Primers and probe for S. suis serotype 2 real-time PCR were
designed using Primer Express Software and BLAST analysis,
and were targeted at the cps2J gene (Smith et al., 1999, 2000),
which is part of the operon encoding the serotype 2 and serotype
1/2 specific polysaccharide capsule of S. suis. Primers cps2JF
(GGTTACTTGCTACTTTTGATGGAAATT) and cps2JR
(CGCACCTCTTTTATCTCTTCCAA) and probe (FAM-
TCAAGAATCTGAGCTGCAAAAGTGTCAAATTGA-
TAMRA) were used for amplification and detection of an
88-bp amplicon. Primers and probes for real-time PCR for
detection of S. pneumoniae, Haemophilus influenzae type b,
and N. meningitidis were as described by Corless et al. (2001)
except that for all probes, FAM (6-carboxyfluorescein) and
TAMRA were used as reporter and quencher, respectively.
Primers and probe for detection of internal control (IC)
DNA (see below) were as described by van Doornum et al.
(2003). The IC probe was labeled with Cy5 and BHQ1.
2.4. Internal control
The efficiency of the DNA extraction and the amplifi-
cation during the PCR was monitored using an IC,
consisting of a pretest determined concentration of Phocid
herpesvirus. IC was added to all samples before DNA
extraction, as described by van Doornum et al. (2003).
Concentration of IC was such that after efficient extraction
and amplification, a Cy5 cycle threshold value (Ct value)
between 33 and 37 should be expected for the IC-specific
PCR reaction. Higher Ct values or negative results were
interpreted as loss of DNA during extraction or inhibition of
the PCR assay, in which case extraction and amplification
were repeated. PhHV was kindly provided by M. Schutten
(EMC, Rotterdam, the Netherlands).
2.5. DNA extraction of pure cultures and CSF samples
A 100-μL aliquot of a bacterial suspension or of unspun
CSF was treated with 0.1 volume of prelysis buffer (1%
SDS, 5% Tween 20, and 5% Sarkosyl in 1× TE) at 37 °C for
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1 h. A 20-μL volume of IC at a predetermined concentration
was added to the sample, and DNA was extracted by manual
extraction (retrospective study) or automated extraction
using the EasyMag extraction system (BioMerieux, Ho Chi
Minh City, Vietnam), according to manufacturer's instruc-
tions (prospective study). The manual extraction was
performed as described by Boom et al. (1999), using lysis
buffer L7 that contains 1 mg/mL α-casein. The DNA was
eluted in a final volume of 100 μL.
2.6. PCR components and amplification
The final PCR volume was 25 μL. The PCRmix consisted
of 5 mmol/L MgCl2, 0.2 mmol/L each deoxynucleoside
triphosphates dATP, dCTP, dGTP, dUTP, and 1 U of Hot
Start Taq DNA polymerase (Qiagen, Hanoi, Vietnam) to
which 5 μL of extracted DNA was added. Final concentra-
tions of the 2 primers and probe sets for target and ICwere 0.4
μmol/L of each primer and 0.1 μmol/L of each probe. PCR
amplification conditions consisted of 15 min at 95 °C and 45
cycles of 30 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C in a
Chromo 4 Real-time PCR system (Biorad, Ho ChiMinh City,
Vietnam). Negative (no-template) controls of both extraction
and PCR were included in each run.
The PCR was considered positive if negative controls
were all negative and a FAM signal with a Ct value of ≤40
could be obtained from the sample. A PCR was considered
negative if negative controls were all negative, and the IC
showed a Cy5 Ct value within the expected range, and a
FAM signal could not be obtained from the sample or the Ct
value was N40. Any PCR that yielded a FAM Ct value N35
was repeated in duplicate for confirmation. The PCR was
considered indeterminate if the IC showed a Cy5 Ct value
outside of the expected range and a FAM signal could not be
obtained or the Ct value was N40, in which case DNA
extraction and the PCR were repeated as described before.
The sensitivity and specificity of the PCR assay were
determined on the basis of PCR results in bacterial culture-
confirmed samples. PCR for S. suis serotype 2 was run on all
culture-positive samples, including those growing S. suis, S.
pneumoniae, N. meningitidis, H. influenzae, or other
pathogens (Tables 2 and 3).
2.7. Analytical sensitivity
To determine the detection limit of the assay, including
the DNA extraction, a 10-fold serial dilution of a 0.5
McFarland suspension of S. suis serotype 2 strain 31533,
kindly provided by M. Gottschalk (Montreal, Canada), was
prepared in Todd Hewitt Broth. Fifty microliters of each
dilution was spread out on blood agar plates in triplicate and
incubated at 37 °C in 5% CO2 overnight for colony counting.
A 100-μL volume of each dilution was used for DNA
extraction in triplicate, in the absence and presence of IC.
Five microliters of DNA was used for real-time PCR, as
described above.
3. Results
The PCR assay detected S. suis serotype 2 at a
concentration of 2 × 102 colony-forming units (CFUs) per
milliliter, resulting in an analytical sensitivity of 1–5 CFUs
per reaction. This analytical sensitivity did not vary in the
presence or absence of IC DNA (Table 1).
Sensitivity of the PCR was 100% when tested against 114
stored samples from culture-confirmed cases of meningitis
with S. suis serotype 2 (Table 2A). The PCR was negative in
Table 1
Comparative analytical sensitivities of S. suis serotype 2 primers in the
presence and absence of IC DNA
IC DNA Mean Ct value at the following bacterial concentration
105 CFU/mL 104 CFU/mL 103 CFU/mL
Present 29.99 33.25 36.78
Absent 30.21 33.19 36.80
Table 2
Sensitivity and specificity of S. suis serotype 2 PCR on culture-confirmed
CSF samples, retrospective study (A) and prospective study (B)
A. No. of
samples
PCR
positive
PCR
negative
S. suis serotype 2 114 114 0
S. suis serotype 14 1 0 1
N. meningitidis 11 0 11
Neisseria species 1 0 1
S. pneumoniae 50 0 50
H. influenzae 5 0 5
Streptococcus bovis 2 0 2
Streptococcus agalactiae 1 0 1
Streptococci, viridans group 6 0 6
Staphylococcus aureus 2 0 2
Escherichia coli 8 0 8
Klebsiella pneumoniae 10 0 10
Proteus mirabilis 1 0 1
Pseudomonas aeruginosa 1 0 1
Total 213 114 99
B. No. of
samples
No. of PCR
positive
No. of PCR
negative
S. suis serotype 2 55 55 0
S. suis serotype 14 2 0 2
S. suis, untypeable 1 0 1
N. meningitidis 4 0 4
S. pneumoniae 16 0 16
H. influenzae 1 0 1
Streptococcus agalactiae 1 0 1
Nonhemolytic streptococci 1 0 1
Staphylococcus aureus 1 0 1
Escherichia coli 3 0 3
Klebsiella pneumoniae 2 0 2
Acinetobacter spp. 1 0 1
Enterococcus avium 1 0 1
Listeria spp. 4 0 4
Salmonella spp. 1 0 1
Total 94 55 39
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all 99 samples that were culture-positive for other bacterial
pathogens, including S. suis of other serotypes (100%
specificity, Table 2A). All PCR-negative samples gave Ct
values for the IC within the expected range.
Stored CSF samples that were culture positive for
S. pneumoniae, N. meningitidis, and H. influenzae type b
were also subjected to real-time PCR for specific detection
of these pathogens. Of 50 samples culture positive for
S. pneumoniae, 48 were positive in the PCR for detection of
S. pneumoniaeDNA, while all 11 samples culture positive for
N. meningitidis and all 4 samples positive for H. influenzae
type b were also positive in the respective specific PCRs.
During the study period, we admitted 248 consecutive
patients with a clinical suspicion of bacterial meningitis.
Demographic, clinical, and outcome characteristics of these
248 patients are shown in Table 3. CSF samples from 238
patients were prospectively studied using bacterial culture
and real-time PCR for detection of S. suis serotype 2,
N. meningitidis, H. influenzae type b, and S. pneumoniae. A
lumbar puncture was contraindicated in one patient because
of risk of brain herniation. CSF samples were erroneously
not sent for PCR analysis for the remaining 9 patients.
All 55 S. suis serotype 2 culture-positive samples
collected prospectively on admission were also positive in
the S. suis serotype 2-specific PCR. The admission CSF
sample of one patient with culture-confirmed S. suis serotype
2 meningitis was not available for PCR analysis and PCR
result of the second CSF sample from this patient (collected
Table 3
Demographic, clinical, and outcome characteristics of 248 patients included
in prospective study
Characteristics Frequency (%) N = 248
Age (years), median (interquartile range) 46.5 (34–59)
Sex, male 181 (73.0)
Occupation
Farmer 79 (31.9)
Worker 35 (14.1)
Student 4 (1.6)
Seller 22 (8.9)
Occupation related to pigs
✓ Butcher 7 (2.8)
✓ Slaughterer 6 (2.4)
✓ Pig breeder 4 (1.6)
Housewife 14 (5.7)
Other 32 (12.9)
No job 45 (18.2)
Underlying diseases/predisposing factors
Diabetes mellitus 19 (7.7)
Alcoholism 18 (7.3)
Otitis media 6 (2.4)
Splenectomy 2 (0.8)
Head trauma 26 (10.5)
Cardiovascular diseasesa 17 (6.9)
Pig/pork exposuresb 51 (20.6)
HIV/AIDS 4 (1.6)
Used intravenous antibiotics before admission 157 (63.3)
a Valvular heart diseases, atrial fibrillation.
b Occupation related to pig/pork, eating pig's intestines and fresh
blood, etc.
Table 4
Results of Gram stain, culture, and real-time PCR for detection of S. suis serotype 2, S. pneumoniae, H. influenzae type b, and N. meningitidis on CSF samples,
and blood culture, prospective study
No. of positive specimens
CSF Gram stain
(n = 247)
CSF culture
(n = 247)
CSF PCR
(n = 238)
Blood culture
(n = 222)
Total
(N = 248)
S. suis serotype 2 50 61a 101a 34 107
S. suis serotype 14 1 2 0 1 2
S. suis untypeable 1 1 0 0 1
N. meningitidis 4 4 11 2 11
S. pneumoniae 9 16 37b 8 39
H. influenzae, nontypeable 0 1 0 1 1
Streptococcus bovis 1 1 ndc 0 1
Streptococcus agalactiae 2 1 0 2 2
β-Hemolytic streptococci 0 0 0 1 1
Nonhemolytic streptococci 0 1 0 1 1
Staphylococcus aureus 1 1 0 3 3
Escherichia coli 1 3 0 2 3
Klebsiella pneumoniae 2 4 0d 1 4
Acinetobacter spp. 0 1 0 0 1
Enterococcus avium 0 1 0 0 1
Listeria spp. 1 4 0 2 4
Salmonella spp. 0 1 0 0 1
Total 73 103 149 58 183
nd = not done.
a CSF samples were unavailable for PCR for 6 patients.
b S. pneumoniae-specific PCR was negative in 1 patient; CSF sample unavailable for PCR for 1 patient.
c CSF sample unavailable for PCR.
d CSF sample unavailable for PCR for 2 patients.
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after 5 days of antibiotic treatment) was negative. The S. suis
serotype 2 specific PCR was negative in all 39 samples,
which were culture confirmed with other bacterial patho-
gens, including S. suis of other serotypes (Table 2B).
S. suis was the most commonly identified pathogen
(Table 4). PCR for S. suis serotype 2 was positive in 101 of
238 (42.4%) samples, of which 55 (23.1%) were culture
positive. S. pneumoniae and N. meningitidis were detected
in 37 (15.5%) and 11 (4.6%) patients of which 16 (6.7%) and
4 (1.7%) were culture positive, respectively. Listeria species
were cultured from CSF of 4 patients. Infections with
multiple bacterial species were not detected. All samples
gave the expected results for the IC. Bacterial pathogens
were detected in 183 of 248 (73.8%) adult patients suspected
of bacterial meningitis when combining results of Gram
stain, bacterial culture and PCR on CSF, and blood culture.
CSF was significantly more often culture negative in
patients who were pretreated with antimicrobial agents
before admission (Table 5). In contrast, detection rates by
PCR were similar in patients who were pretreated and those
who were not, although Ct values were significantly higher
in patients who had received antimicrobial agents before
collection of the CSF sample (Table 5). We compared
characteristics between patients who were only positive by
PCR in CSF and those of whom CSF or blood samples were
also culture positive (Table 6). Patient characteristics related
to exposure and clinical presentation were highly similar
between the two groups, with the exception of a higher age
and a higher prevalence of diabetes mellitus in patients who
were PCR-positive only. In contrast, the median duration of
illness was significantly longer and pretreatment with
antimicrobial agents significantly more common in patients
who were PCR-positive only. This was also reflected by
lower CSF neutrophil counts, higher CSF glucose levels, and
lower CSF lactate levels in the latter patients (Table 6).
4. Discussion
Human infections with S. suis are increasingly reported
from various geographical areas. S. suis serotype 2 is the
most common pathogen detected in adult patients with acute
bacterial meningitis in Vietnam (Mai et al., 2008; Wertheim
et al., 2009b). While S. suis is not difficult to culture on
blood agar plates supplemented with 5% CO2, CSF cultures
may remain negative because of prior use of antimicrobial
agents or low bacterial load. We developed a highly sensitive
and specific real-time PCR for detection of S. suis serotype 2
in CSF. We designed primers targeted at the cps2J gene,
which encodes a putative glycosyl transferase involved in the
formation of the serotype 2 capsular polysaccharide. This
gene was also used by other investigators as a target for
conventional PCR for specific detection of S. suis serotype 2
in tonsillar and other pig samples (Wisselink et al., 2002).
The cps2J gene is present in strains of serotype 2 and of
Table 5
Result of CSF investigations for S. suis serotype 2, S. pneumoniae,
N. meningitidis
Antimicrobial
agents before
admission
Result of CSF investigations for S. suis serotype 2,
S. pneumoniae, N. meningitidis
Culture
positive,
no. (%)
PCR
positive,
no. (%)
Median
Ct valuea
(range)
P
valueb
Used 34/98 (34.7) 97/97 (100) 27.78 (15.39–38) b0.001
Not used 39/47 (82.0) 42/43 (97.7) 24.66 (19.76–31.24)
Unknown 8/11 (72.7) 10/11 (90.9) 24.57 (20.76–29)
a Cycle treshold value of real-time PCR.
b Difference between Ct values for antimicrobial agents used versus not
used, Wilcoxon rank-sum test.
Table 6
Characteristics of patients with S. suis meningitis confirmed by CSF and/or
blood culture and PCR, or only confirmed by PCR
Characteristics CSF and/or blood
culture and PCR
positive (n = 67)
PCR
positive
(n = 43)
P
valuea
General information
Age, median (IQR) 48 (38–56) 53 (45–61) 0.026
Male sex (n, %) 57 (85.1) 34 (79.1) 0.416
Residence (rural) (n, %) 53 (79.1) 32 (74.41) 0.567
Underlying diseases and exposure
Diabetes mellitus (n, %) 1 (1.5) 6 (13.0) 0.010
Alcoholism (n, %) 8 (11.9) 2 (4.7) 0.194
Pig exposure (n, %) 26 (38.8) 14 (32.6) 0.506
Clinical manifestations
Days of illness, median
(IQR)
3 (3–5) 5 (4–7) 0.004
Antimicrobial therapy
before admission (n, %)
35 (53.2) 38 (88.4) b0.001
Fever (n, %) 65 (97.0) 42 (97.7) 0.522
Headache (n, %) 67 (100) 42 (97.7) 0.391
Nausea/vomiting (n, %) 49 (73.1) 27 (62.8) 0.252
Neck stiffness (n, %) 61 (91.0) 40 (93.0) 1.000
Glasgow Coma Score,
median (IQR)
12 (9–14) 13 (9–15) 0.159
Tinnitus (n, %) 50 (74.6) 27 (62.8) 0.118
Deafness (n, %) 19 (28.4) 11 (25.6) 0.714
Skin injuries (n, %) 18 (26.9) 13 (30.2) 0.702
Herpes labialis (n, %) 29 (43.3) 21 (48.8) 0.568
Laboratory investigations median (IQR)
▪ Blood
White blood cells
(103/L)
18 000
(12 400–23 000)
16 840
(12 600–23 550)
0.941
Neutrophil (%) 88 (83–91) 86.3 (80.3–90) 0.131
▪ CSF
White cells (103/L) 1570
(760–3480)
1340
(340–2900)
0.153
Neutrophil (%) 86 (74–91) 70 (49–85) 0.002
Protein (g/L) 1.6 (1.3–2) 1.63 (1.2–2) 0.402
CSF/blood glucose ratio 0.24 (0.15–0.31) 0.40 (0.29–0.5) b0.001
Lactate (mmol/L) 11.2 (6.8–15.7) 5.73 (4.4–8.3) b0.001
Outcome (survival) 67 (100) 40 (100)b
a Determined using Fisher exact test or Wilcoxon rank-sum test, as
appropriate.
b Three patients were transferred to other hospitals and their outcomes
are unknown.
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serotype 1/2. Serotyping confirmed the presence of S. suis
serotype 2 in all culture-positive CSF samples, and none
contained serotype 1/2. To our knowledge, S. suis serotype
1/2 infection has never been reported in humans. So far,
serotype 2 is the cause of more than 95% of reported human
S. suis infections (Wertheim et al., 2009a), and only sporadic
single cases of patients infected with S. suis serotypes 1, 4,
and 16 have been described (Nghia et al., 2008; Wertheim
et al., 2009a). However, one patient in our retrospective
analysis and 2 patients in the prospective analysis were
infected with S. suis serotype 14. As expected, these samples
were negative in the PCR. While the absolute number of
patients reported with S. suis serotype 14 infection is still
very low, this serotype appears to contribute consistently to
the infectious burden of S. suis as reported in Thailand
(Kerdsin et al., 2009) and also observed in our study. While
serotype 2 by far remains the predominant strain associated
with human infection at present, inclusion of additional
primer sets for detection of serotype 14 or generic detection of
S. suis may therefore be considered in the future.
Our assay showed 100% sensitivity against samples that
were culture positive for S. suis serotype 2, while analysis
of CSF samples that were culture or PCR-positive for
other pathogens than S. suis serotype 2, including
S. pneumoniae, N. meningitidis, and H. influenzae, indi-
cated 100% specificity of the assay. Thus, in a tertiary
referral setting in southern Vietnam, the positive and
negative predictive values of the test are 100%. Results of
real-time PCR for specific detection of S. pneumoniae,
N. meningitidis, and H. influenzae on samples studied
retrospectively, which had been culture positive for these
pathogens, showed that bacterial DNA was still detectable
in 97% of samples indicating that the bacterial DNA was
not affected by storage.
Prospective evaluation showed a striking additional
diagnostic value of the S. suis serotype 2 PCR over culture,
further strengthening observations that the prevalence of
S. suis infections among Vietnamese patients with bacterial
meningitis is extremely high. The diagnostic yield increased
by 84% for patients with S. suis serotype 2 infection when
using PCR. Similar differences in detection rates between
culture and PCR were found for S. pneumoniae and
N. meningitidis. In large part, these differences can be
explained by the use of antimicrobial agents before
admission and collection of specimens. In our study, overall
63.3% of patients had received antibiotics before admission,
and this proportion was significantly higher in patients with
culture-negative CSF samples. Furthermore, bacterial loads
as assessed by Ct values in our PCR were significantly lower
in pretreated patients. However, while PCR is clearly an
important tool in the diagnosis of bacterial meningitis, it
should not replace Gram stain and bacterial culture, given the
need of a rapid presumptive diagnosis and antimicrobial
susceptibility data in the treatment of this life-threatening
disease. In addition, the pathogens that can be detected using
PCR generally do not cover the full spectrum of potential
causes of bacterial meningitis, indicating the continued need
of bacterial culture.
S. suis was detected at much higher rates than
S. pneumoniae and N. meningitidis in our study population.
S. suis is increasingly recognized as an important cause of
bacterial meningitis in adults, not only in Vietnam but also in
China, Thailand, Singapore, and other countries in the region,
while sporadic cases are reported worldwide. Risk factors for
S. suis infection include (occupational) exposure to pigs and
pig products. Consumption of undercooked pork products
is increasingly being suggested as an additional risk factor
for S. suis infection (Wertheim et al., 2009a). The mortality
of S. suis infection varies with the clinical presentation, with
the lowest mortality in patients with meningitis and the highest
mortality in those presenting with a streptococcal toxic shock-
like syndrome (Wertheim et al., 2009a). Resistance to
penicillin in S. suis is extremely rare. All cultured strains in
our study were sensitive to penicillin and ceftriaxone, which
are the drugs of choice for treatment of S. suis meningitis.
S. suis meningitis is commonly associated with neurologic
sequelae, in particular hearing loss, which can be found in up to
60% of cases (Mai et al., 2008). To reliably determine the
burden of disease caused by S. suis infection, while taking into
account that over-the-counter sales of antimicrobial agents is
common in regions where S. suis infections predominantly
occur, the availability of sensitive and specific diagnostic tools
to detect S. suis infections is extremely important. To our
knowledge, this is the first prospective study on the molecular
diagnosis of S. suis infections in humans.
In conclusion, we developed a highly sensitive and
specific real-time PCR for detection of S. suis serotype 2 in
CSF, which is now routinely used in a setting where human
S. suis serotype 2 infection is endemic.
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Streptococcus suis: An Emerging Human Pathogen
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Streptococcus suis infection is acquired through exposure to contaminated pigs or pig meat. Over the past few years, the
number of reported S. suis infections in humans has increased significantly, with most cases originating in Southeast Asia,
where there is a high density of pigs. Increased awareness, improved diagnostics, and the occurrence of outbreaks have
contributed to this increase. Meningitis and sepsis are the most common clinical manifestations of S. suis infection; hearing
loss is a frequent complication. In this article, we provide an overview of the emergence and clinical manifestations of S.
suis infection.
Streptococcus suis is a pathogen in pigs that can cause severe
systemic infection in humans [1]. S. suis was first reported by
veterinarians in 1954, after outbreaks of meningitis, septicemia,
and purulent arthritis occurred among piglets [2]. Fourteen
years later, the first human S. suis cases were diagnosed in
Denmark, and subsequently, other cases were reported in other
northern European countries and Hong Kong [3–5].
The number of human S. suis cases reported in the literature
has increased significantly over the past few years. In a review
article published in 2007, 409 human S. suis cases were reported.
At the time of writing of this article, this figure has increased
to 1700 cases, with most cases originating in Southeast Asia
(figure 1) [1]. In this review, we discuss whether this increase
in reported human S. suis cases is attributable to the emergence
and spread of clones with increased capacity to infect humans
in certain geographical areas and/or attributable to increased
awareness and improved diagnostics of S. suis infection.
EPIDEMIOLOGY
S. suis infection in pigs is reported worldwide, from North
America (United States and Canada) to South America (Brazil),
Europe (United Kingdom, The Netherlands, France, Denmark,
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Norway, Spain, and Germany), Asia (China, Thailand, Vietnam,
and Japan), Australia, and New Zealand [7]. In addition to
pigs, S. suis can be isolated from other animals, such as ru-
minants, cats, dogs, deer, and horses, and is believed to be a
commensal in the intestinal flora [7]. Healthy pigs can carry
multiple serotypes of S. suis in their nasal cavities, tonsils, and
upper respiratory, genital, and alimentary tracts [7–9]. Of the
35 known serotypes, only a limited number are responsible for
infections in pigs, including serotypes 1–9 and 14 [10]. Serotype
2 is considered to be the most pathogenic for both humans
and pigs [1]. S. suis is usually transmitted nasally or orally and
colonizes the palatine tonsils of both clinically ill and healthy
pigs. The infant piglets become infected after contact with col-
onized sows [11]. Rates of asymptomatic carriage may be as
high as 80%, and the morbidity ranges from !1% to 150%,
although it rarely exceeds 5% [7, 12].
Since the first human case in Denmark was reported, in-
creasing numbers of human cases have been reported in many
countries (figure 1) [1, 4, 13–16]. Recently, a large series of
151 S. suis meningitis cases was described in southern Vietnam
over a 10-year period [16]. Although most reports concern
sporadic cases of infection, an outbreak of S. suis infection
occurred in Sichuan Province, China, during July and August
2005, that involved 215 cases and 38 deaths, emphasizing the
importance of S. suis as an emerging zoonosis [17]. In contrast
to the serotypes infecting pigs, S. suis serotype 2 is the most
common cause of this disease in humans [1]. Serotypes 1, 4,
14, and 16 have caused severe disease in a limited number of
persons [18].
Human S. suis infections are most often reported from coun-
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Figure 1. World map of human Streptococcus suis cases with background pig density data. Published with permission from the Infectious Diseases
Research Foundation (World Atlas of Infectious Diseases Project) [6].
tries where pig-rearing is common (figure 1). The relative high
mean patient age (47–55 years) and almost complete absence
of children in case series, as well as the high male-to-female
patient ratio (3.5:1.0 to 6.5:1.0) (table 1), support the notion
that infection with S. suis is generally an occupational disease
[4, 12, 13, 16, 17, 19]. The annual risk of developing S. suis
meningitis among abattoir workers and pig breeders has been
estimated to be 3.0 cases per 100,000 population; the risk is
lower for butchers, at 1.2 cases per 100,000 population in de-
veloped countries [4]. Such an estimate has not been made for
Southeast Asia, where the pig density is high (figure 1).
In a matched case-control study of risk factors for human
S. suis infection in Sichuan Province, slaughtering (OR, 11.9;
95% CI, 3.4–42.8) and cutting carcasses and processing sick or
dead pigs (OR, 3.0; 95% CI, 1.0–8.8) were important risk fac-
tors for human infection [20]. Farmers often share accom-
modations with pigs, and it is common practice for diseased
animals to be slaughtered at home and consumed [11]. How-
ever, occupational or household exposure to pigs or pork is
not present in all cases of S. suis infection. Case series from
Hong Kong and Vietnam included not only a significant num-
ber of housewives, presumably infected as a result of contact
with (contaminated) pork [12, 16, 21], but also other individ-
uals who were unaware of any exposure to pork. In Vietnam,
pork is the most important meat source, with 198% of house-
holds consuming pork [22]. Vietnamese consumers prefer to
buy fresh pork from wet markets [22]. Because S. suis was
isolated from 6.1% of raw pork meat from 3 of the 6 wet
markets in Hong Kong, it is likely that, besides occupational
exposure, processing or consuming uncooked or partially
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Table 1. Features of Streptococcus suis infection reported from published clinical case series.
Variable
Vietnam
(n p 151)
China
(n p 204)
Thailand
(n p 32)
The Netherlands
(n p 30)
Demographic characteristic
Male sex 117 (77.5) 171 (83.8) 23 (71.9) 26 (86.7)
Age 46.5 years (19–84 years) 54 years (NA) 49 years (1 month
to 75 years)
49 years (26–76 years)
Clinical signs
Duration of illness, days 4 (1–21) NA 4.5 (1–14) 2 (1–5)
Fever 151 (100) 204 (100) NA NA
Headache 142 (94.0) 164 (80.4) NA NA
Vomiting NA 117 (57.4) NA NA
Glasgow Coma Scale 12 (5–15) NA NA NA
Stiff neck 142 (94.0) NA NA NA
Skin findings 9 (6.0) 56 (27.5) 8 (25.0) 5 (16.7)
CSF findings
Total WBC count, cells/mL 2100 (1–64,000) NA 925 (0–21,800) 1500 (50–110,000)
Percentage of neutrophils 84 (1–99) NA 65 (0–99) NA
Total protein level, g/dL 2.06 (0.2–10.19) NA 1.76 (0.75–4.56) 3 (0.8–9.8)
Glucose level, g/dL NA NA 5 (0–67) 27 (1.8–58.5)
Lactate level, mmol/L 11.2 (2–17) NA NA NA
CSF:blood glucose level, % 13.76 (0.7–71) NA NA NA
Blood findings
Total WBC count, cells/mL 16.8 (3.8–57.0) 14.3 (9.4–31.1) 16.4 (5.6–47.3) NA
Platelet count, cells/mL 159 (18–933) NA 224 (22.9–515) NA
Outcome
Duration of hospital admission, days 14 (1–43) 15.1a NA NA
Died in hospital 4 (2.6) 38 (18.6) 2 (6.3) 2 (6.7)
Hearing loss at hospital discharge 93/140 (66.4) NA 22/32 (68.8) 15/28 (54)
NOTE. Data are no. (%) of patients or median value (range). Data for Vietnam are from Mai et al. [16], data for China are from Tang
et al. [33], data for Thailand are from Suankratay et al. [35] , and data for The Netherlands are from Arends et al. [4]. NA, not available.
a Estimated value.
cooked pork products is also a risk factor for infection. Local
delicacies, such as undercooked pig tonsils, intestines, or uterus
and fresh pig blood, may also represent important sources of
infection.
The incubation period of S. suis infection in 1 Chinese out-
break ranged from 3 h to 14 days (median, 2.2 days) [17]. A
very short incubation time is consistent with direct entry of S.
suis into the blood through skin wounds [17]. Other researchers
have reported incubation periods varying from 60 h to 1 week
[4, 16]. Patients have generally been healthy prior to infection
with S. suis, although predisposing factors, such as splenectomy,
diabetes mellitus, alcoholism, malignancy, and structural heart
diseases have been reported [9, 12]. Whether S. suis infection
has a seasonal variation remains unclear. In China and Thai-
land, more patients were admitted during the rainy season,
from June through September, than during the rest of the year
[9, 12, 13]. In northern Vietnam, more cases were reported
during the warmer months, from April through October, than
during the rest of the year (unpublished data). In southern
Vietnam, where there are fewer climatological differences
throughout the year than in northern Vietnam, this distribution
of cases was not as clear [16].
Although asymptomatic carriage is common in healthy pigs,
it is unknown whether human carriage of S. suis is common.
A seroprevalence study in The Netherlands revealed that 6%
of the veterinarians and 1% of the pig farmers had antibody
titers against S. suis serotype 2 antigen [23]. Nasopharyngeal
carriage of S. suis was studied in a group at high risk of infection
(butchers, abattoir workers, and meat-processing employees)
in Germany. The authors reported a carriage rate of 7 (5.3%)
of 132 persons, although none of the 130 control subjects, who
had no contact with pigs or pork, were carriers [24]; these
findings indicate that S. suis carriage does occur in individuals
with prolonged and recurrent exposure to pigs and pork. The
prevalence, duration, and importance of S. suis carriage in hu-
mans are unknown.
CLINICAL FEATURES
S. suis causes a systemic infection in humans that affects several
organ systems; meningitis is the most common clinical man-
ifestation [4, 13, 17]. The presenting features of S. suis men-
ingitis are generally similar to those of other bacterial pyogenic
meningitis and include headache, fever, vomiting, and menin-
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Figure 2. Skin findings in a patient with Streptococcus suis meningitis and septicemia
geal signs. The duration of illness before hospital admission
was 2–5 days [16, 25]. One striking feature is subjective hearing
loss, which may be reported by up to one-half of patients at
presentation or a few days later [9]. Six percent to 31% of
patients also have skin findings, including petechiae, purpura,
and ecchymoses, all of which can be extensive, and hemorrhagic
bullae and skin necrosis (features of purpura fulminans) (figure
2). Gangrene of the fingers and toes may also be seen in a
minority of patients at a later stage in the disease [16]. Less
common manifestations of S. suis infection include acute and
subacute endocarditis [26–28], acute pyogenic arthritis [28],
endophthalmitis and uveitis [5, 9], spondylodiscitis [29], brain
stem ophthalmoplegia [30], and epidural abscess [31]. Of im-
portance, infective endocarditis was reported to be more com-
mon than meningitis in Chiang Mai, Thailand [13].
Meningitis is often accompanied by bacteremia, similar to
Streptococcus pneumoniae and Neisseria meningitidis meningitis
[32]. S. suis infection can be complicated by acute renal failure
requiring renal replacement therapy, acute respiratory distress
syndrome necessitating ventilation, and consumptive coagu-
lopathy [1]. Recent outbreaks of S. suis infection in China have
highlighted the importance and relative high frequency of a
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severe sepsis syndrome—with some features suggestive of toxic
shock syndrome—associated with a high mortality [17, 33].
The investigators observed erythematous blanching rash on the
extremities, including blood spots and petechia, indicative of
possible toxic shock syndrome [33]. However, no streptococcal
superantigen was found on microbial analyses [33, 34]. Further
investigations revealed that a pathogenicity island in the bac-
terial genome may be responsible for the more-severe S. suis
cases that were found in China [34]. The exact role of this
pathogenicity island is poorly understood, and it remains to
be seen whether it has a function in S. suis virulence.
Hearing loss in S. suis meningitis is sensineural, is in the
high frequency range [35], and can be profound; it was 180
dB on audiometric testing of Vietnamese adults [16]. The prog-
nosis for hearing is guarded; some patients improve over time,
and others do not. Among the Vietnamese adults, 93 (66.4%)
of 140 evaluated patients had mild-to-severe hearing loss at
hospital discharge, compared with 41 (47.7%) of 86 patients
evaluated at 6 months after hospital discharge (table 1) [16].
Vestibular dysfunction (e.g., ataxia) has also been described in
association with hearing loss [36].
MICROBIOLOGICAL DIAGNOSIS
S. suis is a gram-positive coccus that is frequently seen in pairs
but can also be single or in short chains (figure 3). Determi-
nation of S. suis to the species level can be performed with
biochemical tests, such as optochin, Voges-Proskauer, salicin,
trehalose, and 6.5% sodium chloride [37]. Commercial systems
(e.g., API Strep; Biomerieux) can also be used. Some com-
mercial biochemical identification systems also report whether
S. suis is biotype I or II. This should not be mistaken for
serotype 1 or 2, as was done in some reports [38, 39]. The 35
S. suis serotypes can be identified by agglutination with a panel
of antiserum samples. Serotyping is performed in reference
laboratories.
Although S. suis can be cultured from CSF or blood samples
with use of standard microbiological techniques, it is often
misidentified, or infection goes undiagnosed [40, 41]. In our
experience and others’ experience, S. suis has been commonly
misidentified and reported as Streptococcus species,a-hemolytic
or viridans streptococci, Enterococcus faecalis, Aerococcus viri-
dans, or even S. pneumoniae [36, 41].
Culture results can be negative as a result of, for example,
antibiotic use prior to the obtainment of specimens. Molecular
techniques with a S. suis serotype 2–specific PCR have improved
the detection of S. suis cases in Asia, with the cps2J gene as a
target [16, 42]. In a case series of 151 patients in Ho Chi Minh
City, Vietnam, 117 were detected to have S. suis infection by
CSF culture, and 149 had S. suis detected by real-time PCR.
Cases in 22 patients would have remained undiagnosed if PCR
was not available. After 1 week of treatment, S. suis DNA could
still be detected by PCR in the majority of the patients’ samples
[16]. The implementation of molecular techniques is not always
feasible in regions where S. suis is highly prevalent. However,
great improvements can be achieved by simple microbiological
capacity building. As a rule of thumb, clinicians and micro-
biology laboratories in regions with pig farming industries
should consider S. suis if optochin-resistant streptococci are
cultured from a CSF sample obtained from a patient with men-
ingitis (figure 3). The identification of a-hemolytic streptococci
other than Pneumococcus species, cultured from a CSF sample,
requires further microbiological investigation, because this may
be S. suis.
The genetic diversity of S. suis serotype 2 strains has been
studied using various typing techniques, including random am-
plification of polymorphic DNA, PFGE, and ribotyping, but
with the exception of the Vietnamese strain collection, the num-
ber of human strains studied to date outside outbreak situa-
tions, has been small (range, 1–27 strains), and limited epi-
demiological data are available [43–47]. Analysis of Vietnamese
strains with use of multilocus sequence typing [48] identified
98% of the strains as sequence type 1 and belonging to clonal
complex 1. The strain that caused an outbreak of infection in
pigs and humans in China in 2005 was sequence type 7 and
also belonged to clonal complex 1 [49]. Although strains of
clonal complex 1 thus appear to be important in human in-
fection, serotype 2 strains of clonal complex 27 were recently
described to cause infections in humans in Thailand [47], which
suggests that the S. suis population infecting humans may vary
by geographical region, similar to and potentially reflecting the
situation in pigs.
VIRULENCE
Little is known about how S. suis invades the host and how it
crosses the blood brain barrier. Inflammation is likely to con-
tribute to the manifestations of disease in pigs and probably
also in humans, as has been summarized elsewhere [10]. A
series of potential virulence factors of S. suis serotype 2 have
been identified, including the capsular polysaccharide, extra-
cellular protein factor, muramidase-released protein, suilysin,
several adhesins, hyaluronate lyase, and surface antigen 1 [50–
58]. With exception of the capsular polysaccharide, none of
these were shown to be essential for virulence in animal models
of infection, and the presence of extracellular protein factor
and muramidase-released protein varied among human isolates
[16, 59]. Two Chinese outbreak isolates were fully sequenced,
and a proposed pathogenicity island was identified that may
have been involved in the particular clinical manifestations ob-
served during the outbreak in 2005 [34]. This pathogenicity
island contains a 2-component regulatory system that may be
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Figure 3. Gram-positive cocci (Streptococcus suis), single or in pairs, visible in direct Gram stain of a CSF sample (original magnification, 100;
top). Growth of S. suis colonies on blood agar with optochin disk (bottom).
involved in virulence [60]. More research is needed to elucidate
virulence in S. suis.
TREATMENT AND OUTCOME
Similar to the protocol for any other patient with suspected
bacterial meningitis, antibiotic treatment should be started
without delay. Data from Vietnam show that S. suis is suscep-
tible to penicillin, ceftriaxone, and vancomycin [16]. Resistance
was seen to tetracyclin (83.2% of isolates; MIC50, 16 mg/mL;
MIC90, 32 mg/mL), erythromycin (20%; MIC50, 0.064 mg/mL;
MIC90, 1256 mg/mL), and cloramphenicol (3.3%) [16]. Peni-
cillin resistance has been reported in a single human case and
in some pig isolates [61, 62]. In 1 European study, the drug
susceptibility of 384 S. suis strains from diseased pigs was as-
sessed. The strains were susceptible to penicillin (MIC90,0.13
mg/mL). Low rates of resistance were observed for gentamicin
(1.3% of isolates; MIC90, 8 mg/mL) and trimethoprim-sulfa-
methoxazole (6.0%; MIC90, 2 mg/mL), and a high rate of re-
sistance was seen for tetracycline (75.1%; MIC90, 64 mg/mL)
[63].
The principles of treatment are the same as those for other
causes of bacterial meningitis. For empirical treatment, cef-
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triaxone with or without vancomycin (depending on the local
epidemiology of bacterial meningitis and drug resistance) is a
good choice until the diagnosis is laboratory confirmed. The
same treatment dose and duration that is used for pneumo-
coccal meningitis is also recommended for S. suis meningitis
(i.e., ceftriaxone [2 g every 12 h for 14 days for adults]). This
has achieved a high cure rate of 97% [16, 64]. Penicillin G (24
million U over 24 h for at least 10 days) has been used suc-
cessfully for the treatment of S. suis meningitis [65]. Clinical
experience with other drugs (e.g., in instances of penicillin
allergy) is limited. Failure to improve during treatment or the
development of a relapse should prompt a reevaluation, in-
cluding a search for an intracranial abscess, a metastatic infec-
tion, a hospital-acquired infection, or the development of drug
resistance. Some patients with S. suis meningitis have experi-
enced relapse after 2 weeks of treatment with penicillin or
ceftriaxone but responded to prolonged treatment (4–6 weeks)
[10]. It must be stressed that the treatment recommendations
may not be successful for all patients and may need to be
tailored. For instance, in case of S. suis infection involving sites
other than the CNS, such as endocarditis, endophthalmitis, or
arthritis, the recommended guidelines should be observed in
terms of duration of treatment, monitoring, and surgical in-
tervention. There are no clinical data on the treatment of pen-
icillin- or ceftriaxone-resistant S. suis infections.
The use of dexamethasone as an adjunctive treatment to
reduce mortality and improve the outcome of bacterial men-
ingitis remains controversial [66]. In a randomized, double-
blind, placebo-controlled clinical trial in Vietnam, dexametha-
sone (0.4 mg/kg twice daily for 4 days) resulted in a significant
reduction in the risk of death at 1 month (relative risk, 0.43;
95% CI, 0.20–0.94) and in the risk of death and disability at
6 months (OR, 0.56; 95% CI, 0.32–0.98) in patients with con-
firmed bacterial meningitis [64]. A significant proportion of
these patients were infected with S. suis [16, 64]. Of importance,
in the group of patients with S. suis meningitis, 20 (37.7%) of
53 patients who were given placebo were deaf in at least 1 ear,
compared with 7 (12.3%) of 57 patients who were given dex-
amethasone ( ) [16, 64]. In a multivariate analysis, se-Pp .003
vere hearing loss was associated with older age (150 years) and
not receiving corticosteroid treatment [16]. Dexamethasone
(0.4 mg/kg twice daily for 4 days) is now given to adult patients
in southern Vietnam who have a short disease onset (!7 days),
cloudy CSF, WBC count 11000 cells/mL (with 160% neutro-
phils), high CSF lactate level (14 mmol/L), and low CSF glucose
level (!50% of blood glucose) or to patients who have a positive
result of at least 1 of the following tests: Gram stain, bacterial
culture, bacterial antigen test, or PCR.
The reported case-fatality rates associated with S. suis men-
ingitis vary and have generally been low in several meningitis
series, compared with rates among patients in the same age
group with meningitis due to S. pneumoniae and other bacterial
agents (e.g., 2.6% in southern Vietnam [16] and 7% in The
Netherlands [4]). An outbreak in China was associated with
an overall case-fatality rate of 18%, but this reached 63% among
patients with septicemia and septic shock [33].
CONCLUSIONS
The majority of the reported human S. suis cases originate from
Southeast Asia, where the disease can be considered endemic.
This finding can be explained by the high density of pigs in
the region, slaughtering practices without preventive measures,
and the consumption of uncooked or lightly cooked pig prod-
ucts. Currently, a human vaccine is not available, but simple
preventive measures, such as wearing gloves during processing
pig meat or slaughtering, hand washing after handling raw pork
meat, and thorough cooking of pork, should prevent the ma-
jority of cases. Travelers should be aware that dietary habits in
some countries may pose a risk for infectious diseases, including
S. suis infection. A case-control study to identify risk factors
for S. suis infection is lacking and is urgently required, because
S. suis meningitis is one of the most common causes of adult
meningitis in China, northern Thailand, and Vietnam.
Mapping of pig density and human S. suis cases clearly sug-
gests where S. suis is likely to be present but, thus far, has not
been reported. Increased awareness of both clinicians and mi-
crobiologists is needed to fully appreciate the importance of S.
suis as a human pathogen.
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